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ABSTRACT 
 
 
Diabetic peripheral neuropathy (DN) is the most common complication in diabetes 
mellitus affecting up to 50% of this population. Foot ulceration in DN is a major health 
problem, often leading to lower-limb amputations and increased mortality rates. A 
combination of gait and microcirculatory alterations increases the risk of foot 
ulcerations in DN subjects. DN is also linked to an increased risk of cardiovascular 
diseases and poor quality of life (QOL). Physical activity (PA) plays an important role 
in the prevention and treatment of diabetes mellitus. Thus, PA has been associated with 
positive changes in glucose control, obesity and blood pressure. However, almost all the 
studies investigating PA interventions in subjects with diabetes mellitus have been 
carried out in individuals without neuropathic complications, whereas the effect of PA 
programmes in DN subjects is still unknown. In addition to that, the vast majority of 
studies have investigated the association between PA and health problems commonly 
linked to type 2 diabetes whereas the relationship between PA and additional problems 
associated with DN (i.e. risk of foot ulceration, sensory neuropathy or QOL) have 
received minimal attention. Therefore, the principal aim of this study was twofold: 1) to 
quantify differences between DN and healthy individuals in the primary pathologies that 
may co-exist in DN, with special attention to gait and microcirculation due to their 
association with foot problems; and 2) to evaluate the overall effect of a PA 
intervention, based on strengthening and foot mobility exercises, in modifying the 
primary pathologies linked to DN. Prior to the main study, a number of reliability 
studies were carried out to determine the reliability of some the methods used in the 
main part of the study. 
 
Preliminary studies 
 
Three reliability studies were carried in the present investigation. One study 
investigated the reliability (within- between-day) of near infrared spectroscopy to 
quantify muscular blood flow and oxygen consumption in the lower limb using a 
venous occlusion method (microcirculation). The other two studies investigated the 
reliability (within-day) of two different approaches to calculate the time differences 
between electromyography data and mechanical output (force) (electromechanical 
delay) during different conditions. Substantial reliability (ICC>0.6) or higher was found 
in all the three studies. Electromechanical delay values for the distal leg muscles were 
significantly higher in DN subjects compared to healthy individuals. 
 
 
Main study 
 
The main study was composed of two parts. Part 1 (cross-sectional study) investigated 
group differences between subjects with DN (N=53) and healthy individuals (N=25) 
whereas part 2 (intervention study) investigated group differences over time between 
two groups of subjects with DN; one participating in a 16 week PA programme (N=21) 
and the other as controls (N=20). Both studies followed the same experimental protocol 
and investigated the same domains (general health, gait, microcirculation and QOL). 
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Cross-sectional study 
 
This study confirmed that DN is a complex condition that affects all the domains 
measured in the present investigation. Thus, the DN group showed significant 
differences (p<0.05) in: 1) traditional cardiovascular risk factors (blood pressure); 2) 
gait (spatial-temporal characteristics, forefoot foot pressures and muscular activity 
patterns); 3) microcirculation (blood flow and oxygen consumption in response to 
exercise stress); and 4) QOL compared to the healthy group. Interestingly, the present 
investigation showed that EMG alterations in DN may be associated with changes in 
plantar foot pressures and consequently with higher risk of foot complications. 
Furthermore, results from the present study showed for the first time impairments in 
exercise-induced microcirculatory responses in subjects with DN compared to healthy 
individuals. These alterations in the microcirculation were observed both in the 
muscular vasodilatory capacity as well as in the ability of the muscle to consume 
oxygen. 
 
Intervention study  
 
This study demonstrated for the first time that 16 weeks of a PA programme based on 
strengthening and foot mobility exercises can influence a number of aspects of health 
that are altered in DN subjects. The most remarkable finding was that the exercise 
programme improved sensory neuropathy (p=0.027) whilst 16 weeks of strength 
training did not produce significant changes in strength levels (p>0.115 at least) in the 
DN subjects. In addition to this results from the present investigation showed that a well 
controlled strengthening training program does have beneficial effects (p<0.05) on the 
microcirculation, obesity, blood pressure as well as on mental health QOL. On the other 
hand, the exercise program did not seem to have a substantial effect on any aspect of 
gait and HbA1c. Importantly, no adverse effects related to the intervention were reported 
in any of the volunteers who participated in the physical activity program.  
 
Conclusions  
 
The present study demonstrated that DN is a condition that affects different aspects of 
health, of which some are modifiable by a well controlled PA programme (i.e. QOL, 
blood pressure and weight loss). Furthermore, the intervention seemed to trigger 
positive adaptations in the microcirculation, in particular in the ability of the muscle to 
recover from a stress condition (exercise stress). However, the most striking finding was 
that the intervention improved sensory neuropathy in individuals with DN. Surprisingly, 
changes in sensory neuropathy did not coincide with changes in muscular strength. This 
suggests that the lack of muscular adaptation to a PA programme may be caused by 
intrinsic changes in the muscle and not necessarily to lack of efferent muscle 
stimulation. In summary, results from the present investigation highlighted 1) the 
importance of PA as a therapeutic tool in subjects with DN to modify outcome 
measures associated with type 2 diabetes as well as sensory neuropathy; 2) the need to 
investigate the effect of PA on DN subjects to challenge the assumption that similar 
adaptations may occur in DN compared to individuals with type 2 diabetes and no 
neuropathic complications.  
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CHAPTER 1  
 
1 Introduction  
 
Diabetes mellitus has been defined as the disease of the 21st century (Zimmet et al., 
2003). In fact the overall burden of diabetes mellitus is immense with a current 
worldwide estimation between 150 million (Goruns et al., 2004) and 170 million (Kahn 
et al., 2006).  In addition to that, it is estimated that there is a further one third to one 
half of this number of undiagnosed cases (International Working Group on the Diabetic 
foot, 1999). Although there are several distinct forms of diabetes, for classification 
purposes they have been divided into two main categories. Type 1, which is 
characterized by a marked reduction in the amount of insulin produced by the beta cells 
of the pancreas, and Type 2, in which peripheral tissue insulin resistance is a common 
feature (Krentz, 2000). Obesity is a very common cause of insulin resistance and a 
major risk factor for the development of Type 2 diabetes. In fact, about 80% of people 
with type 2 diabetes are overweight (Beck-Nielsen & Hother-Nielsen, 2004). Obesity in 
general and increased fatty acid concentrations in particular result in lipid accumulation 
in muscle and liver, which diminishes the availability of the protein glucose transporter 
type 4  (GLUT4) (insulin-responsive glucose transporter) and compromises the glucose 
transport into the muscle (Savage et al., 2007).  However, diabetes is a complex 
metabolic disorder and other mechanisms in which obesity may lead to type 2 diabetes 
have been proposed (Kahn et al., 2006; Kelley & Goodpaster, 2001). In addition to 
obesity, physical inactivity has also been proposed as a key factor in the development of 
type 2 diabetes. Due to the rising rates of obesity and physical inactivity in our society, 
prevalence of type 2 diabetes is expected to double in the next 20 years (Cheng, 2005). 
Type 2 diabetes accounts for between 85 and 95 per cent of all people with diabetes 
(International Working Group on the Diabetic foot, 1999). 
  
Persistently elevated levels of glucose are thought to trigger long term complications of 
diabetes, which typically affect the eyes (retinopathy), kidneys (nephropathy) and 
nerves (neuropathy) (Clark &Anthony, 1995; Nathan, 1993). Diabetic neuropathy is the 
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most common complication among diabetic patients affecting up to 50% of this 
population (Greene et al., 1997; Reiber et al., 1999). It is clear that high glucose leads to 
peripheral nerve injury over time, which can affect somatic sensory and motor nerves, 
as well as autonomic nerves. In fact the prevalence of diabetic neuropathy ranges from 
7% within 1 year of diagnosis to 50% for those with diabetes for >25 years (Pirart, 
1978).  The mechanism by which hyperglycaemia leads to peripheral nerve injury has 
been a matter for debate over the years. Thus, there have been two main view points. On 
the one hand, some investigators have suggested that vascular problems may lead to 
peripheral nerve damage. Since nerve function depends on adequate blood flow and 
blood flow is known to be diminished in patients with diabetes, the vascular hypothesis 
was proposed as a possible mechanism for diabetic neuropathy (Dyck et al., 1986; 
England et al., 1995; Johnson et al., 1986). In line with this idea, therapeutic 
interventions to improve vasodilatation have been shown to increase nerve perfusion in 
diabetic rats (Maxfield et al., 1993) and diabetic subjects (Reja et al., 1993), which have 
led some investigations to conclude that vascular abnormalities are the cause of 
neuropathies (Cameron & Cotter, 1994). On the other hand, some investigators have 
associated neuropathy with metabolic mechanisms related to hyperglycaemia, among 
which the polyol pathway has been stated as being the most important. While, most 
body cells require the action of insulin for glucose to gain entry into the cell, the cells of 
the retina, kidney and nervous tissue (which are the parts of the body commonly 
associated with diabetic complications) are insulin-independent (Tortora & Derrickson, 
2006). Therefore, there is a free interchange of glucose from inside to outside the cell, 
regardless of the action of insulin, in the eye, kidney and neurons. The cells will use 
glucose for energy as normal, and any glucose not used for energy will enter the polyol 
pathway and be converted into sorbitol (Dyck & Thomas, 1999). Activation of the 
polyol pathway is dependent on the enzyme aldose reductase (AR) and there is little 
doubt that this metabolic cascade contributes to the development of neuropathy 
(Yagihashi et al., 2011). However, the detailed mechanism of how the polyol pathway is 
involved in neuropathy remains elusive. In addition to the polyol pathway, other 
hyperglycaemia-dependent metabolic pathways such as advanced glycation end-
products or increased oxidative stress have been also proposed as possible mechanisms 
of the disease (Cameron & Cotter, 1994; Figueroa-Romero et al., 2008). Although 
neuropathy can occur in every organ including the heart (cardiovascular autonomic 
neuropathy), peripheral neuropathy affecting peripheral nerves in a distal-proximal 
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manner is the most common manifestations of the disease (Vinik et al., 2000). For this 
reason type 2 diabetic patients with peripheral neuropathy (DN) were selected for the 
present investigation.  
 
Foot ulceration in patients with DN is a major health problem, often leading to lower-
limb amputations and increased mortality rates (Leung, 2007; Ramsey et al., 1999). 
Among persons diagnosed as having diabetes mellitus, the prevalence of foot ulcers is 
4% to 10% (Garrow et al., 2005; Singh et al., 2005; Ramsey et al., 1999), the annual 
population-based incidence is 1 % to 4% (Lavery et al., 2003a), and the lifetime 
incidence may be as high as 25% (Singh et al., 2005). Unsurprisingly in the presence of 
neuropathy the annual incidence of foot ulceration has demonstrated an approximately 
10 fold increase (McGill et al., 2005). Moreover, Gordois et al. (2003) estimated that 
the annual cost of DN and its complications in the United States was between $5.6 and 
$13.7 billion, which accounts for up to 27% of the direct medical cost of diabetes. 
These figures highlight the enormous impact foot complications have in DN subjects 
and the total economic burden of the condition.  
 
Commonly, ulceration in patients with peripheral neuropathy is triggered by a cascade 
of events. A minor trauma, which in the presence on neuropathy (sensory loss) is 
unattended, is believed to be the starting point. Thereafter, a lack of adequate blood 
supply at this critical phase contributes to the risk of significant infection and hence 
further tissue breakdown and risk of ulceration (Dinh & Veves, 2005). Changes in gait 
characteristics are considered a common mechanism by which tissue damage may occur 
in DN subjects (Cavanagh et al., 1996; Veves et al., 1991); while impairments in the 
microcirculation are thought to play a key role in the wound healing process (Hile & 
Veves, 2003; Tooke & Brash, 1995). 
 
Most of the investigations analyzing gait characteristics in neuropathic patients have 
been interested in kinetic data, which is believed to predict the risk of foot ulceration in 
this population (Boulton et al., 1983; Guldemond et al., 2006). Thus, foot pressures in 
the form of peak plantar pressures (PP) and pressure time integrals (PTI) are considered 
substitute measures to determine risk of foot ulceration in DN subjects (Frykberg et al., 
1998; Stokes et al., 1975; Veves et al., 1992). It is well established that DN subjects 
suffer from excessive foot pressures during walking (Payne et al., 2002; Uccioli et al., 
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2001), especially under the metatarsals heads (Mueller et al., 2005; Salsich et al., 2005), 
which not surprisingly is the foot area with the highest rate of foot complications 
(Boulton, 1994; Mueller et al., 2005). However, kinematic data by itself provide limited 
information about gait characteristics. The study of muscular activity has played a very 
important role over the decades in the understanding of motor control and human 
movement (Perry & Burnfield, 2010; Winter, 2009). However, the study of muscular 
activity in DN subjects is very limited and only recently a few investigations have 
attempted to assess whether neuropathy affects muscular activity patterns (Abboud et 
al., 2000; Kwon et al., 2003). Although the results from these investigations are 
controversial, early evidence indicates alterations in muscular activity patterns between 
healthy and DN subjects. More interestingly some of these changes have been linked to 
alterations in kinetic parameters (Abboud et al., 2000; Kwon et al., 2003). For instance, 
Kwon et al. (2003) found an early activation of the triceps surae in the DN group 
compared to healthy controls, which may likely result in an early contact of the forefoot 
with the ground and consequently higher PTI values under this foot area. These early 
findings highlight the importance of investigating muscular activity patterns alongside 
kinetic data to develop a more comprehensive understanding of walking characteristics 
in individuals with DN. 
 
Microcirculation has been observed to be impaired in diabetic patients under conditions 
of stress (Kingwell et al., 2003; Mohler et al., 2006), which limits the ability of the foot 
of patients with DN to respond to injury and infection in the usual manner (Schramm et 
al., 2006). Vasodilatory abnormalities in DN subjects have been related to the 
dysfunction of the endothelial cells (endothelial dependent vasodilatation) (Pitei et al., 
1997; Arora et al., 1998) and vascular cells of the arterioles (endothelial independent 
vasodilatation) (Pitei et al., 1997; Veves et al., 1998) as well as to impairments of the 
nerve-axon reflex (Vinik et al., 2001). In addition to that, mounting evidence suggests 
that microcirculatory abnormalities are also responsible for the reduced exercise 
capacity observed in diabetic patients (Regensteiner et al., 1998). Several investigations 
have reported diminished exercise-induced vasodilatory responses in subjects with 
diabetes compared to healthy controls (Kingwell et al., 2003; Pichler et al., 2004). It has 
been therefore concluded that impairments in the microcirculation were responsible for 
the reduced exercise capacity observed in diabetic patients (Scheuermann-Freestone et 
al., 2003). However, it is still unclear whether the muscle oxidative capacity in these 
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patients may be also affected, which could also be a limiting factor for the reduced 
exercise capacity in this population (Baldi et al., 2003). It is noteworthy that all the 
evidence presented above was acquired on type 2 diabetic patients without neuropathic 
complications, while the magnitude of the exercise-induced microcirculatory 
impairments in patients with DN is still unknown. 
 
In addition to gait and microcirculatory alterations, which can predispose foot ulcers 
formation in DN subjects, this population carries further health related problems. On the 
one hand, it is well known that type 2 diabetes increases the risk of cardiovascular 
diseases. In fact cardiovascular diseases are listed as the cause of death in approximately 
65% of persons with diabetes (Grundy et al., 1999). On the other hand, increasing 
evidence suggests that diabetes has an impact on everyday living and consequently a 
diminished health related quality of life (QOL) (Price & Harding, 2000). Furthermore, it 
appears that there is a correlation between diabetes and its complications and QOL, with 
subjects with more severe complications showing the poorest QOL (Lloyd et al., 2001). 
Figure 1-1shows an overview of the health problems related to patients with type 2 
diabetes and peripheral neuropathy. 
 
Overall, the evidence presented above demonstrates that DN is a very complex 
condition that affects multiple aspects of health. Thus, pathologies associated with DN 
include:  1) metabolic abnormalities secondary to diabetes mellitus; 2) alterations in 
traditional cardiovascular risk factors; 3) gait alterations which result in increased 
mechanical stress on plantar surface; 4) microcirculation impairments under stress 
conditions and; 5) poor QOL.  
 
A fundamental goal of rehabilitative exercise programs is promotion of health, which 
should be viewed as a multi-factorial construct that includes several components 
(ACSM, 2000). Diabetes in general and diabetic neuropathy in particular is a very 
complex condition, which results in metabolic, biomechanical, physiological as well as 
psycho-social impairments. Therefore it is imperative that researchers investigate 
interventions that may influence these primary pathologies linked to DN patients.  
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Figure 1-1. Overview of the health problems linked to DN 
  
* The continous arrow lines represent a strong correlation between entities; the dashed arrow lines 
represent a weaker correlation between entities (i.e. although diabetes may lead to some changes in gait, 
neuropathy is the main factor explaining gait changes in DN subjects). 
 
 
The Medical Research Council (MRC) framework for design and evaluation of complex 
interventions provides a methodology for designing and evaluating complex 
interventions (Campbell et al., 2000; Craig et al., 2008). Five distinct phases have been 
identified in this framework to ensure the intervention is fully defined, developed and 
evaluated before long term implementation is appropriate (Figure 1-2 represents these 
phases). The preclinical phase deals with exploring the relevant theory to ensure best 
choice of intervention. This phase is followed by the modelling phase, which aims to 
identify the components of the intervention and the underlying mechanisms by which 
the intervention may possibly influence health in the population under investigation. In 
the exploratory phase the information gathered in the previous phase is used to develop 
the optimum intervention and study design. An important characteristic of this 
framework is that progression from one phase to another may not be linear and in many 
cases phases may need to be repeated. For example, at the exploratory phase different 
versions of the intervention may need to be tested or the intervention may have to be 
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adapted to achieve optimal effectiveness. In exercise based interventions various trials 
using different treatment components (i.e. type of exercise, duration, intensity, etc.) may 
need to be tested in this phase of the framework to ensure the definitive trial achieves 
optimal effectiveness. This highlights the importance of the early phases of the 
intervention to successfully develop the definitive randomized controlled trial (Craig et 
al., 2008).   
 
Figure 1-2. Framework proposed by Campbell et al. (2000) for the development and evaluation of 
complex interventions 
 
 
 
For decades, exercise has been considered a cornerstone of a healthy lifestyle both in 
healthy and in type 2 diabetic patients. Physical activity (PA) is well documented to 
reduce glucose levels in patients with type 2 diabetes (Thomas et al., 2006). There is 
also mounting evidence that PA is associated with significantly lower cardiovascular 
risk and overall mortality in type 2 diabetes (Wei et al., 2000). It is generally believed 
that this protective effect of PA against cardiovascular diseases may be partly achieved 
by positive changes in the metabolic syndrome (ACSM, 2000, McArdle et al., 2010). In 
agreement with this idea, interventions on subjects with diabetes using different types of 
PA programmes (aerobic, resistance exercises and a combination of both) have shown 
beneficial changes in blood pressure (Castaneda et al., 2002; Loimaala et al., 2003; 
Yeater et al., 1990) and obesity (Cauza et al., 2005; Ibañez et al., 2005). It is therefore 
becoming clear that PA should be considered a therapeutic tool in patients with diabetes 
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and for this reason regular PA is considered an important component of diabetes 
treatment. 
 
However, all the evidence shown above has been gathered in individuals with diabetes 
without neuropathic complications whereas there is no information about the effect of 
PA programs on glucose control and cardiovascular risk factors in DN subjects. 
Furthermore, findings from subjects with type 2 diabetes cannot automatically be 
generalized to other diabetic groups such as DN. In addition to this, it is generally 
believed that the amount of weight-bearing activity among individuals with DN is likely 
to influence the amount of mechanical trauma accumulated by plantar tissues 
(Cavanagh et al., 1996). This suggests that at least an adaptation of the exercises used is 
going to be necessary to avoid foot complications in this population (Kanade et al., 
2006). It is therefore crucial to evaluate the effect of PA programmes on health related 
outcome measures in subjects with DN. 
 
Since maximising health with its multiple components is the treatment goal of 
rehabilitation programs in a clinical setting, it is important to understand the whole 
range of effects an intervention may  trigger on the recipients (Craig et al., 2008). The 
vast majority of studies assessing the effect of PA in diabetic patients have investigated 
the association between physical activity and health problems commonly linked to type 
2 diabetes (i.e. glycaemic control and cardiovascular risk factors), whereas the 
relationship between PA and the health problems associated with peripheral neuropathy 
(i.e. sensory neuropathy, motor neuropathy, the risk of foot ulcerations or poor QOL) 
have received minimal attention. For instance, as explained previously, gait 
abnormalities together with microcirculatory impairments play an important role in the 
development of foot ulcers in DN patients. Therefore, it is essential to evaluate the 
effect of PA, not only on glucose levels and traditional cardiovascular risk factors but 
also on outcome measures relevant to neuropathy (sensory and motor neuropathy) or 
foot ulcer formation in this population. 
 
 If this is considered within the context of the complex intervention research framework 
proposed by Campbell et al. (2000), studies in the exploratory phase of the framework 
are required at this stage to evaluate the effect of an exercise-based rehabilitation 
program on the multiple pathologies linked to DN. Therefore, the majority of the work 
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presented in this thesis could fit within the definition of an exploratory study. Prior to 
reaching the exploratory trial phase, it was necessary to review the theoretical basis for 
the intervention (preclinical phase) and to understand the possible mechanism by which 
the intervention may influence the outcome measures (modelling phase) (see Figure 
1-2) 
 
In the present investigation the preclinical phase was fulfilled by reviewing relevant 
theory and evidence to develop a comprehensive understanding of the different 
pathologies associated with DN patients. This work is presented in part 1 of the 
literature review.  This information was supplemented by a cross-sectional study (part 1 
of the main study), which aimed to 1) broaden the understanding of the multiple 
pathologies associated with DN and 2) compare the findings in this study to previously 
published investigations. 
 
In the present study the modelling phase was to some extent addressed by reviewing 
empirical evidence on the potential influence of the different components of physical 
activity programmes (type of exercise, duration, intensity, etc.) on the multiple health 
problems associated with DN. Since, there is no published data on the effect of a physical 
activity program on DN subjects, evidence gathered in this phase was on patients with 
type 2 diabetes with no neuropathic complications. This work is presented in part 2 of the 
literature review. Since foot ulceration is a major problem in patients with DN, the 
components of the PA program were selected to optimize its influence on gait 
characteristics and microcirculation in DN subjects. Thereafter, the information gathered 
in the preclinical phase and in the modelling phase was used to develop an intervention 
and study design. Thus, the second part of the main study of the present thesis designed 
and evaluated an exploratory trial to determine the effect of a physical activity program 
on 1) general health (glucose control, sensory neuropathy, cardiovascular risk factors; 2) 
gait; 3) microcirculation and 4) QOL in DN subjects. Table 1-1shows an overview of the 
present study and how it relates to Campbell´s framework. 
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Table 1-1. Adaptation of the framework proposed by Capmbell et al. (2000) for the development 
and evaluation of complex interventions 
Phases Action 
Theory 
Review available information in the health 
problems associated with DN (Part 1 literature 
review). 
 
Cross-sectional study to broaden understanding 
about pathologies linked to DN diabetes and 
compare results with literature. (Part 1 main 
study) 
 
Modelling 
Identify the components of the intervention and 
underlying mechanism they may influence 
outcomes. To some extent this was covered in 
Part 2 of the literature review 
Exploratory trial 
Design and evaluation of a physical activity 
intervention to influence health in DN subjects 
Definitive randomised controlled 
trial 
More exploratory trials are required before 
designing a definitive randomised controlled 
trial 
Long term implementation 
Substantial evidence needs to be gathered 
before this phase can be achieved. 
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CHAPTER 2  
 
2 Literature review 
 
The objective of this literature review chapter is twofold. The first objective is to build 
up a comprehensive understanding of the different health problems associated with DN. 
Part 1 of the literature review provides a critical review of the pathologies associated 
with type 2 diabetes and DN. Figure 1-1 shows an overview of the health problems 
associated with “each condition”. Since this topic is very broad, the main focus of this 
doctoral thesis is on pathologies linked to DN with particular attention to gait and 
microcirculation alterations due to their association with foot ulcers.  The second 
objective of this chapter is to review the current literature on the effect of PA 
interventions on the different pathologies associated with DN. This review is presented 
in part 2 of this literature review chapter. 
 
2.1 Literature search 
 
The structure of the literature search was split into three stages. The first stage of the 
process was to identify relevant articles concerning the primary pathologies associated 
with DN, namely: cardiovascular risk, gait, microcirculation and QOL. The second 
stage was to identify available literature on the effect of PA interventions in these 
identified pathologies.  For both stages of the literature search process a computer 
search of the medical literature was carried out using the databases AMED, MEDILINE 
and EMBASE. Keywords related to the different pathologies associated with DN were 
combined for the search strategy. A list of the keywords used is included in Appendix 1.  
The comprehensive search was limited to publications between 1996 and 2011, due to 
the large number of articles retrieved, and to articles in the English language. Duplicates 
were removed prior to screening the resultant publications for relevance. Animal studies 
were also excluded. A total of 104 and 49 articles from stage 1 and stage 2 of the search, 
respectively, were considered relevant and consequently included in the review. A 
search history is included in Appendix 1. 
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The third stage of the search process was to review the references cited in the 153 
retained publications to broaden the search strategy, regardless of years of publication. 
Animal studies were considered during this stage of the search process when they were 
relevant to the topic and no studies with humans were available. During this stage 62 
further publications were identified, and a total of 215 references retained for critical 
review. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  13 
2.2 PART 1: Health problems in patients with type 2 
diabetes and peripheral neuropathy 
 
DN is a very complex condition that carries pathologies associated with type 2 diabetes 
and pathologies linked to peripheral neuropathy. Part 1 of this chapter will be composed 
of two sections that review each “condition” separately. The following section provides 
a review of the health problems associated with type 2 diabetes.  
 
2.2.1 Health problems linked to type 2 diabetes 
 
It is well established that there is an association between type 2 diabetes and increased 
risk of cardiovascular diseases and mortality (Grundy et al., 1999; Luscher et al., 2003). 
In fact, a large body of epidemiological and pathological data documents that diabetes is 
an independent risk factor for cardiovascular diseases (McCallum & Fisher, 2006; 
Wilson, 1998). Individuals with type 2 diabetes often suffer from other medical 
conditions such as hypertension and dyslipidemia, whose common denominator is 
thought to be insulin resistance (Gray et al., 1998). The common clustering of these risk 
factors in a single individual is known as metabolic syndrome, and it is partly 
responsible for the 4-fold increased risk of cardiovascular diseases in type 2 diabetes 
compared to healthy individuals (McCallum & Fisher, 2006; Stamler et al., 1993). The 
association between hypertension and dyslipidemia and type 2 diabetes is briefly 
described below. 
 
Patients with type 2 diabetes are likely to have dyslipidemia, which is characterized by 
elevated low density lipoprotein (LDL), very low density lipoprotein and triglycerides 
as well as reduced high density lipoprotein (HDL). One of the major mechanisms 
behind the dyslipidemia of insulin resistant states is the increased flux of free fatty acids 
from adipose tissue to the liver. Free fatty acids promote increased triglyceride synthesis 
in the liver, which can lead to the secretion of very-low-density lipoprotein (Rader, 
2007). An elevated concentration of serum LDL and very low density lipoprotein is a 
major risk factor for vascular diseases. In fact, some elevation of LDL cholesterol 
appears to be necessary for the initiation and progression of atherosclerosis (Grundy et 
al., 1999). Thereby, several elevations in LDL lipoproteins can develop atherosclerosis 
and premature vascular diseases in the complete absence of other risk factors (Grundy et 
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al., 1990). Clinical manifestations of atherosclerosis in diabetes include coronary artery 
disease, cerebrovascular disease and peripheral arterial disease (Luscher et al., 2003). 
Thus, diabetes is associated with a 4-fold increase in the risk of developing coronary 
artery disease (Luscher et al., 2003) and peripheral arterial disease (Abbott et al., 1990), 
and with a more than 10-fold increase in the risk of stroke in diabetic patients younger 
than 44 years of age (Rohr et al., 1996). Alongside hyperglycaemia insulin resistance is 
another mechanism that is generally believed to play an important role in atherosclerosis 
formation in diabetic patients. Wollesen et al. (2002) carried out a multivariate study 
with 136 individuals to determine the association between insulin resistance and 
atherosclerosis. They found that insulin resistance independently predicts 
atherosclerosis in type 2 diabetic patients, but not in type 1 diabetes. However, the 
mechanisms underlying insulin resistance and atherosclerosis are still not fully 
understood (Semenkovich, 2006). More detailed information about the pathophysiology 
of atherosclerosis in diabetes can be found in a well presented review paper written by 
Creager & Lusher (2003).  
 
High blood pressure is another cardiovascular risk factor commonly associated with 
diabetes, and largely independent of age and obesity (DeFronzo, 1992). Thus, some 
studies have reported a prevalence of hypertension as high as 60% in persons with type 
2 diabetes (Albright et al., 2000). The Sixth Report of the Joint National Committee on 
Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (1997) 
concluded that diabetes markedly increases cardiovascular disease risk at any stage of 
hypertension. Thus, some reports have estimated a two fold increase in the number of 
cardiovascular events when hypertension and diabetes coexists (Grossman et al., 2000; 
Grundy et al., 1999). Obesity (Narkiewicz, 2006), impairments in endothelial function  
(Tooke & Brash, 1995) and insulin resistance (Grundy et al., 1999) are some 
pathologies linked to type 2 diabetes that are known to result in hypertension. Based on 
population studies, risk estimates indicate that at least two-thirds of prevalence of 
hypertension can be directly attributed to obesity (Krause et al., 1998). The precise 
mechanism linking obesity to hypertension is not fully understood. However, it is 
thought that obesity may lead to hypertension by activating the rennin-angiotensin-
aldosterone system (Engeli & Sharma, 2000) which is a hormone system that regulates 
blood pressure and water balance. It appears that abnormalities in the endothelial 
function may also contribute to hypertension in patients with diabetes (Pitei et al., 
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1997). Diabetes mellitus is known to diminish nitric oxide (NO) availability (Tooke, 
2000), which is the most important vasodilator substance in the microvasculature 
(Tortora & Derrickson, 2006). Impairments in the endothelial function in subjects with 
diabetes will be discussed in more detail in Section 2.2.2.2.1. In addition to that, it 
seems that there is a particular association between insulin resistance and hypertension; 
however the mechanisms are still not fully understood (Grundy et al., 1999). 
 
Overall it is well established that diabetes is a major risk factor for cardiovascular 
morbidity and mortality, partly due to the association between diabetes and traditional 
risk factors such as insulin resistance, hypertension and dyslipidemias (McCallum & 
Fisher, 2006; Stamler et al., 1993). Treatments to minimize cardiovascular risk include 
correction of the metabolic disturbances and modification of related atherosclerotic risk 
factors, such as hypertension, obesity and dyslipidemia (Grundy et al., 1999). Gaede et 
al. (2003) carried out a follow up interventional study (7.8 years) on 80 patients with 
type 2 diabetes to assess the effect of a targeted, intensified, multifactorial 
pharmacological intervention on modifiable risk factors for cardiovascular disease. 
Pharmacological treatment targeted hyperglycaemia, hypertension, dyslipidemia, and 
microalbuminuria. This study demonstrated that a long term intervention which targeted 
multiple risk factors in patients with type 2 diabetes and microalbuminuria reduced the 
risk of cardiovascular events by about 50%.  This highlights the importance of finding 
interventions that may influence these cardiovascular risk factors in patients with type 2 
diabetes. Part 2 of this literature review chapter will review the role of exercise 
programmes in modifying the metabolic syndrome in patients with type 2 diabetes.  
 
Alongside the increased risk of cardiovascular diseases, there is little doubt that type 2 
diabetes also affects microcirculatory function and QOL. However, those problems are 
worsened by neuropathy, and for this reason these issues will be discussed in the next 
section that covers health problems associated with neuropathy.  
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2.2.2 Health problems linked to peripheral neuropathy 
 
Foot ulceration in diabetic patients with peripheral neuropathy is a major health 
problem, often leading to lower-limb amputations and an increased mortality rate 
(Leung, 2007; Ramsey et al., 1999). Peripheral neuropathy is well documented as an 
independent risk factor for foot ulceration and amputation (Boulton et al., 1997; Veves 
et al., 1992). Potter et al. (1998) investigated the incidence of peripheral neuropathy in 
the contralateral limb of 38 diabetic persons with unilateral amputations. Evidence of 
neuropathy in the contralateral limb was found in 97% of diabetic patients at the time of 
the amputation.  McGill et al. (2005) carried out a follow up study on 477 patients with 
diabetes mellitus of which 250 were diagnosed with DN and 222 were not. They found 
that during the follow up period, 34 new ulcers occurred in the neuropathy group and 
three ulcers in the control group, resulting in an annual incidence of 6.3% and 0.5%, 
respectively.  These figures highlight the impact foot complications have in DN 
subjects.  
 
Commonly, ulceration in patients with peripheral neuropathy is triggered by a cascade 
of events. A minor trauma, which in the presence of neuropathy (sensory loss) is 
unattended, is believed to be the starting point. Changes in gait characteristics are 
considered a common mechanism by which tissue damage may occur in diabetic 
patients with peripheral neuropathy. This population shows changes in gait 
characteristics compared to non-neuropathic counterparts (Courtemanche et al., 1996; 
Kwon et al., 2003), which result in higher stress on the plantar surface and, 
consequently, higher risk of tissue damage. Thereafter, a lack of adequate blood supply 
at this critical phase contributes to the risk of significant infection and hence, further 
tissue breakdown and risk of amputation. Microcirculatory impairments are thought to 
play a key role in the diminished blood flow responses under stressful conditions 
(Tooke & Brash, 1995; Veves et al., 1998), which prevent the diabetic neuropathic foot 
to respond to injury and infection in the usual manner. To sum up, it seems clear that a 
combination of gait biomechanics and microcirculatory changes are responsible for the 
increased risk of foot ulcerations observed in subjects with peripheral neuropathy.  
 
In addition to gait and microcirculatory impairments, diabetes in general and 
neuropathic complications in particular have also been associated with diminished 
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QOL. Furthermore, it seems that there is a positive correlation between diabetes and its 
complications and QOL, with subjects with more severe complications showing the 
poorest QOL (Price & Harding, 2000). 
 
This section provides a critical review of the primary pathologies linked to DN with 
particular attention to changes in gait characteristics and microcirculation function, due 
to their association with foot ulcers. Thus, the pathologies associated with DN will be 
review in the following order: Gait biomechanics, microcirculation and QOL.  
 
2.2.2.1 Gait biomechanics  
 
Gait analysis has been used to objectively quantify changes in the biomechanics of 
walking. Given the fact that normal walking is the end product of a healthy neuro-
musculo-skeletal system, the analysis of walking strategy in DN may lead to a better 
understanding of the dysfunctions produced by this condition.  
 
Most of the investigations analyzing gait characteristics in neuropathic patients have 
been interested in kinetic data, which is believed to predict the risk of foot ulceration in 
this population (Boulton et al., 1983; Guldemond et al., 2006). However, kinetic data 
alone provides limited information about gait characteristics. Therefore, gait should be 
investigated alongside other perspectives (i.e. kinematics and muscular activity) to 
develop a more comprehensive understanding of walking patterns in patients with 
diabetic neuropathy. This section will then investigate the differences between healthy 
and DN walking characteristics from different angles (kinematics, kinetics and muscular 
function). In addition to this, attention will also be paid to the factors that may be 
responsible for those differences.  
 
2.2.2.1.1 Gait characteristics: Healthy vs. Neuropathy   
 
Walking is a very complex movement that requires the coordination of the whole body. 
However, this chapter will only investigate lower limb gait biomechanics since it is the 
part of the body in which most of the walking-related complications occur. 
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According to Perry & Burnfield (2010), the gait cycle (GC) consists of two basic 
components: the stance phase, during which the foot is in contact with the floor and the 
swing phase when the foot is in the air for limb advancement. The stance phase can be 
divided into three parts. The first is the contact phase (initial contact and loading 
response). It starts with the initial contact, which is normally made with the heel, and 
continues until the other foot is lifted for swing. The second is the midstance phase. It 
begins as the other foot is lifted and continues until the heel raises the ground. The third 
phase, the propulsion phase, can be further subdivided into two components: terminal 
stance and pre-swing. Terminal stance starts with heel rise and ends when the other foot 
strikes the ground. Pre-swing begins with opposite heel contact and terminates with 
support-side toe-off (Figure 2-1 provides a graphic representation of the GC).  
 
 
Figure 2-1. Phases of the gait cycle (retrieved from Perry and Burnfield, 2010) 
 
 
 
 
Each part of the stance phase is characterized by a rocker action of the foot and ankle 
(Perry & Burnfield, 2010). During the contact phase, the heel (“heel rocker”) serves as 
an axis to allow both smooth plantarflexion and full contact of the foot with the ground. 
Action by the dorsi-flexor muscles is required to reduce the rate of the foot drop and 
direct the tibia forward. The second rocker (midstance phase) is the ankle rocker. The 
pivotal arc of the ankle rocker advances the tibia over the stationary foot. During this 
phase, plantar-flexor muscles play an important role to make the tibia a stable base for 
knee extension and allow tibia advancement.  The third rocker is referred to as the 
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forefoot rocker. During terminal stance, the first metatarsal-phalangeal joint allows 
progression of the limb over the forefoot and accelerates the heel lift. Both 
gastrocnemius and soleus muscles act vigorously to both decelerate the rate of tibial 
advancement and allow the foot to push off (Perry & Burnfield, 2010; van Schie et al., 
2005). 
 
As briefly described above, the normal GC in the sagittal plane starts at the heel (contact 
phase) and terminates at the toes (propulsion phase). In contrast, people with DN are 
characterized by a significant reduction of the motion along the longitudinal axis. There 
is general consensus that subjects with DN tend to approach the floor with the most 
anterior part of the heel and perform their push off phase at the metatarsals level 
(Giacomozzi et al., 2002; Uccioli et al., 2001). The resulting gait, similar to a flat-footed 
gait, is characterized by a minimum heel strike and a minimum push-off phase. 
Giacomozzi et al. (2002) carried out a very interesting study in which the evolution of 
the centre of pressure (COP) during gait was measured in 21 healthy and 19 DN 
patients. The COP records the point of application of the ground reaction force on a 
force platform during the stance phase, and it is plotted as a sequence of points on the 
ground plane. This study supports the idea that there is a reduction of the COP 
progression along the longitudinal axis in DN individuals when compared to the 
healthy. COP progression was calculated as the maximum COP excursions (cm) along 
the longitudinal axis of the foot. In line with these results, some investigations have 
reported reduced contact areas at the heel and toes in DN patients compared to healthy 
counterparts (Veves et al., 1991). These results further support the idea that during gait 
DN subjects show a shift in their loading pattern from the heel and toes towards the 
midfoot and forefoot, respectively. 
 
Apart from the motion in the longitudinal axis, the transverse plane mobility also plays 
a pivotal role in the normal GC (Perry & Burnfield, 2010). Excursions along the medio-
lateral axis of the foot mainly depend on the inversion-eversion movements performed 
by the subtalar joint. In normal gait eversion begins as part of the loading response 
immediately after the heel contacts the floor. Peak eversion is reached by early 
midstance. Subtalar motion then slowly reverses toward inversion throughout terminal 
stance. Peak inversion is attained at the onset of the passive propulsion phase (Perry & 
Burnfield, 2010).  Neuropathic gait is characterized by a significant reduction of the 
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motion along the medio-lateral axis and a concurrent shift of the loading pattern from 
the lateral toward the medial part of the foot (Giacomozzi et al., 2002; Gutierrez et al., 
2001).  
 
In addition to the gait alterations reported above, there is general agreement in the 
literature that neuropathic patients show different spatial-temporal pattern 
characteristics compared with age-matched control subjects. Hence, DN patients use a 
more conservative walking strategy than healthy subjects, which is characterized by 
shorter steps, less time spent in the single support phase and slower walking speed 
(Courtemanche et al., 1996; Kwon, et al., 2003).   
 
Up to date, numerous studies have assessed gait characteristics in diabetic subjects with 
neuropathic complications and it is well established that individuals with diabetic 
neuropathy adopt a more cautious walking strategy than non-neuropathic patients. This 
altered gait is characterized by shorter and slower steps as well as by a significant 
reduction of the motion along the longitudinal and medio-lateral axis. The section below 
discusses the factors that are thought to be responsible for the modified walking strategy 
observed in DN subjects. 
 
2.2.2.1.1.1 Factors for altered walking strategy in neuropathic patients. 
 
Diabetic neuropathy is a very complex condition and there are several factors that may 
be responsible for the differences in walking characteristics described. Although 
neuropathy is considered a key factor in the explanation of gait changes in patients with 
DN, recent studies have reported gait alterations in diabetic patients without neuropathy 
(Petrofsky et al., 2005a; Yavuver, et al., 2006). This suggests that neuropathy may not 
be the only reason for gait deviations in this population. In this section, neuropathic and 
non-neuropathic factors that may influence walking patterns in DN patients will be 
reviewed separately.  
 
Neuropathic factors 
The loss of protective sensation is generally considered the single most important factor 
in order to explain the gait changes observed with neuropathy (Frykberg et al., 1998). It 
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has been hypothesized that sensory feedback plays a role in adjusting step-to-step limb 
trajectories to maintain balance during locomotion (Gandevia & Burke, 1992). The loss 
of this feedback information resulting from DN may then lead to loss of stability in 
these patients during gait. Consequently, this may increase the need for producing a 
more cautious gait in this population. This idea is supported by previous investigations 
that have assessed stability in DN subjects by measuring the distance travelled by the 
COP during different conditions.  It is assumed that stability is negatively related to the 
distance travelled by the COP during a fixed period of time. Therefore, subjects with 
poorer stability are expected to show higher distances and vice versa. Numerous studies 
have reported a high correlation between the severity of DN and COP distance in this 
population (Simoneau et al., 1994; Simmons et al., 1997b), which demonstrates that 
sensory neuropathy may produce instability in this population. Furthermore, the level of 
neuropathy has been also associated with step times (negative correlation), gait velocity 
(negative correlation) and step length (negative correlation) during gait (Yavuzer, et al., 
2006). This suggests that feeling of instability secondary to sensory neuropathy may 
lead to a more cautious gait in DN subjects characterized by slower gait velocity, 
shorter steps and longer contact times.  
 
Eils and colleagues (2002) carried out an interesting study to investigate the role of 
cutaneous sensory information during walking. In this study walking characteristics 
were assessed in 40 healthy subjects (25.3± 3.3 years of age) with no history of sensory 
disorders during normal conditions (control condition) and after reducing foot sensation 
via foot ice immersion (ice condition). The study found that a short-term reduction in 
the afferent information of the sensors located in the foot plantar surface substantially 
influenced walking characteristics by shifting the load from the heel and toes towards 
the midfoot and forefoot, respectively. Data was collected on a pressure distribution 
platform (EMED ST4 platform, Novel) with a good resolution (4 sensors·cm-2), which 
enables accurate determination of different foot areas.  Interestingly, these changes in 
walking characteristics show similarities with the gait characteristics described above 
for DN patients. Loss of sensation produces a feeling of instability, which leads to a 
change in the walking behaviour so that the body mass centre is positioned more 
directly above the foot during the whole GC (Katoulis, et al., 1997). In disagreement 
with Eil’s study, Hohne et al. (2009) found that reduced plantar cutaneous sensation did 
not cause any changes in plantar loading distribution while walking. It should be noted 
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that Hohne et al. (2009) applied intradermal anaesthesia to reduce plantar cutaneous 
sensation contrary to Eil’s study, in which ice immersion was used. Intradermal 
anaesthesia is thought to target only the end-organs of the plantar cutaneous 
mechanoreceptors while the foot and ankle proprioception as well as intrinsic foot 
muscles are unaffected (Meyer et al. 2004). On the other hand, ice immersion is likely 
to affect the intrinsic foot muscles and joint receptors. This methodological difference 
could explain the differences on the results. These conflicting results show that it is still 
not well understood how the effect of insensitive skin, secondary to peripheral sensory 
neuropathy, may influence changes in walking characteristics. However, it is certainly 
likely that postural instability in subjects with DN may be the result of a loss of 
peripheral sensory receptor function in the lower legs and cannot be attributed 
exclusively to loss of plantar cutaneous sensation (van Deursen et al., 1999). 
In support of this idea, several studies have reported that an impairment of the sensory 
or afferent function of the foot diminishes the ability of the foot to perceive movement 
and furthermore may affect the normal foot progression along the GC (Uccioli et al., 
2001; Yavuzer et al., 2006). Van den Bosch et al. (1995) reported that the 
inversion/eversion proprioceptive thresholds in subjects with DN were about five times 
greater than in age matched subjects without peripheral neuropathy. It should be noted 
that a small sample size (7 volunteers in each group) was used in this study. In line with 
these results, Son et al. (2009) carried out a similar study on 11 DN subjects and 11 
matched control and found that inversion/eversion proprioception thresholds were 
greater in the DN group compared to the healthy group. However, the group differences 
reported by Son et al. (2009) were significantly smaller (2 fold differences) than the 
ones reported by van den Bosch (1995) (5 fold differences). Methodological differences 
are likely to explain the diversity of the magnitude of the differences between both 
studies. Son et al. (2009) set up angle rotation constantly at 5 degrees·s-1 while van den 
Bosch et al. (1995) reported maximum values of 18 and 23 degrees·s-1 in inversion and 
eversion, respectively (no information was published about the mean rotation velocity). 
Higher rotation velocity is likely to explain the higher group differences reported by van 
den Bosch et al. (1995) when compared to the results shown by Son et al. (2009).  A 
reduced ability to perceive movement due to afferent impairment increases the 
excursion of the centre of mass over the foot before the movement is perceived by the 
patient, which, in turn, increases the risk of falls in this population (Yavuzer et al., 
2006). In support of this idea, many investigations have reported an increased risk of 
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falls in patients with DN (Dingwell & Cavanagh, 2001; Richardson & Hurvitz, 1995). 
This may partly explain why individuals with DN show a significant reduction of the 
motion along the longitudinal and medio-lateral axis. Overall, it appears that loss of 
stability secondary to DN is an important contributor factor for the gait characteristics 
described above.  
 
Afferent impairments in isolation would appear to be enough to explain the changes in 
walking strategy observed in neuropathic patients. However, while some peripheral 
nerves have a purely sensory or afferent function, most are mixed and carry both 
sensory and motor fibres (Gutierrez et al., 2001). An efferent/motor deficit, which is 
identified by muscle weakness and is well established in DN subjects (Andersen et al., 
1997; Andersen et al., 1998; van Schie et al., 2004), could further explain the previously 
described neuropathic walking strategy.  
 
At the ankle joint, at least three major muscles contribute substantially to joint moments 
during gait. The tibialis anterior muscle (TA) contributes to ankle dorsi-flexion, while 
the soleus and gastrocnemius muscles, which form the triceps surae (TS), work as 
plantar-flexors (Perry & Burnfield, 2010). On the one hand, TA plays a very important 
role during the early contact phase of the GC to enable normal heel strike. Weakness of 
the TA may result in a reduced dorsi-flexion angle during heel strike, which provokes 
the foot to contact the floor with the most anterior part of the heel (Giacomozzi et al., 
2002). This may partly explain why during gait DN subjects show a shift in their 
loading pattern from the heel to the midfoot. On the other hand, TS is responsible for 
driving the body forward by generating plantar-flexor moment during to the late stance 
phase (Perry & Burnfield, 2010). Weakness of the TS may require compensation of 
proximal hip musculature to push the legs forward. In line with this idea, DN have been 
shown to rely more on the hip flexor muscles and less on the plantar-flexor muscles 
during the push off phase of the GC, compared to healthy individuals (Giacomozzi et 
al., 2002; Mueller et al., 1994). This compensatory mechanism characterized by a shift 
from the distal (ankle muscles) to the proximal musculature (hip muscles) is known as 
hip strategy. Hip strategy is also well known to be highly effective to stabilize body 
posture during weight bearing (Horak & Nashner, 1986) by reducing the displacement 
of the centre of mass along the sagittal and frontal planes (Runge et al., 1999). This 
suggests that the shift from an ankle to a hip strategy is also responsible for the limited 
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excursions of the centre of pressure of the foot observed in DN subjects. Thus, hip 
strategy in DN individuals may be a mechanism not only to compensate for the plantar-
flexor weakness but also to improve stability during weight bearing conditions.  
 
Both sensory neuropathy and motor neuropathy are well known to be responsible for the 
modifications in gait characteristics observed in DN subjects. On the one hand, a 
general loss of peripheral sensory receptor function in the lower legs appears to be 
responsible for the feeling of postural instability observed in DN individuals. 
Furthermore, feeling of instability has been associated with a more cautious gait 
walking strategy. On the other hand, weakness of the distal musculature appears to 
result in compensation of proximal hip musculature, especially during the push off to 
drive the body forward. Furthermore hip strategy is believed to reduce the displacement 
of the centre of mass along the longitudinal and medio-lateral axis.   
 
Non-neuropathic factors: Hyperglycaemia 
Besides well known dramatic alterations in all components of the peripheral nerves, 
diabetes mellitus has a spectrum of hyperglycaemic complications including the 
mechanical characteristics of bones and soft tissues, which may further alter gait 
characteristics in this population (Duffin et al., 2002; Gefen et al., 2003). Abnormally 
high sugar levels promote glycosylation of proteins and the consequent accumulation of 
advanced glycosylation end-products in most human tissues (Rahman et al., 2006; 
Yavuzer et al., 2006). It is well established that glycosylation plays an important role in 
the limited range of motion (ROM) of the foot and ankle joints in patients with 
(Frykberg et al., 1998; Simmons et al., 1997a; Yavuzer et al., 2006; Zimny et al., 2004)  
and without diabetic neuropathy (D´Ambrogi et al., 2003; Duffin et al., 2002). 
Normal joint mobility in the articulations of the foot is necessary to allow for normal 
foot function. Articular mobility of tibiotalar and metatarsophalangeal joints in the 
sagittal plane permits normal initial contact and push-off during the gait cycle, 
respectively (Perry & Burnfield, 2010; van Schie et al., 2005). In addition, an adequate 
range of motion in the subtalar joint is necessary to allow the excursion of the foot 
along the medio-lateral axis (Perry & Burnfield, 2010; van Schie et al., 2005). 
Therefore, reduction of ankle ROM, secondary to hyperglycaemia, may partly explain 
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the reduction of the COP progression along the anterior-posterior and the medio-lateral 
axis in diabetic individuals (with and without neuropathic complications) when 
compared to healthy counterparts (Giacomozzi et al., 2002; Gutierrez et al., 2001).  
 
The plantar aponeurosis (plantar fascia) is rich in collagen (Gefen, 2003) and can 
therefore be susceptible to non-enzymatic glycation of the collagenous component 
(Duffin et al., 2002). In agreement with this suggestion, some studies have observed a 
significantly higher plantar aponeurosis thickness in non-neuropathic diabetic subjects 
when compared with non-diabetic individuals (D´Ambrogi et al., 2003; D´Ambrogi et 
al., 2005; Giacomozzi et al., 2005). This is further supported by Duffin et al. (2002), 
who found that plantar aponeurosis was significantly thickened in 216 young diabetic 
individuals (15.6 years of age) as compared with a non-diabetic age-matched control 
group. This study confirms that structural changes appear soon after the onset of 
diabetes regardless of whether neuropathic complications are present or not. It is 
believed that the thickening of the plantar fascia may provoke the development of a 
rigid foot, fixed in a cavus configuration, with a high longitudinal arch for the entire 
stance period (D´Ambrogi et al., 2005). Thus, the foot is less adaptable to the floor 
during the foot-floor interaction. As a result, most of the plantar surface makes early 
contact with the ground, and propulsion is poorly effective. Therefore, it is likely that 
structural changes in the plantar fascia may be partly responsible for the reduced foot 
motion along the longitudinal axis observed in diabetic patients with and without 
neuropathy (D´Ambrogi et al., 2003; Giacomozzi et al., 2005).  
 
Overall, neuropathy, both sensory and motor neuropathy, is considered the main factor 
in the explanation of gait changes in DN subjects. However, recent studies show that 
gait changes in patients with diabetes are present even in the absence of neuropathic 
complications. Glycosylation changes secondary to hyperglycaemia have been linked to 
reduced joint mobility and/or structural changes in diabetic patients. Mounting evidence 
suggests that these changes may also contribute to gait alterations in diabetic subjects 
even without peripheral neuropathy. Nevertheless, differences in walking characteristics 
by themselves cannot explain the high rate of ulcers observed in diabetic neuropathic 
patients. Next, other variables that may better predict ulceration among those patients 
will be discussed. 
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2.2.2.1.2 Gait analysis: Kinetic perspective   
 
During weight-bearing activities such as standing and walking, the plantar surface of the 
foot is exposed to ground reaction forces (GRFs), leading to tissue deformation (van 
Deursen, 2004). The relationship between force and deformation is expressed as the 
stress-strain relationship. Stress, commonly known as pressure, is equal to normalized 
force (force per unit to which the force is applied) (Hall, 1995; Nigg & Herzog, 1999). 
When standing the magnitude of the GRF is equal to body weight, with each foot 
experiencing about 50% of body weight distributed over the plantar surface area, which 
is predominantly a vertically directed force. During walking, the stresses applied to the 
feet (pressures) are much higher than when standing for a number of reasons. First, 
weight is supported by only one foot for a substantial amount of time. Second, the 
stance phase of gait is characterized by a rollover of the foot. As a result, the plantar 
surface area changes in size and location while the GRFs progress from the heel to 
hallux. Third, the GRFs vary in magnitude, with a peak during heel landing and a 
second peak during push-off with the forefoot (van Deursen, 2004). It is noteworthy that 
in order to represent GRFs as vectors, they must be considered to act at a point that is 
known as COP (COP has been mentioned earlier to describe gait characteristics in DN 
subjects). Besides the double-hump pattern of the vertical force, there are also GRFs in 
the horizontal direction (shear forces) causing stress parallel to the foot skin. However, 
the magnitude of the shear forces is much smaller than the vertical GRF (van Deursen, 
2004).  
 
Beside neuropathy, which is well documented as being related to skin breakdown due to 
the lack of protective sensation, foot plantar pressure (PP) is known to be an important 
contributing factor to plantar tissue damage in people with diabetes and peripheral 
neuropathy (Frykberg et al., 1998; Van Schie., 2005). Thus, PP, which accounts for the 
highest stress generated under the foot plantar surface during stance phase of gait, is 
well known to be higher in DN subjects and has been associated for decades with foot 
ulcerations in this population (Guldemond et al., 2006; Stokes et al., 1975; Uccioli et 
al., 2001). However, there is an ongoing debate whether other kinetic variables may also 
predict foot complications in this population. Thus, PTI, calculated as the area under the 
peak pressure curve, has been postulated to be a better predictor for foot ulceration 
compared to PP since it represents both, the magnitude and duration of plantar loading 
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through stance phase (Mueller & Maluf, 2002). Thus, recent investigations have found 
higher PTI values in DN subjects compared to healthy or diabetic individuals with no 
neuropathic complications (D’Ambrogi et al., 2005; Sacco et al. 2009). The next two 
sections will investigate these two parameters (PP and PTI) in individuals with 
peripheral neuropathy as well as the factors responsible for those alterations.  
 
2.2.2.1.2.1 Peak plantar pressures 
 
Peak plantar pressures have been extensively investigated in the literature as a substitute 
measure to determine risk of foot ulceration (Frykberg et al., 1998; Veves et al., 1992). 
Stokes et al. (1975) was the first to notice that foot ulcers in neuropathic patients tended 
to develop at the sites of the highest load (i.e. metatarsal heads and toes). Since then, 
many other authors have described “high plantar pressures” in the diabetic neuropathic 
foot and their relationship with ulcer development (Guldemond et al., 2006; Payne et 
al., 2002; Uccioli et al., 2001). Veves et al. (1992) carried out a follow up study on 86 
diabetic patients in which 17% developed ulcers over a mean period of 30 months. Of 
these 17%, 93% had neuropathy at baseline, and all had abnormally high foot pressures 
measured by pedobarography. Similar findings were reported by Lavery et al. (2003b) 
who carried out a follow up study over 24 months on 1666 individuals and found that 
PP was significantly higher in patients who developed ulcers during the follow up 
period than in patients who did not develop ulcers. However, none of these prospective 
studies provided a measure of association between foot pressures and ulceration risk. 
Frykberg and colleagues (1998) reported in a study with 251 subjects, that diabetic 
patients with foot pressures >588.6 kPa as measured with the F-scan mat system, were 
twice more likely to develop ulcers than those without high pressures, even after 
adjustment for age, sex, diabetes duration and race. This investigation attempted to 
determine a threshold point, above which the neuropathic foot is at increased risk. 
However, results should be taken with caution. This cross-sectional study assessed the 
relationship between high foot pressures and diabetic foot ulceration retrospectively, in 
a group of diabetic patients with a range of foot complications (diabetes, neuropathy, 
previous ulcer and active ulcer). Kanade et al. (2006) showed differences in PP values 
among neuropathic patients with different foot complications. She reported significantly 
higher peak pressure values in a group of 23 neuropathic patients with current foot ulcer 
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compared to a group of 23 neuropathic patients with no history of foot ulcer. This 
finding suggests that the measure of association between foot pressure and ulceration 
risk used by Frykberg could have been overestimated since the presence of ulcer may 
have been related to higher foot pressures. In addition to that, it should be noted that 
different plantar pressure measurement devices are not always directly comparable, and 
therefore, a universal threshold set for ulceration cannot be established.  Pressure 
measurement devices consist of a number of force sensor elements and the variation in 
the size of these elements has major consequences for the calculation of pressure. Thus, 
a focal area of pressure under the foot will appear to have a lower value on a device 
with a larger element size (Nigg & Herzog, 1999; van Schie, 2005).  
 
At this time, it is well established that subjects with peripheral neuropathy suffer from 
excessive foot pressures during walking (Payne et al., 2002; Uccioli et al., 2001), 
especially at the metatarsals (Mueller et al., 2005; Salsich et al., 2005) and that 
excessive pressures on the surface on the insensitive skin lead to tissue damage and 
ulcers (Lavery et al., 2003b). Current investigations are focused on the understanding of 
the different factors that modify peak foot pressure distribution in subjects with diabetes 
neuropathy. The factors that are widely accepted to potentially disrupt foot loading 
during gait will be discussed next. 
 
Limited ROM in the ankle and first metatarsophalangeal joints has important 
implications in the mechanical loading of the foot and has been found to increase peak 
plantar pressures (Fernando et al., 1991; Frykberg et al., 1998; Zimny et al., 2004) as 
well as the risk of ulceration (Fernando, et al., 1991) in diabetic patients. Limited dorsi-
flexion of the ankle has been associated with abnormal foot pressure distributions 
during gait in different ways; 1) it may lead to an earlier heel rise in the gait cycle and 
an earlier loading of the forefoot (van Deursen, 2004), and; 2) it may increase the 
pressure under the forefoot, particularly when the tibia rolls over the foot during the late 
stance phase of gait (Mueller et al., 1989; Salsich et al., 2005). Some investigations 
have also associated reduced mobility at the subtalar joint with increased foot pressures 
during the first phase of the stance phase (from heel strike to midstance phase) 
(Fernando, et al., 1991). It is believed that the subtalar joint plays an important role 
preventing excessive strain at the ankle as the limb is loaded (Perry & Burnfield, 2010). 
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The elevated plantar foot pressure in neuropathic patients has also been associated with 
structural changes secondary to this condition such as toe deformities and plantar fat-
pad displacement (Mueller et al., 2005; Rahman et al., 2006).  Atrophy of the ankle 
muscles as a result of motor neuropathy, has been suggested to produce an imbalance 
between flexors and extensor of the toes. This may lead to the development of hammer 
toes, claw toes and prominent metatarsal heads, making the metatarsals more likely to 
undergo higher pressure in neuropathic subjects (Mueller et al., 2005; Rahman et al., 
2006; Robertson et al., 2002; van Schie et al., 2004). Since the toes no longer contribute 
to the support area the same amount of force will be transmitted to a smaller area, which 
obviously increases foot pressures on the metatarsal region. In clawing and hammering 
of the toes, the plantar fat pads under the metatarsal heads are believed to migrate 
distally as a result of hypertension of the metatarsal-phalangeal joint, exposing the now 
prominent and unprotected metatarsal heads to elevated levels of mechanical pressure 
during gait (Bus et al., 2002; Bus et al., 2004). Beside the structural changes associated 
to muscle atrophy, the thickening of the plantar fascia (discussed above) may provoke 
the development of a rigid foot, fixed in a cavus configuration, with a high longitudinal 
arch for the entire stance period (D´Ambrogi et al., 2003; D´Ambrogi et al., 2005; 
Giacomozzi et al., 2005). This foot configuration has been associated to higher foot 
pressures at the heel during the heel strike (Morag & Cavanagh, 1999) as well as higher 
stress on the forefoot underneath the metatarsal heads (Cavanagh et al., 1997; 
D´Ambrogi et al., 2003). Nevertheless, the most devastating structural changes in 
patients with neuropathic complications occur when suffering from Charcot foot 
(Mabilleau & Edmonds., 2010). Charcot foot is a condition that causes significant 
disruption of the bony architecture of the foot. Although the pathogenesis of this 
condition is not fully understood, it is generally believed that minor trauma may trigger 
a cascade of events, including inflammation, which may result in progressive osteolysis 
(resorption of bone matrix by osteoclasts) (Mabilleau & Edmonds., 2010). Due to 
excessive resorption of bone matrix the bones of the foot become soft and weak, which 
can lead to multiple fractures, joint disruptions and joint dislocation. It often results in 
foot deformities and causes abnormal pressure distribution on the plantar surface, which 
predispose the foot to ulcer formation. Armstrong & Lawrence (1998) proved that 
neuropathic patients with Charcot foot (N=21) had significantly higher foot pressures 
(1000± 80.5 kPa) than subjects with neuropathy and no Charcot foot (N=21) (650± 256 
kPa).  
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In addition to the factors described above, it has been pointed out that reduction in 
plantar sensory input may be related to increased impact of the foot on the ground. As 
the foot has an impaired ability to sense the ground when landing, this may increase 
pressures under the foot (Payne et al., 2002). This interpretation has been supported by 
some studies that addressed a positive relationship between levels of neuropathy and 
plantar pressure (Boulton et al., 1987; Frykberg et al., 1998; Lavery et al., 2003b).  
Payne et al. (2002) carried out an interesting study on 50 subjects with diabetes mellitus 
to determine, by the use of regression analysis, the factors that may be associated with 
high peak plantar pressures during walking in different regions in the diabetic foot. A 
number of factors, identified as potentially increasing foot pressures, were included in 
the multivariate analysis. Thus, body weight, limited joint mobility, plantar fat pad 
thickness, muscle strength, motor and sensory neuropathy, foot structure, and foot 
deformity, were investigated. They found that sensory neuropathy was the single most 
important factor to explain plantar foot pressures in different regions of the foot (heel, 
forefoot and hallux). They also reported that the range of motion of the first 
metatarsophalangeal joint was related to hallux pressures while body weight was 
associated to pressures under the heel. Unexpectedly, structural changes in the foot and 
limited joint mobility were not significantly correlated to plantar pressures under the 
metatarsal heads. This finding contradicts the widely published belief that structural 
changes are important factors in the high foot pressures observed in subjects with DN 
(Fernando et al., 1991; Frykberg et al., 1998; Salsich et al., 2005). This result could be 
due to the high correlation that would be expected to exist between limited joint 
mobility and structural changes and neuropathy. It is likely that both structural changes 
(including limited ROM) and neuropathy are both secondary to a longer duration of 
diabetes, rather than each one having a causal relationship with the other (Gefen et al., 
2003).  
 
It should be also noted that, for Payne’s study, an in-shoe pressure measuring system 
was employed, contrary to investigations that have determined foot pressures during 
bare foot walking over a pressure platform (Boulton et al., 1987; Fernando et al., 1991; 
Uccioli et al., 2001). Footwear has been shown to significantly reduce plantar pressure 
in both diabetic and control groups with a greater reduction in the diabetic group 
(Sarnow et at., 1994). Healthy subjects with intact protective sensation are likely to 
adopt a safer walking style to avoid excessive foot pressures during barefoot tasks. On 
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the other hand diabetic patients with impaired sensation are not aware of excessive 
pressure and gait is not readjusted. In support of this idea, as mentioned earlier, the level 
of neuropathy has been positively correlated to foot pressure (Frykberg et al., 1998; 
Lavery et al., 2003b). This could have affected the range of variables that explained the 
variability of plantar pressures in the study carried out by Payne et al. (2002).  
 
Overall, it is well established that peak plantar pressures are associated with foot ulcers 
in patients with DN.  Multiple factors account for the higher foot pressures observed in 
DN subjects including loss of sensation, limited joint mobility, structural changes and 
foot deformities. Neuropathy appears to be the single most important factor to explain 
plantar foot pressures in different regions of the foot in this population. However, 
structural changes secondary to hyperglycaemia are also considered to play an 
important role in the high peak pressures observed in DN subjects.  
 
2.2.2.1.2.2 Pressure-time Integral 
 
PTI is a relatively recently used parameter, which has not been widely investigated in 
DN subjects. However, all the investigations up to date point in the same direction 
demonstrating differences in regional PTI values between neuropathic and healthy 
individuals (D’Ambrogi et al., 2005; Rao et al., 2010; Sacco et al., 2009). 
 
D´Ambrogi et al. (2005) investigated the PTI of the vertical GRFs under the heel, 
metatarsal heads and hallux, both during the landing (0-27% of stance) and propulsion 
(66-100% of stance) phases of the GC on 21 healthy and 19 DN patients. They found 
that neuropathic patients compared to healthy controls had; 1) lower heel integrals and 
higher metatarsal integrals during landing, which is typical of a flat landing; and 2) 
higher heel and metatarsal integrals and lower hallux integrals during propulsion, which 
again is typical of a flat walking (hip strategy). As a result neuropathic patients 
experienced an earlier and more prolonged loading of the metatarsal heads. Similar 
results were obtained by Sacco et al. (2009), who found higher PTI values during the 
push off at the heel and forefoot areas in the DN group compared to the control group. It 
should be noted that Sacco et al. (2009) failed to find group differences in PTI values 
both at the heel and forefoot during the landing phase, which disagrees with the results 
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presented by D’Ambrogi et al. (2005) and described above. The fact that the stance 
phase in both studies was calculated differently may explain those differences. 
D’Ambrogi et al. (2005) defined landing as the time period from 0 to 27% of the stance 
phase, whereas Sacco et al. (2009) calculated this period as the time period from heel 
strike (0% of the stance phase) to the instant of the minimum vertical force between the 
two vertical peaks (approx 50% of the stance phase). It is likely that differences in PTI 
values during the landing phase between DN and healthy individuals only occur during 
the first phase of the stance phase, which could explain why Sacco et al. (2009) who 
accounted for a longer period of time did not find any group differences. In addition to 
this, Rao et al. (2010) investigated PTI values at the heel and forefoot during the whole 
GC on 15 DN and 15 control subjects and found higher PTI values in the DN group 
both at the heel and forefoot when compared to the control group.  
 
These results prove that not only the magnitude of the stress (pressure) is altered in DN 
subjects but also the amount of time stress is applied to the different foot regions. In 
addition to this, the forefoot seems the foot region with higher PTI differences between 
DN and healthy individuals, which coincides with the foot region in which more ulcers 
occur in this population (Boulton, 1994; Mueller et al., 2005). This suggests that PTI 
may be associated with foot complications in this population. Next, possible factors that 
may account of the higher PTI observed in DN subjects will be postulated. 
 
Foot mobility during walking has been identified as an important contributor to plantar 
loads, especially in individuals with diabetic neuropathy (Fernando et al., 1991, Zimny 
et al., 2004). Thus, a few recent investigations have studied the relationship between 
reduced mobility of the foot-ankle complex and increased sustained plantar loads. 
Turner et al. (2007), in agreement with previous studies (Frykberg et al., 1998; 
Simmons et al., 1997a), found reduced ROM (subtalar joint and 1st 
metatarsalsophalangeal joint) in a group of 78 diabetic patients (with a range of diabetic 
complications) compared to healthy subjects. However those differences were only 
significant during passive movements while ROM values during gait, which was 
measured using a 3D electromagnetic tracking system, did not differ between groups. In 
addition to that, they found no statistical correlation between any of the gait-derived 
ROM variables and PTI over the whole foot. A more recent study carried out by Rao et 
al. (2010) went a step further and investigated the relationship between segmental foot 
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mobility (first metatarsal relative to the calcaneus, lateral forefoot relative to the 
calcaneus and calcaneus relative to the tibia), measured with a 3D infrared system, and 
regional PTI (heel and forefoot) (studied presented earlier). They found that frontal 
plane excursion of the calcaneus was negatively associated with PTI values at the 
forefoot and heel and that first metatarsal sagittal plane excursion during gait was 
negatively associated with PTI values under the forefoot. These findings support the 
theory that subtalar joint mobility plays a key role in mediating plantar load distribution 
(Perry & Burnfield, 2010), particularly in individuals with diabetes. The relationship 
between first metatarsal sagittal plane excursion and PTI values under the forefoot could 
be explained by the association between increased plantar fascia thickness and reduced 
mobility at the 1st metatarsalphalangeal joint (D’Ambrogi et al., 2002). Thickening of 
the plantar fascia may provoke the development of a rigid foot, fixed in a cavus 
configuration, with a high longitudinal arch for the stance period (D’Ambrogi et al., 
2002; Giacomozzi et al., 2005), which may explain prolonged forefoot contact time and 
consequently increase PTI forefoot values in DN patients. Overall, this study highlights 
the importance of segmental foot mobility in individuals with DN. However, more 
investigations in this direction are needed to understand better those associations. 
 
Turner et al. (2007) also compared PTI values between diabetic patients with and 
without neuropathy and they found higher PTI values in the neuropathic group (N=28) 
compared to the non-neuropathic group (N=25). This result suggests that neuropathy 
may also influence sustained plantar loads during gait. Sensory neuropathy is known to 
cause postural instability in DN subjects (van Deursen & Simoneau, 1999), which leads 
to walking alterations to increase stability during the gait cycle. Gait in DN individuals 
is characterized by a longer period of time during the stance phase especially at the heel 
and the metatarsals (Courtemanche et al., 1996; Giacomozzi et al., 2002; Sacco & 
Amadio, 2000; Zimny et al., 2004). Higher contact times (longer duration of the stress) 
at those sites may increase PTI values at the heel and forefoot, which agrees with the 
data presented above (D’Ambrogi et al., 2005; Sacco et al., 2009; Rao et al., 2010). 
However, it should not be neglected that another well known characteristic of the way 
DN subjects walk is that they tend to demonstrate an increase in flat foot contact time 
(larger contact area) (Courtemanche et al., 1996), which should decrease the magnitude 
of the stress (pressures) on the plantar surface. D’Ambrogi et al. (2005) and Rao et al. 
(2010) found that PTI at the heel during the push off phase was increased in DN 
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subjects compared to healthy individuals. Heel involvement during the push off can 
theoretically be associated with less stress on the forefoot during this phase of the gait 
cycle. However, PTI at the forefoot during the push off continued to be higher in the 
DN group compared to the control group. This highlights the role of factors intrinsic to 
the foot, such as segmental foot mobility and/or foot deformities, in contributing to PTI 
values in patients with DN.  
 
Beside sensory neuropathy, motor neuropathy has also been proposed to influence PTI 
during gait. Muscle weakness is well known to play a crucial role in altering the foot 
rollover process in DN patients (Giacomozzi et al., 2005; van Schie, 2005), which, in 
turn, may modify load distribution over the plantar surface. Weakness of the TA has 
been proposed to reduce ankle flexion prior the heel contacts the ground, which may 
lead to premature contact of the forefoot to the ground during the first phase of stance. 
This earlier contact of the forefoot to the ground in the first phase of stance adds loads 
on the anterior areas of the foot that will be loaded at late stance phase during the 
propulsion phase. The consequence will be an accumulation of loads on the anterior 
regions of the foot (forefoot) during the whole stance phase and higher PTI values on 
this foot region.   
 
 
It is well established that subjects with DN show alterations in the foot loading patterns 
during gait, and that increased peak pressures and PTI are undoubtedly associated with 
foot complications in this population. Although the exact mechanisms underlying these 
changes are not well understood, there is little doubt that loss of sensation, weakness of 
the distal musculature, limited ROM and structural changes secondary to 
hyperglycaemia are all contributing factors. Most of the studies assessing gait 
characteristics in diabetic patients have investigated kinetic or kinematic data, whereas 
the underlying functional factors that may be driving these changes are not well 
understood. Thus, the assessment of muscle activities in the lower limb may be useful 
for interpreting and clarifying those kinetic and kinematics changes as well as for 
gaining additional insights into the relative influence of biomechanical and neural 
factors on neuropathic patient’s gait. The next section will attempt to summarize the 
current understanding about this issue.  
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2.2.2.1.3 Gait analysis: muscular activity perspective 
 
Electromyography (EMG) is a widely used technique for recording the electrical signal 
associated with the contraction of a skeletal muscle (Winter, 2009). EMG can be used to 
measure the timing and relative intensity of muscular function during different 
conditions and therefore has played a crucial role in the understanding of human 
movement over the last decades (Perry & Burnfield, 2010; Winter, 2009). It should be 
noted that EMG signal refers to the electrical event produced by the muscle and not to 
the mechanical output (force). The time lag between muscle activation and muscle force 
production is known as electromechanical delay (EMD) (Cavanagh & Komi, 1979) and 
it should be taken into consideration when attempting to associate EMG signal and 
muscle function. Otherwise the prediction of segmental movement from EMG data 
could be mistimed and could lead to misinterpretation.  
 
Although EMG data has provided valuable information about gait biomechanics over 
the years in healthy as well as in clinical populations (Perry & Burnfield, 2010), the 
study of EMG data during gait in DN patients is very limited. To the best of my 
knowledge only 4 investigations have studied this issue (Abboud et al., 2000; Akashi et 
al., 2008; Kwon et al., 2003; Sacco & Amadio, 2003) and the findings reported by the 
different studies are not in agreement. It should be noted that none of these 
investigations took into account EMD when processing EMG data, which as mentioned 
above could compromise the estimation of segment movements from EMG data.  Next, 
results from previous investigations that have assessed muscular activity patterns in DN 
subjects will be presented. Special attention will be given to the association between 
EMG data and both spatial-temporal characteristics and foot loading patterns.  
Gait changes in DN subjects, characterized by slower velocity and shorter steps, are 
thought to be a mechanism to improve motor control and reduce instability during gait 
in this population (Yavuzer et al., 2006). EMG alterations in DN subjects appear to 
support this hypothesis. It has been postulated that co-contraction is the result of poor 
motor control and that it may contribute to stiffen the joint and enhance stability during 
the stance phase of the GC (Benjuya et al., 2004; Manchester et al., 1989). Thus, Kwon 
et al. (2003) reported that the activity of the TA and TS was significantly prolonged in 
the subjects with DN compared to the healthy group, which suggested higher co-
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contraction between the dorsi-flexor and plantar-flexor muscles. In addition to that, 
Petrofsky et al. (2005a) found similar results in a population of 25 subjects with 
diabetes mellitus without neuropathic complications compared to 25 healthy controls. 
Thus, Petrofsky et al. (2005a) reported that during the initial contact and toe off phases 
of the GC, the diabetic group showed muscle activity to be at least five fold higher in 
antagonist muscle groups compared to healthy controls. Therefore, early evidence 
suggests that co-contraction may be a strategy used by DN subjects (even diabetic 
subjects without neuropathy) to improve the feeling of instability associated with this 
condition. It is not surprising then that gait in this population is slower and the steps 
shorter, since agonist and antagonist muscles are firing at the same time.  
In addition to this, the assessment of EMG patterns throughout the GC on different 
lower limb muscles may provide additional insights into the association between 
individual muscle function and kinetic and/or kinematic changes. At the ankle joint, at 
least two major muscle groups contribute substantially to joint moments during gait. 
The TS works as plantar-flexor, while the TA muscle contributes to ankle dorsi-flexion. 
Next, the activation patterns of those muscles in DN subjects will be examined. 
The onset of TS activity normally occurs once the forefoot strikes the floor as it 
contracts to make the tibia a stable base for knee extension and to allow tibial 
advancement (Perry & Burnfield, 2010).  From that moment in time TS activity rises 
consistently throughout the mid stance phase to peak at the middle of terminal stance 
phase (push off). The main function of the plantar-flexors is to drive the body forward 
by generating plantar-flexor moment during the late stance phase (Perry & Burnfield, 
2010).  Kwon et al. (2003) found an earlier activation of this muscle group in 
neuropathic patients. The premature activation of TS could be a mechanism to facilitate 
early forefoot contact with the ground and therefore provide the foot with a more stable 
base of support during walking in subjects with DN resulting in enhanced feeling of 
stability (Courtemanche et al., 1996). An early activation of the TS could be also the 
result of an anticipatory strategy of the DN muscles to efficiently produce force during 
the most demanding phase of the stance phase, the push off. Although an anticipatory 
mechanism has not been considered in the literature to explain differences in muscular 
activity patterns in DN subjects, it is a likely option. 
Gutierrez et al. (2001) demonstrated a decrease in the ability to rapidly develop torque 
about the ankle in a group of 6 DN subjects compared to 6 diabetic individuals without 
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neuropathy. Force generation in this study was determined from the rate of change of 
the ground reaction force vector in the lateral direction (measured with a force platform) 
during 1) a rapid lateral loss of balance and 2) a quick voluntary inversion movement of 
the ankle. The results show that DN subjects were able to produce about half the rate of 
torque than the healthy group in both conditions. Although the reasons for this slower 
force production are not fully understood, evidence from animal studies suggests that 
the fast-twitch fibres (type 2) of the muscles are highly sensitive to the loss of strength 
due to atrophy (Bishop & Milton, 1997). Therefore, a generalized DN is likely to cause 
distal loss of fast twitch muscle fibres, which may result in slower force production by 
the muscles, especially the distal ones (Gutierrez et al., 2001). This limitation to 
generate force quickly might require DN subjects to activate the muscles earlier as a 
mechanism to overcome the slower rate of force production and ensure the peak force is 
produced at the right moment in time. In addition to that, some investigations have 
reported slower muscle fibre conduction velocities in DN subjects compared to 
individuals with non-neuropathic complications (Chisari et al., 2002; Meijer et al., 
2008). Slower conduction velocities may result in longer delay from muscle activation 
to force production (EMD) and therefore it could be another factor that may contribute 
to the need in this population to develop an anticipatory mechanism. Few studies have 
reported differences in EMD due to gender (Winter & Brookes, 1991), type of muscle 
contraction (Cavanagh and Komi, 1979), movement velocity (Howatson et al., 2009), 
after ligament reconstruction (Kaneko et al., 2002), in response to a training programme 
(Grosset at al., 2009), and in cases of neuropathies (Granata et al., 2000). However, no 
investigation has assessed whether EMD is affected in patients with DN. Therefore, 
further studies investigating the rate of force production during gait as well as EMD in 
DN subjects are needed to determine whether an anticipatory muscular activation is a 
likely adaptive mechanism in this population.  
 
Regardless of the exact mechanism by which DN subjects require an earlier activation 
of the TS muscle, it is clear that a premature activation of the TS may result in an earlier 
forefoot contact. This, in turn, may partly explain the abnormal forefoot PTI values 
observed in this population (Sacco et al., 2009; Turner et al., 2007). It should be noted 
that Abboud et al. (2000), Akashi et al. (2008) and Sacco & Amandi, (2003) failed to 
find differences in TS activation times between diabetic neuropathic and healthy 
subjects. However, activations times in these studies were defined as the time at which 
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peak activity was achieved, in contrast to Kwon et al. (2003) who defined activity onset 
as the moment in time when EMG activity raised 3 standard deviations above resting 
EMG. The results from these three studies (Abboud et al., 2000; Akashi et al., 2008; 
Sacco & Amandi, 2003) suggest that the moment in time at which peak TS activity is 
produced do not differ between healthy and DN subjects, however, no conclusion can 
be drawn in relation to whether TS activation is earlier in DN compared to healthy 
individuals.  
Together with the TS, TA also plays a very important role during gait. TA is active at 
heel strike and is responsible for the impact reduction over the forefoot during the flat 
foot phase (Perry & Burnfield, 2010). EMG data shows a delayed activation of the TA 
muscle during the initial phase of the GC (Abboud et al., 2000; Sacco & Amadio, 
2003). A later firing of the TA means that its normal modulating role in lowering the 
foot to the ground after heel strike through eccentric contraction is disturbed, and the 
result is that the foot reaches the flat stage quicker and in a less controlled manner. 
Although the exact reason why TA activation appears to be delayed in DN subjects is 
not clear, a few theories have been proposed. Following the lack of stability theory, an 
early contact with the ground by the forefoot could be a mechanism to enlarge the base 
of support quicker after the heel strike and therefore to increase stability during the 
initial phase of the GC (Courtemanche et al., 1996).  
In addition to this, sensory neuropathy has been hypothesized to be responsible for 
those changes in activation patterns. The neuromuscular system generates responses 
according to the afferent sensory information caused by mechanical loads placed on the 
foot (Dingwell & Cavanagh, 2001). It has been suggested that due to the fact DN 
subjects have less sensitivity in the foot; the muscular and joint mechanisms responsible 
for the load attenuation are altered in these patients. As a consequence, a delayed 
muscular activation pattern during gait may be expected, especially in the initial contact, 
and mainly with respect to muscles related to the shock attenuation: dorsi-flexor 
muscles and knee extensors (Sacco & Amandi, 2003). In agreement with this theory, 
vastus lateralis (VL), that decelerates knee flexion during load reception, working as a 
shock absorber by transferring part of the impact to the thigh muscles mass (Perry & 
Burnfield, 2010), has also been reported to activate later in DN subjects compared to 
participants with no neuropathic complications (Abboud et al., 2000; Akashi et al., 
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2008; Sacco & Amadio 2003). Sacco et al. (2010) carried out a study which supports 
this theory. In this study muscular activity patterns were compared between barefoot 
and shod gait in participants with diabetic neuropathy and healthy controls. They 
reported a delayed muscular activation pattern during shod gait in the healthy group 
when compared to the barefoot condition. These differences were only noticeable in the 
muscles responsible for the shock attenuation during the initial ground contact (TA and 
VL).  Interestingly, the diabetic group kept the same pattern of VL activation during 
both conditions, whereas they had a delayed VL activation compared to the control 
group when walking barefoot. This may support the idea that a reduction in afferent 
information may alter muscular activation patterns. However, the fact that healthy 
individuals show different muscular activity patterns during in shoe and barefoot 
conditions does not necessarily prove that the lack of afferent information is responsible 
for those differences in activation patterns between healthy and DN subjects. Healthy 
individuals, having intact sensory information, can adapt to different conditions easier 
than DN subjects who perform tasks in a more automatic way. Therefore, since walking 
in shoes reduces the stress on the sole of the foot, the requirements for the TA and VL 
to work as shock absorbers are also reduced, which could have also altered the way 
these muscle were engaged during this part of the GC by the healthy group.   
Although the exact mechanism behind this delayed activation of the TA is not clear, the 
result is that the foot reaches the foot flat stage in a less controlled manner, which may 
lead to increased pressure values and longer contact times of the metatarsal heads with 
the ground in this population compared to healthy individuals (Abboud et al., 2000). 
Moreover, Bevans (1992) justified the higher prevalence of ulcers in the forefoot of 
neuropathic patients by the delayed activation of the TA, which consequently may 
change the distribution of foot pressure beneath the metatarsal heads. However, it 
should be pointed out that some studies failed to find any delay in the activation of the 
TA at the beginning of the stance phase (Akashi et al., 2008). It is possible that the fact  
that these studies used different population groups may partly explain the difference in 
the results. For instance, Sacco & Amadio (2003) and Akashi et al. (2008) recruited DN 
subjects with no other previous foot complications whereas Kwon et al. (2003) studied 
DN subjects with history of ulcers and Abboud et al. (2000) included patients with 
diabetes mellitus who were not assessed for neuropathy. Another possible explanation 
for the discrepancies in the results is that muscular activation was not interpreted 
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consistently among all the studies. On the one hand, Sacco et al. (2003), Abboud et al. 
(2000) and Akashi et al. (2008) defined muscle activation as the time delay from heel 
strike to peak muscular activity. On the other hand, Kwon et al. (2003) defined 
activation onset as the EMG activity 3 standard deviations above resting EMG activity. 
Therefore, it is likely that methodological difference may explain the discrepancies in 
the results 
Overall, studies investigating EMG patterns during gait in subjects with diabetic 
neuropathy are limited in number, and all of them have processed EMG data without 
considering EMD, which makes interpretation of the data difficult in relation to segment 
movement. However, it appears that DN subjects show different EMG activity patterns 
compared to healthy individuals and that those alterations in EMG patterns may lead to 
changes in kinetic and kinematic parameters. On the one hand, higher co-contraction, 
which has been associated with poor motor control, has been observed in DN subjects. 
This may partly explain some of the changes in the spatial-temporal characteristics (i.e. 
lower velocity) observed in this population. On the other hand, changes in the onset 
activation times of the TA and TS have been linked to changes in kinetic data. Thus, 
although the exact mechanisms underlying those changes are not understood, it appears 
that a delayed activation of the TA and an early activation of the TS may be partly 
responsible for the higher pressures on the forefoot (PP and PTI) shown by DN subjects. 
This early findings highlight the importance of investigating EMG data alongside 
kinetics and kinematics data to develop a more comprehensive understanding of 
walking patterns in individuals with DN. In addition to that, future studies using EMG 
must take into account EMD when relating EMG signal to muscle function. 
Furthermore, it appears very important to determine whether EMD values are different 
in DN subjects, which could have compromised the interpretation of the results 
presented above.   
Evidence presented demonstrates that patients with DN present a variety of gait 
alterations compared to healthy individuals. Thus, DN subjects show changes in 1) gait 
parameters, in the form of spatial-temporal and floor-foot interaction characteristics 
(COP); 2) foot pressures, especially at the metatarsals region; and 3) muscle activation 
patterns. Although neuropathy, both sensory and motor neuropathy, has for decades 
been considered the main factor altering walking patterns and foot pressure in DN 
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subjects, there is growing evidence that changes in gait characteristics occur even before 
neuropathy. Thus, structural changes secondary to diabetes (hyperglycaemia) have been 
recently acknowledged to affect gait and foot loading patterns in this population. In 
addition to that, early evidence suggests that differences in EMG activity patterns 
during gait may also be partly responsible for the changes in gait characteristics 
observed in DN subjects. Moreover, changes in the onset activation times of the TA and 
TS have been linked to changes in kinetic data, which suggests that EMG data should 
be considered as a potential contributing factor for the higher foot pressures (PP and 
PTI) observed in DN subjects, especially in the forefoot.   
Beside changes in gait biomechanics, vascular alterations in the microcirculation are 
also known to play an important role in the increased risk of foot ulcers observed in 
patients with DN. The next section will review alterations in the microcirculation in 
type 2 diabetic patients with and without neuropathy and their link to foot complication 
in this population.  
 
2.2.2.2 Microcirculation 
 
It has been postulated that abnormalities in foot microcirculation could play a 
significant role in the development of foot ulcers in diabetic neuropathic patients (Tooke 
et al., 2000). In fact, abnormalities in microcirculation are caused directly by diabetes 
and they are not secondary to impairments in macrocirculation as previously believed 
(Goldenberg et al., 1959; Tooke & Brash, 1995). In agreement with this theory, 
numerous investigations have reported impairments in microcirculation despite normal 
macrocirculation (Jorneskog et al., 1998; Kizu et al., 2003). Therefore, due to the 
primary role microvasculature plays in the development of foot ulcers in diabetic 
patients, this chapter will focus solely on the microcirculatory function.  
 
This section will describe the main structural and functional abnormalities of 
microcirculation in the diabetic neuropathic foot and will assess the importance of these 
alterations in the pathogenesis of ulceration. The last section in this chapter will 
investigate the responses of the microcirculation to an exercise bout in diabetic patients.  
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Definition and regulation of microcirculation  
The microcirculation is composed of a dense network of tiny vessels (diameter 5-10 
um) known as capillaries. These capillaries are interposed between feeding arterioles 
and draining venules. The walls of these vessels consist of a single layer of endothelial 
cells; this is the site at which the vital functions of the circulatory system occur (i.e. 
transport and exchange of nutrients and hormones, clearance of waste products of 
metabolism, tissue defence and repair or maintenance of fluid homeostasis) (Tooke, 
2004; Tortora & Derrickson, 2006).  
 
Flow in the microvasculature is regulated by the relaxation and contraction of smooth 
muscle sphincters on the arterial side of the capillaries (Tuma et al., 2008). Pressure and 
flow in these vessels is controlled through alteration in vessel diameter. At a local level 
this is achieved by the balance of pre-post-capillary resistance under neurogenic control. 
An increase in pressure is believed to bring about a reflex pre-capillary vasoconstriction 
via the local sympathetic axon (venoarteriolar reflex) (Tortora & Derrickson, 2006; 
Tuma et al., 2008). The purpose of this mechanism is to protect the capillaries from 
excessive hydrostatic pressure on standing (Korzon-Burakowska & Edmonds, 2006). 
An impaired venoarteriolar reflex leads to hyperperfusion on dependency, increases 
venous pressure, and contributes to a reduction in skin capillary flow, increased fluid 
filtration, and oedema (Korzon-Burakowska & Edmonds, 2006). 
 
In many tissues the simultaneous accommodation and control of multiple organic 
functions lead to the development of another category of microvessels, called shunts, 
which specialize in the regulation of blood flow between compartments. When blood 
pressure is reduced, flow in the shunts is reduced, while flow in the preferential channel 
(nutritional capillaries) is maintained due to its lower hydraulic resistance. However, 
when the nutritional capillaries have an increased resistance, much of this flow is 
probably diverted through the shunts, a path of lesser resistance, which “steals” the 
needed blood flow (Korzon-Burakowska & Edmonds, 2006; Tooke & Brash, 1995). It 
is generally believed that a common denominator of some of the major complications in 
diabetic patients is the pathological regulation of these shunts, leading to a 
maldistribution of blood flow between nutritional and non-nutritional microvessels 
(Watkins & Edmonds, 1983).  
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Structural Changes 
While there are no occlusive lesions in the diabetic microcirculation, as generally 
believed in the early days (Goldenberg et al., 1959), structural changes do exist, most 
notably, thickening of the basement membrane (Raskin et al., 1983; Tooke, 2000). The 
capillary basement membrane is thicker in diabetic patients and these alterations are 
more pronounced in the legs, most likely due to the higher hydrostatic pressure in this 
part of the body (Ward, 1997). These changes decrease the elastic properties of the 
capillary vessel walls and therefore limit vasodilatation capacity (Tooke, 1995). The 
basement membrane thickening may also act as a barrier to the normal exchange of 
nutrients and cellular migration, decreasing the ability of the diabetic foot to fight 
infection (Schramm et al., 2006). 
 
The first step in the development of capillary basement membrane thickening is 
increased hydrostatic pressure in the microcirculation. High hydrostatic pressure is 
thought to trigger an inflammatory response in the microvascular endothelium, which, 
over time may result in basement membrane thickening (Schramm et al., 2006). The 
association between elevated pressure and basement membrane thickening is supported 
by the fact that capillary basement is increased in the legs, where hydrostatic pressure is 
highest in the upright posture (Tooke, 2004). Metabolic control has also been linked to 
structural changes.  Raskin et al. (1983) reported a correlation between the extent of 
basement membrane thickening and the level of glycaemic control, with poorly 
controlled diabetic patients showing more basement membrane thickening than well-
controlled diabetic patients.  
 
Functional changes 
Despite these structural changes, it is currently understood that the most important 
changes in the microcirculation are functional. Over the last decade, abnormalities in 
microcirculation have been reported in neuropathic patients both at rest as well as when 
responding to vasodilatory stimulus.  
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Resting blood flow 
Resting peripheral blood flow has been demonstrated not to be diminished in 
neuropathic patients when compared to non-diabetes individuals. Furthermore, foot 
blood flow has been shown to be either increased (Flynn et al., 1988; Tooke & Brash, 
1995; Urbancic-Rovan et al., 2004) or unchanged (Schramm et al., 2006) in diabetic 
neuropathic patients when compared to healthy individuals. Although such findings 
suggest no reduction in blood flow to the foot, capillary ischemia can be present, which 
may compromise nutrient delivery to the tissues. Microcirculation of the lower limb is 
rich in arteriovenous shunts. The arteriovenous shunts are innervated by sympathetic 
nerves; therefore, the presence of diabetic neuropathy with sympathetic denervation 
may lead to the opening of these shunts with blood flow bypassing the skin capillaries, 
the so-called capillary steal syndrome (Korzon-Burakowska & Edmonds, 2006; 
Schramm et al., 2006). In support of this theory, studies with nail fold capillaroscopy 
have shown reduced capillary nutritional flow in neuropathic patients compared to 
healthy controls (Jorneskog et al., 1998; Nabuurs-Franssen et al., 2002). In addition 
several studies have reported an increased skin temperature in this population, which 
therefore increases metabolic demand (Flynn et al., 1988; Nabuurs-Franssen et al., 
2002). This increase in metabolic demand will further amplify the potential problems 
originating from the reduction in nutritive capillary flow in diabetic neuropathic 
patients.  
 
Vasodilatory  responses 
The most critical functional changes in diabetic patients with and without neuropathic 
complications occur in response to tissue injury. Maximal vasodilatation has been 
observed to be impaired in diabetic patients under conditions of stress (Kingwell et al., 
2003; Petrofsky et al., 2005b). This defect is known to play a crucial role in the wound 
healing process (Hile & Veves, 2003). Commonly, ulceration is precipitated by 
relatively minor trauma, which, in the presence of sensory neuropathy is unattended. A 
lack of adequate blood supply at this critical phase contributes to the risk of significant 
infection and hence, further tissue breakdown.  
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Vasodilatory abnormalities in diabetic patients are mainly related to the dysfunction of 
the endothelial cells and vascular smooth cells of the arterioles, as well as to 
impairments of the nerve-axon reflex (Hile & Veves, 2003; Schramm et al., 2006). 
Functional alterations in the microcirculation are also reported in response to exercise 
stress, which are believed to the responsible for the reduced exercise capacity observed 
in patients with type 2 diabetes. These changes will be reviewed in more detail next.  
 
2.2.2.2.1 Endothelial dysfunction 
 
Vascular endothelium plays an important role in controlling the microvascular tone by 
synthesizing and releasing substances that modulate the vasomotor tone and regulate 
blood flow. NO is the most important vasodilator substance in endothelium-dependent 
vasodilatation. After its production and secretion from the endothelium, it diffuses to 
the adjacent smooth muscle cells (and stimulates the guanylate cyclase enzyme), which 
leads to smooth muscle relaxation and vasodilatation (Palmer et al., 1988; Tortora & 
Derrickson, 2006).  
 
Endothelial dependent vasodilatation  
The majority of studies agree that endothelium-dependent vasodilatation is impaired in 
diabetes, regardless of the presence or absence of neuropathy (Kingwell et al., 2003; 
Pitei et al., 1997). Furthermore, it has been demonstrated that changes in the endothelial 
function precede the development of diabetes and are present at the prediabetic stage 
(Tooke, 2000). It has been postulated that endothelial changes may be associated with 
reduced insulin sensitivity, which commonly precedes type 2 diabetes (Tooke, 2000). 
To further validate this theory, impaired microvascular vasodilatory capacity has been 
reported in individuals with impaired fasting glucose (Jaap et al., 1994). Furthermore, 
Jaap et al. (1997) found a correlation between vasodilatory impairments in 
microcirculation and the level of insulin sensitivity in pre-diabetic subjects. 
It has been recently proposed that oxygen derived radicals, which in excess produce 
oxidative stress, inactivate endothelium-derived NO affecting the endothelium-
dependent function (Schramm et al., 2006; Taddei et al., 1998). Evidence on the 
association between oxidative stress and vascular dysfunction come from experimental 
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studies using antioxidants administration. Vitamin C, an effective antioxidant, has been 
found to improve endothelial function in normal individuals with high insulin levels 
(Arcaro et al., 2002),  hypertensive subjects (Taddei et al., 1998) as well as in diabetic 
patients (Ting et al., 1996). It should be pointed out that oxidative stress is aggravated 
by hyperglycaemia, hypertension and/ or hyperinsulinemia (Tooke et al., 2000). This 
may partly explain why changes in the endothelial function are present at the 
prediabetic stage.   
 
However, it is important to consider that some studies failed to report microcirculatory 
impairments in the form of reduced endothelium-dependent vasodilatation in diabetic 
patients without neuropathy (Pfutzner et al., 2001; Veves et al., 1998). In both studies, a 
large number of the non-neuropathic subjects had type 1 diabetes of long duration and 
were therefore less likely to have microvascular complications. Oxidative stress, which 
results in changes in the endothelial function (as mentioned above), is known to be 
aggravated by hyperglycaemia, hypertension and/or hyperinsulinemia (Tooke et al., 
2000). These metabolic conditions are commonly associated with type 2 diabetes and 
not necessarily with type 1 diabetes, which could partly explain why individuals with 
type 2 diabetes are more likely to suffer from endothelial dysfunction (Tooke, 2000).  
 
Endothelial independent vasodilatation 
Endothelium-independent vasodilatation reflects the function of the vascular smooth 
muscle cell. Smooth muscle vasodilatation is stimulated by direct donors of NO (such 
as sodium nitropusside, which is normally administrated transdermally using a 
iontophoresis technique), which act directly on the smooth muscle cell, independent of 
the endothelium (Dinh & Veves, 2004). There is substantial evidence to suggest that 
neuropathic patients show abnormalities in the endothelial independent vasodilatation 
(Pitei et al., 1997; Veves et al., 1998). However, conflicting results have been reported 
regarding whether abnormalities in smooth muscle vasodilatation are present before 
neuropathy develops. Although early studies demonstrated impairment of endothelium-
independent vasodilatation in non-neuropathic patients (Furchgott & Zawadzki, 1980), 
subsequent work failed to find such abnormalities (Kingwell et al., 2003; Veves et al., 
1998). It has therefore been suggested that dysfunction at the smooth muscle level 
might be associated specifically with neuropathy (Pitei et al., 1997). However, the exact 
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mechanism explaining this association between smooth muscle function and neuropathy 
is still unclear.  
 
2.2.2.2.2 Neurogenic factors 
 
The ability to increase blood flow depends on the existence of a normal neurogenic 
vascular response referred to as Lewis’ triple flare response. In healthy subjects, skin 
trauma results in stimulation of the C nociceptive nerve fibres leading to antidromic 
stimulation (nerve conduction in the opposite direction, therefore along the axon away 
from axon terminal and towards the soma) of the adjacent C-fibres, which secrete 
vasodilators and cause increased local blood flow in injured tissues and thereby promote 
healing (Dinh & Veve, 2004; Vinik et al., 2001). This response is typically equal to one 
third of the maximal vasodilatory capacity (Schramm et al., 2006).  
 
Neurogenic vascular responses have been shown to be impaired in the feet of 
neuropathic patients, which can predispose a significant reduction in blood flow under 
stressful conditions (Pfutzner et al., 2001; Veves et al., 1998). Thus, the diabetic 
neuropathic foot fails to respond to injury and infection in the usual manner, which may 
explain the lack of hyperaemia observed in the infected or injured diabetic foot (Dinh & 
Veves, 2004). It has been suggested that the impaired flare response observed in 
neuropathic patients may be related to both impaired C-nociceptive fibre function and 
impaired ability of the microvasculature to response to vasomodulators (i.e. NO) 
secreted by these fibres (Vinik et al., 2001). 
 
Neurogenic vascular response impairments are usually associated with vasodilatory 
dysfunction in DN patients. However, vasodilatory responses to local warming, which 
are largely controlled by small C fibre nociceptors, have also been reported to be 
diminished in non-neuropathic individuals (Colberg et al., 2005). Nevertheless, more 
evidence is required to understand better the way diabetes may affect neurogenic 
vascular responses.  
 
Overall, vasodilatory abnormalities in DN patients are mainly related to the dysfunction 
of the endothelial (endothelial dependent vasodilatation) and vascular smooth cells of 
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the arterioles (endothelial independent vasodilatation), as well as to impairments of the 
nerve-axon reflex (neurogenic responses). It appears that alterations in the endothelial 
cell function are associated with type 2 diabetes, whereas changes in the endothelial 
independent vasodilatation and in the nerve-axon reflex are related to neuropathy.  In 
addition to this, functional alterations in the microcirculation have also been reported in 
response to exercise stress, which are believed to be responsible for the reduced exercise 
capacity observed in patients with type 2 diabetes. The next section will review 
microcirculatory responses to an exercise bout in subjects with type 2 diabetes.  
 
2.2.2.2.3 Microcirculatory responses to an exercise bout 
 
Patients with diabetes have shown a 20-30 % reduction in peak aerobic capacity 
(Ozdirenç et al., 2003; Regensteiner et al., 1998), which may limit their daily walking 
activities and functional capacity (Baldi et al., 2003; Ozdirenç et al., 2003), especially in 
sedentary elderly people with low fitness levels.  Martin et al. (1995) reported that when 
exercising during 40 minutes on a bicycle ergometer at the same sub-maximal intensity 
(60% of maximal oxygen uptake) patients with type 2 diabetes (N=8) showed higher 
lactate values (determined in whole blood) compared to healthy individuals (N=7). This 
demonstrates that the aerobic capacity in this population is impaired. In line with this 
finding, Scheuermann-Freestone et al. (2003), who assessed blood acidity levels (pH 
levels) throughout a fatiguing exercise bout reported a faster decrease in pH (more 
acidity due to lactate acid accumulation) during exercise in the group of subjects with 
type 2 diabetes (N= 21) compared to the healthy group (N=15). They also demonstrated 
that all subjects (diabetic and healthy) fatigued at the same acidic pH. These findings 
prove that impairment in the aerobic capacity may be responsible for the reduced 
exercise capacity observed in diabetic patients.  
 
Some investigations have demonstrated that reduced circulatory responses to exercise in 
diabetic patients are present even in the absence of peripheral arterial disease (Mohler et 
al., 2006; Petrofsky et al., 2005b). This suggests that vascular impairment may originate 
via changes in microcirculation. In line with this idea, Baldi et al. (2003) demonstrated 
that maximal oxygen consumption (VO2max) in a group of 11 diabetic patients is mostly 
limited by abnormalities in the peripheral oxygen (O2) extraction (microcirculation) and 
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not by cardiac output abnormalities. Cardiac output and arteriovenous differences in this 
study were estimated noninvasively during cycling by the carbon dioxide re-breathing 
equilibration method using the Fick equation. It should be noted that although 
microcirculatory abnormalities are believed to be a crucial contributor to the reduced 
exercise capacity observed in diabetic patients, other abnormalities, secondary to 
diabetes, such as autonomic neuropathy (Petrofsky et al., 2005b; Saltin et al., 1998) or 
peripheral arterial diseases (Adler et al., 1999, Boyko et al., 1997) may also contribute 
to this limitation. However, due to the primary role microvasculature plays both in 
reduced exercise capacity and in the development of ulcers in diabetic patients, this 
chapter will focus solely on the microcirculatory responses to exercise. It should be 
noted that all the evidence included in this section has been acquired from diabetic 
patients without neuropathy since no investigation has been carried out assessing 
microcirculatory responses to an exercise bout on DN subjects. Although similar 
alterations in the microcirculation may be expected from both populations, it is likely 
that DN patients have more diminished circulatory responses to exercise compared to 
non-neuropathic individuals. Therefore, the results presented might underestimate the 
microcirculatory responses to exercise in DN subjects. Moreover, this highlights the 
importance to investigate this issue in DN patients.   
 
2.2.2.2.3.1 Blood flow during exercise 
 
Investigations assessing acute circulatory responses to exercise in diabetic patients have 
reported that the increase in exercise-induced blood flow was reduced in diabetic 
patients compared to healthy individuals (Kingwell et al., 2003; Mohler et al., 2006; 
Petrofsky et al., 2005b; Pichler et al., 2004). These findings have shown consistency 
regardless of the method used and/or the vascular bed investigated (microvasculature 
and macrovasculature). Thus, diminished vascular responses to exercise have been 
reported when investigating total limb blood flow as measured by Plethysmography 
(Petrofsky et al., 2005b) and local muscle blood flow as measured by near infrared 
spectroscopy (NIRS) (Mohler et al., 2006; Pichler et al., 2004). It is noteworthy that 
plethysmography and NIRS are the most commonly used techniques to measure blood 
flow during exercise. 
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Volume plethysmography measures changes in whole limb volume. An arterial 
occlusion cuff is placed around the distal part of the limb (wrist and ankle for upper 
limb and lower limb measurements, respectively) and a venous cuff on the proximal 
part of the limb (upper arm or upper leg for upper limb and lower limb measurements 
respectively). During flow measurements the change in arm size due to arterial flow is 
transduced to an electrical output to determine total limb blood flow (Whitney, 1953).  
 
Skeletal muscles form approximately 40% of the total body mass, thus representing an 
important percentage of cardiac output and total oxygen consumption even at rest. 
Under working conditions, muscle blood flow can increase to 80-85% of cardiac output 
and VO2 can exceed the resting value by 50-fold (McArdle et al., 2000; Tortora  & 
Derrickson, 2006). Therefore, NIRS is becoming a widely used research instrument to 
measure muscle haemodynamics during exercise bouts (van Beekvelt et al., 2001a; 
Boushel et al., 2000a). NIRS is based on the relative transparency of tissue to light in 
the near- infrared region, and on the oxygen- dependent absorption changes of 
haemoglobin and myoglobin. NIRS enables non-invasive continuous measurement of 
changes in the concentration of oxygenated haemoglobin (HbO) and deoxygenated 
haemoglobin (HbdO). The sum of HbO and HbdO concentrations reflects the total 
amount of haemoglobin (tHb), and changes in tHb can be interpreted as changes in 
blood volume in the tissue.  In addition, this technique allows quantifications not only 
of blood flow but also oxygen consumption in the muscle (van Beekvelt et al., 2001a).  
Therefore, NIRS provides valuable information about overall muscular function, in the 
form of oxygen delivery and consumption. 
 
Although circulatory responses to exercise are well known to be altered in diabetic 
patients, the exact mechanisms controlling exercise hyperaemia are still unclear. Early 
investigations found that NO blockade, which stops NO production, diminished blood 
flow at rest and during recovery, but it had no effect during exercise (Shoemaker et al., 
1997). It was therefore concluded that other mechanisms instead of endothelium-related 
responses, were more likely to control blood flow during exercise. Thus, Saltin et al. 
(1998) in a comprehensive review of the literature suggested that an elevation in muscle 
sympathetic nerve activity, secondary to the muscle contraction, was likely to have an 
important functional role in controlling blood flow during exercises. In conflict with  
the findings shown above, Boushel et al. (2002) demonstrated that a combined 
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inhibition of NO and prostaglandins, which are considered the most important 
endothelium-derived vasodilator substances, reduced muscle blood flow during exercise 
in healthy individuals (up to 50%). Contrary to the study from Shoemaker et al. (1997), 
in which only NO production was blocked, Boushel et al. (2002) inhibited NO as well 
as prostaglandins production. This suggests that compensatory responses may result to 
ensure flow matches metabolic demand when only one vasodilator substance is 
inhibited. In line with this, Kingwell et al. (2003) reported the first study providing 
evidence that impaired endothelium-dependent vasodilatory responses in patients with 
type 2 diabetes limits blood flow during exercise. They measured leg blood flow 
responses in the right femoral venous blood flow by constant-rate infusion of cold saline 
(thermodilution). Thus, responses to 1) intrafemoral arterial infusions of acetylcholine 
(endothelium-dependent vasodilator); and 2) to a standardized 25-min cycling bout at 
60% VO2max were measured in 9 males with type 2 diabetes and 9 matched controls. 
They found that a reduced blood flow response to exercise was significantly correlated 
(r=0.54) with a reduced blood flow response to acetylcholine. It is worth mentioning 
that they also investigated endothelium independent vasodilatation by the injection of 
sodium nitroprusside and no relationship between smooth cell function and blood flow 
response to exercise was found. These results suggest that abnormalities in the 
endothelial function may be responsible for the reduced circulatory responses during 
exercise in individuals with type 2 diabetes.  
 
Although more evidence supporting these initial findings is needed, abnormalities in 
endothelial function may be a potential mechanism responsible for the diminished 
circulatory responses to exercise observed in diabetic patients. However, it is likely that 
other abnormalities related to diabetes, such as impairments in the autonomic nervous 
system (ANS) (Petrofsky et al., 2005b; Saltin et al., 1998) or  peripheral arterial 
diseases (Adler et al., 1999; Boyko et al., 1997) may also contribute to this limitation in 
subjects with type 2 diabetes.  
 
2.2.2.2.3.2 Oxygen uptake during exercise 
 
It is widely accepted that the reduced exercise capacity observed in diabetic patients 
reflects a reduced delivery rate of oxygen through a restricted circulation to the muscle 
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mitochondria. However, diabetic patients have increased oxidative stress as well as a 
spectrum of muscle metabolic abnormalities that may have implications in the 
mitochondrial function (Scheuermann-Freestone et al., 2003; Sivitz, 2010).  
 
Submaximal oxygen consumption has been reported to be lower in diabetic patients 
compared to healthy individuals during identical submaximal workloads (Baldi et al., 
2003; Regensteiner et al., 1998). In addition to that, Baldi and colleagues (2003) 
demonstrated that arteriovenous oxygen differences, which assess the muscular 
oxidative capacity, were also reduced in type 2 diabetic subjects compared to healthy 
controls when working at maximal (100% VO2max) as well as submaximal intensities 
(70% VO2max). They concluded that a reduction in the oxidative capacity of the skeletal 
muscle due to muscle metabolic abnormalities, may be responsible for less O2 being 
consumed by working muscles during the exercise bouts. In line with these findings, 
Martin et al. (1995) found that when exercising at the same sub-maximal intensity (60% 
VO2max), the total leg oxygen uptake was similar between groups while lactate 
production was higher in diabetic patients compared to healthy counterparts. This 
finding suggests impairments in the ability to use oxygen efficiently in the diabetic 
groups. 
 
Contrary to the findings shown above, Bauer et al. (2007) reported that the diminished 
aerobic capacity in diabetic patients is due to abnormalities in the microvascular blood 
flow. They measured systemic oxygen uptake (breath to breath gas analyzer) and 
muscular oxygen uptake (NIRS) simultaneously during a submaximal workout (85% of 
the individual’s estimated lactate threshold) and they found that oxygen uptake (breath 
to breath gas analyzer) was reduced after the onset of exercise while muscle 
deoxygenation was unchanged in diabetic patients compared to healthy controls. They 
therefore concluded that the limitation of oxygen uptake during submaximal exercise in 
type 2 diabetes may be related to impaired control or maldistribution of muscle blood 
flow.  In agreement with this, Mohler et al. (2006) did not find differences in exercise-
induced muscular deoxygenation, measured with NIRS, when comparing healthy and 
diabetic individuals.  
 
There is some evidence that metabolic abnormalities such as increased type II to type I 
fibre ratio (Marin et al., 1994) and lower oxidative enzyme activity (Kelley et al., 2002) 
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may be present in the diabetic skeletal muscle. However, it is unclear whether oxygen 
uptake responses are affected in this population. To date, only a few studies have 
investigated muscular oxygen uptake during exercise in diabetic patients and more 
studies are necessary to better understand whether and to what extent muscular 
oxidative capacity is impaired in this population.  
 
In summary, it looks clear that patients with type 2 diabetes show alterations in the 
microcirculatory responses to exercise stress. However, it is still unclear whether those 
abnormalities are solely related to exercise-induced vasodilatory responses or whether 
muscular oxidative capacity is also impaired in this population. It should be highlighted 
that all the studies presented in this section have been carried out on patients without 
neuropathy. The magnitude of microcirculatory impairments in response to an exercise 
bout is therefore unknown in DN subjects. Future investigations are warranted to 
investigate microcirculatory responses to exercise in this group of patients.  
 
Figure 2-2. Overview of the microcirculatory problems linked to DN 
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Overall, it is well established what the association is between microcirculatory 
impairments and risk of foot ulceration in individuals with diabetes mellitus, especially 
in DN individuals (see Figure 2-2). Thus, diabetes carries a complex set of changes in 
the microcirculation, including structural and functional changes. Despite structural 
changes, such as the development of capillary basement membrane thickening, it is 
currently understood that the most important changes in the microcirculation are 
functional. Vasodilatation has been observed to be impaired in diabetic patients with 
and without neuropathic complications under conditions of stress (Kingwell et al., 2003; 
Petrofsky et al., 2005b) and this defect is known to play a crucial role in the wound 
healing process. Vasodilatory abnormalities in DN patients are mainly related to the 
dysfunction of the endothelium (endothelial dependent vasodilatation) and vascular 
smooth cells of the arterioles (endothelial independent vasodilatation), as well as to 
impairments of the nerve-axon reflex (neurogenic responses). On the one hand, 
alterations in the endothelial cells function are associated with metabolic impairments 
(reduced insulin sensitivity, hypertension and hyperinsulinemi), which commonly 
precede type 2 diabetes. On the other hand, alterations in the endothelial independent 
vasodilatation and in the nerve-axon reflex are thought to be related to neuropathy. This 
suggests that microcirculatory problems in type 2 diabetic patients are worsened by 
neuropathy, which explains, in conjunction with gait alterations, why this population is 
approximately 10 times more likely to develop foot ulcers compared to non-neuropathic 
subjects (McGill et al., 2005).  
 
In addition to this, functional changes have also been observed in response to exercise 
stress. Patients with type 2 diabetes show a diminished exercise-induced vasodilatory 
capacity compared to healthy individuals, and preliminary evidence suggests that 
changes in the endothelial function may be partly responsible for these alterations. It is 
believed that these modifications are associated with the reduced exercise capacity 
observed in subjects with type 2 diabetes (Ozdirenç et al., 2003; Regensteiner et al., 
1998). However, there is an ongoing debate about whether the diminished exercise 
capacity observed in diabetic patients is caused by solely a reduction in oxygen delivery 
or in combination with a reduction in the muscular oxidative capacity.  It should be 
noted that all the evidence included in this section has been acquired from diabetic 
patients without neuropathy since no investigation has been carried out assessing 
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microcirculatory responses to an exercise bout on DN subjects. This highlights the 
importance to investigate this issue in DN patients.    
 
Foot ulcerations are well established as a major health problem in individuals with 
diabetic neuropathy. Commonly, ulceration is precipitated by repetitive and/or 
excessive pressure on the surface of the insensitive skin during gait activities. A lack of 
adequate blood supply at this critical phase contributes to the risk of significant 
infection and hence, further tissue breakdown (van Schie, 2005; Schramm et al., 2006). 
Thus, the previous two sections have investigated gait and microvascular alterations in 
individuals with diabetes neuropathy and their association with foot problems.  
 
Beside the foot complications associated with diabetes neuropathy, increasing evidence 
suggest that diabetes in general and DN in particular impact everyday living and 
consequently diminish health related QOL in this population (Price & Harding, 2000). 
Thus, QOL measurements are increasingly being used to assess the impact of a given 
health state on functioning in three key areas: physical functioning, social functioning 
and psychological well-being, which reflects the World Health Organization definition 
of health (WHO, 1959). The next section will discuss the impact of diabetes and DN on 
individual’s quality of life.  
 
2.2.2.3 Quality of life 
 
Although glycaemic control, the development of foot complications and mortality 
represent critical outcomes in people with type 2 diabetes, health-related QOL outcomes 
are also important (ACSM, 2000). The value of optimizing QOL is increasingly 
recognised as it represents an important goal for health care. Also, importantly, 
associations between poor QOL and adverse outcomes in people with type 2 diabetes, 
including poor response to therapy, disease progression and even mortality have been 
well documented (Ali et al., 2010; Kleefstra et al., 2008). Landman et al. (2010) 
reported that lower physical and mental QOL were associated with a higher total 
mortality and cardiovascular mortality in patients with type 2 diabetes regardless of 
confounders such as age and sex. It has been therefore hypothesized that QOL 
instruments may become an increasingly important clinical tool to not only identify 
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those patients with a low QOL but also to identify those patients with an associated 
increase mortality risk (Kleefstra et al., 2008).  
 
The adverse effects of diabetes on health-related quality of life are well established in 
the literature (Luscombe et al., 2000; Price & Harding, 2000). Furthermore, Lloyd et al. 
(2001) assessed the effect of diabetic complications (i.e. neuropathy, retinopathy, and 
nephropathy) on QOL in 1,233 patients with type 2 diabetes. It was found that even 
mild complications can have a profound effect on the patient’s perceived QOL, as 
recorded using the SF-36 questionnaire. They also reported that biochemical markers of 
the disease (i.e. blood pressure or glycaemic control) did not appear to directly affect 
QOL. This disagrees with other studies that found a direct relationship between blood 
glucose and QOL in hyperglycaemic subjects (Wikblad et al., 1996). Currie et al. (2006) 
demonstrated that the severity of diabetic peripheral neuropathy symptoms was 
predictive of poor health-related utility and decreased quality of life. Moreover, they 
also related the effect of neuropathic symptoms such as burning or numbness (as 
measured with the Neuropathic Total Symptom Score) to different dimensions of 
health-related QOL (as measured with the SF-36 questionnaire). These findings suggest 
that there may be specific symptoms associated with diabetes as well as biochemical 
markers of the disease that may have a direct effect on QOL. Although these early 
findings represent a step forward in the understanding of the association between 
diabetes and reduced QOL, more studies are needed to understand the relationship 
between physiological and psychological markers.  
 
Even though diabetic foot problems are the most common cause of hospitalization for 
patients with diabetes (Boulton, 1997), the QOL aspect of the diabetic foot has received 
little attention in the literature. Price & Harding (2000) published a comprehensive 
review of the literature in which they investigated the impact of foot complications 
secondary to diabetes on QOL. They concluded that there is a relationship between 
number of and severity of complications and QOL, and that the everyday experiences of 
patients with foot ulceration may be even poorer than for those with amputations. It has 
been hypothesized that limitations on physical functioning and mobility secondary to 
foot ulceration can reduce self-reported health-related quality of life in these subjects 
and may explain why QOL in patients with foot ulceration is worse than in mobile 
diabetic amputees (Price, 2004). A study carried out by Brod (1998) highlights the 
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impact of foot complications on everyday living for both the patients with ulceration 
and their carers. This study of 14 patients and 11 caregivers reported that reduction in 
social activities, increased family tensions, lost time from work, and a negative impact 
on general health were experienced by both groups.  
 
In summary, QOL represents an important goal for health care professionals and it has 
been associated with adverse outcomes in people with type 2 diabetes, including poor 
response to therapy, disease progression and even mortality. It is well established that 
diabetes is associated with poor QOL. Furthermore, it appears that there is a positive 
correlation between diabetes and its complications and QOL, with subjects with more 
severe complications showing the poorest QOL. Interestingly, early evidence suggests 
that QOL could be associated with biochemical markers; however, more studies are 
needed to understand the relationship between physiological and psychological markers.  
 
In conclusion, this part of the literature review has demonstrated that type 2 diabetes 
and peripheral neuropathy are associated with a complex set of complications including 
increased risk of cardiovascular problems (mainly due to metabolic abnormalities linked 
to type 2 diabetes), increased risk of foot problems, (partly due to gait alterations and 
partly due to microcirculatory problems) and reduced QOL. The next section will 
provide a critical review of the potential effect of PA programmes on the primary 
pathologies linked to DN.   
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2.3 PART 2: Physical activity, type 2 diabetes and 
peripheral neuropathy 
 
For decades, exercise has been considered a cornerstone of a healthy lifestyle. It is well 
documented that PA reduces hyperglycaemia, insulin resistance, hypertension and 
dyslipidemias and provides a protective effect against cardiovascular diseases and death 
in healthy individuals (ACSM, 2000; McArdle et al., 2000). Moreover, it is becoming 
increasingly clear that the growing prevalence of type 2 diabetes is associated with 
decreasing levels of activity and an increasing prevalence of obesity. Yates et al. (2007) 
demonstrated in a systematic review, that included 4 studies, that the risk of diabetes 
was reduced by approximately 50% (range 42-63%) in individuals who were 
encouraged to reduce their body mass through changes in diet and PA. However, Yates 
and colleagues failed to demonstrate the effect of exercise independent of other factors 
on the risk of diabetes in individuals with impaired glucose tolerance and they 
concluded that weight loss may largely explain those results. In type 2 diabetes, the 
promotion of weight loss is one mechanism through which exercise may be beneficial 
since obesity, especially abdominal obesity, is associated with metabolic abnormalities 
in diabetes (Kahn et al., 2006; Kelley & Goodpaster, 2001). Thomas et al. (2006) 
carried out a systematic review with 14 studies to explore the independent effect of 
exercise in people with type 2 diabetes. They reported a clinically significant 
improvement in glycaemic control in the exercise groups compared to controls. 
Interestingly, they found that improvements in glycaemic control were achieved over a 
range of exercise intensities as well as types of exercises (aerobic exercises, strength 
training and combination of aerobic and strengthening exercises). It was also stated that 
the beneficial effect of exercise on glycosylated haemoglobin (HbA1c) was independent 
of body mass.  This finding is supported by Jeon et al. (2007) who, in his systematic 
review, found that the inverse association between PA and type 2 diabetes persisted 
after adjusting for body mass index (BMI). This proves PA as an independent factor to 
reduce type 2 diabetes prevalence even in the absence of weight loss.  
 
In addition to this,  there is mounting evidence that physical activity is associated with 
significantly lower cardiovascular risk and overall mortality in healthy individuals 
(ACSMS, 2000) as well as in type 2 diabetes (Wei et al., 2000). It is generally believed 
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that this protective effect of PA against cardiovascular diseases and mortality may be 
partly produced by positive changes in metabolic syndrome (blood pressure, 
dyslipidemia) (ACSMS, 2000). It is, therefore, becoming increasingly clear that 
physical activity may be a therapeutic tool in a variety of patients with, or at risk of 
diabetes. For this reason exercise should be considered an important component of 
diabetes treatment.  
 
Current physical activity recommendations for diabetic patients include aerobic 
exercises as well as resistance exercises. A consensus statement from the American 
Diabetes Association (Sigal et al., 2006) recommends: at least 150 minּweek-1 of 
moderate intensity aerobic physical activity; and/or at least 90 minּweek-1 of vigorous 
aerobic exercise and 3 sessions a week of resistance training. The resistance training 
should target 3 sets of 8-10 repetitions at a weight that cannot be lifted more than these 
repetitions. However, the separate effect of each type of exercise in health-related 
outcome measures has not been widely investigated in diabetic patients. Recent review 
papers have evaluated the role of physical activity in potentially enhancing health in 
type 2 diabetes (American Diabetes Association, 2010; Thomas et al., 2006); however, 
those reviews included studies that used aerobic training, resistance training or/ and a 
combination of both; whereas the particular effect of each mode of exercise was 
neglected. Different types of exercise will trigger different physiological adaptations; 
therefore it is important to understand the potential benefits that each type of exercise 
may have on diabetic patients so better and more efficient rehabilitation programmes 
can be put into place.  
 
The vast majority of studies have investigated the association between physical activity 
and health problems commonly linked to type 2 diabetes (i.e. glycaemic control and 
cardiovascular risk factors), whereas the relationship between PA and the health 
problems associated with peripheral neuropathy (i.e. the risk of foot ulcerations or poor 
QOL) have received minimal attention. For this reason, this review of the literature will 
attempt for the first time to gather evidence on the potential effect of PA interventions 
on the whole range of pathologies linked to DN. This section will therefore include two 
subsections. Subsection 1 will review the relationship between different types of 
exercises programmes (aerobic, anaerobic or combination of both) and pathologies 
linked to type 2 diabetes (glucose control, blood pressure and cholesterol levels). 
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Subsection 2 will review the relationship between different types of exercise 
programmes (aerobic, anaerobic or combination of both) and pathologies related to DN 
(gait, microcirculation and QOL). 
 
It should be noted that almost all the studies investigating PA interventions in type 2 
diabetic patients have been carried out in individuals with no neuropathic 
complications. In fact, after a comprehensive search only 1 study was found in which an 
exercise programme was carried out on subjects with DN (Allet et al., 2010).  For this 
reason the majority of studies presented in this section were carried out with type 2 
diabetic patients with no neuropathic complications.   
 
2.3.1 Physical activity and type 2 diabetes 
 
The traditional management of type 2 diabetes focuses on lifestyle interventions, 
lowering cardiovascular risk factors (metabolic syndrome), and maintaining blood 
glucose levels within the normal range. Therefore, evidence increasingly supports the 
beneficial effect of PA programmes on the management of glycaemic control and 
cardiovascular risk factor both in healthy individuals (Yates et al., 2007) as well as in 
type 2 diabetes patients (Thomas et al., 2006). However, evidence from PA programmes 
include aerobic training, strength training and a combination of both, while the separate 
effect of each mode of exercise have not been fully investigated (Sigal et al., 2006; 
Thomas et al., 2006). In the next section, evidence will be presented on the effect of 
different types of exercise on glycaemic control and traditional risk factors.  
 
2.3.1.1 Glycaemic control 
 
Thomas et al. (2006) carried out a meta-analysis in which 13 studies assessing the effect 
of an exercise programme on glycaemic control were included. They reported a 
clinically significant reduction in glycated haemoglobin of 0.62% when the exercise 
group (N=185) was compared to the non exercise group (N=176). An absolute decrease 
of 1% in HbA1c levels has been associated with a 15% to 20 % decrease in major 
cardiovascular disease events (Selvin et al., 2004). Thus, the observed reduction of 
0.62% HbA1c levels might be expected to produce a 9.3% reduction in cardiovascular 
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disease risk. It should be pointed out that these risk reduction estimates are likely to be 
conservative because they are derived from medication studies and do not take into 
account other risk factors associated with exercising, such as improvements in cardio-
respiratory fitness and strength, or reductions in fat mass and waist circumferences 
(Selvin et al., 2004). Unfortunately, this powerful review of the literature did not 
distinguish between different modes of exercising. 
 
The positive effect of physical activity programmes to lower HbA1c levels have been 
reported for aerobic training (Raz et al., 1997; Ronnema et al., 1986; Yeater et al., 
1990), strength training (Castaneda et al., 2002; Dunstan et al., 2006) and combined 
aerobic and resistance training (Loimaala et al., 2003, Maiorana, et al., 2001). However, 
it is impossible to compare the results from different investigations due to 
methodological differences such as training intensity [ranging from low intensity 
(Yeater et al., 1990) to high intensity (Ronnemaa et al., 1986)]; duration  of the 
intervention [ranging from 2 months  (Yeater at al., 1990) to 14 months (Dunstan et al., 
2006)]; or  baseline HbA1c levels [ranging from 7.8% (Dunstan et al., 2006) to 12.9% 
(Raz et al., 1997)].  
 
Cauza et al. (2005) undertook the first investigation directly comparing the effect of 
aerobic and resistance training in glycaemic control after a 4 month exercise 
programme. They found that the strength training programme decreased HbA1c levels 
significantly more than the aerobic training programme (-1.2% versus -0.3%). It should 
be pointed out that the exercise groups reported different, although not significant, 
baseline HbA1c levels (8.3% the resistance group versus 7.7% the aerobic group), which 
could have partly compromised the findings. Thus, there is evidence that exercise-
induced improvements in glycaemic control are greater among persons with higher 
baseline HbA1c values (Sigal et al., 2007). In addition to this finding, there have been 
three recent powerful studies (N>250 in each study) that have assessed the effects of 
long-term (>22 weeks) aerobic training, resistance training, or both (combined aerobic 
and resistance training) on glycaemic control in subjects with type 2 diabetic (Church et 
al., 2010; Dunstan et al., 2008; Sigal et al., 2007). All three have agreed that a 
combination of aerobic and resistance training was the most efficient exercise modality 
to reduce HbA1c levels. Furthermore, Dunstan et al. (2008) and Sigal et al. (2007) 
reported that the effect of aerobic training and resistance training on HbA1c were 
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approximately equal (approximately a reduction of 0.40% when combining both 
studies), and those of the combined exercise training were twice those of aerobic or 
resistance exercises (approximately a reduction of 0.90% when combining both 
studies). On the other hand, Church et al. (2010) reported that only the combination of 
aerobic training and resistance training was associated with a reduction in HbA1c. It 
should be pointed out that, whereas Dunstan et al. (2008) and Sigal et al. (2007) 
attempted to minimize hypoglycaemic medication changes, resulting in low changes in 
medications, Church et al. (2010) did not interfere with that, resulting in substantial 
changes in hypoglycaemic medications across groups. This may explain the lower effect 
size reported by Church et al. (2010) on all types of exercise. These findings suggest 
that a combination of aerobic and resistance training may be more effective for blood 
glucose management than either type of exercise alone, hence suggesting that each type 
of exercise may trigger different and complementary metabolic adaptations. Therefore, 
any increase in muscle mass that may result from resistance training could contribute to 
blood glucose uptake without altering the muscle’s intrinsic capacity to respond to 
insulin. On the other hand, aerobic exercise may enhance its uptake via a greater insulin 
action, independent of changes in muscle mass or aerobic capacity (American Diabetes 
Association et al., 2010).  
 
The evidence shown above suggests that physical activity can reduce blood glucose 
levels in patients with type 2 diabetes, and that a combination of aerobic and anaerobic 
exercises may trigger further reductions than either aerobic or anaerobic training alone. 
In addition to this, aerobic and anaerobic training programmes appear to trigger 
comparable improvements in HbA1c levels.  
 
2.3.1.2 Blood pressure 
 
Although glucose control is essential for preventing microvascular diseases, intensive 
blood pressure control is needed to reduce cardiovascular events in diabetic patients 
with hypertension (Grossman et al., 2000). Luscher and colleagues (2003) carried out a 
review study and reported that lowering blood pressure reduced the risk of 
cardiovascular diseases in diabetic patients by approximately 40%. This figure 
highlights the importance of controlling blood pressure in this population.  
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Aerobic training is commonly recommended to lower blood pressure both in healthy 
and hypertensive individuals. Thus, a meta-analysis of 54 randomized trials carried out 
on healthy subjects found that aerobic exercise was associated with an overall reduction 
in mean blood pressure of 3.9 (systolic)/2.6 (diastolic) mmHg across all initial blood 
pressure levels (Whelton et al., 2002). Evidence on the role strength training may play 
to reduce blood pressure in healthy subjects is less clear. However, there is growing 
evidence to support the benefits of strengthening exercises on reducing blood pressure 
(Carter et al., 2003; Collier et al., 2008). It is believed that the positive effect of PA on 
endothelial function, due to an increased NO release, may be a strong exercise-related 
hypotensive mechanism (McArdle et al., 2000; Tortora & Derrickson, 2006). 
Additionally, central adaptations such as attenuation of the sympathetic pathway 
(responsible for increasing heart rate) secondary to physical training has also been 
postulated (Lesniak & Dubbert, 2001) as a likely mechanism to lower blood pressure.  
 
In agreement with data from non-diabetic populations, physical activity programmes 
have been shown to lower blood pressure in type 2 diabetic patients. Thus, aerobic 
training programmes (Yeater et al., 1990), resistance exercise programmes (Castaneda 
et al., 2002; Dunstan et al., 2002) as well as a combination of aerobic and resistance 
exercises (Loimaala et al., 2003) have been proven to effectively reduce blood pressure 
in diabetic subjects. Cauza et al. (2005) reported a similar improvement in blood 
pressure (both systolic and diastolic) when aerobic training was compared to resistance 
training. However, other investigations failed to find changes in blood pressure 
following an exercise programme (Church et al., 2010; Dunstan et al., 2006).  It is well 
established that hypertensive individuals experience a greater reduction in blood 
pressure than normotensive subjects (Lesniak & Dubbert, 2001). It is worth mentioning 
that the majority of patients with type 2 diabetes take antihypertensive medications. 
This explains why some of the studies which failed to demonstrate a change in blood 
pressure after the exercise training, reported normal baseline blood pressure values 
(Middlebrooke et al., 2006; Sigal et al., 2007).  
 
Overall, there is evidence that PA programmes trigger improvements in blood pressure, 
especially in hypertensive individuals, both with and without diabetes. Although aerobic 
exercises are commonly recommended to lower blood pressure, there is growing 
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evidence to support the benefits of strengthening exercises on reducing blood pressure 
in healthy as well as in type 2 diabetic patients. However, some studies failed to find 
changes in blood pressure following an exercise programme, which suggests that more 
studies have to be carried out to clarify the role of PA in this cardiovascular risk factor.  
 
2.3.1.3 Lipids profile  
 
Comparisons between sedentary and physically active groups have been used to 
establish a positive influence of physical activity on blood lipids. Physical active 
individuals typically exhibit greater HDL and lower triglyceride levels compared to 
their less active counterparts (ACSM, 2000). A meta-analysis including 25 articles 
found that aerobic training (longitudinal data) does increase HDL levels, and that 
exercise duration per session was the most important element to enhance HDL levels in 
healthy individuals (Kodama et al., 2007). In line with those results,  a review of the 
literature carried out by Durstine et al. (2001) also showed evidence of a positive effect 
of aerobic training in LDL, triglyceride and total cholesterol (TC) levels, when weekly 
energy expenditure reached a minimum threshold of 1200 kcalּweek -1. Unlike aerobic 
training, the effect of strength training to enhance lipid profiles in healthy individuals 
has been investigated much less and has provided conflicting results. (Boyden et al., 
1993; Elliot et al., 2002). 
 
The effect of physical activity on blood lipids looks less promising in patients with type 
2 diabetes compared to healthy individuals. A meta-analysis carried out by Thomas et 
al. (2006) showed a significant lowering of plasma triglycerides in the exercise 
intervention groups compared with the control groups. However, there was no 
significant difference between the exercise and the control group in TC, HDL or LDL. 
In agreement with this, another study carried out by Sigal et al. (2007), which assessed 
the effect of different types of physical activity (aerobic, resistance, or combination of 
both) on lipid values on 251 volunteers with type 2 diabetes, reported no changes in 
HDL, LDL, TC or triglycerides in any of the exercise groups. However, they reported a 
trend toward lower triglyceride levels in the resistance training group (p=0.089) when 
compared to baseline levels. The available literature reporting changes in lipid levels 
due to physical activity in type 2 diabetes does not look very promising. However, more 
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investigations are needed to better understand the role of physical activity, in particular 
the different modes of physical activity in changing lipids profile in type 2 diabetes.  
 
Overall, it is well established that physical activity programmes (aerobic training, 
endurance training and a combination of both) can improve health in patients with type 
2 diabetes. Physical activity interventions have been shown to lower glucose levels and 
blood pressure values. On the other hand, the role of PA to enhance lipids profile in 
diabetic patients is less clear. Furthermore, aerobic and strengthening exercise 
programmes appear to trigger comparable improvements in HbA1c and blood pressure 
levels, whereas a combination of aerobic and resistance exercises may trigger a further 
reduction of up to 50% in HbA1c than either type of exercise training alone. This leads 
to the conclusion that a combination of aerobic and resistance exercise may be more 
efficient to improve health related outcome measures in patients with type 2 diabetes 
than each type of exercise alone. Since this evidence has been obtained from studies 
with type 2 diabetic patients with no peripheral neuropathy, these conclusions cannot be 
generalized to other diabetic groups such as neuropathic patients.  
 
DN carries further health complications than the ones related to type 2 diabetes. The 
next subsection will explore the association between physical activity and the health 
problems associated with peripheral neuropathy. Special attention will be paid to the 
potential role of exercise-based rehabilitation programmes in reducing the risk of foot 
ulcers in diabetic patients.  
 
2.3.2 Physical activity and peripheral neuropathy 
 
Foot ulceration in diabetic neuropathic patients is a major health problem commonly 
associated with gait alterations and microvascular impairments. It is therefore essential 
to investigate the effect of PA, not only on glucose levels and traditional cardiovascular 
risk factors, but also on outcome measures relevant to foot ulcer formation in this 
population. In addition to that, QOL, which is increasingly recognized as an important 
goal for health care, is known to be poorer in subjects with neuropathic complications. 
It is therefore important to assess whether PA programmes can promote changes in well 
being in this population. Therefore, this section will investigate the role physical 
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activity interventions may play to influence gait characteristics and microcirculation, 
due to their strong association with foot ulcers, as well as QOL.  
 
2.3.2.1 Gait biomechanics 
 
As previously discussed, patients with diabetes in general and neuropathic patients in 
particular show gait changes when compared to healthy controls, which result in higher 
foot pressures when walking and consequently higher risk of foot ulcerations (Frykberg 
et al., 1998; Veves et al., 1991). Sensory loss is believed to be the single most important 
factor to explain plantar foot pressure (Payne et al., 2002). However, other factors such 
as reduced joint mobility or muscular weakness are also considered to play an important 
role in gait abnormalities in this population. In line with this, some investigators have 
suggested that therapies aiming to improve joint mobility in diabetic patients (Herriott 
et al., 2004) and/or muscle weakness (Akashi et al., 2008) could improve gait in this 
population and consequently reduce foot pressures during walking. In the next section, 
studies that have reported exercise-related changes in 1) sensory loss; 2) limited joint 
mobility; and 3) muscular weakness and their effect on gait characteristics, will be 
presented. 
 
2.3.2.1.1 Sensory loss 
 
Balducci et al. (2006) is the only study to investigate the role of exercise training in the 
progression of neuropathy. Balducci and colleagues carried out a supervised 4 year 
interventional study on diabetic patients with no signs of neuropathy. They found that 
low intensity long term aerobic training (4 h·week-1) can prevent sensory neuropathy in 
non-neuropathic diabetic patients. The percentage of diabetic patients who developed 
sensory neuropathy during the 4 years of the study was significantly higher in the 
control group (N=47) than in the exercise group (N=31) (28.9% and 6.5% occurrence 
rate for the control and exercise group, respectively). Although sensory loss has been 
recognized as the main factor to explain differences in gait in DN patients compared to 
healthy individuals, no investigation to date has assessed whether sensory neuropathy 
can be changed through a physical activity programme. It would also be of interest to 
explore whether other types of exercise can produce beneficial effects on the 
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progression of neuropathy or whether the progression of neuropathy can only be altered 
by aerobic training. The ultimate goal would be to investigate whether improvements in 
sensation could trigger changes in gait characteristics in subjects with DN. 
 
2.3.2.1.2 Limited joint mobility  
 
To date, there is little information available on the treatment of high peak plantar 
pressure in conjunction with limited joint mobility. One preliminary study found that 
physical therapy resulted in significant, although temporary, improvements in the 
mobility of the ankle and foot joints in diabetic neuropathic patients with limited joint 
mobility (Dijs et al., 2000). In addition to this, Goldsmith et al. (2002) found that an 
unsupervised range-of-motion therapy, carried out over a 4 week period did reduce peak 
foot pressures in patients with type 2 diabetes and no neurological complications. They 
reported that peak plantar pressures during gait decreased on average 4.2% in the 
treatment group (N=9) while they increased on average 4.4% in the control group 
(N=10). Despite these interesting results, it should be pointed out that no significant 
changes were observed in joint mobility when comparing pre- and post-intervention 
values, which suggests that factors other than ROM could have explained the results.  
The lack of association between foot pressures and ROM could be also due to the fact 
that ROM was measured passively and not during the walking task.  Spatial-temporal 
characteristics, such as gait velocity or step length, which are well known to affect foot 
pressure, were not reported in this study (Goldsmith et al., 2002). Although final 
conclusions cannot be drawn from this study, it should inspire other researchers to 
investigate the effect of range-of-motion therapies on plantar pressure distribution 
patterns in diabetic populations.  
 
Non-enzymatic glycosylation changes in diabetic patients result in greater joint 
stiffness, which consequently reduces overall joint mobility (Goldsmith et al., 2002). It 
should be pointed out that the greater the joint stiffness, the greater the force required 
for a corresponding displacement. Hence, muscle weakness secondary to motor 
neuropath may further account for the reduction in foot range of motion observed in 
patients with neuropathic complications, especially during dynamic conditions such as 
walking (Giacomozzi et al., 2005). In line with this, Mueller et al. (1995) reported a 
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strong correlation between foot strength levels and ankle dorsi-flexion ROM (r=0.76) 
when measured actively in 19 subjects with type 2 diabetes. It is therefore reasonable to 
think that combined flexibility and resistance training may result in greater mobility 
compared to flexibility exercises alone. In support of this, Fatouros et al. (2002) 
demonstrated that strength training did improve joint mobility in older adults without 
diabetes when compared to aerobic alone or no training. Moreover, Herriott et al. (2004) 
demonstrated that a combination of flexibility and resistance training over an 8 week 
period produced joint mobility gains in type 2 diabetic patients.  
 
Although there is little evidence for the effect of physical therapy and/or strengthening 
exercises on foot mobility and foot pressure modification, the data presented above 
highlights the importance of undertaking further studies to explore whether, or to what 
extent, foot pressures can be reduced by improving joint mobility. 
 
2.3.2.1.3 Muscle weakness  
 
Muscle weakness has been recognized to play an important role in the gait 
abnormalities observed in diabetic patients with motor neuropathy. Muscular 
impairments especially of the foot muscles, have been associated with slower and 
shorter steps and higher foot pressures, as well as producing a different walking strategy 
(hip strategy) (Mueller et al., 1994, Uccioli et al., 2001).  Although muscle 
strengthening has been hypothesized as a promising intervention to reduce foot 
pressures (Akashi et al., 2008) and to improve gait functionality (Gutierrez et al., 2001), 
the role PA programmes may have on walking biomechanics is still uncertain. 
Interestingly, patients with type 2 diabetes without neuropathy have also reported 
significantly lower strength levels when compared to healthy age-matched controls 
(Andersen et al., 2004), which may partly explain the changes in gait characteristics 
observed in this population (Yavuzer et al., 2006). More information about gait 
characteristics in neuropathic and non-neuropathic diabetic patients can be found in 
Section 2.2.2.1.1.  
 
Exercise programmes have been demonstrated to be an efficient tool to improve 
strength levels in subjects with diabetes and without neuropathic complications. 
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Thereby, muscular strength gains have been reported through resistance training (Cauza 
et al., 2005; Dunstan et al., 2006), combined aerobic and resistance exercises (Loimaala 
et al., 2003) as well as aerobic exercises alone (Cauza et al., 2005). Thus, it is expected 
that strengthening exercises, due to the specificity of the training, may trigger the 
greatest improvements in strength levels than any other type of exercise. Strength 
training is well known to improve muscle size as well as intramuscular coordination, 
which result in strength gains (McArdle et al., 2000). However, no study on patients 
with type 2 diabetes has directly compared the effect of different types of exercises on 
strength levels. 
 
The effect of strengthening exercises in diabetic neuropathic patients is much less clear 
than in their non-neuropathic counterparts. The majority of studies assessing resistance 
training programmes in diabetic patients are carried out on non-neuropathic participants 
where little is known about the effect of strengthening exercises on this population. In 
the past, patients with neuromuscular diseases were advised not to exercise because of 
the fear that too much exercise might produce “overuse weakness” (White et al., 2004). 
However, new evidence on patients with different neuromuscular diseases suggest that 
strength training is safe when performed with proper supervision; and that it can reverse 
any component of disuse weakness as well as potentially improving absolute muscle 
strength in those with more slowly progressive musculoskeletal diseases (Krivickas, 
2003).  
 
There appears to be only one systematic review paper which has investigated exercise 
based programmes in subjects with peripheral neuropathy (White et al., 2004). White et 
al. (2006) only found 1 controlled trial comparing the effect of exercise therapy (at least 
8 weeks) with no exercise therapy in people with peripheral neuropathy (any type of 
peripheral neuropathy not just diabetic neuropathy). This trial carried out by Lindeman 
et al. (1995) reported that long-term resistance training (24 months programme) did 
improve knee extension strength values in patients with hereditary motor and sensory 
neuropathy when pre-intervention values were compared to post-intervention values. 
However, the percentage of improvement was moderate when compared with the 
strength increases observed in healthy as well as diabetic persons with no neurological 
complications (Cauza et al., 2005; McArdle et al., 2000) after comparable training 
programmes. Similar results were reported in a recent study carried out by Allet et al. 
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(2010), which has been the first investigation assessing strength changes in diabetic 
neuropathic patients following an 12 week exercise programme. Allet at el. (2010) 
investigated changes in strength levels following a 12 week exercise programme in an 
exercise (N=35) and a control group (N=36). The exercise programme in this study 
consisted of functional strength and endurance exercises (sitting to standing, stair 
climbing, etc.) in contrast to Lindeman’s (1995) study, which controlled weight lifting 
exercises at a specific % of 1 maximal repetition. Allet et al. (2010) reported small 
increases in strength at the hip, knee and ankle muscles following the exercise 
programme in the exercise group compared to the control group. However, only the hip 
flexors and plantar-flexors reached significant levels. It should be pointed out that in 
this study muscle strength was measured with a hand-held dynamometer; the reliability 
of this device is limited by the investigator’s ability to hold the dynamometer stationary 
and by the fact that participants may overpower the testers. The data presented above 
suggest that although neuropathic patients may have diminished muscular strength gains 
compared to non-neuropathic counterparts, resistance training could improve strength 
levels in this population. However, more investigations are needed to understand better 
the muscular responses to strengthening exercise in diabetic patients with motor 
neuropathy.  
 
Studies on different clinical populations that suffer from muscular weakness, including 
elderly people (Rubenstein et al., 2000), have shown that interventions that improve 
neuromuscular performance are efficient in modifying spatial-temporal gait 
characteristics (i.e. walking speed or step length). In agreement with this, Brandon et al. 
(2003) reported that improvements in lower extremity strength levels following 6 
months of training were positively associated with mobility performance in subjects 
with type 2 diabetes (i.e. walking). Interestingly, similar results have been obtained in 
diabetic patients with neuropathic complications. Thus, Allet et al. (2010) found that a 
resistance based exercise programme improved walking speed in DN patients when 
comparing pre- and post-intervention data. Although there is some evidence that 
strengthening exercise programmes may be effective in changing walking patterns in 
diabetic patients, only spatial-temporal gait characteristics have been assessed. Further 
investigations are required to determine the effect of strengthening programmes on 
other aspects of gait, such as foot kinematics, kinetics or muscular activity in diabetic 
patients.   
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Although gait abnormalities in DN subjects are known to contribute to the high rate of 
foot ulcers that occur in this population, this review of the literature demonstrates that 
little is known about the effect of PA interventions on changing gait characteristics in 
DN subjects. It is well established that muscular weakness and limited joint mobility are 
important factors explaining gait alterations in DN subjects. Therefore, it is reasonable 
to think that strength training, together with foot range of motion exercise is the most 
likely physical intervention to trigger changes in gait characteristics in this population. 
Early evidence suggests that flexibility exercises together with strengthening exercises 
could improve ROM and strength levels in DN patients. However, only changes in 
spatial-temporal characteristics has been investigated whereas nobody has yet attempted 
to assess whether joint mobility and/or muscle strength can alter loading patterns during 
gait in this population. In addition to that, aerobic training has been shown to produce 
beneficial effects on the progression of neuropathy, which is considered to be the single 
most important factor to explain gait alterations in DN subjects. However, the effect of 
other types of exercise on sensory neuropathy is unknown as well as whether 
improvements in sensation could lead to changes in gait characteristics in subjects with 
DN.   
 
2.3.2.2 Microcirculation 
 
It is generally accepted that abnormalities in foot microcirculation may play a 
significant role in the development of foot ulcers in diabetic neuropathic patients 
(Korzon-Burakowska & Edmonds, 2006). In addition, impairments in the 
microvasculature have also been associated with conventional vascular risk factors such 
as hypertension (Higashi & Yoshizumi, 2004; Tortora & Derrickson, 2006). Thereby, 
many investigators consider that the attenuation or reversal of microvascular function 
may be important for the prevention of cardiovascular morbidity and mortality in 
diabetes (Cohen et al., 2008) as well as in the reparation of tissue breakdown (Korzon-
Burakowska & Edmonds, 2006).  
 
Exercise training has been demonstrated to improve microcirculation in healthy 
subjects. Available data suggests that exercise programmes may improve endothelium-
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dependent vasodilatation, but not vascular smooth muscle function in healthy 
individuals (Higashi et al., 1999). In line with this, Kingwell et al. (1997) observed that 
4 weeks of aerobic training did significantly improve resting NO production in young 
healthy individuals. It is generally believed that the increase in vascular stress resulting 
from increased exercise-induced blood flow may stimulate the release of NO, which 
consequently improves endothelial function (Higashi & Yoshizumi, 2004). However, a 
number of other factors, including reduced oxidative stress secondary to improvements 
in glycaemic control or hypertension (Higashi & Yoshizumi, 2004; Scott et al., 1999), 
may also account for the exercise-induced improvements in vascular function. Thereby, 
it has been reported that an absolute decrease of 1% in HbA1c levels has been associated 
with a 37% decrease in microvascular complications (Stratton et al., 2000). 
Increasing evidence suggests that regular exercise can improve endothelial function in a 
number of populations in which endothelial dysfunction is common. These include 
individuals with chronic heart failure (Horning et al., 1996), hypertension (Higashi & 
Yoshizumi , 2004),  or type 1 diabetes (Fuchjager-Mayrl et al., 2002). 
Results from exercise interventions in type 2 diabetic patients are controversial. A 
cross-sectional study carried out by Colberg et al. (2002) reported that chronic exercise 
(self reported) is associated with enhanced skin blood flow in type 2 diabetes. 
Interestingly, no differences in maximal levels of NO were found between the exerciser 
and the sedentary groups, which suggests that exercise improves vascular function by 
enhancing sensitivity to NO and not necessary due to NO bioavailability (Higashi & 
Yoshizumi, 2004).  Improvements in vascular function secondary to exercise have also 
been reported during interventional studies. Maiorana et al. (2001) found that 8 weeks 
of combined aerobic and resistance training improved endothelium dependent 
vasodilatation, but did not change endothelium independent vasodilatation in type 2 
diabetic patients. It should be pointed out that Maiorana investigated endothelium 
function in the macrocirculation (brachial artery). In accordance with these results, 
Cohen et al. (2008) found that a 14-month resistance exercise training programme in 
adults with type 2 diabetes improved endothelial dependent vasodilatation in the 
microcirculation (skin blood flow). In addition to this, endothelium independent 
vasodilatation was also shown to be enhanced by the strength training programme. 
Although, vascular responses seem to be enhanced by physical activity programmes, 
some investigations failed to find such association. Colberg et al. (2005) investigated 
the effect of 10 weeks of aerobic training on foot cutaneous blood flow both at rest and 
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during local heating in patients with type 2 diabetes. This study reported that the defect 
in perfusion, evident initially in diabetic participants, was not significantly affected by 
the exercise programme when compared to the healthy group. In line with this, 
Middlebrooke et al. (2006) reported that 6 months of aerobic exercise did not improve 
microvascular function, both endothelium dependent or independent vasodilatation, in 
type 2 diabetes. It is worth mentioning that the interventions that included resistance 
exercises (Cohen et al., 2008; Maiorana et al., 2001) reported an exercise-related 
improvement in vascular function, whereas aerobic training interventions did not. 
Before any final conclusion can be drawn further investigations are required into which 
exercise modality may be the most efficient to improve microvascular function in type 2 
diabetes.  
 
Early evidence suggests that a physical activity intervention may produce beneficial 
changes in the microcirculation of type 2 diabetic patients without neuropathy. 
Although it is difficult to determine which type of exercise (aerobic, resistance or a 
combination of both) is more effective in this matter, strengthening exercises have been 
linked to changes in the microvasculature of type 2 diabetic patients. It is noteworthy, 
that all investigations assessing the effect of PA interventions on the microcirculation of 
type 2 diabetic patients have looked at either resistance vessels or skin microcirculation 
whereas nobody has investigated muscular microcirculation. In addition to this, the 
effect of physical activity on oxygen consumption, which may be another aspect of the 
microcirculation impaired in diabetic individuals (Baldi et al., 2003; Martin et al., 
1995), has not been investigated by any study. 
 
A combination of gait and microcirculation alterations is known to be responsible for 
the high rate of ulcers observed in DN subjects. It is therefore reasonable to think that 
interventions that can influence these factors may reduce the risk of foot ulcers in this 
population. It seems that strength training together with foot range of motion exercises, 
is the most likely intervention to trigger changes in gait characteristics in patients with 
diabetes. Early evidence suggests that strengthening and foot mobility exercises could 
improve ROM (Herriott et al., 2004) and influence spatial-temporal characteristics 
(Allet et al., 2010) in diabetic patients with and without DN. However, nobody has 
investigated whether joint mobility and/or muscle strength can alter loading patterns 
during gait in diabetic patients. Furthermore, early evidence suggests that resistance 
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training may trigger beneficial changes in the microcirculation of type 2 diabetic 
patients without neuropathy (Cohen et al., 2008). Overall, it appears that a combination 
of strengthening and foot mobility exercise is the most likely PA intervention to modify 
gait and microcirculation in diabetic patients.  However, the vast majority of 
investigations assessing PA programmes in diabetic patients have been carried out on 
subjects with type 2 diabetes whereas little is known about the effect of PA 
interventions on DN subjects. Therefore, it is very important to investigate whether 
strength training can improve gait and microcirculation in DN subjects, who are the 
population at highest risk of developing foot problems.   
 
2.3.2.3 Quality of life 
 
Although glycaemic control, the development of foot complications and mortality 
represent critical outcomes in people with type 2 diabetes, health-related QOL outcomes 
are also important (Ali et al., 2010). The value of optimizing QOL is increasingly 
recognised as it represents an important goal for health care (Rejeski & Mihalko, 2001). 
The question remains whether QOL is a modifiable risk factor in diabetic patients or 
just a marker of disease burden. Recently, Harkness et al. (2010) carried out a meta-
analysis to indentify psychosocial interventions that improve both physical and mental 
health in patients with diabetes mellitus. They concluded that although there are 
efficient treatments to improve both diabetes and mental health, they did not identify 
types of interventions that consistently provide benefits for both simultaneously.  
 
The evidence provided above demonstrates that PA can influence some aspects of 
health in patients with diabetes including glucose control and cardiovascular risk factors 
(Thomas et al., 2006; Sigal et al., 2006). However, little is known on the effect of PA 
interventions to modify mental health in patients with diabetes. Glasgow et al. (1997) 
carried out a survey study on 2056 adults with diabetes (type 1 and type 2) to identify, 
using a multiple regression analysis, factors related to lower QOL. Interestingly, they 
found that the level of self-reported exercise was the only significant-management 
behaviour to predict the QOL, after controlling for demographic and medical variables. 
Similar results were found by Green et al. (2011), who reported an association between 
self-reported physical activity levels and self-reported QOL in type 2 diabetic patients 
  75 
(N=2419). Therefore, it seems that participation in physical activity may be associated 
with an improvement in general well-being and QOL in diabetic patients. However, it is 
noteworthy that the majority of studies have investigated this issue retrospectively 
(Glasgow et al., 1997; Green et al., 2011), whereas little is known about whether QOL 
can be modified in diabetic patients (both with and without neuropathy) through a 
structured physical activity programme.   
  
Overall, the evidence presented above demonstrates that the vast majority of studies 
investigating PA interventions on type 2 diabetic patients have been carried out in 
individuals with no neuropathic complications. In fact after a comprehensive search 
only 1 study was found in which an exercise programme was carried out on subjects 
with DN (Allet et al., 2010). This highlights the importance of investigating PA 
interventions on DN subjects. Nevertheless, it is noteworthy that DN subjects are at risk 
to develop foot ulcers during weight bearing activities. It is generally believed that the 
amount of weight-bearing activity among individuals with diabetes is likely to influence 
the amount of mechanical trauma accumulated by plantar tissues (Cavanagh et al., 
1996). This suggests that adaptation of the exercises used is necessary to avoid foot 
complications (Kanade et al., 2006). Contrary to this idea, Mueller & Maluf (2002) have 
proposed the “physical stress theory”, the basic premise of which is that changes in 
physical stress (i.e. plantar tissue stress) cause a predictable adaptative response in all 
biological tissues. According to the physical stress theory, higher cumulative plantar 
tissue stress may result in an increased stress tolerance, whereas low levels of stress 
may lead to tissue weakness. In support of this theory, recent studies have indicated that 
moderate walking does not increase the risk of foot ulcers or reulceration in those with 
DN (Maluf & Mueller, 2002; LeMaster et al., 2008). More evidence is needed to 
recommend weight-bearing activities in DN subjects since it may result in devastating 
consequences in the form of foot ulceration. In line with this interpretation, physical 
activity guidelines for DN subjects recommend non-weight-bearing activities to 
decrease the risk of skin breakdown due to excessive stress (Sigal et al., 2006). More 
studies therefore need to be carried out on DN subjects to find out whether physical 
activity programmes based on non-weight bearing may increase the risk of ulceration in 
this population.  
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2.4 Summary of the literature review 
 
This literature review has attempted to 1) review in detail the pathologies related to DN 
with particular attention to gait and microcirculation alterations due to their association 
with foot ulcers; and 2) review the current literature on the effect of PA interventions on 
the primary pathologies associated with DN. Therefore, this summary of the literature 
review will be divided into two sections.  
 
Health-related characteristics of DN subjects 
The first part of this literature review shows that DN is a complex condition that affects 
different aspects of health including traditional cardiovascular risk factors, gait, 
microcirculation and quality of life. 
 
It is well established in the literature that type 2 diabetes is associated with an increased 
risk of cardiovascular diseases and mortality. It appears that alterations in blood 
pressure, cholesterol levels and obesity secondary to type 2 diabetes, known as 
metabolic syndrome, are partly responsible for the 4 – fold increased risk of 
cardiovascular diseases compared to healthy individuals. 
 
Neuropathy is associated with foot complications. Foot ulceration in diabetic patients 
with DN is considered a major health problem, often leading to lower-limb amputations 
and increased mortality rate. It seems that a combination of gait and microcirculatory 
changes is responsible for the increased risk of foot ulcerations observed in DN 
subjects.  
 
The evidence presented in this literature review chapter demonstrates that patients with 
DN present with a variety of gait alterations compared to healthy individuals. Thus, DN 
subjects show changes in: 1) gait parameters, in the form of spatial-temporal and floor-
foot interaction characteristics (COP); 2) foot pressures, especially in the metatarsals 
region; and 3) muscle activation patterns. This review of the literature shows that, while 
kinetic and kinematic data have been widely investigated in DN subjects, only a handful 
of studies have assessed EMG activity in this population. Furthermore early evidence 
suggests that changes in the onset activation times of the TA and TS have been linked to 
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changes in kinetic data. This suggests that EMG data should be considered as a potential 
contributing factor for the higher foot pressures (PP and PTI) observed in DN subjects, 
especially on the forefoot. This highlights the importance for future studies to study 
EMG activity patterns in patients with DN. 
 
The evidence presented in this chapter shows that there is a general consensus in the 
literature that impairments in microcirculation, especially in vasodilatory capacity, are 
associated with foot ulcer formation in DN subjects. Furthermore, it is well established 
that vasodilatory abnormalities in patients with diabetes are related to impairment in 
endothelial dependent vasodilatation, endothelial independent vasodilatation and nerve-
axon reflex. In addition to this, functional alterations in the microcirculation have also 
been reported in response to an exercise bout (exercise stress), which may partly explain 
the reduced exercise capacity observed in subjects with diabetes. Patients with type 2 
diabetes show a diminished exercise-induced vasodilatory capacity compared to healthy 
individuals, and preliminary evidence suggests that changes in endothelial function may 
be partly responsible for these alterations. However, all the studies investigating 
microcirculatory responses to an exercise bout have been carried out in diabetic patients 
without neuropathic complications.  Moreover, there is an ongoing debate about 
whether the diminished exercise capacity observed in diabetic patients is caused solely 
by a reduction in oxygen delivery or in combination with a reduction in the muscular 
oxidative capacity. This highlights the importance to investigate 1) exercise-induced 
vasodilatory responses in DN patients; and 2) muscular oxygen consumption in patients 
with diabetes mellitus. 
 
Increasing evidence suggests that diabetes in general and DN in particular, impact on 
everyday living and consequently diminish health related QOL. Furthermore, it appears 
that there is a positive correlation between diabetes and its complications and QOL, 
with subjects with more severe complications showing the poorest QOL. Interestingly, 
preliminary evidence suggests that QOL could be associated with biomechanical 
markers; however, more studies need to be carried out to draw any further conclusions.  
 
Overall, it is well known that DN is a complex condition that affects different aspects of 
health including cardiovascular risk factors, gait, microcirculation and QOL. 
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Nevertheless, this literature review shows there are still some gaps in the literature that 
need to be addressed.  
 
Exercise and diabetic peripheral neuropathy 
The second part of this literature review highlights the importance of exercise for 
diabetic patients. There is mounting evidence that physical activity (aerobic, resistance 
and a combination of both) can produce positive changes in blood sugar levels and 
cardiovascular risk factors in diabetic patients. However, all the studies that have 
investigated the effect of PA on traditional cardiovascular risk factors have been carried 
out on diabetic patients with no neuropathic complications. Thus, findings from patients 
with diabetes cannot necessarily be generalized to other diabetic groups such as 
neuropathic patients. This highlights the importance of investigating whether PA can 
produce beneficial changes in the glucose control and cardiovascular risk factors in 
patients with DN.  
 
Foot ulceration in DN subjects is a major health problem, often leading to lower-limb 
amputation and increased mortality rate as well as lower QOL. Therefore, it is essential 
to investigate the effect of PA, not only on glucose levels and traditional cardiovascular 
risk factors but also on outcome measures relevant to foot ulcer formation in this 
population. Muscular weakness and limited joint mobility are important factors when 
exploring gait alterations in DN subjects. Therefore, it is reasonable to think that 
strength training together with foot range of motion exercise is the most likely physical 
intervention to trigger changes in gait characteristics in this population. In line with this 
argument, some investigators have suggested that therapies which aim to improve joint 
mobility in diabetic patients and/or muscle weakness could modify gait characteristics 
in DN subjects, and consequently reduce foot pressures during walking. Early evidence 
suggests that flexibility exercises together with strengthening exercises could improve 
ROM in patients with diabetes and strength levels in DN patients. However, only 
changes in spatial-temporal characteristics has been investigated whereas no study to 
date has attempted to assess whether joint mobility and/or muscle strength can alter 
loading patterns during gait in this population.  
Beside gait alterations, abnormalities in the microcirculation also play a significant role 
in the development of foot ulcers in DN subjects. Thus, early evidence suggests that a 
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physical activity intervention, including strengthening exercises may produce beneficial 
changes in the microcirculation of type 2 diabetic patients without neuropathy. 
Interestingly, the evidence presented above suggests that a combination of mobility and 
strengthening exercises is the most likely intervention to modify both gait and 
microcirculation. Therefore, it can be speculated that if beneficial changes in gait and 
microcirculation can be elicited, the risk of foot complications may be reduced. 
However, to date, no study has attempted to assess the effect of a physical activity 
programme on gait modification (spatial-temporal characteristics, foot pressures 
distributions, etc) and microcirculation in DN subjects. 
 
In addition to that, QOL represents an important goal for health professionals and it has 
been associated with adverse outcomes in people with type 2 diabetes, including poor 
response to therapy, disease progression and even mortality. Although physical activity 
appears to improve QOL in healthy individuals, it is unknown whether QOL in diabetic 
patients can be modified through an exercise programme. 
 
Overall, this literature review chapter shows that there is a gap in the literature when it 
comes to PA interventions in patients with DN. DN subjects appear to be at greatest risk 
of developing foot ulcers during weight bearing activities. Thus, it is generally believed 
that the amount of weight-bearing activity among individuals with diabetes is likely to 
influence the amount of mechanical trauma accumulated by plantar tissues. This 
suggests that an adaptation of the exercises used may be necessary to avoid foot 
complications. 
 
The next chapter outlines the aims, objectives and null hypotheses of this thesis to 
address the areas identified in the literature review requiring further investigation. 
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CHAPTER 3  
3 Aims, objectives and hypotheses 
 
3.1 Aims of the thesis 
 
This thesis has three main aims:  
 
The first aim was to determine the reliability of some of the methods used in the main 
part of the present study. This includes three different pilot studies 
 
1) To determine the reliability of near infrared spectroscopy (NIRS) to quantify 
muscular blood flow and oxygen consumption in the calf muscle simultaneously during 
a venous occlusion.  
2) To develop and ascertain the reliability of a new approach to calculate EMD during 
isometric contractions. 
3) To develop and ascertain the reliability of a new approach to calculate EMD for the 
plantar-flexor muscles during walking.  
 
The second aim was to investigate differences between DN and healthy individuals in 
the primary pathologies associated with DN  
 
The third aim was to investigate the effect of a 16-week PA programme, which included 
strengthening and joint mobility exercises, on identified pathologies associated with 
peripheral neuropathy in DN subjects. . 
 
On this basis, this thesis includes two main sections: Section 1 contains the three 
preliminary studies on the reliability of some of the methods used in the main study.  
Section 2 includes the main study of the thesis and was conducted in two different parts: 
Part 1 investigated the difference in health-related outcome measures between healthy 
and DN subjects. Part 2 evaluated the effect of a PA intervention on health-related 
outcome measures in DN individuals.  
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3.2 Objectives 
 
3.2.1 Preliminary studies 
 
Near Infrared Spectroscopy (NIRS) reliability study 
To test within-day and between-day reproducibility of NIRS when measuring blood 
flow on the calf muscles (medial gastrocnemious) during venous occlusion. 
 
To test within-day and between-day reproducibility of NIRS when measuring oxygen 
consumption on the calf muscles (medial gastrocnemious) when using the venous 
occlusion method. 
 
Electromechanical delay (EMD) determination during isometric contractions. 
To test within-day reliability of a new approach to calculate EMD during isometric 
contractions in healthy and DN subjects. 
 
To compare EMD values during knee extension, knee flexion, plantar-flexion and dorsi-
flexion between healthy and DN individuals. 
 
Electromechanical delay (EMD) determination for the plantar-flexor muscles 
during gait. 
To test within-day reliability of a new approach to calculate EMD during gait. 
 
To compare EMD values for the plantar-flexor muscles during gait between healthy and 
DN individuals. 
 
3.2.2 Main study- Part 1 (Cross-Sectional study) 
 
To investigate differences between healthy and DN subjects in outcome measures 
related to general health, in the form of cholesterol levels and blood pressure. 
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To investigate differences between healthy and DN subjects in outcome measures 
related to gait characteristics, in the form of strength levels, gait parameters, kinetic data 
and muscular activity patterns.  
 
To investigate differences between healthy and DN subjects in outcome measures 
related to microcirculation, in the form of muscle blood flow and oxygen consumption, 
both at rest and in response to an exercise bout. 
 
To investigate differences between healthy and DN subjects in outcome measures 
related to self reported QOL. 
 
3.2.3 Main study- Part 2 (Intervention study) 
 
To investigate the effect of a 16-week strengthening and joint mobility training 
programme in general health related outcome measures, in the form of HbA1c, sensory 
neuropathy, blood pressure, cholesterol levels and obesity.  
 
To investigate the effect of a 16-week strengthening and joint mobility training 
programme in outcome measures related to gait characteristics, in the form of strength 
levels, gait parameters, kinetic data and muscular activity patterns.  
 
To investigate the effect of a 16-week strengthening and joint mobility training 
programme in outcome measures related to microcirculation, in the form of muscle 
blood flow and oxygen consumption, both at rest and in response to and exercise bout. 
 
To investigate the effect of a 16-week strengthening and joint mobility training 
programme in outcome measures related to self reported QOL. 
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3.3 Null Hypotheses 
 
The null hypotheses for the preliminary study and the 2 parts of the main study were: 
3.3.1 Preliminary studies  
 
Near Infrared Spectroscopy reliability study 
Null Hypotheses 1 
There will be moderate reliability (ICC<0.6) between the within-day and between-day 
scores of blood flow when measured on the calf muscles during venous occlusion. 
 
Null Hypothesis 2 
There will be moderate reliability (ICC<0.6) between the within-day and between-day 
scores of muscle oxygen consumption when measured on the calf muscles during 
venous occlusion. 
 
EMD determination during isometric contractions 
Null Hypothesis 1 
There will be moderate reliability (ICC<0.6) between the within-day scores when 
calculating EMD during isometric contractions in healthy and DN subjects. 
 
Null Hypothesis 2 
There will be no differences in EMD values during knee extension, knee flexion, 
plantar-flexion and dorsi-flexion contractions between healthy and DN individuals. 
 
EMD determination for the plantar-flexor muscles during gait. 
Null Hypothesis 1 
There will be moderate reliability (ICC<0.6) between the within-day scores when 
calculating EMD for the plantar-flexor muscles during gait.  
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Null Hypothesis 2 
There will be no differences in EMD for the plantar-flexor muscles during gait between 
healthy and DN individuals.  
 
3.3.2 Main Study- Part 1. 
 
Null Hypothesis 1 
There will be no differences in general health outcome measures in the form of blood 
pressure and cholesterol levels between the healthy and DN groups.  
 
Null Hypothesis 2 
There will be no differences in 1) gait characteristics in the form of gait parameters, foot 
pressures and muscular activity patterns during a gait task between the healthy and DN 
groups; and 2) lower limb muscle strength. 
 
Null Hypothesis 3 
There will be no differences in microcirculation in the form of capillary blood flow and 
oxygen consumption both at rest and in response to an exercise bout between the 
healthy and DN groups. 
 
Null Hypothesis 4 
There will be no differences in self reported quality of life in the form of mental health 
and physical health between the healthy and DN groups. 
 
3.3.3 Main study- Part 2 
 
Null Hypothesis 1 
There will be no differences in HbA1c, sensory neuropathy, cholesterol levels and blood 
pressure before and after the intervention (over time) between the control and the 
exercise group. 
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Null Hypothesis 2 
There will be no differences in: 1) gait parameters, foot pressures and EMG patterns 
during a gait task; and 2) lower limb strength levels before and after the intervention 
between the control and the exercise group. 
 
Null Hypothesis 3 
There will be no differences in capillary blood flow and oxygen consumption at rest and 
in response to an exercise bout before and after the intervention between the control and 
the exercise group.  
 
Null Hypothesis 4 
There will be no differences in self reported QOL before and after the intervention 
between the control and the exercise group.  
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CHAPTER 4  
 
4 Preliminary studies 
 
4.1 Reliability of near infrared spectroscopy (NIRS) to 
quantify muscular blood flow and oxygen consumption 
in the calf muscle using the venous occlusion method. 
 
4.1.1 Introduction 
 
Skeletal muscles make up approximately 40% of the total body mass, thus representing 
an important percentage of cardiac output and total oxygen consumption even at rest. 
Under working conditions, muscle blood flow can increase to 80-85% of cardiac output 
and oxygen consumption can exceed the resting value 50-fold (McArdle et al., 2000; 
Tortora & Derrickson, 2006). Thereby, the study of blood flow and oxygen 
consumption of limbs is of great relevance in exercise physiology and in patients with 
cardiocirculatory impairments. 
 
The standard for measurement of blood delivery and oxygenation in the arm and leg is 
the combination of strain-gauge plethysmography and blood gas analysis for 
determination of blood flow and arteriovenous O2 difference, respectively (van 
Whitney, 1953; Cort et al., 1991). However, the volume of interest for both techniques 
is limited to the total limb, whereas tissues other than the muscle tissue can influence 
muscle oxygen consumption and blood flow.  
 
NIRS is a non-invasive, continuous, and direct method to determine oxygenation and 
haemodynamics in tissue. It enables the study of local differences in muscle O2 
consumption and delivery.  Furthermore, NIRS enables the measurement of O2 
consumption and blood flow at rest (van Beekvelt et al., 2001a) as well as during 
exercise (Homma et al., 1996) and it discriminates between normal and pathological 
states (Boushel et al., 2001; Kooijman, et al., 1997).  
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Numerous studies have shown the validity of NIRS to determine muscle blood flow 
(BF) by comparing it against well-established methods such as strain-gauge 
plethysmography (van Beekvelt et al., 2001b; De Blasi et al., 1994; Homma et al., 1996; 
Mancini, et al., 1994) or dye dilution in combination with magnetic resonance imaging 
(Boushel et al., 2000b). Muscle oxygen consumption (mV O2) measured by NIRS has 
also shown good agreement with blood gas analysis for determination of arteriovenous 
O2  differences (van Beekvelt et al., 2001b; De Blasi et al., 1994; Homma et al., 1996). 
 
Non invasive quantification of mV O2  and BF using NIRS has become possible by 
applying an occlusion to control circulation in the limb. BF measurements are carried 
out when applying a venous occlusion. This method has shown high reproducibility 
both within one session (van Beekvelt et al., 2001a; van Beekvelt et al., 2002) and 
between days (De Blasi et al., 1994). The studies reported above investigated the 
reliability of NIRS for measurements in the upper limb. However little is known about 
the reproducibility of the NIRS device both within a session and between days when 
measuring blood flow in the lower limb.  
 
Unlike blood flow measurements, mVO2  can be measured during both venous (De 
Blasi et al., 1994; van Beekvelt et al., 2001b) and arterial occlusion (Kragelj et al., 
2000; van Beekvelt et al., 2001a). It has been suggested that the venous occlusion (VO) 
method is to be preferred over the arterial occlusion method because venous occlusion 
is less inconvenient for the subject, the recovery is much faster, and oxygen 
consumption and blood flow can be measured simultaneously (van Beekvelt et al., 
2002; De Blasi et al., 1997). In addition to this, arterial occlusion, which requires a cuff 
inflation of at least 30 mmHg above the individual systolic blood pressure for 
approximately 45 seconds, may not be recommended for patients with hypertension or 
cardiovascular impairments.   
 
Van Beekvelt and colleagues (2001a) showed high within day reproducibility when 
resting muscular oxygen consumption was measured on the forearm during arterial 
occlusion. They reported a coefficient of variation of 16.2 % for the three arterial 
occlusions carried out during the session. A coefficient of variation slightly higher 
(17.6%) was reported by the same research group using the same procedures when 
assessing the reproducibility on three separate days (van Beekvelt et al., 2002). In line 
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with these results, Kragelj and colleagues (2000) reported a coefficient of variation of 
22.3% when oxygen consumption at rest was assessed on the distal part of the foot on 
four to six different days using arterial occlusion. 
 
Contrary to the arterial occlusion method to assess muscular oxygen consumption, the 
reproducibility of the “preferable” VO method is less certain. To the best of my 
knowledge, van Beekvelt et al. (2001b) is the only study, which reports the 
reproducibility of NIRS for mV O2 measurements using the VO method. They carried 
out three VO on the forearm and reported a coefficient of variation of 30.6 % and 25.4% 
when the inter-optode distance was 35 and 50 mm, respectively. They concluded that 
the arterial occlusion method was the preferred method to quantify mV O2  because it 
offers higher reproducibility compared to the VO method. However, there is only one 
study investigating the reliability of the “preferable” venous occlusion method and 
nothing is known about the reproducibility of this technique to assess oxygen 
consumption in the lower limb.  
 
The purpose of this study was therefore 1) to test within day and between day 
reproducibility of NIRS when measuring BF on the calf muscles (medial 
gastrocnemious); 2) to determine whether quantification of mVO2 by NIRS using VO is 
reproducible both within a session and between sessions.  
 
4.1.2 Materials and Methods 
 
Subjects 
Ten healthy volunteers (5 men, 5 women) participated in this study. The study was 
approved by the School Ethics Committee, and all subjects gave their written consent. 
The subject characteristics were 33± 4.3 year in age, 168.1± 6.3 cm in height, and 70.4± 
5.3 kg in weight. None of the volunteers were taking any medication that may affect 
muscle peripheral circulation.  
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NIRS 
NIRS is based on the relative transparency of tissue to light in the near-infrared region, 
and on the oxygen-dependent absorption changes of haemoglobin and myoglobin. 
Although there is not a general agreement on the contribution of myoglobin to the near 
infrared absorption changes (Mancini, 1994), this does not affect the results from the 
present study, since the current study was interested in the amount of O2 consumed, 
regardless of whether it was supplied by haemoglobin or myoglobin. NIRS 
measurements were performed using the Oxymon MK III (Artinis Medical systems 
B.V, Zetten, The Netherlands), which generates light at 781 nm and 856 nm. NIRS 
enables non-invasive continuous measurement of changes in the concentration of 
oxygenated haemoglobin (HbO) and deoxygenated haemoglobin (HbdO). The sum of 
HbO and HbdO concentrations reflects the total amount of haemoglobin (tHb), and 
changes in tHb can be interpreted as changes in blood volume in the tissue.  
NIRS measurements were done on the belly of the medial gastrocnemious (MGast) with 
an inter-optode distance (distance between source and detector) of 40 mm. Waterproof 
markers on the MGast avoided variation in placement over separate days.  
 
 
Quantification of BF and mVO2 was carried out during VO. Venous occlusion causes an 
increase blood volume by an undisturbed arterial (in) flow and interrupted venous (out) 
flow (see Figure 4-1).  Blood flow can therefore be calculated during venous occlusion 
from the linear increase of tHb (∆tHb). Concentration changes of tHB ([Hb]) were 
expressed in micromolars per second and were converted to millilitres blood per 100 
millilitres tissue per minute using an average Hb concentration of 7.5 mmolּL-1 for 
female subjects and 8.5 mmolּL-1  for male subjects. The molecular weight of 
haemoglobin (64.458 gּmol-1) and the molecular ration between haemoglobin and 
oxygen (1:4) were taken into account (Beekvelt et al., 2002; De Blasi et al., 1994). 
Muscular oxygen consumption was calculated from the linear increase of HbdO 
(∆HbdO). Since the venous outflow is blocked the increase in HbdO is thought to be 
solely due to the O2 consumed under the assumption the arterial O2 saturation is near 
100%. Concentration changes HbdO were expressed in micromolars per second and 
converted to mlO2ּO2-1ּ100 g-1 taking into account that each molecule of haemoglobin 
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binds for molecules of O2 and that the molar volume of gas is 22.4 L. A value of 1.04 
kg·l-1 was used for muscle density (Beekvelt et al., 2002; De Blasi et al., 1994).  
 
Equations:   
 
BF= Abs(((∆tHb*60)/([Hb]*1000)/4))*1000)/10 in mlּmin -1ּ100 ml-1  
mVO2= Abs(((∆HbdO*60)/(10*1.04))*4)*22.4/1000 in mlO2ּmin -1ּ100 g-1 
 
 
 
Figure 4-1. Overview of the venous occlusion method to quantify muscular BF and mVO2 
 
 
 
Procedures 
 
 
 
 
Note: The blue line represents the deoxygenated haemoglobin (HbdO), the red line represents the 
oxygenated haemoglobin (HbO) and the green line represents the total haemoglobin content (tHb). 
 
NIRS measurements were carried out on the MGast of the right leg with the subject 
lying down in a supine position on a KINCOM machine. The right leg was semi-
extended (30º± 10 flexion) while the foot rested on a foot dynamometer. The foot was 
positioned above the heart level and the leg in an upward position to avoid venous 
pooling of the blood.  A pneumatic cuff was placed around the thigh and was used to 
apply venous occlusion during the test. 
 
After placement of the instruments, the experiment started with a 5 minutes rest period, 
followed by a VO (50 mmHg). The cuff was maintained inflated for 30 seconds. This 
procedure was repeated three times with a resting period of 40 seconds between 
inflations. All subjects attended three times on separate days to test the between days 
tHB 
HbdO 
HbO 
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reproducibility of NIRS to measure muscular BF and mVO2 using the VO method. 
NIRS data was processed and analyzed using the Oxysoft 2.1.2 software (Artinis 
Medical systems B.V, Zetten, The Netherlands). 
 
Statistics 
Systematic bias for within day and between day reliability data was assessed by a one-
way analysis of variance (ANOVA) for repeated measures. The within-subject 
variability was calculated as the coefficient of variation (CV) for each subject 
[(SD/mean)*100]. CV was determined both for the within day as well as for the 
between days data.  The day to day and between days reproducibility was determined by 
calculating the Intraclass correlation coefficient (ICC). The same statistical tests were 
applied when assessing the reproducibility of blood flow and muscular oxygen 
consumption. The level of statistical significance was set at P≤0.05. All analyses were 
performed with SPSS version 16.0 (SPSS Inc., Chicago, IL, USA). 
 
4.1.3 Results 
 
The reproducibility of the NIRS measurements for within day mVO2 and BF 
measurements were investigated by means of the repetitions of three venous occlusions. 
All results for within day reliability measurements are shown in Table 4-1and Table 
4-2. No significant differences between within day measurements were observed for BF 
as well as mVO2 values (p=0.535). In addition to that, the relative variability within 
subjects (CV) for within days was 10.4% and 14.40% for BF and mVO2, respectively. 
An ICC for within day measurements of 0.92 and 0.86 was observed for BF and mVO2, 
respectively. 
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Table 4-1. Within-day reliability: Blood flow 
Subject BF rep 1 (mlּmin -
1
ּ100 ml-1) 
BF rep2 
(mlּmin -
1
ּ100 ml-1) 
BF rep3 
(mlּmin -
1
ּ100 ml-1) 
Anova   
p value 
CV % ICC 
1 0.492 0.474 0.478 1.98 
2 0.802 0.854 0.993 11.14 
3 0.578 0.527 0.460 11.30 
4 0.895 1.202 0.945 16.25 
5 0.375 0.415 0.300 16.01 
6 0.123 0.110 0.111 6.20 
7 0.414 0.553 0.505 14.32 
8 0.619 0.673 0.766 10.84 
9 0.356 0.362 0.305 9.10 
10 0.607 0.527 0.583 7.12 
Overall 0.526 0.570 0.545 0.535 10.43 0.92 
 
 
 
Table 4-2. Within-day reliability: Muscular Oxygen Consumption 
Subject mVO2 rep 1 (mlO2ּmin -
1
ּ100 g-1) 
mVO2 rep2 
(mlO2ּmin -
1
ּ100 g-1) 
mVO2 rep3 
(mlO2ּmin -
1
ּ100 g-1) 
Anova 
p value 
CV % ICC 
1 0.015 0.013 0.013 7.34 
2 0.025 0.022 0.022 7.63 
3 0.020 0.023 0.024 10.77 
4 0.024 0.018 0.029 22.77 
5 0.029 0.019 0.030 22.30 
6 0.009 0.006 0.006 20.78 
7 0.012 0.011 0.017 19.91 
8 0.035 0.045 0.037 13.83 
9 0.011 0.011 0.010 6.99 
10 0.020 0.024 0.025 11.71 
Overall 0.020 0.019 0.021 0.442 14.40 0.86 
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The reproducibility of the NIRS measurements for between day mVO2 and BF 
measurements were investigated by averaging the repetitions of three venous occlusions 
on three separate days (average day 1, average day 2 and average day 3).  
 
All results for between day reliability measurements are shown in Table 4-3 and Table 
4-4. No significant differences between day measurements were observed for BF as 
well as mVO2 values. The relative variability within subjects (CV) for between days 
was 20.94% and 22.80% for BF and mVO2, respectively. An ICC for between day 
measurements of 0.72 and 0.68 was observed for BF and mVO2, respectively. 
 
 
 
Table 4-3. Between-day reliability: Blood flow 
Subject BF day 1 (mlּmin -
1
ּ100 ml-1) 
BF day 2 
(mlּmin -
1
ּ100 ml-1) 
BF day 3 
(mlּmin -
1
ּ100 ml-1) 
Anova 
p value 
CV % ICC 
1 0.481 0.464 0.390 10.80 
2 0.883 0.882 0.953 4.46 
3 0.522 0.364 0.328 25.44 
4 1.014 1.766 0.887 38.84 
5 0.363 0.371 0.485 16.68 
6 0.114 0.307 0.309 45.76 
7 0.422 0.491 0.542 12.40 
8 0.686 0.480 0.499 20.52 
9 0.341 0.341 0.310 5.46 
10 0.572 0.398 0.328 29.07 
Overall 0.540 0.586 0.503 0.638 20.94 0.72 
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Table 4-4. Between-day reliability: Muscular Oxygen consumption 
Subject mVO2 day 1 (mlO2ּmin -
1
ּ100 g-1) 
mVO2 day 2 
(mlO2ּmin -
1
ּ100 g-1) 
mVO2 day 3 
(mlO2ּmin -
1
ּ100 g-1) 
Anova 
p value 
CV % ICC 
1 0.0139 0.012 0.007 32.52 
2 0.023 0.017 0.020 15.27 
3 0.023 0.026 0.021 9.56 
4 0.024 0.022 0.029 14.50 
5 0.026 0.033 0.046 29.45 
6 0.007 0.010 0.014 34.66 
7 0.020 0.014 0.013 25.34 
8 0.039 0.030 0.032 13.80 
9 0.011 0.027 0.015 45.61 
10 0.023 0.026 0.023 7.30 
Overall 0.021 0.021 0.022 0.911 22.80 0.68 
 
 
4.1.4 Discussion 
 
The main finding in this study was that the venous occlusion method showed good 
reproducibility when measuring BF and mVO2 in the calf muscle both within-day and 
between-days. Data also shows that the relative variability within-subjects, when 
looking at the SD in relation to the mean, and the ICC values were consistently better 
for the BF compared to the mVO2 data both within-day and between-days. 
 
 
Reproducibility of BF measurements  
Blood flow measurements in the calf muscles showed good reproducibility. An ICC 
value of 0.92 and 0.72 for within-day and between-days demonstrated that the 
reproducibility of the venous occlusion methods to quantify BF is excellent and 
substantial, respectively (Landis & Koch, 1977). The relative variability within subjects 
(CV) was 10.43% and 20.94% for within and between-days respectively. In line with 
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the results from the present study, de Blasi (1994) reported a coefficient of variation of 
10% and 22% when blood flow was calculated in the forearm within the same day and 
between days, respectively. It should be pointed out that de Blasi (1994) only tested two 
individuals over three different days to quantify the reproducibility of this method 
between days. Van Beekvelt and colleagues in two different studies found higher 
coefficient of variation, 28.6% and 22.4% compared to the results from the current 
investigation when assessing within day reliability of the NIRS to quantify forearm BF 
(van Beekvelt et al., 2001b & van Beekvelt et al., 2002).  
 
Previous studies have used NIRS to investigate blood flow delivery in the lower limb in 
patients with circulatory problems (Kooijman et al., 1997; Mohler et al., 2006). 
Kooijman et al. (1997) stated that NIRS is an effective noninvasive method for 
assessing claudication following a walking exercise in patients with peripheral arterial 
diseases. In addition to this, Mohler et al. (2006) investigated the vasodilatory responses 
of the calf muscles to physical activity in diabetic patients and they reported significant 
differences in blood flow delivery when diabetic patients were compared to age 
matched healthy individuals. Therefore, mounting evidence demonstrates that NIRS is 
an efficient non-invasive tool to assess muscle circulation in healthy and clinical 
population. However: 1) the reproducibility of NIRS to quantify BF on different days 
was uncertain; and 2) the reproducibility of NIRS to assess BF on the lower limb was 
unknown. This is the first study that shows that NIRS is a reliable tool to 1) quantify 
blood flow on different days and 2) assess blood flow on the lower limb.  
 
Reproducibility of mV O2 measurements  
There is a debate as to which occlusion method should be used to assess mVO2 with a 
NIRS device. It has been suggested that the venous occlusion method should be the 
preferred option over the arterial occlusion since it is less inconvenient for the subject, 
the recovery is much faster, and oxygen consumption and blood flow can be measured 
simultaneously. Arterial occlusion requires a cuff inflation of at least 30 mmHg above 
the individual systolic blood pressure for approximately 45 seconds, which may not be 
advisable for patients with circulatory problems.  
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In the present study it has been shown that venous occlusion is a reliable method to 
quantify oxygen consumption on the calf muscles. ICC values show an excellent 
reproducibility for within-day reliability (0.86) and a substantial reproducibility for 
between-days reliability (0.68).  
 
In disagreement with the results from the current study, van Beekvelt et al. (2001b) 
suggested that venous occlusion was not a reliable method to assess O2 consumption 
using NIRS. They investigated the reproducibility of mVO2 during three consecutive 
venous occlusions (within day) and they found significant differences among them by 
running a one-way analysis of variance for repeated measures. It was therefore 
concluded that because no differences were expected on the basis of physiological 
background the venous occlusion method was not reliable to measure mVO2. 
Interestingly, Beekvelt et al. (2001b) measured the same muscle (Flexor digitorum 
superficialis) using two different inter-optode distances, 35 and 50 mm. They found that 
a distance of 50mm generated reproducible results whereas and distance of 35mm did 
not. Although the mVO2 measurements using an inter-optode distance of 50mm were 
considered reproducible, a CV of 25.4% was reported which is considerably higher that 
the 14.4% observed in the present study. Near infrared spectroscopy light travels in a 
“banana shape” from the source to the detector, and the maximum penetration depth is 
roughly half the inter-optode distance (Homma et al., 1996). Therefore, a possible 
explanation for the conflicting results observed in Beekvelt´s study, compared to the 
present investigation, is that an inter-optode distance of 35mm may have not been 
appropriate to measure the Flexor digitorum superficialis and could have compromised 
their results. In the present investigation, the NIRS device was applied on the bulk of 
the MGast using an inter-optode distance of 40mm. Furthermore results from the 
present investigation (using the venous occlusion method to quantify mVO2) show a CV 
of 14.40%, which is comparable with the CV of 16.2% reported by Beekvelt et al. 
(2001) when assessing mVO2 using the arterial occlusion method. This confirms that 
venous occlusion is a reliable method to measure mVO2. 
 
Expectedly, results from the present investigation show that CV values for muscular O2 
consumption were consistently higher when calculated between days (22.80%) than 
when measured within the same day (14.40%). However, the CV obtained in the present 
study for between days is in agreement with CV values reported in the literature when 
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mVO2 was determined using the considered “more reliable” arterial occlusion method 
(Kragelj et al., 2000). Kragelj et al. (2000) reported a CV of 22.3% when O2 
consumption at rest was assessed on the distal part of the foot on four to six different 
days using arterial occlusion.  In addition to that, Van Beekvelt et al. (2002) published a 
CV of 17.6% when mVO2 measurements were carried out three times on separate days. 
Therefore, our results show for the first time that the “preferable” venous occlusion 
method is reliable to measure mVO2 in the calf muscle within the same day and 
between days.  
 
In conclusion, the present results suggest that venous occlusion is a reproducible 
method both within day and between days to quantify blood flow and muscular oxygen 
consumption in the MGast using an inter-optode distance of 40 mm. 
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Reliability studies for “EMD” determination  
 
Electromyography is a non invasive method to measure the electrical signal associated 
with the contraction of a muscle (Winter et al., 2009). Hence, EMG data provides with 
useful information about to the timing and relative intensity of muscular function during 
different conditions, and has played a very important role in the understanding of 
human movement over the last decades (Perry & Burnfield, 2010). However, the EMG 
signal refers to the electrical event produced by the muscle and not to the mechanical 
output (force) (Winter et al., 2009). The time lag between EMG activity and force 
production is called electromechanical delay (EMD) and it is suggested to include the 
propagation of the action potential over the muscle membrane, the excitation-
contraction coupling process and; the stretching of the series elastic component by the 
contractile element (Cavanagh & Komi, 1979; Nordez et al., 2009). Therefore, there is 
little doubt that EMD should be taken into consideration when attempting to associate 
EMG signal and muscle function. Otherwise the prediction of segmental movement 
from EMG data could be mistimed and could lead to misinterpretations. 
 
The question remains how to better account for the time delay between muscular 
activity and force production when attempting to predict muscular function from EMG 
data. Previous investigations have reported differences in EMD values due to the type 
of muscle contraction (Cavanagh and Komi, 1979) and movement velocity (Howatson 
et al., 2009). This suggests that the task used to calculate EMD values should be the 
same as for the EMG analysis. Since in the present study EMG traces were investigated 
during gait, it appears ideal to determine EMD for the different muscles under 
investigation during walking. For this reason a reliability study was carried out to 
determine the reliability of a novel approach to determine EMD for the plantar-flexor 
muscles during gait. However, the instrumentation used during gait only allows the 
measurement of the forces generated by the plantar-flexion (PF) muscles whilst the 
forces produced by the dorsi-flexion (DF), knee-extension (KE) and knee-flexion (KF) 
muscles were not be determined. For this reason, another approach to determine EMD 
values for all the muscle groups during isometric contractions was also investigated.  
The next sections present the 2 reliability studies carried out prior to the main study to 
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determine the reliability of two different approaches to investigate EMD 1) during 
isometric contractions; and 2) during gait.  
 
4.2 Electromechanical delay determination during 
isometric contractions. 
 
4.2.1 Introduction 
 
When EMD is determined as the time delay from the onset of muscular activity to the 
onset of force production (definition of EMD), EMG and torque production signals are 
synchronised at the beginning of the muscular contraction (the timing at the beginning 
of the muscular output is accurately predicted by the EMG signal). However, if the 
relationship between tested muscle/s EMG and the total joint moment is not linear then 
the prediction of muscular output from EMG signal may be inaccurate later on during 
the contraction. This obviously will compromise the interpretation of the EMG data in 
relation to movement. Many studies have intended to predict mechanical output on the 
basis of EMG signal (Amaranti & Martin, 2004; Hof et al., 1987; van Zandwijk, et al., 
2000). However, there is not a general consensus on whether there is a linear 
relationship between EMG and force production even during isometric conditions. Hoff 
(1997) stated that in isometric conditions there is, usually, a linear relationship between 
muscle force and EMG data. In contrast, Metral & Cassar, (1981) found a linear 
relationship between these traces only during low intensity (< 50%) whereas above that 
intensity the relationship was not linear. This suggests that accounting for EMD does 
not fully resolve this issue and EMG cannot estimate mechanical output during 
sustained contractions.  
 
Following this logic, it is reasonable to think that instead of calculating time differences 
from onset of muscular activity to onset of force production (EMD), the calculation of 
the mean time differences between EMG and isokinetic data during the whole 
contraction may be more meaningful in this context.  Cross-correlation is a 
mathematical solution that provides the average time differences between two traces 
over a period of time. However, to the best of my knowledge, no study has investigated 
the reliability of this method to assess time differences between EMG data and 
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isokinetic dynamometer data. For the purpose of this investigation the term “EMD” 
refers to the average time differences between EMG and force data.  However, EMD is 
usually defined as the time lag between the onset of muscular activity to the onset of 
mechanical output.  
 
In the main study of the present thesis EMG data was used to investigate muscular 
activity patterns during gait in healthy subjects, as well as in patients with DN. For this 
reason the reliability of this new approach to calculate “EMD” was investigated both in 
healthy and DN subjects. An additional aim of the present study was to investigate 
“EMD” differences between healthy individuals and patients with DN. To the best of 
my knowledge no study has investigated whether subjects with DN show differences in 
EMD values compared to healthy counterparts.  
 
Thus, the aim of this investigation was twofold: 1) to assess the reproducibility of cross-
correlation to calculate “EMD” during 3 maximal isometric voluntary contractions in 
healthy as well as in DN patients; 2) to investigate “EMD” differences between healthy 
individuals and diabetic patients.  
 
4.2.2 Methods 
 
Subjects 
78 volunteers participated in this study of which 53 were diagnosed with DN (DN 
group) and 25 were healthy (HEALTH group). The study was approved by the Cardiff 
and Vale NHS Trust Research & Development Office and the South East Wales Local 
Research Ethics Committee and all subjects gave their written consent.  
 
The subjects characteristics were 62.20± 7.55 years of age, 169.1± 9.8 cm in height, and 
93.03± 17.47 kg in body mass for the diabetic group and 57.76± 10.60 years of age, 
171.1± 8.6 cm in height, and 78.63± 9.56 kg in body mass for the healthy group.   
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Procedures 
“EMD” was assessed during 3 maximal isometric contractions for the knee extensors, 
knee flexors, ankle dorsi-flexors and ankle plantar-flexors. Ankle PF and ankle DF 
measurements were carried out with the subject lying down on a supine position. The 
right leg was semi-extended (30º± 10 flexion) with the ankle fixed at 15º plantar-
flexion. The external malleoli was placed in line with the rotation axis. This position 
was chosen to maximize the muscular activity in the calf muscles during the PF. KF and 
KE were tested with the subject seated in an upright position (90º hip flexion) with their 
knees flexed to 90º and 70º, respectively. The right leg was secured into an 
instrumented cuff positioned at a point a few centimetres above the ankle joint with a 
stabilization strap across the femur of the right leg. A seat belt was used to secure the 
subject in the sitting position and prevent them from altering their position during the 
data collection. The moment arm distance was recorded and used when processing 
strength data for all 4 movements. 
 
Prior to data collection, a warm up period was performed. To increase body temperature 
and therefore reduce the risk of muscular problems such as cramps, participants were 
asked to ride an indoor bike for 5 minutes at an increasing (moderate) pace. Once, on 
the isokinetic dynamometer device (on the position described above), they performed 15 
contractions for 2 seconds at different levels of intensity (40% and 60%). Data 
collection consisted in three maximal voluntary contractions (MVC) per movement over 
a 3 second periods. Each contraction was followed by a 30 second rest period before the 
next MVC.  Altogether 12 MVCs were recorded.  
 
EMG device 
EMG data was recorded using surface electromyography (TeleMyo™ 2400T G2 
Transmitter, Noraxon Inc., Scottsdale, Arizona, USA) on the VL (knee extersor 
muscle), biceps femoris (BicFem) (knee flexor muscle), TA (dorsi-fkexir muscle) and 
TS (plantar-flexor muscle) of the right lower limb. TS EMG activity was calculated as 
the sum of the MGast, lateral gastrocnemious (LGast) and soleus EMG activity. EMG 
data was recorded at 1500 Hz using bipolar surface Ag/AgCL electrodes with a 
conductive area of 10 mm2  (Kendall Meditrace 230; Tyco Healthcare, Hampshire, 
  102 
PO13 0AS, UK). The diameter of the electrodes was 18 mm, and the inter-electrode 
distance was 37 mm. EMG data was collected and saved using the MyoResearch XP 
Clinical Application software (Noraxon Inc, Noraxon Inc., Scottsdale, Arizona, USA). 
EMG data processing was performed using a purpose written programme in Matlab 
(R2007a, Mathworks, Natick, USA). The raw EMG signal was full wave rectified and 
low pass filtered using a second order Butterworth filter with a 50 Hz cut off frequency 
to create a linear envelope that was used for further analysis.  
 
Isokinetic dynamometer device 
The KINCOM dynamometer (KinCom 125E plus; Chattecx, Oxfordshire, UK) was 
used to measure maximal isometric strength. The KINCOM dynamometer was 
connected to The TeleMyo™ 2400R receiver via an input analog channel. Data was 
collected and saved using the MyoResearch XP Clinical Application software. Further 
processing of the data was performed using a purpose written programme in Matlab. 
Further information about the instrumentation set up can be found in Chapter 4 (Section 
5.4.1.2). 
 
Calculations 
A written-purpose Matlab programme was developed to calculate the time differences 
between EMG an isokinetic data. The cross-correlation function available in the Matlab 
programme was used to determine time differences between the traces during the 
isometric contractions. Thus, VL, BF, TA and TS EMG activity was investigated in 
relation to isokinetic data during KE, KF, DF and PF measurements, respectively. 
Figure 4-2 shows an example of both EMG and force traces processed with Matlab. 
 
Statistics 
Systematic bias for within-day reliability data was assessed by a one-way ANOVA for 
repeated measures. The within-subject variability was calculated as the CV for each 
subject [(SD/mean)*100].  The within-day reproducibility was determined by 
calculating the ICC. The same statistical tests were applied when assessing the 
reproducibility during the different types of contraction. In addition to this, an 
independent t-test was carried out to assess differences in “EMD” values for the 
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different types of contractions between the DN and HEALTH group. The level of 
statistical significance was set at p≤0.05. All analyses were performed with SPSS 
version 16.0. 
 
 
Figure 4-2. Example of EMG and Force data processed with matlab to calculate “EMD” values 
during isometric contractions  
 
Note: The blue line represents the EMG trace and the black line represents the force generated in the 
KINCOM machine. The red line represents the periods during which the differences between both traces 
were investigated.  
 
 
 
 
4.2.3 Results 
 
All the results for within-day reliability measurements are shown in Table 4-5. No 
significant differences between within-day measurements were observed for any of the 
muscle groups (KE, KF, DF, PF) both in the HEALTH and DN groups. The relative 
variability within-subjects (CV) was 9.21% during DF, 12.68 % during PF, 13.77 % 
during KE and 14.96% during KF in the HEALTH group and 13.11% during DF, 
13.15% during PF, 15.43% during KE and 16.62% during KF in the DN group.  ICC 
values of 0.68 and 0.62 during DF, 0.75 and 0.65 during PF, 0.61 and 0.64 during KE 
and 0.62 and 0.60 during KF were observed for the HEALTH and DN groups, 
respectively.  
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Furthermore, Figure 4-3 presents the results with regard to the differences in “EMD” 
values for the different group muscles between the HEALTH and the DN group. 
“EMD” during DF is the only value that significantly differed between both population 
groups (p<0.001). Thus, the DN group reported significantly higher “EMD” values 
(67.31± 21.19) compared to the HEALTH group (142.24 ± 13.40). 
 
 
 
Table 4-5. Within-day reliability for “EMD” calculations during isometric contractions 
 
Mean over 3 
Rep (ms) 
Anova 
p value 
CV % ICC 
Dorsi-Flexion 
  HEALTH (N=25) 
  DN (N=53) 
 
142.24± 13.40 a 
167.31± 21.19 a 
 
0.659 
0.579 
 
9.21 
13.11 
 
0.68 
0.62 
Plantar-Flexion 
  HEALTH (N=25) 
  DN (N=53) 
 
204.95± 26.71 a 
206.98± 26.08 a 
 
0.426 
0.101 
 
12.68 
13.15 
 
0.75 
0.65 
Knee Extension 
  HEALTH (N=25) 
  DN (N=53) 
 
110.34± 15.10 a 
119.76± 18.11 a 
 
0. 759 
0.572 
 
13.77 
15.43 
 
0.61 
0.64 
Knee Flexion 
  HEALTH (N=25) 
  DN (N=53) 
 
116.16± 17.35 a 
107.83± 19.17 a 
 
0.625 
0.735 
 
14.96 
16.62 
 
0.62 
0.60 
 a
 Values are means ± SD. 
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Figure 4-3.  “EMD” values calculated during isometric contractions: Comparison between the 
HEALTH and the DN groupa 
0
50
100
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250
DF KE PF KF
Type of contraction
EM
D 
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Healthy
Diabetes
a
 Mean and standard deviation (SD) (error bar) ; **Significance value is less than 0.01 level (2-tailed). 
 
 
4.2.4 Discussion 
 
The present investigation demonstrated that cross-correlation is a reproducible (within-
day) technique to calculate “EMD” values during 3 maximal isometric voluntary 
contractions in healthy as well as in subjects with DN. This is the first study that 
demonstrates that EMD values may be affected by DN.  
 
Reliability  
“EMD” values for PF, DF, KE and KF showed substantial within-day reliability both 
for the healthy and DN group (Landis & Koch, 1977). ICC values in the health group 
ranged from 0.61 during KE to 0.75 during PF whilst ICC values in the DN group 
ranged from 0.60 during KF to 0.65 during PF. These results demonstrated that cross-
correlation is a reliable approach to calculate average time differences between 
muscular activity and force production traces over a period of time during maximal 
isometric contractions. However, the CV values obtained in the present study, which 
ranged from 9.21% (DF) to 14.96% (KF) in the HEALTH group and from 13.11% (DF) 
to 16.62% (KF) in the CN group, were substantially higher than the CV values reported 
by Howatson et al. (2009) when assessing EMD in the elbow flexors during isometric 
** 
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contractions (CV 3.1%). To the best of my knowledge, Howatson et al. (2009) is the 
only study that has assessed the reliability of a similar approach to calculate EMD. 
Furthermore, Howatson et al. (2009) reported EMD values of 58.35 ms while in the 
present investigation “EMD” values ranged from 110 ms during KE to 210 ms during 
PF in the HEALTH group. It is likely that methodological differences may explain the 
diversity in these results. For instance, Howatson and colleagues (2009) calculated 
EMD as the time differences between EMG onset and force production onset. Since the 
present study used a longer time frame to determine EMD (whole contraction versus 
onset), and considering that the relationship between muscular activity and force 
production may be non-linear at maximal intensities (Metral & Cassar, 1981), it is 
logical that results from the present study show higher CV compared to Howatson et al. 
(2009). Furthermore, differences in the approach to determine EMD values (whole 
contraction versus onset) may also partly explain the greater EMD values found in the 
present investigation compared to Howatson´s study. Metral & Cassar (1981) 
investigated the relationship between force and EMG in the forearm (biceps brachii) 
when working at different intensities. They found a linear relationship between those 
traces between 0 and 50% of the maximum force while at forces greater than 50% the 
relationship was non-linear. They reported that the slope of the EMG signal was steeper 
than the one from the force and this became more obvious at intensities near the 
maximal force. This finding may partly explain why Hotwatson et al. (2009), who 
calculated EMD at the onset of the contraction, found lower EMD values compared to 
the present study, in which “EMD” values were calculated over the whole contraction. 
This finding is particularly important since it suggests that EMD values calculated at the 
onset of the contraction may represent EMD values during the whole contraction. This 
highlights the usefulness of this new approach to calculate “EMD” when attempting to 
predict muscular function from EMG data during a sustained contraction. 
 
Overall, the present study demonstrated that this new approach to determine the time 
differences between EMG and force production during the whole contraction is 
reproducible. Furthermore, this method may result in a more accurate estimation of the 
mechanical output timing from EMG data during prolonged activities.  
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EMD differences between healthy and DN subjects 
Several investigations have demonstrated differences in EMD values due to gender 
(Winter & Brookes, 1991), after ligament reconstruction (Kaneko et al., 2002), in 
response to a training programme (Grosset at al., 2009), and in case of neuropathies 
(Granata et al., 2000). This is the first investigation reporting that EMD may be affected 
in patients with diabetic neuropathy. The present study shows that “EMD” values for 
the TA muscle during DF were significantly higher (p<0.001) in the DN group (167.31) 
compared to HEALTH group (142.24). However, no significant differences were found 
during PF, KE or KF.  
 
According to Richardson et al. (1992), the first nerve to show electrophysiological 
alterations due to diabetic motor neuropathy is the fibular nerve, which innervates the 
TA. This may explain why the TA is the only muscle that shows significant differences 
when comparing “EMD” values between healthy individuals and patients with DN.  
This finding in the context of EMG data processing is particularly important since it 
highlights the importance of calculating individual EMD values in DN subjects when 
attempting to estimate muscular output from EMG data. For instance, if this finding is 
related to EMG activity during gait, a longer EMD is expected to bring the activation 
patterns forward. Since the time lag from activation onset to muscle production is 
longer muscle activation is expected to occur earlier.  
 
Overall the present investigation demonstrated for the first time changes in EMD values 
in DN subjects when compared to healthy individuals. This highlights the importance of 
assessing individual EMD values when attempting to estimate muscular output from 
EMG data, especially when comparing populations with different EMD values such as 
DN. 
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4.3 Electromechanical delay determination for the plantar-
flexor muscles during gait 
 
4.3.1 Introduction 
 
Howatson et al. (2008) investigated EMD values during isometric and isokinetic 
contractions and they found that EMD was somewhat shorter during isometric 
compared to isokinetic contractions. They reported values of 57± 5.5 ms and 72.3± 8.9 
for isometric and slow isokinetic contractions, respectively. In addition to this, 
Cavanagh & Komi (1979) found that the EMD under eccentric contractions (49.5 ms) 
was significantly shorter than during concentric movements (55.5 ms). These findings 
suggest that EMD values determined during isometric conditions may not represent 
EMD values during more dynamic conditions such as walking.  
 
Some studies looking to estimate muscular forces from EMG recordings have skipped 
the problem of calculating EMD and focused on the similarity between EMG and joint 
moment traces (Hof et al., 1987; Metral & Cassar, 1981). It is generally believed that 
the TS muscle group, which consists of the soleus and gastrocnemious muscles, is the 
main responsible for the PF of the ankle (Winter, 2009). Furthermore, the ankle moment 
during the stance phase of gait is believed to be indicative of the torque generating 
capability for the plantar-flexor muscles (TS) (Winter, 2009). Some studies have linked 
EMG and kinetic data during gait by synchronising EMG activity patterns with the joint 
moments obtained when walking over a force platform (Hof et al., 1987 & Metral & 
Cassar, 1981). However, to the best of my knowledge, no study has investigated the 
reliability of this approach. 
 
In this study “EMD” was defined as the time delay from the peak muscular activity of 
the TS to the max vertical GRF generated on the forefoot during the second half of the 
stance phase. This approach may allow the synchronization of EMG (TS) and kinetics 
data accurately during gait. 
 
In the main study of this thesis EMG data was measured to investigate muscular activity 
patterns during gait in healthy subjects and patients with DN. For this reason the 
reliability of this new approach to calculate “EMD” was investigated both in healthy 
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and DN subjects. An additional aim of the present study was to investigate “EMD” 
differences between healthy individuals and patients with DN during gait.  
 
Thus, the aim of this investigation was twofold: 1) to assess the reproducibility of a new 
approach to calculate the time differences from the peak TS muscular activity to the 
max GRF during the push off phase of the gait cycle;  2) to compare “EMD” values 
during gait between healthy individuals and patients with DN. 
 
4.3.2 Methods 
 
Subjects 
78 volunteers participated in this study of which 53 were diagnosed with DN (DN 
group) and 25 were healthy (HEALTH group). The study was approved by the Cardiff 
and Vale NHS Trust Research & Development Office and the South East Wales Local 
Research Ethics Committee and all subjects gave their written consent.  
 
The subject characteristics were 62.20± 7.55 years of age, 169.1± 9.8 cm in height, and 
93.03± 17.47 kg in body mass for the diabetic group and 57.76± 10.60 years of age, 
171.1± 8.6 cm in height, and 78.63 ± 9.56 kg in body mass for the healthy group.   
 
Protocol 
Participants were asked to walk barefoot at their self-selected speed on a 9 meter 
walkway. Before data acquisition, the subjects were instructed to walk freely on the 
walkway to reproduce their normal gait and to adapt to the laboratory environment. 
Multiple trials were permitted to allow the subjects to practice walking without visually 
targeting the platform surface. The testers adapted the subjects starting position to 
ensure the platform was always hit on the fourth step. Data was collected over 5 trials 
for the right foot.  
 
EMED platform 
Ground reaction forces were measured with the EMED platform (EMED-m, Novel 
GmbH, Munich, Germany). The platform was positioned level with the floor at the 
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midpoint of the 9 meter walkway.  The platform consists of a matrix of 3840 force 
transducers that are uniformly distributed in an area of 24 × 38 cm. The platform has a 
resolution of 4 sensors·cm-2 with a sampling frequency of 50 Hz. The sensors have a 
pressure range from 10 kPa to 1200 kPa. 
 
The data was processed and analysed by Novel Software (Novel 13.3.42, Novel GmbH, 
Munich, Germany). Using this software the instance of roll over process (in 
milliseconds) in which the maximal vertical GRF occurs during the push of phase was 
calculated.  
 
EMG 
Muscle activation patterns during walking were recorded using surface EMG 
(TeleMyo™ 2400T G2 Transmitter) on the MGast, LGast and soleus of the right lower 
limb. EMG data was recorded at 1500 Hz using bipolar surface Ag/AgCL electrodes 
with a conductive area of 10 mm2. The diameter of the electrodes was 18 mm, and the 
inter-electrode distance was 37 mm. EMG data was collected and saved using the 
MyoResearch XP Clinical Application software. EMG data processing was carried out 
using a purpose written programme in Matlab.   
 
Data Processing and Calculations 
A purpose written Matlab programme was created to calculate the time delay between 
the peak muscular activity of the TS (calculated as the sum of the MGast, LGast and 
soleus EMG activity) and the max vertical GRF generated on the forefoot during the 
second half of the stance phase. As discussed in the introduction, it is believed that the 
TS muscle group is the main responsible for the PF of the ankle. This suggests that the 
vertical GRFs during the stance phase are originated from the TS.  
 
The raw EMG signal was full wave rectified and low pass filtered using a second order 
Butterworth filter with a 50 Hz cut off frequency to create a linear envelope that was 
used for further analysis. To be able to relate EMG activity to the GC, EMED data and 
EMG data were collected simultaneously. See Chapter 5 (Section 5.4.1.1) for more 
information about the instrumentation set up during this task. Therefore, EMG data 
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could be processed in relation to the heel strike. In addition to that, the instant of the 
max vertical GRF was calculated by Novel Software. 
 
Figure 4-4 shows a graphical representation of how the time delay between the peak 
muscular activity of the TS and the max vertical GRF generated on the forefoot during 
the second half of the stance phase was calculated. 
 
 
Figure 4-4. Overview of the “EMD” calculation for the TS muscle during gait 
 
Note: The black line represents the EMG activity for the TS muscle during the gait cycle. The greem line 
shows the instant of the maximal vertical GRF. 
 
 
Statistics 
Systematic bias for within day reliability data was assessed by a one-way ANOVA for 
repeated measures (5 measurements). The within-subject variability was calculated as 
the coefficient of variation for each subject [(SD/mean)*100].  The within-day 
reproducibility was determined by calculating the ICC. In addition to that, an 
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independent t-test was used to assess group differences in EMD values during PF. The 
level of statistical significance was set at p≤0.05. All analyses were performed with 
SPSS version 16.0. 
 
4.3.3 Results 
 
Results for within-day reliability measurements are shown in Table 4-6. No significant 
differences between within-day measurements were observed both in the HEALTH 
(p=0.22) and DN (p=0.24) groups. In addition to that the relative variability within 
subjects (CV) was 19.01% for the HEALTH group and 13.92% in the DN group. An 
ICC of 0.89 and 0.77 was observed in the HEALTH and DN groups, respectively.  
Figure 4-5 shows the results from the independent t-test, which investigated differences 
in EMD values between the HEALTH and the DN group. Thus, results from the present 
study show significantly higher values in the DN group compared to the HEALTH 
group when EMD were calculated during gait.  
 
 
 
Table 4-6. Within day reliability for “EMD” calculations for the PF muscles during gait 
 
Mean over 5 
Rep (ms) 
Anova 
p-value 
CV % ICC 
 
Peak to Peak 
 
HEALTH (N=25) 
  DN (N=53) 
 
 
 
129.28± 69.62 a 
224.77± 67.85 a 
 
 
 
0.222 
0.245 
 
 
 
19.01 
13.92 
 
 
 
0.89 
0.77 
a
 Values are means ± SD. 
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Figure 4-5. “EMD” values for the TS muscle calculated both during isometric and gait conditions: 
Comparison between the HEALTH and the DN groupa 
0
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a
 Mean and SD (error bar); **Significance value is less than 0.01 level (2-tailed). 
 
 
 
4.3.4 Discussion 
 
Results from the present investigation demonstrated a good reproducibility of this 
method to calculate “EMD” during gait. Furthermore, results from the present 
investigation show that “EMD” values in the plantar-flexor muscles during gait were 
affected by DN. 
 
Results from the present investigation show that “EMD”, calculated as the time delay 
from the peak muscular activity of the TS to the max GRF generated during the push 
off, is a reproducible solution to estimate muscular output from EMD recordings. An 
ICC value of 0.89 and 0.77 for within-day measurements for the HEALTH and DN 
groups respectively, demonstrated that the reproducibility of this approach to estimate 
** 
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“EMD” was excellent for the HEALTH group and substantial for the DN group (Landis 
& Koch, 1977). 
Furthermore, the present investigation showed significant differences in “EMD” values 
between the HEALTH and the DN group. Interestingly, the previous section, which 
estimated EMD values in the same muscle group during isometric contractions, did not 
find group differences. Although this is a remarkable finding the understanding of these 
results go beyond the purpose of this preliminary study. This finding in the context of 
EMG data processing highlights the importance of assessing individual EMD values 
when attempting to estimate muscular output from EMG data, especially when 
comparing populations with different EMD values such as DN. 
 
Overall, the present investigation demonstrated that the synchronization of EMG and 
kinetics data is a reliable approach to estimate muscular output from EMG data during 
gait. In addition to that, it appears that EMD values determined during isometric 
conditions may not represent EMD values during more dynamic conditions such as 
walking.  For this reason during the main study EMD values for the PF muscles will be 
calculated during gait using the approach tested in this section. However, EMD values 
for the DF, KE and KF muscles will be calculated during isometric contractions using 
the method evaluated in the previous section (see Section 4.2), as absence of appropriate 
force measuring devices prevented DF, KE, and KF moments being calculated.  
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CHAPTER 5   
 
5 Methods- Main study- Part 1 and 2 
 
This chapter outlines the methodology for Part 1 and 2 of the main study. Part 1 of the 
main study followed a comparative case-control study design to investigate differences 
between patients with diabetic peripheral neuropathy (DN) and matched healthy 
controls (HEALTH) in general health outcome measures, gait characteristics, 
microcirculation and QOL. Part 2 followed a quasi-experimental test-retest intervention 
study-design to investigate the effect of a 16-week physical activity programme on 
general health outcome measures, gait characteristics, microcirculation and QOL in 
patients with DN.  
 
Part 1 and part 2 of the main study were not independent of one another. Therefore, the 
volunteers from the DN group from the cross-sectional comparative study were 
included in the intervention study (see Figure 5-1). Part 1 and 2 followed the same 
experimental protocol and used the same outcome measures. Therefore, sections on 
instrumentation, experimental procedures, data processing and ethical considerations 
apply to both parts whereas sections on the study design, sample size (from recruitment 
to study completion) and the statistics are presented for each part separately.  
 
5.1 Study design 
 
Part 1 
To address the hypotheses for part 1 of the main study, a case-control cross-sectional 
comparative study design was carried out. This study design is commonly used to 
compare patients who have a disease or outcome of interest (the “cases”) with patients 
who do not have the condition, but are otherwise similar (the “controls”) (Rose & 
Barker, 1978). Furthermore, it allows for potential confounding factors to be controlled 
by measuring them and making appropriate adjustments in the analysis (Rose & Barker, 
1978). In this study, age, height, sex and body mass were identified as potential 
confounding variables. 
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Part 2  
A quasi-experimental, test-retest, interventional study design investigated the effect of a 
16-week physical activity programme on the multiple health problems associated with 
DN including general health, gait and microcirculatory parameters as well as self-
reported QOL in DN patients. Two groups were compared over time; an exercise (EXE) 
group, which participated in the exercise programme, and a control (CON) group, which 
was not provided with any intervention. Randomisation in the present study was based 
on the patient’s preferences and therefore cannot be called an experimental randomised 
control trial (RCT). Randomisation based on patient preferences is considered an 
acceptable randomisation method when patients have strong preferences for one 
intervention group or the other (Campbell, et al., 2000; Craig, et al., 2008). 
 
Random allocation increases internal validity and minimise the selection and testing 
bias related to pre-testing subjects with the knowledge of group allocation (Craig et al., 
2008). However, the main problem of RCTs is if a substantial proportion of patients 
refuse the allocation group, and as a consequence differences in outcome may be 
obscured  (Rose & Baker, 1978). In addition to this, it may also result in a high number 
of drop outs, which may compromise the power of the study (Bratcher et al., 1970). It is 
noteworthy that previous studies have reported high rates of drop-out in PA intervention 
in diabetic populations (Thomas et al., 2006). Therefore, a study design which allowed 
participants the opportunity to choose in which group they wanted to be included was 
used for the present investigation.  
 
Due to the nature of the study design and since randomisation was based on the 
patient’s preferences, it was impossible to blind the participants to the intervention 
group they were allocated to. Since the vast majority of the outcome measures were 
calculated quantitatively by computerised systems, it was not considered necessary to 
blind the tester with regard to which intervention group participants were allocated.  
 
The subjects were tested on two visits split by a 16-week period. Between the two visits, 
the EXE group carried out a structured physical activity programme whereas the CON 
group continued as before.
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Figure 5-1. Overview of the study design. Population groups: Neuropathic group (DN) and healthy group (HEALTH); Intervention groups: exercise group (EXE) 
and control group (CON); Tests: T1 (pre-intervention measurements) and T2 ( Post-intervention measurements). 
 
Cross-sectional 
study 
Interventional study 
N=78 
HEALTH 
DN 
53 
25 
EXE= 21 
CON= 20 
T1 
T2 
Pre- intervention Post- intervention INTERVENTION             
(16-weeks) 
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5.2 Intervention 
 
The study was a semi-controlled interventional study, in which participants were asked 
to both attend supervised training sessions and undergo home-based exercises for 16 
weeks. All the supervised sessions took place in the outpatients physiotherapy gym at 
the University Hospital of Wales (UHW). Permission to use the facilities was obtained 
from the Head of Department. 
 
Each supervised session lasted approximately 1hour and included 10 minutes warm up, 
40 minutes resistance training using resistance training machines, and a 10 minute cool-
down. During warm-up and cool-down phases flexibility and stretching exercises were 
included. In addition to this, during cool-down a variety of foot mobility exercises were 
included for at least 5 minutes. Subjects were asked to perform 2-3 sets of 8-12 
repetitions on each machine per session. 5 different exercises were carried out each 
session to work out all main muscles on the lower limbs. The resistance training 
protocol was designed to provide progressive increases in volume of approximately 
10% every two weeks. However, to minimise the risk of injury and overtraining (Fleck 
& Kraemer, 1997), volume was reduced by approximately 20% during weeks 7 and 16.  
In the present study, individual volume was calculated weekly in order to ensure that the 
appropriate amount of training was completed for each subject. Volume was calculated 
by adding the amount of kilograms lifted per muscle group per week. Training 
intensities during weeks 1-8 were set up at 60-80 % of 1RM (percentage of a one 
repetition maximum contraction), whereas intensities during weeks 9-16 weeks were 
programmed at 70-80 of 1RM. 1-RM testing was repeated at week 8 to establish a new 
baseline. All subjects were required to perform each repetition in a slow, controlled 
manner, with a rest of 75-120 seconds between sets.  
 
Home based exercises included 2 sets of 12 repetitions targeting the major muscle 
groups on the upper body. These exercises were carried out using a resistive exercise 
band (Thera-band, UK). In addition to this a variety of joint mobility exercises targeting 
all the main joints were also included in the home based programme (see Appendix 2).  
All the participants were required to exercise at least 70% of all the sessions in order to 
be included for analysis. In order to control the home-based training programme, each 
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participant was provided with a diary which they were asked to fill out daily.  Every 
week each participant was asked to bring the diary so the home-based session could be 
inspected and therefore controlled. However, it was observed early in the intervention 
that the dairy was not a reliable tool to control home exercises. For instance, some 
participants who reported in the dairy that they successfully completed the home 
exercises did not remember the exercises or had lost the resistance exercise band. For 
this reason home exercises were left optional for the participants. Therefore, the 
inclusion criterion for the participants to be included in the analysis was at least 70% of 
all the gym based sessions.  
 
5.3 Subjects 
 
The characteristics of the subjects who were invited to participate in the study are 
specified below. 
5.3.1 Inclusion Criteria 
 
The inclusion criteria for the subjects with diabetic peripheral neuropathy were: 
• Diabetic peripheral neuropathy (inability to detect 10 g monofilament in at least 
one of four plantar areas) 
• Age (45 – 70 years old) 
• Type 2 diabetes + non insulin dependent 
• All the participants should be capable of walking independently to perform their 
activities of daily life without a walking aid 
• Corrected vision 20/20 
The inclusion criteria for the healthy group were: 
• No diabetes 
• Age (45 – 70 years old) 
• All the participants should be capable of walking independently to perform their 
activities of daily life without a walking aid 
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5.3.2 Exclusion Criteria 
 
The participation criteria were framed to exclude individuals with conditions that could 
affect the outcome measures under investigation independently of DN. Since one of the 
aims of the study was to investigate gait characteristics, people with foot deformities, 
which are known to affect gait parameters, were excluded from the study. Similarly, 
people with peripheral vascular diseases or taking medications that could affect 
circulation were also excluded from the present investigation since they may have an 
effect on the microcirculation. In addition to this, to avoid any adverse effect during 
either the data collection or the physical activity intervention subjects suffering from 
cardiac or lung diseases, uncontrolled blood pressure, current ulcers or other 
neuropathic complications were also not invited to participate in this study. People with 
high levels of physical activity were excluded from the study since physical activity 
may have a direct effect on many of the outcome measures under investigations 
including general health microcirculation, gait and metal health. Subjects involved in 
PA programmes are less sensitive to long-term exercise-induced adaptations, which 
may compromise the results from the intervention study. A more detailed description of 
the exclusion criteria can be found below. 
 
The exclusion criteria for the subjects with diabetic peripheral neuropathy were: 
• Foot deformities  
o Charcot foot  
o Osteomyelitis 
• Ulcers  
o Previous ulcers must be prior to 3 months before the study starts.  
o All previous ulcers must have been superficial (no bone, tendons or 
cartilage must have been affected) 
• Peripheral vascular diseases 
o Patients with a history or any symptoms of peripheral vascular disease 
(pain in calf after walking 100 yards) 
• Severe cardiac or lung diseases 
o History of cardiac events (i.e. heart attack, stroke, angina pectoris) 
o History or clinical evidence of cardiac abnormality (complications)  (i.e. 
arrhythmias, heart blockage)  
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o Patients taking medications that may affect the cardiovascular system 
(i.e. vaso-active agents). 
o Severe lung diseases 
• Other neuropathic complications 
o Retinopathy  
• Glaucoma (High blood pressure) 
o Nephropathy 
• Clinically diagnosed nephropathy 
• Serious history of kidney failure (dialysis) 
o Patients with severe painful forms of diabetes peripheral neuropathy 
• Patients with high blood pressure not controlled by medication 
• Patients with any major neurological and/or musculo-skeletal impairment other 
than those resulting from diabetic foot complications   
• People who underwent regular physical exercise 
 
The exclusion criteria for the healthy group were: 
• Peripheral vascular diseases 
o Patients with a history or any symptoms of peripheral vascular disease 
(pain in calf after walking 100 yards)  
• Severe cardiac or lung diseases 
o History of cardiac events (i.e. heart attack, stroke, angina pectoris) 
o History or clinical evidence of cardiac abnormality (complications)  (i.e. 
arrhythmias, heart blockage)  
o Patients taking medications that may affect the cardiovascular system 
(i.e. vaso-active agents). 
o Severe lung diseases  
• Patients with high blood pressure not controlled by medication 
• Patients with any major neurological and/or musculo-skeletal impairment 
• People who underwent regular physical exercise 
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5.3.3 Recruitment Strategy 
 
Eligible patients for the DN group were identified by the referring clinician1 and given a 
brief outline of the study for their consideration. Clinicians were contacted through two 
main routes: 1) Podiatric clinics and 2) Wound healing clinics in the Cardiff & Vale 
Trust.  At the podiatric clinics clinicians were contacted via the departmental director, 
Mr Scott Cowley, whereas at the wound healing clinics clinicians were contacted via the 
clinical director, Professor Keith Harding. 
Patients who were in agreement were then contacted by the researcher. The first contact 
was done by correspondence in which an invitation letter together with an information 
sheet explaining the characteristics of the study were attached (Appendix 3 and 
Appendix 4, respectively). They were offered up to two weeks time to decide whether 
they were interested in participating in the study, and if interested, in which group (EXE 
or CON) they would like to be included (see Section 5.1 to find out more details about 
the randomisation process). After this period participants were contacted by phone to 
ask them about their decision; if positive an interview was held on the phone to confirm 
whether or not the participant was suitable for the study (see Appendix 5). If the 
interview was successful, an appointment for them to visit the Research Centre for 
Clinical Kinaesiology (RCCK) laboratory at Ty Dewi Sant (Heath Park Campus, 
Cardiff) was arranged. Once the appointment was made, a confirmation letter was 
mailed to each participant, together with the informed consent sheet (Appendix 6 and 
Appendix 7, respectively). During this first visit to the RCCK, an electrocardiogram 
(ECG) at rest was carried out on the participants interested in participating in the 
exercise programme. If the ECG at rest was within normal limits, which was determined 
by a qualified anaesthetist who reviewed the ECGs, participants were invited to 
participate in the exercise programme. On the other hand, if the ECG was not within 
normal limits the participant was referred to their GP following consultation with the 
clinical supervisor. After the first visit, participants belonging to the CON group were 
contacted again in 16 weeks to arrange the second visit to the RCCK. Further 
information about the recruitment strategy can be found in the flow chart presented in 
Figure 5-2. 
 
                                                 
1
 Note: Clinical data was used by the referring clinician to identify suitable participants (i.e. type of 
neuropathy, peripheral vascular diseases, history of cardiac or lung diseases, foot deformity, etc) 
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One of the exclusion criteria for the study was severe (or a history of) cardiac diseases. 
However, an ECG on the exercise group was carried out to confirm that participants did 
not suffer from any heart condition that could be worsened by the exercise programme. 
 
The healthy control group was contacted: 1) from social clubs in the Cardiff & Vale 
Trust catchment area; 2) from university staff members; and 3) from the DN group. 
Participants from the DN group were asked whether any family member without history 
of diabetes would be interested in participating in the study as a healthy control.  
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Figure 5-2. Recruitment strategy for the patients with diabetic neuropathy 
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5.3.4 Sample size: From the recruitment stage to the study 
completion 
 
Initial statistical analysis consultation determined that for part 1 of the main study 60 
subjects in the DN group and 30 subjects in the HEALTH group were needed. No 
additional recruitment was required for part 2 of the main study since volunteers who 
participated in the intervention study were obtained from the DN group in part 1(see 
Figure 5-1 for more information about the study design). Information about how sample 
size was determined can be found in Section 5.6.1.  
 
5.3.4.1 Part 1 of the main study 
 
To achieve those numbers recruitment was extended for a 2-year period (from April 
2008 to March 2010). This period included the recruitment of patients with diabetic 
peripheral neuropathy as well as the healthy group. Data collection was carried out over 
16 months (from January 2009 until April 2010). The time from the start of recruitment 
(April 2008) to the start of data collection (January 2009) was spent in creating a pool 
of participants (DN group) who were interested and suitable for the study.  Prior to the 
start of recruitment, this part of the study was expected to be completed within 12 
months. This time frame was constructed based on experience from previous research at 
the Research Centre for Clinical Kinaesiology (RCCK) with the same population. 
However, due to difficulties in the recruitment this time frame had to be extended for 
another 12 months.  
 
During those two years a total of 425 patients with diabetic neuropathy were 
approached in clinics (by clinicians), provided with information about the study 
(information sheet) and agreed to be contacted by researchers. Following this first 
contact, all participants were contacted by phone to find out about their decision. If 
interested, an interview over the phone was carried out to make sure they were suitable 
for the study. 325 of those 425 candidates (76%) refused to participate or were not 
eligible for the study. If the interview was successful, an appointment for them to visit 
the RCCK laboratory at Ty Dewi Sant (Heath Park Campus, Cardiff) was arranged. The 
main motives to refuse to participate in the study were: 1) not interested in research and 
2) lack of time due to work or family commitments. The main causes to be excluded 
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from the study were: 1) type I diabetes (insulin dependents); 2) history of heart 
problems (heart attack or angina); 3) walking difficulties (walking aids); and 4) regular 
physical activity. 
 
Once the appointment was made a confirmation letter was mailed to each participant, 
together with the informed consent sheet. Out of the 100 confirmation letters, sent to as 
many individuals, at the end only 58 attended. 5 out of those 58 had to be excluded from 
the study. 2 people were excluded due to ECG abnormalities, 1 person due to 
uncontrolled hypertension and 2 people since they were undertaking regular physical 
activy. The subjects who did not attend the appoinment were recontacted to find out the 
reasons for their absence and to give them the opportunity to rearrange another 
appoinment if still interested. Therefore, 53 participants with diabetic neuropathy 
visited the RCCK for the first visit and were included in the DN group for the cross-
sectional study.  In summary out of 425 persons who were invited to participate in the 
study, only 53 participated in part 1. 
 
The healthy group was recruited in two different time frames. Ten healthy individuals 
were measured together with our first DN patients, and the remaining 15 volunteers 
were measured at the later part of the study. The reason for leaving half of the HEALTH 
group for the end of the study was to match both groups, DN and HEALTH, on weight, 
height, age and gender since those variables may influence the outcome measures 
investigated in the present study. However, it was impossible to succesfully match both  
groups on weight. Due to the characteristics of our DN group, whose mean age and 
weight were 62 and 93 kg respectively, it was imposible to find sufficient individuals 
with those characteristics and no further health issues (i.e. diabetes or heart problems). 
See results Chapter (Section 6.1.1) for more information about the participants 
characteristics. In summary 53 subjects were included in the DN group while 25 
individuals were included in the HEALTH group. See Figure 5-3 for more information 
about the recruitment process. 
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5.3.4.2 Part 2 of the main study 
 
Of the 53 individuals included in the DN group, 27 subjects were then included into the 
EX group while the CON group was composed of 26 individuals. During the 16-week 
period between visits, 6 participants dropped out from each group.  Then, 21 subjects 
completed the exercise programme in the EXE group and 20 individuals completed the 
2 visits to the RCCK as controls, which resulted in  a 22 and 23% of drop outs for the 
CON and the EXE groups, respectively. See Figure 5-3 for more information about the 
recruitment process. 
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Figure 5-3. Sample size from recruitment stage to study completion  
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5.4 Data collection 
 
To test the study hypotheses data was collected on four different domains named 
general health, gait characteristics, microcirculation and quality of life. Table 5-3 
provides an overview of the different measurements carried out during data collection 
and how they relate to the different domains investigated in the present study. As 
mentioned earlier, data collection did not differ between the cross-sectional and 
intervention studies and for this reason this section applies to both studies. This section 
will start providing some specific information about some of the instrumentation set up 
carried out during the main tasks of the data collection. Thereafter, the procedures 
carried out during the whole data collection will be explained.  
 
5.4.1 Instrumentation set up 
 
Data collection included three main tasks, during which 1) gait measurements, 2) 
strength measurements and 3) microcirculation measurements were carried out. During 
these tasks data was collected simultaneously with different equipments. This section 
will provide details of the specific instrumentation set up used during each task.   
 
5.4.1.1 Instrumentation set up during gait  
 
During gait analysis, foot-floor interaction and muscular activity data were collected 
simultaneously. Foot-floor interaction parameters during barefoot walking were 
assessed using a pressure platform (EMED, Novel) while muscular activity on the lower 
limb (TA, TS, VL and BicFem) was measured using a wireless 8 channel EMG device 
(TeleMyo™ 2400T G2 Transmitter). To be able to accurately relate EMG data to the 
phase of the GC it was necessary to link both sets of data via a synchronisation box 
(TeleMyo™ 2400R G2 receiver, Noraxon Inc., Scottdale, Arizona, USA). See Figure 
5-4 for a picture of the instrumentation set up.  
 
TeleMyo™ 2400R G2 is a receiver with 8 channels of analogue input, which allows the 
synchronisation of data coming from different sources. The EMG device was connected 
wirelessly using WIFI technology to the Telemyo 2400 G2, which was also linked to a 
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computer where data was saved using the MyoResearch XP Clinical Application 
software. At the same time, the EMED platform was also connected via a USB cable to 
the TeleMyo™ 2400R G2 receiver. EMED platform sent a signal to the TeleMyo™ 
2400R G2 receiver when heel strike on the pressure platform occurred. Heel strike was 
identified when vertical GRF in the EMED platform exceeded 5 Newtons. The number 
5 in Figure 5-4 shows the data display in the EMG computer during gait. Thus, the top 6 
rows (channels) display EMG activity of 6 different lower limb muscles while the 
bottom row displays the exact moment in time where the heel strike occurred. As a 
result EMG data can be analysed in relation to the heel strike. In addition to that, the 
EMED platform was also connected via USB cable to a different laptop, where EMED 
data was processed and analysed by Novel Software.  
 
5.4.1.2 Instrumentation set up during strength measurements 
 
The KINCOM dynamometer was used to measure maximal isometric strength.  During 
these measurements EMG data was also collected so peak EMG activity could also be 
determined. Peak EMG activity is normally used to normalise EMG signal to the peak 
activity during maximal effort (Perry & Burnfield, 2010). Normalisation is a necessary 
step during EMG data processing to be able make statements about the relative intensity 
of an EMG signal. In order to be able to synchronise force and EMG data the following 
instrumentation set up was carried out: 
 
The KINCOM machine was connected with a cable to the TeleMyo™ 2400R G2 
receiver. Simultaneously the TeleMyo™ 2400R G2 received EMG data wirelessly via 
WIFI and was also linked via a USB cable to the EMG computer, where EMG and 
KINCOM data were visualised and saved using the MyoResearch XP Clinical 
Application software. The number 4 in Figure 5-5 shows the data display in the EMG 
computer. Thus, the top 6 rows (channels) display EMG activity of 6 different lower 
limb muscles while the bottom row displays the force generated in the KINCOM 
machine. Therefore, EMG data could be analysed in relation to amount of force 
produced during the MVC.  
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5.4.1.3 Instrumentation set up during microcirculation 
measurements 
 
Muscular microcirculation was assessed using a NIRS device (Oxymon MK III). 
Measurements using NIRS were carried out in the MedGast at rest and during an 
exercise protocol, which included 14 submaximal isometric contractions with the calf 
muscle on the KINCOM machine (plantar-flexion at 50% of MVC value). However, 
since plantar-flexion moment is the sum of the moments generated by the different 
plantar-flexion muscles (especially the soleus, LGast and MGast), with only the 
KINCOM data it is impossible to determine the amount of work coming from each of 
those muscles separately. Van Beekvelt et al. (2002) demonstrated that muscular 
microcirculation during an exercise bout, measured by NIRS, was dependent on the 
intensity of the work of the specific muscle under investigation. Thus, in the present 
investigation muscular activity on the MGast during the exercise protocol was measured 
together with microcirculation data on the same muscle. Hence, microcirculatory 
responses during the exercise protocol could be related to the amount of work coming 
from the same muscle. To allow the NIRS and the EMG electrodes to be placed on the 
same muscle, the EMG electrodes were placed slightly lateral to the medial-lateral 
centre of the muscle belly. As seen in Figure 5-6, the position of the electrode was still 
on the muscle belly and did not change throughout the whole measurement. In order to 
be able to synchronise: 1) force (KINCOM data); 2) EMG data; and 3) NIRS data, the 
following instrumentation set up was carried out (see Figure 5-5 for a picture of the 
instrumentation set up). 
 
The KINCOM machine was connected with a cable to the Telemyo 2400 G2. 
Simultaneously the Telemyo 2400 G2 received EMG data wirelessly via WIFI and was 
also linked via a USB cable to the EMG computer, where EMG and KINCOM data 
were visualised and saved using the MyoResearch XP Clinical Application software. 
The number 4 in Figure 5-5 shows the data display in the EMG computer. Thus, the top 
6 rows (channels) display EMG activity of 6 different lower limb muscles (channel 2 
corresponds to the MedGast) while the bottom row displays the force generated in the 
KINCOM machine. Therefore, EMG data could be analysed in relation to amount of 
force produced by the plantar-flexor muscles during the isometric contractions. This 
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part of the instrumentation set up is the same as explained above for the strength 
measurements. 
 
The KINCOM machine was also connected with a cable to the NIRS device. This 
device has 16 channels of analogue input so additional traces can be added to the NIRS 
data. KINCOM data and NIRS data were then inspected and saved together using the 
Oxysoft 2.1.2 software. Number 6 Figure 5-5 shows the data display in the NIRS 
computer. The green, red and blue traces represent total haemoglobin content, 
oxygenated haemoglobin and deoxygenated haemoglobin respectively, while the black 
trace at the bottom of the graph represents the mechanical output coming from the 
KINCOM machine. 
 
 
Figure 5-4. Instrumentation set up during gait measurements 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1) The participant with all the EMG electrodes and carrying the EMG device, 2) the walk way were gait 
measurements took place. 3) EMED platform in the centre of the walk way; 4) the synchronization box 
(Telemyo 2400 R G2); 5) laptop 1 with the “EMG” software; and 6) laptop 2 with the “EMED” software. 
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Figure 5-5. Instrumentation set up during microcirculation measurements 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1) Subject carrying EMG device and NIRS device; 2) KINCOM machine; 3) the synchronization box 
(Telemyo 2400 R G2); 4) laptop 1 with the “EMG” software; 5) NIRS machine; and 6) laptop 2 with the 
“NIRS” software. 
 
 
 
 
Figure 5-6. Picture of the Medial Gastrocnemious with the NIRS device and EMG electrodes 
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5.4.2 Summary of the procedures 
 
All experimental testing was carried out at the research Centre for Clinical Kinaesiology 
(RCCK). A summary of the procedures followed at each data collection session is 
presented in this section. Further details of specific methods can be found at sections 
referred to in the flow chart (see Figure 5-7). 
 
Prior to the measurement day, subjects received a confirmation letter in which they were 
requested not to do unusual physical activity for 24 hours before the appointment and to 
refrain from caffeine containing drinks on the day of the measurements. At arrival at the 
RCCK they were welcomed and given a detailed explanation of procedures to be 
executed. They were also encouraged to re-read the information sheet and ask anything 
they wanted about the study. After this informative introduction, they were asked to 
read and sign the consent form. Once the required consent documentation had been 
completed participants were asked to fill in the SF-36 questionnaire as a measure of self 
reported quality of life (Luscombe et al., 2000). 
 
Then a general examination was conducted. This included foot visual inspection, 
anthropometric (height, body mass and body fat %), peripheral neuropathy (touch 
pressure sensation and vibration perception) and blood pressure measurements. In 
addition blood samples (to analyse cholesterol and sugar levels) and a 12-lead ECG at 
rest were both taken on the diabetic group only. 
 
Thereafter, skin was prepared to reduce skin impedance during EMG recondings and 
EMG electrodes were placed on the following muscles: TA, MGast, LGast, Soleus, VL 
and BicFem. Prior to that, skin was prepared to reduce skin impedance. Gait analysis 
was carried out after. Spatial and temporal parameters of gait were recorded using a 
digital video at 25Hz while foot-floor interaction parameters were assessed using the 
EMED platform system. During gait EMG was used to assess muscular activity patterns 
on the TA, TS (MGast, LGast and soleus), VL and BicFem (see Section 5.4.1.1 for 
more information about the instrumentation set up during gait). 
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Muscle strength was tested isometrically using the KINCOM dynamometer on the right 
knee extensor, knee flexor, and ankle dorsi-flexor and ankle plantar-flexor muscles. 
EMG data was recorded during the strength testing and this was used to calculate peak 
muscular activity (see Section 5.4.1.2 for more information about instrumentation set up 
during strength measurements). Microcirculation measurements were carried out 
afterwards. Blood flow and muscle oxygen consumption were assessed on the calf 
muscle (MGast) using a NIRS device. These measurements were performed at rest and 
after an exercise protocol, which included 14 submaximal isometric contractions with 
the calf muscle (plantar-flexion at 50% of MVC value calculated during muscle strength 
test). During the exercise protocol EMG data and NIRS data were collected 
simultaneously to quantify the effect of muscular activity on the muscular physiological 
responses (see Section 5.4.1.3 for more information about the instrumentation set up 
during microcirculation measurements). 
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Figure 5-7. Overview of the data collection procedures  
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5.4.3 Explanation of the Procedures  
 
5.4.3.1 Questionnaire 
 
The SF-36 questionnaire was used to assess health related quality of life. This 
questionnaire has been widely used and validated to assess wellbeing in different 
populations including diabetic patients (Jacobson et al., 1994; Luscombe et al., 2000).  
 
The SF-36 comprises 36 questions that measure eight dimensions of health: physical 
functioning, role limitations due to physical health, bodily pain, general health, vitality, 
social functioning, role limitations due to emotional health, and mental health. In 
addition to the dimension scores two summary scales, which assess the overall mental 
and overall physical function, were calculated.  
 
Answers to each question were scored and transformed to a 0-100 scale. Then, the 
average for each dimension and summary scale (sum of the transformed scores from 
each item divided by the number of items belonging to that dimension or summary 
scale) was computed using Excel 2003 (Microsoft Office Excel 2003, Microsoft 
Corporation, USA).  
 
5.4.3.2 General examination 
 
5.4.3.2.1 Foot Visual inspection 
 
All participants were inspected for foot deformities (i.e. Charcot foot, claw toes, and 
hammer toes) by the clinicians before being referred to the study. Only subjects with no 
severe foot deformity were given the opportunity to participate in the study.  
 
Feet were inspected visually by the researcher to confirm that foot deformity was not 
present prior to collecting foot-floor interaction data during gait.  Static inclination of 
first phalanx at the metatarsophalangeal joint in relation to the longitudinal axis of the 
first metatarsal head was measured with a hand goniometer to confirm no foot 
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deformities (claw toes). Foot deformity was defined as an angle higher than 10 degrees. 
Myerson and Shereff (1989) defined an extension of 5 degrees of the 
metatarsophalangeal joint as a foot deformity (measured on cadaver feet). Since 
structural changes are related to aging independently of DN (Caselli et al., 2003) and the 
sample of the present study was expected to be relatively elderly a broader definition of 
foot deformity was chosen for the present study.  
 
5.4.3.2.2 Anthropometric data 
 
Height in metres was measured when standing barefoot using a wall attached height 
measure (Seca 222 telescopic wall mounted measuring rod; Seca Ltd, Medical scales 
and measuring systems, Birmingham, B5 5QB, UK). Body mass was measured in 
kilograms using a digital weighing scale (Seca 888 digital weighing scales; Seca Ltd, 
Medical scales and measuring systems, Birmingham, B5 5QB, UK). Body mass 
measurements were carried out with the subject wearing shorts and a t-shirt. 
 
Body fat percentage was measured using the Harpenden Skinfold Calliper (Baty 
International, Victoria Road, Burgess Hill, West Sussex RHI5 9LR). The four site 
system, which requires measuring skin fold at the following sites: biceps, triceps, 
subscapular and suprailiac, was the selected protocol. These measurements were 
converted to an estimated body fat percentage by the Siri equation (Siri, 1961). Three 
measurements were taken per site. If repeated measurements varied by more than 1mm, 
the test was repeated. Numerous researchers have demonstrated the validity and 
reproducibility of this technique to predict body fat percentage (Patterson, 1992). 
 
5.4.3.2.3 Peripheral neuropathy 
 
The subjects recruited for the study were already clinically established cases of diabetic 
peripheral neuropathy. Touch pressures sensation using the Semmes-Weinstein 
monofilament, and vibration perception using a neurothesiometer, were used to confirm 
the presence of diabetic peripheral neuropathy in these patients.  
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5.4.3.2.4   Touch pressure sensation 
   
Semmes-Weinstein monofilament (Bailey Instruments Ltd, Manchester, UK) is known 
to be a valid and reliable clinical tool to test peripheral neuropathy (Collins et al., 2010). 
The S-W monofilament is a set of 20 pressure-sensitive nylon filaments attached to a 
penholder. Each monofilament is a piece of nylon line of a precise diameter that is 
applied end-on-to the skin until the line begins to bend (see Figure 5-8), providing a 
reproducible, metered sensory stimulus (Kumar et al., 1991). 
 
Cutaneous sensation was measured by the 5.07 monofilament. The Semmes–Weinstein 
5.07 monofilament exerts 10 grams of force when bowed into a C-shape against the skin 
for one second. Patients who cannot detect application of the 10 g monofilament are 
considered to have lost protective sensation against foot ulceration (Olmos et al. 1995).
  
 
Diabetic peripheral neuropathy was defined as inability to perceive the 5.07 (10 g) S-W 
monofilament (loss of protective sensation) (Kumar et al., 1991) in at least one of the 4 
plantar areas tested in this study (heel, 1st metatarsal head, 5th metatarsal head and 
hallux).  
 
The four sites were tested in the prone lying position and the subject needed to perceive 
80% of the trials to be graded as the sensation present over that site.  
 
5.4.3.2.5  Vibration sensation 
 
Vibration sensation was measured using a neurothesiometer (Bailey Instruments Ltd, 
Manchester, UK), which has being widely accepted as a valid and reliable method 
(Cassella et al., 2000) to assess diabetic peripheral neuropathy. The neurothesiometer is 
considered the preferable method to assess vibration sense due to the ease and rapidity 
of testing by this method (Brill & Perkins, 2002). In addition to that, this method 
provides the very specific threshold above which sensation can be perceived by the 
subject (vibration perception threshold), while other methods such as the commonly 
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used tuning fork (128Hz) can only assess whether sensation is perceived above an 
established cut off point (128 Hz).  
  
Vibration perception threshold (VPT) was measured over the 1st metatarsal head with 
the subject in prone lying position with the knee flexed 90º (see Figure 5-8). This 
position was chosen to blind the participant.  The head of the device was placed on the 
1st metatarsal head with the neurothesiometer turned off. After a few seconds (randomly 
to avoid the learning effect) the vibration was increased constantly from 0 until the 
vibration was perceived by the participant. Five trials were performed and the average 
represented the final vibration score (in volts). If repeated measurements varied by more 
than five volts the test was repeated.  
 
5.4.3.2.6  Blood pressure 
 
Blood pressure (BP) was assessed by an automatic blood pressure device (Microlife BP 
A100 Plus, 60 Cranmer Terrace; London; SW17 0QS). This device has been proven to 
be reliable and valid (Stergiou et al., 2006) and has been recommended by the British 
Hypertension Society. 
 
Blood pressure was measured from the right arm. Participants were placed in a sitting 
position with both arms resting comfortably on a table. Subjects were required to rest in 
that position for two minutes before the measurements started. Three consecutive 
measurements were taken automatically by the device and the average of those three 
readings was used as the final score. In addition to systolic and diastolic BP, resting 
heart rate (HR) was also measured by this device.   
 
5.4.3.2.7  Blood Samples 
 
Finger-prick blood samples were taken in this study to measure: HbA1c and cholesterol 
levels. HbA1c was measured using the DCA VantageTM Analyzer (Siemes Healthcare, 
Camberley, Surrey, GU16 8QD). DCA Vantage has been proven to be a valid and 
reliable portable device to assess HbA1c rapidly (Carter et al., 1996).  
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HbA1c has been chosen to monitor blood sugar level because it provides information 
about glucose control history contrary to normal blood tests which determine instant 
glucose levels. In addition to this, these measurements can be carried out on site and it 
does not require prior fasting. Subjects were asked to perform different physical tasks 
during the data collection. For this reason, a fasting test was not considered appropriate 
since it may increase the risk of hypoglycaemia in diabetic patients. 
 
Cholesterol levels (TC, HDL and LDL) were measured with the Cholestech´s LDX 
system (Cholestech Corporation, Inverness Medical, UK). This device has become very 
popular both in clinical settings and research studies due to the prompt and accurate 
results. Cholestech´s LDX has shown very good correlation (r>0.8; p<0.001) when 
compared to well established laboratories (Parikh, et al., 2009).  
 
5.4.3.2.8  ECG at rest 
 
A rest 12-lead electrocardiogram was performed on all the subjects included in the 
intervention programme using an ESAOTE P80 (ESAOTE S.P.A, Florence, Italy) 
device. Diabetic individuals have a 4-fold increased risk of cardiovascular diseases 
compared to healthy people (McCallum & Fisher, 2006).  The ECG test was therefore 
carried out to confirm that the participants in the exercise group did not suffer from any 
heart condition that could be worsened by the exercise programme. 
 
The resting ECG was taken by the researchers, who were trained by a qualified clinician 
at the ECG department at the University Hospital of Wales. The skin was shaved where 
necessary and cleaned with alcohol free wipes before the application of the electrodes, 
in order to ensure good electrode-skin contact. Electrode placement was carried out 
following the American Heart Association (AHA) recommendations (Kossmann, et al., 
1967) (see Figure 5-8). 
 
 
 
 
 
  142 
 
Figure 5-8. Touch pressure measurements, vibration sensation measurements and ECG electrodes 
placement  
   
Touch pressure sensation Vibration sensation 
Electrodes placement during ECG measurements 
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5.4.3.3 Preparation for data collection using surface 
electromyography (EMG) 
 
The subject was positioned in a sitting position with legs extended on the plinth. The 
skin was shaved where necessary and cleaned with alcohol free wipes before application 
of the electrodes, in order to ensure good electrode-skin contact. Good electro-skin 
contact improves the EMG recordings by reducing electrical interference and noise. 
Ag/AgCL electrodes with a conductive area of 10 mm2 were applied to VL 
(quadriceps), BicFem (hamstrings), TA, MGast, LGast and soleus of the right lower 
limb according to the European recommendations for surface electromyography (Zipp, 
1982). The electrode application position was determined by palpation (during muscular 
contraction) along with the use of accurate anatomical landmarks to ensure that the 
electrode was applied to the muscle belly. The reference electrode was placed in the 
medial part of the tibia, which is considered to be electrically inactive. The distances 
between agonist and antagonist bipolar electrodes were greater than 10 cm. It is, 
therefore, unlikely that EMG cross-talk could have contaminated agonist or antagonist 
signals (Mullany et al., 2002). As a precaution against any possible signal 
contamination, the electrodes were applied in a parallel orientation to the muscle fibres 
being tested, mid-way and central along the muscle belly. The diameter of the 
electrodes was 18 mm, and the inter-electrode distance (centre to centre distance 
between conductive areas of 2 bipolar electrodes) was 37 mm. 
 
In order to minimise the risk of artefacts due to cable movement, the pre-amplifier 
cables were attached to the subject’s skin using adhesive tape (Micropore; 3M 
Healthcare, D-41453 Nuess, Germany). Once the electrodes were placed and the cables 
fixed, the raw signal was visually inspected for any distortion of the signal using the 
MyoResearch XP Clinical Application software. EMG data was acquired using a 
wireless 8 channel EMG device (TeleMyo™ 2400T G2 Transmitter).  
 
NIRS and EMG data were collected simultaneously on the MGast during a plantar-
flexion exercise protocol (see Section 5.4.1.3 for further information about 
instrumentation set up during this procedure). Therefore, it was necessary to place the 
EMG electrodes slightly lateral to the medio-lateral centre of the muscle belly (Figure 
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5-6). The position of the electrode was still on the muscle belly and did not change 
throughout the whole measurements. 
 
As it was necessary that the subjects were not encumbered by numerous EMG cables 
and fatigued by a lengthy data collection, a practical approach of collecting the EMG 
data from the right leg of each individual was chosen.  
 
5.4.3.4 Gait analysis 
 
Gait analysis was carried out during barefoot conditions. To protect the foot during the 
experiments the subjects only removed the shoes at the walkway. Special attention was 
paid not to allow any participant to step out from the walkway without shoes on. Prior 
to each measurement the walkway was cleaned with an alcohol free wipe to minimise 
any potential hazard to the bare foot. 
 
Participants were asked to walk barefoot at their self-selected speed on a 9 meter 
walkway. The platform to analyse foot-floor interaction (EMED-m) was positioned 
level with the floor at the midpoint of the 9 m walkway (see Figure 5-9). Self-selected 
gait speed is considered to be the most efficient walking speed for an individual and has 
been found to be an appropriate predictor of function and disability (Guralnik et al., 
2000) 
 
Before data acquisition, the subjects were instructed to walk freely on the walkway to 
reproduce their normal gait and to adapt to the laboratory environment. Multiple trials 
were permitted to allow the subjects to practice walking without visually targeting the 
platform surface. The testers adapted the subjects starting position to ensure the 
platform was always hit on the fourth step. Data was collected over 5 trials for each foot 
(five successful trials with the left foot followed by five successful trials with the right 
foot). The EMED system has demonstrated overall reliability when 3 to 5 walking trials 
are used (McPoil et al., 1999). During this task gait characteristics, kinetic data and 
muscular activity characteristics were evaluated.   
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5.4.3.4.1 Gait parameters 
 
Spatial-temporal characteristics 
Spatial and temporal parameters of gait were recorded using the Sony digital video 
camera at 25Hz (Sony digital Camcorder, DSR-PD1P, STYLUS, Cardiff, UK). During 
the gait task, only four trials (two in which the right foot hit the platform and two in 
which the left foot hit the platform) were recorded and saved on a DV tape for further 
analysis.  
 
The camera position was perpendicular to the walkway at a distance of 3.5 meters. The 
video clip was downloaded onto a computer and processed using the SiliconCoach 
software (SiliconCoachPro 6.0, SiliconCoach, London, UK). The time difference 
between the 3 consecutive heel strikes was used to calculate the step and stride times. 
The frame capturing the heel strike was identified and saved for further analysis using 
Matlab. A purpose written programme in Matlab was used to calculate gait velocity, 
cadence and stride length. To compute spatial parameters two parallel sticks (1 meter 
long each) were positioned on both sides of the walk way (See Figure 5-9).   
 
Centre of pressure parameters 
Foot-floor interaction parameters were measured with the EMED platform. This system 
has been proven to be an accurate method to quantify foot-floor interaction 
characteristics (Putti et al., 2008). 
 
The platform consists of a matrix of 3840 force transducers that are uniformly 
distributed in an area of 24 × 38 cm. The platform has a resolution of 4 sensorsּcm-2 
with a sampling frequency of 50 Hz. The sensors have a pressure range from 10 kPa to 
1200 kPa.  
 
The data was processed and analysed by Novel 13.3.42 software. With this software it is 
possible to customise the data analysis by selecting specific areas of the foot (masks) 
and parameters you are interested in. Then, individual masks were created for each trial 
subdividing the foot into 9 masks: heel, midfoot, metatarsals, 1st metatarsal head, 2nd 
metatarsal head, 3rd, 4th and 5th metatarsal heads, bit toe, 2nd toe and 3rd, 4th and 5th 
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toes. These masks were determined automatically by the Novel software after applying 
the PRC-mask on all files. After the automatic masking, visual inspection of all the trial 
was carried out. If the mask did not look correct it was corrected manually to ensure the 
mask was covering the right area. Although the PRC-mask did determine 9 masks 
(regions) automatically, only 3 areas were used for further analysis: heel, metatarsals 
and big toe (see Figure 5-10).  
 
Centre of pressure parameters were investigated. Although COP parameters are kinetic 
data (COP is the point of application of the GRFs) it provides descriptive information 
about gait in general and the roll over process in particular. For this reason COP data 
was included in this section together with spatial-temporal characteristics. Total 
distance travelled by COP gives information about the transverse plane foot mobility 
during the GC. In addition to that, velocity of the COP within different foot regions may 
provide information about the roll over process throughout the stance phase. Thus, total 
distance travelled by the COP, velocity of the COP at the heel, metatarsal heads and 
hallux were measured (Figure 5-10 shows an example of COP data).   
 
5.4.3.4.2 Kinetic data 
 
Kinetic data was measured with the EMED platform. (See previous section for details 
about the EMED platform).  Same as for COP parameters (Section 5.4.3.4.1 ) the data 
was processed and analysed by Novel Software and 3 areas were used for further 
analysis: heel, metatarsal heads and big toe.  
 
Foot plantar pressures are known to be an important contributing factor for plantar 
tissue damage in DN subjects (Frykberg et al., 1998), Although there is an ongoing 
debate on which kinetic variables predict foot problems in this population, there is little 
doubt that PP which accounts for the highest stress generated under the sole of the foot 
(or foot region) and PTI which represents the magnitude and duration of the stress, are 
important contributing factors (Mueller & Maluf, 2002; Uccioli et al., 2001; Veves et 
al., 1992). For this reason, PTI and PP were examined in this study. In addition to that 
other parameters related to PP and PTI such as contact area (CA), maximal force (Max 
Force) and contact time (CT) (both in milliseconds and as % of the stance phase) were 
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also investigated. These parameters related to peak pressure and PTI may provide some 
extra information to better understand PP and PTI values. Therefore, PTI, PP, CA, Max 
Force, CTms and CT% during the whole stance phase were calculated for each of the 
areas under investigation (heel, metatarsals and hallux).  
 
Push off is known to be the phase of the GC where the forefoot, which is the foot area 
more likely to develop ulceration (Boulton, 1994), undergoes the highest pressures. 
Then further analysis was carried out to investigate loading patterns on the forefoot area 
during this critical phase of the GC. In this context forefoot was defined as the foot area 
that covered the metatarsal heads and the toes. The new forefoot mask was created 
manually and it included the masks metatarsal heads and toes, which were previously 
created by the novel software. Push off was defined as the time period from 40% to 
100% of the stance phase (Perry & Burnfield, 2010). Therefore PP and Max Force were 
analysed for this new created mask and time frame. The instant of Max Force and the 
instant of PP during the push off phase in relation to the full roll over process (% ROP) 
were also investigated. They may provide some information about the exact time that 
the highest stress occurs in the forefoot during the push off phase. Although, arch index 
provides information about the structural characteristics of the foot and it is therefore 
not a kinetic variable, some investigators have stated that arch index is an important 
predictor for foot pressures (especially under the metatarsal heads) (Morag & Cavanagh, 
1999). For this reason arch index is included into this section together with kinetic data.  
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Figure 5-9. Overview of the gait task with the walkway and the force platform           
 
 
 
 
 
 
 
 
 
 
 
 
 
A. 1 meter long sticks to determine spatial parameters; B. EMED platform in the middle of            
the walkway.  
 
 
Figure 5-10. Example of EMED data with the COP line and the foot 
areas under investigation 
 
A
B
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5.4.3.4.3 Surface electromyography during gait 
 
EMG data was recorded at 1500 Hz using a wireless 8 channels EMG device 
(TeleMyo™ 2400T G2 Transmitter). EMG data was collected and saved using the 
MyoResearch XP Clinical Application software. Further processing of the EMG signal 
was performed using a purpose written programme in Matlab. Next, the steps followed 
to process and analyse EMG data are explained. 
 
The raw EMG signal was full wave rectified and low pass filtered using a second order 
Butterworth filter with a 50 Hz cut off frequency to create a linear envelope that was 
used for further analysis. To be able to relate EMG activity to the GC, EMED data and 
EMG data were collected simultaneously. (See Section 5.4.1.1 for more information 
about the instrumentation set up during this task). Therefore, EMG data could be 
processed in relation to the heel strike (See picture 4 from Figure 5-4). Furthermore to 
be able to relate EMG data not only to the heel strike but to the rest of the GC, the 
duration of the stance phase, which was calculated by the Novel 13.3.42 software, was 
taken into account when processing the EMG signal. Then, if the instant of the heel 
strike and the duration of the stance phase are known the instant of the push off can also 
be determined. It has been stated that stance phase normally represents 62% of the GC 
while swing phase accounts for the remaining 38% (Perry & Burnfield, 2010). 
Therefore, the swing phase of the GC was estimated based on these percentages. This 
approach was used in the present investigation to relate EMG data to the GC (stance 
phase and swing phase).  
 
Thereafter each step was normalised to 100% of the GC. 0% represents the heel strike 
and 100% represents the end of the swing phase. Regarding to the normalisation of the 
EMG amplitude, EMG is usually normalised to EMG registered during a maximum 
effort test (Perry & Burnfield, 2010). In the present investigation some participants from 
the DN group showed muscular activity values during gait up to 600% of the highest 
EMG activity recorded during MVCs (see Section 5.4.3.5 and Section 5.4.1.2 for more 
information about MVC measurements and instrumentation set up during this task). 
This shows that EMG data normalised to % MVC was not a valid approach to use with 
the patients with DN in the present study. It was then decided to normalise EMG signal 
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to the peak activity during the GC, which is an acceptable and widely used 
normalisation technique during dynamic conditions (Burden, 2010).  
 
EMG data was collected throughout the entire gait task. However only the steps in 
which the right foot hit the EMED platform were analysed (5 steps in total). To help 
identify the correct step a sheet was used during data collection in which the correct 
heel strikes were written down.    
 
For each of the six muscles recorded, an average EMG trace for each subject was 
obtained by getting an average across all five trials. For a more comprehensive 
interpretation of the results, it was decided to analyse the three plantarflexor muscles 
(MGast, LGast and soleus) as a single muscle, TS. Then, EMG activity was investigated 
for TS, TA, VL (quadriceps), BicFem (hamstrings). EMG signal was then investigated 
1) over the entire GC; 2) per phase of the GC; and 3) during the push off phase. 
 
Firstly, the % of time each muscle was kept active during the whole process was 
determined. Perry & Burnfield (2010) suggested a cut off point of 5% of the peak 
activity to define muscular activity. Then, muscle activity was calculated when the 
average EMG trace was above 5% of the peak activity during gait (Figure 5-11 shows 
an example of EMG data processed with Matlab to determine % of time EMG trace was 
kept above 5% of the peak activity).  
 
Secondly, the mean EMG activity (normalised) was calculated within selected phases of 
the GC. According to Perry & Burnfield (2010) the GC is composed of 7 phases: 
loading (0-10% of the GC), mid-stance (10-30% of the GC), terminal swing (30-50% of 
the GC), pre-swing (50-60% of the GC), initial swing (60-73%), mid swing (73-87%) 
and terminal swing (87-100% of the GC). Since foot problems are related to the stance 
phase of the GC, initial swing and mid swing were not investigated in the present study. 
Therefore, average activity was calculated only for 5 phases (Figure 5-12 displays an 
example of EMG output processed with Matlab to calculate mean EMG activity 
throughout the different phases of the GC).  
 
Numerous studies have reported excessive foot pressures on the forefoot during push 
off in patients with diabetic neuropathy (See Chapter 2 for more information about foot 
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pressure in neuropathic patients). It was therefore decided to create time windows to 
investigate TS and TA EMG data around the push off phase during the GC. The time 
window for the TS covered the time from the peak activity during the push off phase 
(around 50% GC) to the initiation of that activity. The time window for the TA covered 
the time from the peak activity during the initial swing phase to the initiation of that 
activity. Hence, a time frame window was created for the TA and TS muscles to 
investigate: 1) when the peak activity occurred in each window, expressed as % of the 
GC; and 2) the time delay from the onset of the activity, which was defined as 5% of the 
peak activity during gait, to the peak muscular activity. This measure was calculated in 
milliseconds. (See Figure 5-13 for more information on how the windows were defined 
as well as the calculations carried out within each window).  
 
EMG signal refers to the electrical event produced by the muscle and not to the 
mechanical output (force) (Winter et al., 2009). The time lag between EMG activity and 
force production is called electromechanical delay. Therefore, it has been proposed that 
EMD should be taken into consideration when processing EMG data, so muscle 
function during dynamic conditions such as walking can be investigated in relation to 
movement (Amaranti & Martin, 2004). Since in the current study we were not interested 
in when EMG activity was present but when muscle output from that activity was 
produced, EMG data was processed taking in consideration EMD. Two different 
approaches were followed in this study to determine EMD. Thus, one method was used 
to determine EMD for dorsi-flexors, knee extensors and knee flexor muscles, while a 
second method was used to quantify EMD for the plantar-flexor muscles. The reliability 
of the EMD measurements used in the present study were not well established prior to 
the start of the study. For this reason two reliability studies were carried out before the 
main study started, which demonstrated that these methods were reliable to quantify 
EMD. See Chapter 4 (Section 4.2 and Section 4.3) for more information about these 
reliability studies. 
 
 
 
 
 
  152 
Figure 5-11. Example of EMG data to quantify the amount of time each muscle was kept active 
during the gait cycle 
 
 
Figure 5-12. Example of EMG activity throughout the different phases of the gait cycle 
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Figure 5-13. Example of how the time window was determined to calculate time related EMG 
variables for the TA and TS muscles  
 
 
 
 
 
5.4.3.5 Muscle strength  
 
Muscle weakness secondary to DN is considered an important factor in explaining gait 
abnormalities in this population (Mueller et al., 1994; Giacomozzi et al., 2002). It has 
been hypothesised that gains in strength levels in this population may change gait 
characteristics in DN patients. For this reason strength levels were measured in part 1 
and part 2 of this study.   
 
The KINCOM dynamometer was used to measure maximal isometric strength. This 
device has been shown to be accurate and reliable in these measurements (Farrell & 
Richards, 1986).  Muscle strength was assessed isometrically for the ankle plantar-
flexors, ankle dorsi-flexors knee extensors and knee flexors. Ankle plantar-flexion and 
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ankle dosi-flexion measurements were carried out with the subject lying down on a 
supine position. The right leg was semi-extended (30º±10 flexion) with the ankle fixed 
at 15º plantar-flexion. The external malleoli was placed in line with the rotation axis. 
This position was chosen to maximise muscular activity in the calf muscles during the 
plantar-flexion.  
 
Knee flexion and knee extension were tested with the subject seated in an upright 
position (90º hip flexion) with their knees flexed to 90º and 70º, respectively.  The right 
leg was secured into an instrumented cuff positioned at a point a few centimetres above 
the ankle joint with a stabilisation strap across the femur of the right leg. A seat belt was 
used to secure the subject in the sitting position and prevent them from altering their 
position during the data collection. The moment arm distance was recorded and used 
when processing strength data for all 4 movements. 
 
Prior to data collection, a warm-up period was performed. To increase body temperature 
and therefore reduce the risk of muscular problems such as cramps, participants were 
asked to ride an indoor bike for 5 minutes at an increasing (moderate) pace. Then, 
participants were taken to the KINCOM machine, where (on the positions described 
above), they performed 15 contractions for 2 seconds at different levels of intensity 
(40% and 60%). During these contractions, EMG was used as a feedback tool for the 
tester to ensure participants were doing the movement correctly (contractions was 
observed in the correct muscle) (see Section 5.4.1.2 for more information about the 
instrumentation set up). This tool was especially useful during plantar-flexion. When 
subjects were doing the movement at a high intensity, they tended to recruit the whole 
leg which resulted in a shift in activity from the calf muscles (soleus, MGast and LGast) 
to the quadriceps. By providing live feedback participants achieved better movement 
awareness which resulted in better muscle isolation.  
 
Data collection consisted of three maximal isometric voluntary contractions per 
movement lasting 3 seconds per contraction. Each contraction was followed by a 30-
second rest period before the next MVC. All together 12 MVCs were recorded.  
 
Data collected in the KINCOM dynamometer was saved in a laptop using the 
MyoResearch XP Clinical Application software (see Section 5.4.1.2 for more 
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information about the instrumentation set up). Further processing of the data was 
performed using a purpose written programme in Matlab. Thus, maximal force was 
defined as the mean activity during the middle of the three seconds contraction periods 
(Figure 5-14 display an example of how maximal force was defined during MVCs). The 
highest of these three means (one per MVC) was considered the maximal force for that 
specific movement. The moment arm distance for the different movements was 
recorded and the joint moment used to quantify maximal strength.  EMG data during 
MVCs was used to normalise the EMG data collected during gait to maximal voluntary 
contraction (see Section 3.4.4. for more information about EMG data normalization 
during gait). 
 
Figure 5-14. Example of how the Maximal Force was determined during MVCs 
 
 
 
5.4.3.6 Microcirculation measurements 
 
Microcirculation measurements were carried out on the skeletal muscle using NIRS. 
NIRS is a non-invasive optical and direct method to determine oxygenation and 
hemodynamics in tissue. This technique is based on the relative transparency of tissue 
to light in the near-infrared region, and on the oxygen-dependent absorption changes of 
haemoglobin and myoglobin. It enables non-invasive continuous measurements of 
changes in the concentration of HbO and HbdO. The sum of HbO and HbdO 
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concentrations reflects the total amount of haemoglobin (tHb), and changes in tHb can 
be interpreted as changes in blood volume in the tissue.  
 
Numerous studies have proven the validity of NIRS to determine muscle BF and mVO2 
by comparing it against well-established methods such as strain-gauge plethysmography 
or the Fick method (De Blasi et al., 1994; Mancini et al., 1994; van Beekvelt et al., 
2001b). Data collection was performed using the Oxymon MK III. This device has been 
proven to be a reliable and valid method to investigate local muscle O2 consumption 
and blood flow, both in resting and exercising muscle (van Beekvelt et al., 2001b; van 
Beekvelt et al., 2002).  
 
Quantification of muscle oxygen consumption and blood flow was performed by 
applying a VO to control circulation in the limb (see Figure 4-1 in Chapter 4). Venous 
occlusion causes an increase blood volume by an undisturbed arterial (in) flow and 
interrupted venous (out) flow. Blood flow can therefore be calculated during venous 
occlusion from the linear increase of tHb. Muscular oxygen consumption is calculated 
from the linear increase of HbdO. Since the venous outflow is blocked, the increase in 
HbdO is thought to be solely due to the O2 consumed under the assumption the arterial 
O2 saturation is near 100%. NIRS measurements in our study were done on the belly of 
the MGast with an inter-optode distance of 40 mm. The reliability of the method to 
measure blood flow and O2 consumption in the lower limb was not well established 
prior to the start of this study. For this reason a reliability study was carried out before 
the main study started, which demonstrated that this method is reliable both within-day 
and between-days to quantify blood flow and oxygen consumption in the calf muscle. 
See Chapter 4 (Section 4.1) for more information about this reliability study.  
 
NIRS measurements were carried out with the subject lying down on the KINCOM 
machine (in the same position as during the ankle plantar-flexion measurements) (see 
Section 5.4.3.5) (see Section 5.4.1.3 for information about the instrumentation set up 
during these measurements). This position was chosen to ensure the heart position was 
not above the limb position. The opposite may result in venous pooling and therefore 
may compromise the quality of the measurements. A pneumatic cuff was then placed 
around the right thigh and was used to apply venous occlusion during the test. Venous 
occlusion was performed at 50 mmHg and maintained for 30 seconds. A resting period 
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of 40 seconds was allowed between inflations. In total, six venous occlusions were 
carried out throughout the NIRS measurements, 3 during resting conditions and 3 
following an exercise protocol. The exercise protocol consisted of two sets of seven 
isometric plantar-flexion contractions at 50% of the MVC, separated by a one minute 
resting period. Contractions were maintained for 10 seconds. A 20-second resting 
period was allowed between contractions. 
 
To control the intensity of the contractions, the maximal force produced during plantar-
flexion MVC was computed and the 50% was calculated (see Section 5.4.3.5 for more 
information about how MVC was carried out). This value was entered on the KINCOM 
machine. The KINCOM machine has got an option by which continues feedback 
(current force and target forces) can be displayed on the screen (see Figure 5-16). 
 
NIRS data was processed and analysed using the Oxysoft 2.1.2 software. Oxygen 
consumption as well as blood flow in the MGast was measured to investigate muscle 
microcirculation during three different conditions: 1) circulation at rest; 2) circulatory 
responses to exercise and; 3) circulatory recovery from exercise.  
 
Blood flow was calculated during venous occlusion from the linear increase of tHb. 
Concentration changes of tHb were expressed in micromolars per second and were 
converted to mlּmin -1ּ100ml-1 using an average Hb concentration of 7.5 mmolּL-1  for 
female subjects and 8.5 mmolּL-1  for male subjects. The molecular weight of 
haemoglobin (64.458 gּmol-1) and the molecular ration between haemoglobin and 
oxygen (1:4) were taken into account. Muscular oxygen consumption was calculated 
from the linear increase of HbdO. Concentration changes HbdO were expressed in 
micromolars per second and converted to millilitres O2 per minute per 100 grams. A 
value of 1.04 kgּL-1 was used for muscle density (van Beekvelt et al., 2002).  
 
Circulation at rest was presented in absolute values. Blood flow values were then 
expressed in mlּmin -1ּ100ml-1 and oxygen consumption in mlO2ּmin -1ּ100g-1. Resting 
BF and mVO2 were calculated as the average of the three values acquired during the 
first three VOs. Responses to exercise were calculated as the % of change in BF and 
mVO2 from resting condition values (average values obtained during VO1,VO2 and 
VO3) to post-exercise values (values obtained during VO4). Recovery from exercise 
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investigated the % of recovery in BF and mVO2 from VO4 (first VO after the exercise 
protocol) to VO5 (second VO after the exercise protocol finished). (See Figure 5-15 for 
more details about the microcirculation measurements).  
 
During the exercise protocol, force and EMG were collected simultaneously (see 
Section 5.4.1.3 for more information about instrumentation set up). This enabled us to 
relate NIRS data (blood flow and oxygen consumption in the MGast) to the amount of 
work done by the MGast during the exercise protocol. Even though force was controlled 
during the exercise protocol, the amount of work coming specifically from MGast was 
unknown. EMG data during the exercise protocol was calculated using Matlab and was 
processed in relation to the maximal activity obtained during the plantar-flexion MVCs 
(strength test). Then, the mean activity during the 14 contractions (10 seconds each) was 
determined.  
 
 
 
Figure 5-15. Example of the microcirculation data obtained from the NIRS device.   
 
 
  
 
 
Note: The blue line represents the deoxygenated haemoglobin, the red line represents the oxygenated 
haemoglobin and the green line represents the total haemoglobin content. 
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Figure 5-16. Example of the display of the KINCOM machine during the exercise protocol  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5.4.4 Summary of the outcome measures in relation to the aims of 
the study.  
 
 
Table 5-3 shows an overview of the outcome measures investigated in the present 
investigation and how they relate to the different domains under investigation. 
 
5.5 Ethical Considerations 
 
General ethical consideration 
The study was approved by the Cardiff and Vale NHS Trust Research & Development 
Office and the South East Wales Local Research Ethics Committee (See copy of 
approval letters in Appendix 8). All work undertaken complied with the Research 
Governance Framework for Health and Social care in Wales and Cardiff University 
Research Governance Framework. Patients were free to withdraw from the study at any 
time without a given reason, and without medical care or legal rights affected. 
 
 
Target force
Actual force
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Ethical issues related to data collection 
The participants were required to wear shorts and a t-shirt during the data collection. 
Changing facilities were available on site. During skin-folds measurements participants 
were required to lift the t-shirt so the skin folds were accessible to the researcher. 
During the ECG measurements, in order to place the chest electrodes in the right 
position participants were requested to take the t-shirt off. Women were also asked to 
unfasten their bra. A towel was placed on the chest of the women participants during the 
whole duration of the ECG recordings to protect their privacy. In addition to that, in 
order to respect the dignity of the participants all the measurements were carried out by 
someone of the same gender as the subject, a male researcher for men participants and a 
female research for women participants.   
 
Since DN subjects are at risk of developing foot problems, special attention was paid in 
protecting their feet throughout the entire data collection session. Participants were 
provided with a pair of comfortable and adjustable shoes (Classic xtra, Chaussures 
Pulman, Saint Paul Les Dax, France) that they wore throughout the data collection. 
When measurements required barefoot standing (gait analysis, weight and height 
measurements) a mat or walkway was placed on the foot to avoid direct contact between 
the foot and the floor at any time during the whole session. 
 
Ethical issues related to data storage 
All data was collected, processed and analysed at the Research Centre for Clinical 
Kinaesiology, department of Physiotherapy at Cardiff University. To ensure anonymity 
all participants were allocated a unique subject code. All collected data was then kept 
anonymous and saved under the subject code in password protected computers. Any 
written data as well as the video taken from the gait analysis were kept in a key-locked 
cabin and only the researcher (PhD student) had access to the key.  
Cardiff University was/is the data controller. In this capacity, the School of Healthcare 
Studies Cardiff University will retain all data collected during the research for 15 years, 
in accordance with the Data Protection Act (1998). 
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Ethical consideration of the exercise programme 
(This section only applies to the part 2 of the main study).  
The exercise programme was designed and supervised by the researcher, who is a 
qualified exercise scientist. The exercise programme was planned to be performed both 
in the gym and at home. It was thought that encouraging people to exercise by 
themselves will improve their confidence and determination to integrate physical 
activity as part of their daily lives which will extend the benefits of physical activity 
beyond the duration of this study. During the first fortnightly gym sessions special 
attention was paid to teach participants; 1) how to exercise by themselves; and 2) how 
to reduce the risk of any hypoglycaemic events caused by the exercise bout (i.e. 
controlling glucose levels before and after training). After that period subjects were 
provided with a guide which included the exercises they had to do at home (see 
Appendix 2).  
 
There are some exercise-induced risks associated with the interventional study. Even 
though the strictness in the inclusion/exclusion criteria may minimise these risks, there 
were still some threats secondary to peripheral neuropathy, which need to be taken into 
consideration. Foot problems and hypoglycaemic episodes are the most common risks 
associated with exercise training. To reduce the risk of foot complications the amount of 
weight bearing exercises were reduced to a minimum and only non-impact exercises 
were used. In addition to that, all participants were encouraged to closely examine their 
feet after each training session to prevent sores and were required to use proper 
footwear. To reduce the risk of hypoglycaemic episodes, subjects were advised before 
each session to check their sugar levels. If sugar levels were below 100 mgּdL-1 
participants were provided with a carbohydrate snack (Flood & Constance, 2002). The 
information sheet included a section in which the potential risks of the study were 
addressed. Moreover, participants were encouraged to ask about their concerns before 
accepting to take part in the study.  
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5.6 Statistical consideration  
 
5.6.1 Sample size determination 
 
Prior to the beginning of the study, the sample size and power calculation were assessed 
for the primary outcome measures.  The primary outcome measures in the present 
investigation were PP and microcirculation due to their association with foot ulceration 
in subjects with DN. Two power calculations were performed, 1) to determine the 
numbers for the cross-sectional study and 2) to determine the numbers for the 
intervention study. Details on the power calculations for the cross-sectional and 
intervention studies are provided below.  
 
5.6.1.1 Cross-Sectional  
 
Effect size for peak pressure 
Data from previous research investigating group differences in forefoot peak pressures 
between healthy and subjects with DN were used for the calculations. Forefoot peak 
pressures were chosen since most of the foot ulcers in subjects with DN occur in this 
foot region. Pitei et al. (1999) reported mean values of 242± 25.1 kPa and 204.6± 37.8 
kPa for subjects with DN and healthy individuals, respectively. These values indicate a 
standard difference of 1.18 (Bratcher et al., 1970). For this power calculation, a more 
conservative estimate of the standard difference of 1 was used.   
 
Effect size for microcirculation 
Data from previous research investigating group differences in vasodilatory changes in 
the microcirculation between healthy and subjects with DN were used for the 
calculations. Colberg et al. (2005) reported mean values of 119.7± 12 units and 91.6± 
14.9 units for healthy individuals and patients with type 2 diabetes, respectively. These 
values indicate a standard difference of 2 (Bratcher et al., 1970). For this power 
calculation an effect size of 2 was used.  
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Study Power calculation  
Two groups namely DN and HEALTH were compared in the cross-sectional study. 
Minimum sample size was calculated using a standardised difference of 1 (which 
reflects the lower of the two effect sizes reported above), and a power of 0.90 (α= 0.05). 
Each group therefore needed a minimum of 22 participants. 
 
5.6.1.2 Intervention study 
 
The main objectives of this research study were: 1) to determine whether a physical 
activity programme based on strengthening exercises can modify gait characteristics in 
patients with diabetic neuropathy and 2) to examine whether a strength training 
programme can improve circulation in this population.  
 
Effect size for chances in strength levels 
An important aim of this investigation was to increase strength levels in a sample of 
patients with diabetic neuropathy. Therefore, available literature was investigated for 
changes in strength levels due to a physical activity programme in patients with diabetic 
neuropathy. Since prior to the beginning of the present investigation there was no 
information available on the effect of a PA programme on strength levels on subjects 
with DN, the effect size calculation was carried out on individuals with type 2 diabetes 
and no neuropathic complications. Cauza et al. (2005) carried out a 4 months resistance 
training programme on 22 individual with type 2 diabetes. They reported changes in 
lower limb strength levels from 113.6± 7.8kg to 167.9±  9.7kg that indicate a 
standardised difference of 8.7  (Bratcher et al., 1970). For this power calculation an 
effect size of 8 was used.  
 
Effect size for chances in circulation parameters  
An important aim of this study is to explore the effects of resistance training on 
microcirculation in a diabetic population with peripheral neuropathy. Therefore, 
available data in the literature was investigated for changes of microcirculation 
parameters through a strength training intervention. Vasodilatory responses to local heat 
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were chosen for the power calculations since they indicate adaptations in 
microcirculation. Colberg, et al. (2006) carried out 8 weeks of strengthening exercises 
in a group of 10 subjects with type 2 diabetes. They reported pre-intervention values of 
91.6+14.9 units and post-intervention values of 102.9± 16.9 that indicate a standardised 
difference of 1 (Bratcher et al., 1970). For this power calculation an effect size of 1 was 
used.  
 
Study power calculation  
Two groups namely EXE and CON were compared based on physiological outcomes. 
Minimum sample size was calculated using a standardised difference of 1 (which 
reflects the lower of the two effect sizes reported above) and a power of 0.90 (α= 0.05). 
Each group therefore needed a minimum of 27 participants. However, due to fact that 
some studies reported high rates of drop-out in physical activity interventions with 
diabetic populations (Thomas et al., 2006), which could drastically affect the power of 
the study, it was attempted to recruit about 30 participants per group to minimise this 
risk, whilst aiming to limit the drop-out as much as possible by motivating participation.  
 
Part 1 and part 2 of the main study were not independent to one another. Therefore, the 
volunteers from the DN group from the cross-sectional study were included in the 
intervention study either as exercisers (EXE group) or controls (CON group) (see 
Figure 5-1). The intervention study required a larger number of subjects with DN (30 in 
each group, totalling 60 subjects with DN) than needed for the cross-sectional study 
(only 22 individuals required). This resulted in a higher number of subjects for the DN 
group than needed based on the power calculation.  
 
5.6.2 Statistical analysis 
 
The present investigation includes two different studies, a cross-sectional study, and an 
intervention study. Table 5-1and Table 5-2 include a summary of the statistical analysis 
followed for the cross-section and longitudinal studies, respectively. SPSS 16.0 
software was used for all statistical analyses of the data. 
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5.6.2.1 Cross sectional study 
 
Normality and equal variance of the data were assessed to allow for the appropriate 
choice of statistical test (Field, 2009; Portney & Watkings, 2009). Histograms and Q-Q 
plots were used to inspect the distribution of the data visually (skewness and kurtosis), 
whereas the Shapiro Wilk test was used to confirm whether the data was normally 
distributed. Since the Shapiro Wilk test is more appropriate for small sample sizes (<50) 
compared to the Kormogorov-Smirnow test (Elliot & Woodward, 2010), the Shapiro 
Wilk test was used in the present study. In addition to this, to further explore the 
distribution of the variables, the values of skewness and kurtosis were recorded. 
Homogeneity of variance was tested using Levene’s test. Pearson’s correlations and in 
cases where normality was not shown the non-parametric Kendall´s tau-b was used to 
identify possible confounding variables. Kendall’s tau-b was chosen instead of 
Spearman’s correlation coefficient since Kendall’s statistic is considered a better 
estimate of the correlation in the population compared to Spearman’s coefficient 
(Howell, 2006). Independent t-test and in cases where normality was not shown the 
non-parametric Mann Witney U test was used to assess between group differences. 
When confounding variables were identified group differences were investigated using 
analysis of covariance (ANCOVA), which allows a group comparison after controlling 
for the confounding variables. ANCOVA assumes that data is normally distributed, 
therefore, in the case where normality was not shown data transformation was carried 
out. Square root transformations for positive skew data and reverse score 
transformations for negative skew data were chosen (Field, 2009). After the data was 
transformed and prior to carrying out ANCOVA it was checked via histograms, Q-Q 
plots and the Shapiro Wilk test that the data was normally distributed.  
 
Significance was set at an alpha level of 0.05. Data was considered to show a trend 
when alpha level was <0.1. Descriptive statistics were presented in the form of means 
and standard deviations when the data was normally distributed and in the form of 
medians and ranges when the assumption of normality was violated. Variables that were 
not normally distributed can be identified in the results Chapter since: 1) they were 
presented as median and range; and 2) they were analyzed with a non parametric test. 
When a non parametric test was used to analyse the data, it was stated in the table with 
  166 
the results.  Transformed data was presented in the form of original means and standard 
deviations not to lose the meaning of the actual units.  
 
The two groups were matched on marginal distributions for age, body mass, sex and 
height as those variables would potentially affect the findings in the present study. Since 
matching for body mass was not possible the effect of body mass on the data was 
explored. Thereafter when body mass was identified as a confounding variable 
ANCOVA was used to control for the effect of body mass in the analysis. 
 
 
 
Table 5-1. Overview of the statistical analyses carried out for the cross-sectional study.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
5.6.2.1.1 Further data exploration 
 
After performing the statistical analyses to test the hypotheses of the cross-sectional 
study, it was considered of interest to explore the possible variables that may explain 
those results. The main objective of the cross-sectional study was to understand the 
differences between healthy and neuropathic patients when investigating “health 
ANCOVA*
Confoundings
identifed
Independent
t-test
Procedure Statistical test
Normality check Q-Q plot, Histogram and Shapiro-Wilk test
Correlations 
(confounding 
variables)
Normality  assumed Normality NOT 
assumed
Pearson’s Correlation
(Parametric)
Kendall’s tau-b
(Non Parametric)
Group differences
Normality assumed Normality NOT 
assumed
No confounding
identified
Mann Witney U 
(Non Parametric)
* In the case where normality was not shown data transformation was 
performed
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characteristics” from a multidimensional comprehensive approach. Further to this 
information, it was interesting to explore the factors that may better account for those 
group differences as well as whether those factors play a similar or a different role on 
the diabetic neuropathic patients when compared to the healthy counterparts. It is 
noteworthy that only outcome measures that have been identified in the literature to 
influence the dependent variable were explored. In the results chapter and prior to the 
presentation of the exploratory data the variables that were investigated and the 
theoretical reasons behind that choice were explained.  
 
The main analysis of the exploratory data was carried out using bivariate correlations. 
Normality and equal variance of the data were assessed to allow for the appropriate 
choice of statistical test. Histograms and Q-Q plots were used to inspect the distribution 
of the data visually, whereas the Shapiro Wilk test was used to confirm whether the data 
was normally distributed (Field, 2009). Then, Pearson’s correlations were used when 
the data was normally distributed whereas Kendall’s tau-b was used when normality 
was not shown (Howell, 2006). Significance was set at an alpha level of 0.05. The 
exploratory analysis of the data was intended to give an indication of the variables that 
may contribute to the main outcome measures investigated within the cross-sectional 
study. For instance, it was explored whether sensory neuropathy or muscle weakness, 
which are considered two important factors responsible for the gait differences between 
healthy and DN subjects (Mueller et al., 1994; Payne et al., 2002), were important 
contributing factors in the present investigation.  
 
5.6.2.2 Intervention study  
 
Two groups namely CON and EXE were compared over time to assess the effect of a 
resistance training programme on cardiovascular risk factors, gait characteristics, 
circulation and quality of life. Adaptations to the exercise programme were calculated 
using a 2 way Mixed ANOVA design. The analysis of interest was the interaction of 
group*time. Prior to running the analysis for ANOVA, normality of the data was 
inspected as described in the section above. Since for 2 way Mixed ANOVA there is no 
non-parametric counterpart, no alternative test was carried out in the present study when 
the data broke the assumption of normality (Field, 2009). Although 2 way Mixed 
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ANOVA assumes that data are normally distributed, it is well known that ANOVA is 
robust to violations of the assumption of normality of the data (Field, 2009; Howell, 
2006). Thus, it is believed that normality of the data do not seriously affect the results. 
For this reason and to reduce the risk of losing the “meaning” of the actual units due to 
data transformation, variables that were not normally distributed were not transformed. 
2 way Mixed ANOVA also assumes that the data do not violate the assumption of 
sphericity. However, at least three means are required for sphericity to be an issue 
(Field, 2009) and in the present study only two means (pre-intervention and post-
intervention) were analysed. 
 
Hence, pre- and post-intervention data sets were entered in the within subjects box 
whereas the intervention groups (CON and EXE) were entered for the between subjects 
analysis in the SPSS 16 software. The covariates used throughout the intervention 
results section were carried over from the cross sectional results sections. No post hoc 
tests or contrast were carried out since only two means were (pre-intervention and post-
intervention) were analyzed.  
 
Significance was set at an alpha level of 0.05. Data was considered to show a tendency 
when alpha level was <0.1. Descriptive statistics were presented in the form of means 
and standard deviations.In addition to this, F values and degrees of freedom were also 
displayed. Please note that the F values only relate to the group*time interaction effect. 
 
 
Table 5-2. Overview of the Statistical analyses carried out for the intervention study 
Procedures Statistical Test 
Normality check Q-Q plot, histogram and Shapiro- Wilk test 
Confounding NOT 
identified in the Cross-
Sectional study 
Confounding IDENTIFIED in the 
Cross-Sectional study 
Group*Time interaction 
2 way Mixed ANOVA Covariate was entered in the 2 way 
mixed ANOVA analysis 
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Table 5-3. Overview of the outcome measures investigated in the present study 
Domain Measurement Instrument Outcome measure 
Total cholesterol 
LDL Cholesterol LDX system 
HDL 
Systolic Blood Pressure 
Blood Pressure Microlife BP 
Diastolic Blood Pressure 
Glucose Control DCA 2000 HbA1c 
Neurothesiometer VPT 
General Health 
Neuropathy 
Monofilaments N/A (only for confirmation 
of DN) 
Strength KINCOM Peak Moment 
Gait velocity 
Step length Video Camera 
Step time 
Distance COP 
Velocity COP 
Gait parameters 
EMED Platform 
Arch Index 
Peak Pressure 
PTI 
Contact Area 
Contact time 
Max Force 
Instance Max Force 
Kinetic data EMED Platform 
Instant Max Pressure 
% peak activity per gait 
phase 
% GC muscle active  
Time to peak (push off 
phase) 
Gait 
Muscular Activity NORAXON EMG device 
Instant Peak Activity (Push 
off) 
Muscular Blood flow 
 Microcirculation Muscular 
microcirculation NIRS Muscular Oxygen 
Consumption 
Physical Health  
Quality of Life Self-Reported Quality of life 
SF-36 
Questionnaire 
Mental Health 
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CHAPTER 6  
 
6 Results 
 
The present investigation includes two different studies, a cross-sectional study (Part 1 
of the main study), and an intervention study (Part 2 of the main study). The cross-
sectional study investigated differences between patients with DN and healthy controls 
whereas the intervention study analysed the effects of a 16-week semi-controlled 
strength training programme on subjects with peripheral neuropathy. As mentioned in 
the methods chapter both studies investigated the same outcome measures, which 
included parameters related to general health, gait, microcirculation and QOL These are 
considered the primary pathologies associated with DN.  
 
This chapter was therefore divided into two sections named cross-sectional study and 
intervention study. Therefore, section 1 presents the results related to the hypotheses for 
the part 1 of the main study and section 2 presents the results related to the hypotheses 
for the part 2 of the main study.  
 
6.1 CROSS-SECTIONAL STUDY 
 
The aim of this cross-sectional study was to investigate differences in the primary 
pathologies associated to diabetic peripheral neuropathy between healthy and DN 
subjects. Therefore, after the demographic characteristics of the sample groups are 
presented, results of the outcome measures relating to general health, gait, 
microcirculation and QOL are displayed in different sections in this chapter (see Table 
6-1). These results compose the main analysis. Each section begins by exploring the 
effect of previously identified possible confounders (in the literature) on the dependent 
variable. Thereafter, based on this exploration the decision was made to which analysis 
would be appropriate. Further information about the statistical approach used during the 
cross-sectional study can be found in the Chapter 5 (Section 5.6.2.1). In addition to that, 
the last section of the results includes an exploratory analysis which provides some 
additional information regarding the factors that may account for the group differences 
investigated in the main analysis.  
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Table 6-1. Overview of the results presented in cross-sectional study 
DOMAIN Measurement Outcome measure 
TC 
LDL Cholesterol 
HDL 
Systolic Blood Pressure 
Blood Pressure 
Diastolic Blood Pressure 
Glucose Control HbA1c 
Body mass 
Obesity 
Body fat % 
General Health 
Neuropathy VPT 
Strength Peak Moment 
Gait velocity 
Step length Spatial-temporal 
Step time 
Distance COP 
Gait 
parameters 
COP parameters 
Velocity COP 
Heel 
Metatarsals Peak Pressure 
Big toe 
Heel 
Metatarsals 
Kinetic data 
PTI 
Big toe 
% peak activity per gait phase 
% GC muscle active 
Time to peak (push off phase) 
Gait 
Muscular Activity 
Instant Peak Activity (Push off) 
Rest 
Post-Exercise 
Muscular 
Blood flow 
 Recovery 
Rest 
Post-Exercise 
Microcirculation Muscular microcirculation 
Muscular 
Oxygen 
Consumption 
Recovery 
Physical Health Quality of Life Self-Reported Quality of life 
Mental Health 
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6.1.1  Subjects characteristics 
 
The two groups were matched on marginal distributions for age, height and gender. 
Table 6-2 presents the demographic features of the subjects belonging to the 2 groups 
(DN and HEALTH). No statistical differences were shown between the groups 
regarding to age, height or gender. However, both groups differed significantly in body 
mass (<0.01). Mean± standard deviation was 93.03± 17.47 kg and 78.63± 9.56 kg for 
DN and HEALTH groups, respectively. Since matching for body mass was not possible 
the effect of body mass on the outcome measures was explored prior to the main 
analysis.  
 
 
 
Table 6-2. Subject characteristics for the HEALTH and DN groupa 
Group 
Inferential statistical 
results 
Variable 
DN (N=53) HEALTH (N=25) Case*Control 
comparison 
Age (years) 62.20± 7.55 57.76± 10.60 t(76)=1.851, p=0.068 
Mass (kg) 93.03± 17.47 78.63± 9.56 t(76)=3.846, p<0.001 ** 
Height (m) 1.69± 0.98 1.71± 0.86 t(76)=-0.939, p=0.350 
Sex 
Male (n) 
Female (n) 
 
34 (64%) 
19 (36%) 
 
16 (64%) 
9 (36%) 
 
NA 
a
 Values are means ± SD; ** Significance value is less than 0.01 level (2-tailed).  
 
 
6.1.2 General Health 
 
This section investigates characteristics related to general health. Thus, blood pressure, 
body fat% and lipids profile were explored. 
 
Table 6-3 shows the medications that were taken by the DN group at the time of the 
measurements and that could have affected some of the group comparisons discussed 
later. Thus, Table 6-3 shows that all the subjects in the DN group were taking 
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medications against hypertension, hyperglycaemia and hypercholesterolemia. In 
addition to this, 7 subjects (13%) were taking antidepressants.   
 
 
Table 6-3. List of medications taken by the DN group 
Treatment Medication 
Number of 
patients taking 
specific 
medications 
Number of 
patients taking 
medications 
for specific 
treatment 
• ACE inhibitor (i.e. 
Ramipril, Lisinopril, 
Perinpopril, Losartan or 
Valsartan 
48 (92%) 
Hypertension 
• Thiazide diuretic (i.e. 
Bendroflumethiazide 6 (11%) 
52 (100%) 
• Metformin 51 (98%) 
Hyperglycaemia 
• Repaglinide 3 (5%) 
52 (100%) 
Hypercholesterolemia • Statin (i.e. Simvastatin, 
atorvastatin) 52 (100%) 52 (100%) 
Antidepressant • Amitriptyline (i.e. 
tryptomer, Lentizon) 7 (13%) 7 (13%) 
 
 
Main results: Comparison of general health related outcome measures between the 
DN and the HEALTH group 
Information with regards to the risk factors associated with cardiovascular diseases is 
presented in Table 6-4. DN group showed significantly higher values in systolic blood 
pressure, heart rate at rest and body fat % compared to the HEALTH group. Diastolic 
blood pressure did not differ significantly between the groups. Since cholesterol levels 
were only measured in the DN group Table 6-5 presents cholesterol levels in the DN 
group. For informative reasons current recommendations from the National Cholesterol 
Education Programme (NECP) regarding LDL, HDL and TC (Expert Panel on 
Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults, 1993) were 
also presented.  
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Table 6-4. Cardiovascular risk factors: Comparison between the HEALTH and the DN group 
Group 
Inferential statistical 
results 
Variable 
DN (N=53) HEALTH (N=25) Case*Control 
comparison 
Systolic blood 
pressure (mmHg) 136.00 (53.00) 127.00 (62.00) 0.032* (NPT) 
Diastolic blood 
pressure (mmHg) 
79.77± 9.06 a 83.24± 8.80a t(76)=-1.590, p=0.116 
Body fat % 37.74± 6.32a 31.41± 6.40 a t(76)=4.111, p<0.001** 
Heart rate at rest 
(beatsּmin -1) 
76.73± 12.42 a 70.76± 10.36 a t(76)=2.085, p=0.040* 
a
 Values are means ± SD; b Values are medians with range in parentheses; * Significance value is less 
than 0.05 level (2-tailed); ** Significance value is less than 0.01 level (2-tailed); NPT. Non parametric 
test. 
 
 
Table 6-5. Cholesterol levels: Values in the DN group in relation with current recommendations 
Group 
Variable 
DN (N=53) 
Recommendations from 
NECP 
HDL (mmolּL-1) 1.11± 0.31a >0.9 
LDL mmolּL-1) 1.83± 0.73a <3.4 
TC (mmolּL-1) 3.81± 0.94 a <5.2 
a
 Values are means with SD in parentheses. 
 
 
6.1.3 Gait biomechanics 
 
Gait was investigated from different perspectives. This intended to provide a more 
comprehensive analysis of walking in patients with diabetic neuropathy. This section 
starts presenting results of the strength levels in the lower limb muscles. Although 
strength is not a gait-related outcome measure, these results are included in this section 
due to the close association that exists between muscle weakness and gait alterations in 
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individuals with DN (Mueller et al., 1994). See Chapter 2 (Section 2.2.2.1) for more 
information about the way muscle weakness can affect gait in DN subjects. Thereafter 
three more subsections are included in which outcome measures related to gait 
parameters, kinetic data and muscular activity data during gait are presented.  
 
6.1.3.1 Isometric strength  
 
Maximal strength levels during isometric testing for the DN and HEALTH groups are 
presented in Figure 6-1. Results show that the DN group was significantly weaker in all 
muscle groups compared to HEALTH group. 
 
 
 Figure 6-1.  Strength levels: Comparison  between the HEALTH and the DN group a 
 
a
 Mean and SD (error bar); **Significance value is less than 0.01 level (2-tailed) 
 
 
6.1.3.2 Gait parameters 
 
Possible confounders for spatial-temporal and COP parameters 
Since body mass was not sufficiently controlled it was explored as a potential 
confounder variable for spatial-temporal parameters. Table 6-6 shows that body mass 
did not correlate significantly with any of the spatial-temporal parameters. However, 
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both groups showed a trend toward longer step times and slower cadence in subjects 
with larger body mass (p<0.06).  
 
Body mass was also explored as a possible confounder variable for COP measurements. 
Thus, body mass appeared to be positively correlated to the total distance travelled by 
the centre of pressure in the DN group. This correlation was not present in the 
HEALTH group (p=0.013). However, there was a trend toward a positive correlation 
between the total distance travelled by the COP and body mass in the HEALTH group 
(p=0.081). Apart from that, no other significant correlation was observed between body 
mass and all the other floor-foot interaction parameters (velocity of COP at the heel, 
forefoot and hallux). 
 
Beside body mass, gait velocity was also explored as a possible confounding variable 
for COP measurements. Since some of the COP variables are velocity related it was 
important to explore the effect of gait velocity on those variables. Gait velocity was 
found to be positively correlated to the velocity of the COP at the heel in both groups 
(p<0.15) and not to the velocity of the COP at the forefoot or hallux either in the DN or 
HEALTH groups. Table 6-7 shows the effect of body mass and gait velocity on COP 
outcome measures 
 
In the main analysis, body mass and gait velocity were therefore handled as follows: 
body mass was controlled for when analysing the total distance travelled by the COP 
whilst gait velocity was controlled for when analysing the velocity of the COP at the 
heel.  
 
Table 6-6. Spatial-Temporal parameters: Possible confounding variables (Bivariate 
correlation) 
  Step time Step length Cadence velocity 
N=53 
(DN group) 
r=0.267 
p=0.055 
r=-0.131 
p=0.928 
r=-0.271 
p=0.052 
r=-0.165 
p=0.243 
B
o
dy
 
M
as
s 
N=25 
(HEALTH group) 
r=0.381 
p=0.060 
r=-0.112 
p=0.593 
r=-0.386 
p=0.056 
r=-0.113 
p=0.589 
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Table 6-7. Floor-foot interaction parameters: Possible confounding variables (Bivariate 
correlation) 
  
COP (total 
distance) 
COP velocity 
Heel 
COP velocity 
Forefoot 
COP velocity 
Hallux 
N=53 
(DN group) N/A 
r=0.560** 
p<0.001 
τ=-0.049 
p=0.615 
(NPT) 
r=0.049 
p=0.738 
V
el
o
ci
ty
 
N=25 
(HEALTH 
group) 
N/A 
r=0.480* 
p=0.015 
r=-0.402 
p=0.052 
r=0.135 
p=0.519 
N=53 
(DN group) 
r=0.339* 
p=0.013 
r=0.06 
p=0.968 
r=-0.269 
p=0.054 
r=0.082 
p=0.569 
B
o
dy
 
M
as
s 
N=25 
(HEALTH 
group) 
r=0.356 
p=0.081 
r=0.205 
p=0.325 
r=-0.134 
p=0.534 
r=0.280 
p=0.175 
* Significance value is less than 0.05 level (2-tailed); ** Significance value is less than 0.01 level (2-
tailed). 
 
 
 
Main results: Comparison of gait parameter outcome measures between the DN and 
the HEALTH group 
Group differences in gait parameters are shown in Table 6-8 and Table 6-9. The 
HEALTH group reported significantly quicker and longer steps, higher cadence and 
higher walking velocity when compared to DN group.  With regard to the COP 
parameters the velocity of the COP at the heel was the only dependent variable that 
differed significantly between the groups. Hence, the HEALTH group showed slower 
velocity of the COP at the heel when compared to the DN group (p=0.07). A trend 
toward longer distance travelled by the COP in the HEALTH group compared to the 
DN groups was also observed (p=0.084). No group differences were observed in all the 
other floor-foot interaction parameters (p>0.05).  Overall, the data shows that the main 
group differences in gait parameter refer to spatial-temporal parameters.  
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Table 6-8. Spatial-temporal parameters: Comparison between the HEALTH and the DN group a 
Group 
Inferential statistical 
results 
Variable 
DN (N=52) HEALTH 
(N=25) 
Case*Control comparison 
Step time (sec) 0.55± 0.05 0.51± 0.02 t(75)=3.299, p<0.001** 
Step length (m) 0.61± 0.07 0.71± 0.06 t(75)=-5.466, p<0.001** 
Cadence (stepsּmin-1) 109.86± 9.81 117.22± 6.71 t (75)=-3.386, p=0.001** 
Velocity (mּsec-1) 1.13± 0.18 1.39± 1.64 t(75)=-6.003, p<0.001** 
a
 Values are means±SD; ** Significance value is less than 0.01 level (2-tailed). 
 
 
 
Table 6-9. COP parameters: Comparison between the HEALTH and the DN group 
Group Inferential statistical results 
Case*Control comparison Variable 
DN  
(N=53) 
HEALTH 
(N=25) without 
covariate 
with covariate 
(ANCOVA) 
Distance travelled by 
the COP (cm) 24.49± 2.00
a
 24.72± 1.50 a N/A F(1,75)=3.064, p= 0.0841 
Velocity COP at the 
heel (mּsec-1) 0.47± 0.12
 a
 0.485± 0.11 a N/A 
 
F(1,73)=7.827, 
p=0.007**2 
Velocity COP at the 
metatarsals (mּsec-1) 0.27 (0.25)
 b
 0.28 (0.16) b 0.140 (NPT) N/A 
Velocity COP at the 
hallux (mּsec-1) 0.81± 0.29
 a
 0.752± 0.21 a t(74)=0.899, p= 0.372 N/A 
a
 Values are means ± SD; b Values are medians with range in parentheses; 1Analysis of covariance with 
body mass as a covariate; 2Analysis of covariance with gait velocity as a covariate; ** Significance value 
is less than 0.01 level (2-tailed); NPT. Non parametric test. 
 
 
6.1.3.3 Kinetic data 
 
Due to the high association between plantar pressures and foot problems peak pressure 
and pressure time integral were the primary outcome measures under investigation. In 
addition to this, parameters related to PP (i.e. CA, Max Force and arch index) and PTI 
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(i.e. CT) were also investigated. Kinetic data was investigated in three different foot 
areas, the heel, the metatarsal heads and the hallux. Figure 6-2 shows an example of the 
distribution of the plantar pressures in a healthy individual with normal foot pressures 
and in a DN subject with abnormal loading patterns.  
 
In addition to this, peak pressure, Max Force, the instant of peak pressure and the 
instant of Max Force were investigated under the forefoot (metatarsals and toes) during 
the push off phase.  These results may provide some valuable information about the 
amount of stress the forefoot undergoes during the most critical phase of the GC.  
 
6.1.3.3.1  Primary outcome measures: Peak Pressure and Pressure Time 
Integral. 
 
 
Comparison of peak pressure and pressure time integral parameters between the right 
and the left foot for the HEALTH and DN groups are presented in Table 6-10. This 
Table shows that there were no significant differences in PP and PTI variables between 
the right and the left foot in the DN group and in the HEALTH group. This justifies that 
further analysis on the kinetic parameters were done only on the right foot.  
 
 
Figure 6-2. Example of foot pressure distribution of a DN subject with loading abnormalities (left 
picture) and a healthy individual (right picture) 
 
 
 
 
PP= 975kPa PP= 570kPa 
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Table 6-10. Foot pressures: Comparison between the right and left foot in the HEALTH (N=25) and 
DN group (N=53) 
Foot 
Inferential statistics 
results 
Variable Group 
Right  Left  
Right*Left 
comparison 
PP 
Heel 
(kPa) 
 
HEALTH 
DN 
 
546.60± 155.89 a 
450.60± 136.25 a 
 
535.32± 137.88 a 
444.67± 117.87 a 
 
t(24)=0.271, p=0.788 
t(76)=0.239, p=0.811 
PP       
Metatarsals 
(kPa) 
 
HEALTH 
DN 
 
647.36± 230.68 a 
779.45± 270.14 a 
 
642.04± 213.00 a 
797.16± 264.05 a 
 
t(24)=0.085, p=0.933 
t(76)=-0.341, p=0.733 
PP 
Hallux 
(kPa) 
 
HEALTH 
DN 
 
575.92± 240.09 a 
405.00 (1275.0)b 
 
618.88± 306.13 a 
403.00 (1207,0)b 
 
t(24)=-0.552, p=0.583 
p=0.943 (NPT) 
PTI 
Heel 
(kPaּsec ) 
 
HEALTH 
DN 
 
99.93± 24.26 a 
110.64± 34.56 a 
 
102.16± 26.59 a 
111.90± 32.11 a 
 
t(24)=0.194, p=0.758 
t(76)=-0.194, p=0.836 
PTI 
Metatarsals 
(kPaּsec ) 
 
HEALTH 
DN 
 
145.42 (328.80)b 
206.94 (318.86)b 
 
151.66 (794.00)b 
222.92 (430.08)b 
 
p=0.776 (NPT) 
p=0.543 (NPT) 
PTI 
Hallux 
(kPaּsec ) 
 
HEALTH 
DN 
 
100.35± 48.00a 
68.42 (258.70)b 
 
114.81± 64.42a 
79.32 (310.86)b 
 
t(24)=-0.207, p=0.372 
0.836 (NPT) 
a
 Values are means ± SD; b Values are medians with range in parentheses; NPT. Non parametric test. 
 
 
Possible confounders for peak pressure and pressure time integral 
Since group matching for body mass was not possible in the present study and it is 
known that it may affect foot pressures (Cavanagh et al., 1991), body mass was 
explored as a potential confounding variable for PP and PTI parameters. The effect of 
gait velocity on PP and PTI was also investigated since its influence in PP and PTI has 
been stated in the literature (Morag & Cavanagh, 1999).  
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Table 6-11 presents the correlations between PP and PTI outcome measures and the 
potential confounders. Gait velocity was the only variable that was significantly related 
to PP or PTI data. Thus, gait velocity was positively correlated to PP at the heel both in 
the DN (p=0.012) and the HEALTH (p=0.016) groups whereas gait velocity was 
negatively correlated to PTI at the heel in the DN group (p=0.01) and not in the 
HEALTH group (p=0.553). Contrary, PP and PTI both at the metatarsals and hallux 
were not significantly correlated to either velocity or body mass. Body mass did not 
seem to be related to PP and PTI at the heel either. Therefore, in the main analysis gait 
velocity was accounted for when analysing PP at the heel.  
 
 
 
Table 6-11. Peak pressure and Pressure time integral: Possible confounding variables (Bivariate 
correlation) 
 
PP 
Hallux 
PP 
Metatarsals 
PP 
Heel 
PTI 
Hallux 
PTI 
Metatarsals 
PTI 
Heel 
N=53 
(DN group) 
τ=0.032 
p=0.740 
(NPT) 
r=-0.128 
p=0.364 
r=0.350* 
p=0.012 
τ=0.047 
p=0.625 
(NPT) 
τ=-0.087 
p=0.360 
(NPT) 
r=-0.353* 
p=0.010 
V
el
o
ci
ty
 
N=25 
(HEALTH 
group) 
r=0.332 
P=0.105 
r=-0.066 
p=0.754 
r=0.488* 
p=0.016 
r=0.246 
p=0.235 
τ=-0.140 
p=0.327 
(NPT) 
r=-0.125 
p=0.553 
N=53 
(DN group) 
τ=0.114 
p=0.228 
(NPT) 
r=-0.182 
p=0.192 
r=0.017 
p=0.906 
r=-0.126 
p=0.184 
(NPT) 
τ=-0.015 
p=0.872 
(NPT) 
r=-0.181 
p=0.195 
Bo
dy
 
M
as
s 
N=25 
(HEALTH 
group) 
r=-0.163 
p=0.436 
r=-0.113 
p=0.591 
r=0.183 
p=0.392 
r=-0.129 
p=0.538 
τ=0.178 
p=0.215 
(NPT) 
r=-0.182 
p=0.383 
* Significance value is less than 0.05 level (2-tailed); NPT. Non parametric test.  
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Main results: Comparison of peak pressure and pressure time integral parameters 
between the DN and the HEALTH group 
Group differences in peak pressures are shown in Table 6-12. The HEALTH group 
showed significantly higher foot pressure values than the DN group at the hallux 
(p=0.033) whereas the DN group reported significantly higher values at the metatarsals 
compared to the HEALTH group (p=0.03).  Group differences in PP at the heel were 
not significant after controlling for the effect of gait velocity (p=0.481).  
 
 
Table 6-12. Peak pressure: Comparison between the HEALTH and the DN group 
Group Inferential statistical results 
Case*Control comparison Variable 
DN  
(N=53) 
HEALTH 
(N=25) without 
covariate 
with covariate 
(ANCOVA) 
Peak Pressure Heel  (kPa) 
 
453.63± 
136.36a 
546.60± 
155.89 a N/A 
F(1,75) =0.500, 
p= 0.4811 
Peak Pressure Metatarsals  
(kPa) 
 
779.45± 
270.14 a 
 
647.36±  
230.68 a 
 
t(76)=2.211, 
p=0.030* 
 
N/A 
Peak Pressure Hallux  
(kPa) 
405.00  
(1275.00) b 
548.00 
(1020.00) 
p=0.033* 
(NPT) N/A 
a
 Values are means ± SD; b Values are medians with range in parentheses; 1Analysis of covariance with 
gait velocity as a covariate; * Significance value is less than 0.05 level (2-tailed); NPT. Non parametric 
test. 
 
 
Table 6-13 shows that when comparing PTI parameters between the HEALTH and the 
DN group, the only significant group difference is observed at the metatarsal area. The 
DN group obtained median values (range) of 206.94 (318.86) kPaּsec compared to the 
145.42 (328.80) kPaּsec reported by the HEALTH group (p=0.01).   
 
Overall, these results show that the metatarsal area is the foot region in which the 
greatest PP and PTI differences occur between healthy and DN individuals.   
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Table 6-13. Pressure Time Integral: Comparison between the HEALTH and the DN group  
Group 
Inferential statistical 
results 
Variable 
DN 
(N=53) 
HEALTH 
(N=25) 
Case*Control 
comparison without 
covariate 
PTI Heel 
(kPaּsec ) 110.64± 34.56
a
 99.93± 24.26a t(76)=1.391, p=0.168 
PTI Metatarsals 
(kPaּsec ) 206.94 (318.86)
b
 145.42 (328.80)b p=0.01** (NPT) 
PTI Hallux 
(kPaּsec ) 68.42 (258.70)
 b
 101.42 (328.80) b p=0.156 (NPT) 
a
 Values are means ± SD; b Values are medians with range in parentheses; ** Significance value is less 
than 0.01 level (2-tailed); NPT. Non parametric test. 
 
 
 
6.1.3.3.2 Secondary outcome measures: Parameters related to Peak Pressure 
and Pressure Time integral 
 
 
1) Parameters related to peak pressure 
Peak pressure is defined as the force per unit area. Therefore it is important to 
investigate vertical GRFs and CA outcome measures to better understand PP values. 
Structural characteristics are also known to play an important role in PP. For this 
reason, arch index, which measures the height of the foot arch, was also analysed and 
included in this section.  
 
Possible confounders for contact area  
Body mass is likely to affect CA. In fact some investigations have found an association 
between these two variables (van Deursen, 2004). For this reason, body mass was 
explored as a possible confounder for CA. Table 6-14 displays the correlations between 
CA in different foot areas and body mass for both the DN and HEALTH groups 
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separately. A strong positive correlation between body mass and CA on different foot 
areas was observed for both groups. The only parameter that did not reach significant 
levels when related to body mass was CA at the hallux and this non significant 
correlation was only observed in the HEALTH group (p=0.235). Due to the high 
correlation that is expected between body mass and forces (GRFs), Max Force (vertical 
GRF) was normalised to body mass (Nּkg-1). 
 
Results from the present study show that CA is highly dependent on body mass. For this 
reason, body mass was controlled for when comparing CA between the healthy and DN 
groups.   
 
 
Table 6-14. Contact area: Possible confounding variables (Bivariate correlation)  
 
CA 
All foot 
CA 
Metatarsals 
CA 
Heel 
CA 
Hallux 
N=53 
(DN group) 
r=0.724** 
p<0.001 
r=0.770** 
p<0.001 
r=0.642** 
p<0.001 
r=0.301* 
p=0.028 
Bo
dy
 
M
as
s 
N=25 
(HEALTH group) 
r=0.439* 
p=0.028 
r=0.410* 
p=0.042 
r=0.618** 
p<0.001 
r=0.235 
p=0.258 
* Significance value is less than 0.05 level (2-tailed); ** Significance value is less than 0.01 level (2-tailed). 
 
Main results: Comparison of CA and Max Force between the DN and the HEALTH 
group 
Table 6-15 presents data on the parameters that are related to peak pressure. It shows 
that the only significant differences in CA between groups were found at the hallux 
(p=0.005). Table 6-15 also shows that there are significant group differences in the Max 
Forces (normalized to body mass) measured on the different foot areas. The DN group 
reported significantly higher Max Force values (Nּkg-1) at the metatarsals compared to 
the HEALTH group (p=0.018) whereas the HEALTH group showed significant higher 
Max Force values (Nּkg-1) at the heel (p<0.001) as well as at the hallux (p=0.002). The 
results also show significant group differences in the structure of the foot as 
demonstrated by the higher foot arch observed in the DN compared to the HEALTH 
group (p=0.048). Overall, these results show that Max Force is the main factor 
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explaining the differences in PP between the DN and the HEALTH group in the 
different foot regions under investigation.  
 
 
Table 6-15. Parameters related to Peak Pressure: Comparison between the HEALTH and the DN 
groupa 
Group Inferential statistical results 
Case*Control comparison Variable 
DN 
(N=53) 
HEALTH 
(N=25) without covariate 
with covariate 
(ANCOVA) 
Contact Area 
(cm2) 
Metatarsals 
Heel 
Hallux 
 
 
49.20± 6.14 
33.82± 4.52 
8.91± 1.92 
 
 
45.33± 5.21 
32.11± 3.37 
9.83± 1.99 
 
 
N/A 
N/A 
N/A 
 
 
F(1,75)=0.010,  p=0.921 
F(1,75)=0.811, p=0.3711 
F(1,75)=8.210, p=0.005*1 
Max Force 
(Nּkg-1)                                 
Metatarsals 
Heel 
Hallux 
 
 
9.34± 1.09 
7.05± 0.97 
1.37± 2.06 
 
 
8.72± 1.04 
7.75± 0.78 
2.06± 0.80 
 
 
t(76)=2.411,  p=0.018* 
t(76)=-3.915, p<0.001** 
t(76)=-3.112, p=0.002** 
 
Arch Index  0.20±  0.06 0.18± 0.046 t(76)=2.011, p=0.048*  
a
 Values are means ± SD; * Significance value is less than 0.05 level (2-tailed); ** Significance value is 
less than 0.01 level (2-tailed); 1Analysis of covariance with body mass as a covariate. 
 
 
 
2) Parameters related to Pressure Time Integral 
PTI, calculated as the area under the peak pressure curve, represents the magnitude 
(pressure) and duration of the plantar stress (Mueller & Maluf, 2002). Therefore, the 
contact times in the different foot regions were analyzed. Since contact times, when 
measured in milliseconds, are dependent on gait velocity, contact times were normalized 
to the percentage of the stance phase.  
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Main results: Comparison of contact times between DN and HEALTH groups 
Table 6-16 shows that there are significant differences between the HEALTH and the 
DN group in the amount of time the metatarsals and the heel areas contact the floor 
during the GC. The DN group reported higher contact times (% of the roll over process) 
at the metatarsals (p<0.001) and heel areas (p<0.001) compared to the HEALTH group. 
The contact time spent on the hallux area did not differ significantly between both 
groups (p=0.251).  
 
 
Table 6-16. Parameters related to PTI: Comparison between the HEALTH and the DN group a 
Group 
Inferential statistical 
results 
Variable 
DN 
(N=53) 
HEALTH 
(N=25) 
Case*Control comparison 
without covariate 
Contact Time 
 (% ROP) 
    Metatarsals 
    Heel 
    Hallux 
 
 
84.99± 2.75 
62.23± 7.44 
52.32± 16.47 
 
 
82.10± 3.04 
55.19± 8.51 
56.57± 11.65 
 
 
t(76)=4.181,  p<0.001** 
t(76)=3.722,  p<0.001** 
t(76)=-1.152,  p= 0.251 
a
 Values are means ± SD in parentheses; ** Significance value is less than 0.01 level (2-tailed). 
 
 
 
6.1.3.3.3 Kinetic parameters during the push off phase 
 
Main results: Comparison of kinetic parameters between DN and HEALTH groups 
during the push off phase 
Table 6-17 presents data during the push off phase, which is thought to generate the 
highest stress on the sole of the forefoot. No significant differences were observed when 
comparing time related variables between the HEALTH and the DN group. Therefore, 
both groups reported very similar results when investigating the instant during the roll 
over process in which PP (p=0.547) as well as Max Force (p=0.957) were produced. 
Interestingly, no significant group differences were observed in PP at the forefoot 
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(metatarsals and toes) during the push off. Even though, the DN group obtained higher 
PP mean values (855.36± 259.08 kPa) compared to the HEALTH group (772.69± 
209.97 kPa), those differences did not reach significant levels (p=0.161). Regarding to 
the amount of vertical GRF generated during push off, the DN group showed 
significantly higher values compared HEALTH groups (p<0.001). However, those 
differences disappeared after controlling for body mass (p=0.811). Thus, the DN and 
HEALTH groups reported a mean value of 10.83± 0.82 Nּkg-1 and 10.88± 0.82 Nּkg-1, 
respectively. 
 
Table 6-17. Peak pressure and Max Force parameters during the push off phase: Comparison 
between the HEALTH and the DN group  
Group 
Inferential statistical 
results 
Variable 
DN  
(N=53) 
HEALTH  
(N=25) 
Case*Control 
comparison without 
covariate 
PP (kPa) 855.36± 259.08 a 772.69± 209.97 a t(76)=1.416, p=0.161 
Instant PP (% ROP) 83.24 (25.54) b 80.00 (23.92) b 0.547 (NPT) 
Max Force (N) 999.38± 178.16 a 868.30± 126.66 a t(76)=3.85, p<0.001** 
Instant of Max Force  
(%ROP) 
77.38 (8.38) b 76.94 (19.90) b 0. 957 (NPT) 
Max Force Normalised 
(Nּkg-1) 
10.83± 0.82 a 10.88± 0.82 a t(76)=-0.24, p=0.811 
a
 Values are means ± SD; b Values are medians with range in parentheses; ** Significance value is less 
than 0.01 level (2-tailed); NPT. Non parametric test. 
 
 
In summary, when comparing foot pressures between the HEALTH and the DN group, 
the most noticeable differences occurred underneath the metatarsal heads. Thus, results 
from the present study showed significantly higher PP and PTI values at the metatarsals 
area in the DN group when compared to the HEALTH group. Interestingly, no 
significant group differences in PP or Max Force (Nּkg-1) at the forefoot (which 
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included the metatarsal heads and the toes) were observed during the push off phase. 
 
6.1.3.4 Surface Electromyography 
 
This section presents the results obtained from the EMG measurements. Firstly, the 
group differences in mean muscular activity during the differences phases of the GC are 
presented. Thereafter, time related variables are shown, which include: 1) the 
percentage of time each muscle was kept activity during the whole GC; 2) the instant of 
the GC at which TS and TA activity peaked during and after the push off phase, 
respectively; and 3) time lag from the onset to peak activity during and after the push 
off phase for the TS and TA muscles, respectively.  
 
Main results: Comparison of mean activity during different phases of the gait cycle 
between DN and HEALTH groups 
EMG data during the GC is displayed in Figure 6-3. On the top of the picture the 
different phases of the GC as well as their duration in relation to the GC can be 
observed.  EMG data traces from the different muscles (TS, TA, VL and BicFem) as 
well as the results Table shown at the bottom of the picture have been presented in 
relation to the phases of the GC. Figure 6-3 shows the average EMG values during a GC 
for the DN (blue line) and HEALTH (red line) groups. EMG values are presented for 
the TA, TS, quadriceps (VL) and hamstrings (BicFem) muscles. The Table at the 
bottom of Figure 6-3 displays the differences in mean activity for the TA, TS, 
quadriceps (QUADS) and hamstrings (HAMS) during each phase of the GC when the 
DN group was compared to HEALTH group. Note that no statistical analysis has been 
carried out to investigate group differences in muscular activity during the initial swing 
and mid-swing phases of the GC. EMG data is presented as percentage of the peak 
activity during the GC. 
 
During the loading phase (0-10% of GC) the DN group reported significantly higher 
mean values than the HEALTH group for TS (28.6± 13.36% vs. 17.35± 9.14%), TA 
(77.11± 11.07% vs. 63.77± 18.03%) and QUADS (68.95± 19.82% vs. 64.03± 14.70%) 
while no significant differences were observed for the HAMS (67.25± 18.31% vs. 
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63.00± 22.19%). The same trend was observed for the TS during the mid-stance phase 
(10-30% of GC), in which the DN group showed higher mean values (p<0.001) than the 
HEALTH group (47.63± 12.63% vs. 33.94± 11.78%). Unlike TS, TA activity during 
this phase was significantly higher (p<0.05) in the HEALTH compared to the DN group 
(57.21± 14.92% vs. 47.63± 16.99%). Muscular activity patterns for QUADS and 
HAMS during the mid-stance did not differ considerably between groups. During the 
terminal stance phase (30-50% of GC), the DN group showed significantly higher 
(p<0.05) mean values for the TS (75.62± 9.33% vs. 70.18± 8.80%) and QUADS 
(31.98± 14.48%  vs. 23.02± 17.85%) compared to the HEALTH group while no 
significant differences were observed for TA or HAMS. During the pre-swing phase no 
significant group differences were observed for any of the four muscles (p>0.15).  
The analysis of muscular activity levels during the last phase of the GC (Terminal 
swing) showed significant group differences for all 4 muscles. TS, TA QUADS and 
HAMS activity levels were consistently higher in the DN group compared to the 
HEALTH group. Significance values were lower than 0.01 for all four muscles. 
 
 
Main results: Comparison of time related EMG variables between DN and HEALTH 
groups 
Table 6-18 presents time related EMG data. Parameters under the heading % GC muscle 
active refer to the amount of time (as percentage) each muscle is kept activity during the 
whole GC. The other two sets of results refer to a specific time window around the push 
off phase for the TA and TS. More information about the time windows for those 
muscles can be found in the Chapter 5 (Section 5.4.3.4.3).   
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Figure 6-3. EMG activity patterns during the GC: Comparison between the HEALTH and the DN 
group 
 
 
 
 
 
 
 
 
 
* Significance value is less than 0.05 level (2-tailed); ** Significance value is less than 0.01 level (2-
tailed); NPT. Non parametric test. 
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When investigating muscular activity patterns during the whole GC, results from the 
current study showed that the DN group maintained the TS, QUADS and HAMS 
muscles active during the GC significantly longer (% GC) than the HEALTH group 
(p<0.05). However, no statistical group differences were observed when looking at the 
TA.  
 
When assessing time related outcome measures during the specific time window around 
the push off phase for the TA and TS muscles, results from the present study show that 
the DN and HEALTH groups did not differ significantly in the instant of the GC TA 
and TS peaked. When looking at the time delay from the onset of muscular activity to 
the peak activity, longer time delays were observed in the DN group compared to the 
HEALTH group for the TA (p=0.026) and the TS (p<0.001). Therefore activation was 
started earlier in the GC for the DN group for the TA and TS muscles compared to the 
HEALTH group.  
 
Results from the present study showed significant differences in EMG activity patterns 
between the DN and the HEALTH group. Thus, the DN group showed significantly 
higher EMG activity compared to the HEALTH group as demonstrated by: 1) higher 
mean activity values throughout different phases of the GC; 2) higher amount of time 
the muscles were activity during the GC; and 3) earlier muscular activation of  the TA 
and TS muscles. 
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Table 6-18. Time related EMG variables: Comparison between the HEALTH and the DN group 
Group 
Inferential statistical 
results 
Variable 
DN 
 (N=52) 
HEALTH 
(N=23) 
Case*Control comparison 
without covariate 
% GC muscle active 
 
TS 
TA 
QUADS 
HAMS 
 
 
67.46± 11.15a 
75.33± 9.69a 
68.46± 12.01a 
70.29± 15.22a 
 
 
59.04± 9.11a 
72.78± 12.16a 
59.68± 14.51a 
62.16± 17.63a 
 
 
t(74)=3.101,  p=0.003** 
t(74)=0.956, p=342 
t(74)=2.700,  p=0.009** 
t(74)=2.001,  p=0.049* 
Time From Onset To 
Peak Activity (ms) 
 
TS 
TA 
 
 
 
75.86± 12.43a 
25.21 (83.58) b 
 
 
 
61.36± 12.73a 
20.93 (19.98) b 
 
 
 
t(74)=4.552,  p<0.001** 
p=0.026* (NPT) 
Instant of peak activity  
(% GC) 
TS 
TA 
 
 
47.50 (10.70) b 
72.95 (38.30) b 
 
 
47.65(4.70) b 
77.35 (22.30) b 
 
 
0.323 (NPT) 
0.201 (NPT) 
a
 Values are means ± SD; b Values are medians with range in parentheses; * Significance value is less 
than 0.05 level (2-tailed); ** Significance value is less than 0.01 level (2-tailed); NPT. Non parametric 
test. 
 
 
6.1.4  Microcirculation  
 
Muscular BF and mVO2 were investigated during different conditions: at rest, in 
response to an exercise bout and during recovery from an exercise bout.  
 
Possible confounders for microcirculation variables 
Since body composition was not controlled body mass and body fat% were explored as 
potential confounder variables for microcirculatory data. Table 6-19 shows that during 
resting conditions body mass was positively correlated to blood flow and oxygen 
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consumption in the DN group (p<0.05), while those correlations did not reach 
significant levels in the HEALTH group (p>0.05).  Body fat% was not significantly 
correlated to either resting BF or resting mVO2. Table 6-20 shows that body mass and 
body fat% did not correlate significantly to BF or mVO2 variables during the other 2 
conditions.   
 
Table 6-19. BF and mV O2 at rest: Possible confounding variables  (Bivariate correlation) 
 BF at rest mVO2 at rest 
N=50 
(DN group) 
τ=0.176 
p=0.072 
τ=-0.014 
p=0.891 
NPT 
Bo
dy
 
Fa
t %
 
N=25 
(HEALTH groups) 
τ=-0.100 
p=0.484 
τ=-0.276 
p=0.052 
NPT 
N=50 
(DN group) 
τ=0.335** 
p=0.001 
NPT 
τ=0.239* 
p=0.018 
NPT 
B
o
dy
 
M
as
s 
N=25 
(HEALTH groups) 
r=-0.128 
p=0.542 
τ=-0.003 
p=0.981 
NPT 
* Significance value is less than 0.05 level (2-tailed); ** Significance value is less than 0.01 
level (2-tailed); NPT. Non parametric test. 
 
 
Beside body mass and body fat%, the effect of MGast muscular activity on 
microcirculation during the exercise bout was also explored.  Microcirculatory 
responses to an exercise bout will depend on the intensity of the exercise. For this 
reason the intensity of the exercise bout was set up constantly at 50% of the individual’s 
MVC. However, even thought force was controlled during the exercise protocol the 
amount of work coming specifically from the MGast (which is the muscle under 
investigation) was not controlled. Therefore, the possible effect of the specific amount 
of work carried out by the MGast on the microcirculatory responses was investigated.  
 
Table 6-20 shows that EMG activity (normalised to the peak activity during MVC) 
during the exercise bout (measured on the MGast) appeared to be positively correlated 
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to the microcirculatory responses to exercise (measured also in the MGast). Thus, the 
muscular oxygen consumption response to exercise (calculated as the percentage of 
change from baseline to post-exercise values) was significantly correlated to EMG 
activity in the DN (p=0.01) and HEALTH groups (p<0.001). Furthermore, the change in 
BF in relation to the exercise bout was correlated to EMG activity in the DN group 
(p=0.002). However, this correlation did not reach significant levels in the HEALTH 
group (p=0.180). Table 6-20 also shows that the microcirculatory recovery from the 
exercise bout (blood flow and muscular oxygen consumption) did not appear to be 
related to the activity level of the MGast during the exercise protocol both in the DN 
group and in the HEALTH group. 
 
Table 6-20.  BF and mVO2  in relation to the exercise protocol: Possible confounding variables 
(Bivariate correlation) 
 
BF 
PreVsPost % 
BF 
Recovery % 
mVO2 
PreVsPost % 
mVO2 
Recovery % 
N=53 
(DN group) 
τ=-0.169 
p=0.098 
NPT 
r=0.110 
p=0.467 
τ=-0.127 
p=0.225 
NPT 
r=0.271 
p=0.056 
B
o
dy
 
Fa
t %
 
N=24 
(HEALTH 
group) 
τ=-0.100 
p=0.484 
NPT 
τ=-0.167 
p=0.254 
NPT 
r=0.073 
p=0.607 
r=-0.070 
p=0.624 
N=53 
(DN group) 
τ=-0.125 
p=0.222 
NPT 
r=-0.006 
p=0.968 
τ=-0.135 
p=0.199 
NPT 
r=-0.311 
p=0.053 
B
o
dy
 
M
as
s 
N=24 
(HEALTH 
group) 
τ=-0.077 
p=0.591 
NPT 
τ=-0.302 
p=0.052 
NPT 
r=-0.199 
p=0.341 
r=-0.180 
p=0.388 
N=53 
(DN group) 
τ=0.320** 
p=0.002 
NPT 
r=-0.035 
p=0.817 
τ=0.338** 
p=0.001 
NPT 
r=0.084 
p=0.589 
M
u
sc
u
la
r 
A
ct
iv
ity
 
N=24 
(HEALTH 
group) 
τ=0.196 
p=0.180 
NPT 
τ=-0.043 
p=0.771 
NPT 
r=0.664** 
p<0.001 
r=-0.108 
p=0.615 
** Significance value is less than 0.01 level (2-tailed); NPT. Non parametric test. 
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In the main analysis, body mass and EMG activity were therefore handled as follows: 
body mass was accounted for when comparing resting BF and mVO2 between the 
groups while EMG was entered as a covariate when comparing group differences for  
BF and mVO2 responses to the exercise bout. 
 
Furthermore, muscular activity during the exercise bout was significantly higher (mean 
± SD) in the DN group compared to the HEALTH group (40.26± 21.88 vs. 28.54± 
12.20, p=0.017).  Figure 6-4 shows a typical example of the force and EMG traces 
during the exercise protocol in two different subjects, one from the DN group and one 
from the HEALTH group. 
 
 
 
 
 
Figure 6-4. Example of the force and EMG traces during the exercise protocol in two different 
people, one from the DN group (A) and one from the HEALTH group (B) 
50%Force EMG
A
B
 
Note: The red trace represents the force generated in the KINCOM machine whilst the blue trace 
represents the EMG activity. The green line shows the force targeted during the exercise bout (50% of 
MVC). 
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Main results: Comparison of microcirculatory related variables between the DN and 
the HEALTH group 
Table 6-21 presents data on the comparison of microcirculatory related outcome 
measures during different conditions between the DN and the HEALTH group. It 
should be noted that the main analysis for the different microcirculatory related outcome 
measures was carried out with 46 subjects in the DN group and 24 subjects in the 
HEALTH group whereas all the other analyses were carried out with 53 in the DN 
group and 25 in the HEALTH group. Some individuals suffered from muscle cramps 
during the exercise protocol and the exercise had to be stopped. This explains the 
reduction in the numbers compared to the other analyses.   
 
During resting conditions, no significant differences were observed when comparing 
either BF (p=0.167) or mVO2 (p=0.535) between the DN and the HEALTH group. With 
regard to the microcirculatory responses to exercise, results from the present study 
showed significant lower exercise-induced vasodilatation in the DN group compared to 
the HEALTH group (p=0.003) as demonstrated by the smaller percentage of change in 
BF from baseline to post-exercise conditions. Group differences were also significant 
when comparing the percentage of change of mVO2 from the baseline to the post-
exercise condition between the DN and the HEALTH group (p<0.034). Table 6-21 also 
shows that the DN group recovered from the exercise bout significantly slower than the 
HEALTH group. Thus, significant group differences were observed when comparing 
BF recovery (p<0.004) and mVO2 recovery (p<0.033) after 70 seconds.  
 
Overall, results from the present study show that the DN group had reduced 
microcirculatory responses to an exercise bout compared to the HEALTH group and 
that the recovery from the exercise was slower in the DN compared to the HEALTH 
group.  
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Table 6-21. Microcirculation parameters: Comparison between the HEALTH and the DN groupa 
Group 
Inferential statistical 
results 
Case*Control comparison 
Condition Variable 
DN 
(N=46) 
HEALTH 
(N=24) without 
covariate 
with 
covariate 
(ANCOVA) 
BF 
(mlּmin -1ּ100g-1) 
0.60± 
0.28a 
0.64± 
0.26a 
N/A 
F(1,67)=1.951, 
p=0.1671 3 
At rest 
mVO2 rest 
(mlO2ּmin -1ּ100g-1) 
0.024± 
0.012a 
0.025± 
0.012a 
N/A 
F(1,67)=0.389, 
p=0.5351 3 
BF pre vs. post 
exercise (% change) 
112.40± 
75.15a 
154.18± 
68.36a 
N/A 
F(1,67)=9.633, 
p=0.003** 2 3 
 
Responses to 
exercise 
protocol 
mVO2 pre vs. post 
exercise (% change) 
301.42± 
228.86a 
346.78± 
253.60a 
N/A 
F(1,65)=4.683, 
p=0.034* 2 3 
BF recovery after 70 
sec (%) 
74.99 
(114.08)b 
91.05 
(76.67)b 
p= 0.004** 
NPT 
N/A 
Recovery 
from 
exercise 
protocol 
mVO2 recovery 
after 70 sec (%) 
77.77± 
22.08a 
89.83± 
22.11a 
t(65)=-2.17; 
p=0.033* 
N/A 
a
 Values are means with SD in parentheses; b Values are medians and range in parentheses * Significance 
value is less than 0.05 level (2-tailed); **Significance value is less than 0.01 level (2-tailed); NPT. Non 
parametric test; 1Analysis of covariance with body mass as a covariate; 2Analysis of covariance with 
muscular activity (EMG) as a covariate; 3 Data transformed not to break the assumption of the normal 
distribution of the data when using parametric tests. 
 
 
 
6.1.5 Quality of life (SF-36) 
 
Table 6-22 displays the group differences in the different dimensions measured by the 
quality of life questionnaire. Thus, significantly lower scores were reported by the DN 
group in every single dimension compared to the HEALTH group (p<0.001).  
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Table 6-22. Quality of life dimensions: Comparison between the HEALTH and the DN groupa 
Group 
Inferential 
statistical results 
Variable 
DN (N=53) HEALTH (N=25) 
Case*Control 
comparison without 
covariate 
Physical Function 70.00 (100.00) 95.00 (20.00) p<0.001 ** NPT 
Role Physical 75.00 (100.00) 100.00 (0.00) p <0.001 ** NPT 
Body Pain 70.00 (100.00) 100.00 (55.00) p <0.001 ** NPT 
General Health 60.00 (90.00) 85.00 (60.00) p <0.001 ** NPT 
Vitality 55.00 (90.00) 70.00 (45.00) p <0.001 ** NPT 
Social Function 100.00 (100.00) 100.00  (45.00) p =0.001 ** NPT 
Role Emotional 100.00 (100.00) 100.00 (0.00) p <0.001 ** NPT 
Mental Health 84.00 (100.00) 88.00 (52.00) p <0.001 ** NPT 
Physical Health 
Overall 
66.25 (92.50) 93.75 (42.50) p <0.001 ** NPT 
Mental Health 
Overall 
80.37 (95.00) 90.00 (37.50) p <0.001 ** NPT 
a
 Values are medians with range in parentheses; ** Significance value is less than 0.01 level (2-tailed); 
NPT. Non parametric test. 
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6.1.6 Summary of the main results for the cross-sectional study 
 
Table 6-23 provides a summary of the results in relation to the null hypotheses for part 
1 of the main study. 
 
The null hypothesis 1 relating to differences in general health between the DN and the 
HEALH group was rejected for the systolic blood pressure but was accepted for the 
diastolic blood pressure. The DN group demonstrated higher systolic blood pressure 
compared to the HEALTH group.  
 
The null hypothesis 2 relating to differences in gait characteristics between the DN and 
the HEALTH group was rejected for spatial-temporal characteristics, foot pressures 
under the metatarsal heads, and EMG parameters but it was accepted for COP 
parameters and foot pressures at the heel. Compared to the HEALTH group, the DN 
group demonstrated higher PP and PTI under the metatarsal heads, slower gait velocity 
(gait velocity, shorter steps and slower cadence) and overall higher EMG activity. 
Furthermore, null hypothesis 2 relating to differences in strength levels between the DN 
and the HEALTH group was rejected for all the muscle groups. The DN group was 
significantly weaker in all the muscle groups compared to the HEALTH group.  
 
The null hypothesis 3 relating to differences in microcirculation during different 
conditions between the DN and the HEALTH group was rejected for non-resting 
conditions but it was accepted for resting conditions. The DN group demonstrated 
smaller BF and mVO2 responses to an exercise protocol and slower BF and mVO2 
recovery from the exercise protocol compared to the HEALTH group. 
 
The null hypothesis 4 relating to differences in QOL between the DN and the HEALTH 
group was rejected for physical and mental health. Compared to the HEALTH group, 
the DN group demonstrated significantly lower scores in all the physical and mental 
dimensions of the SF 36 QOL questionnaire.  
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Table 6-23. Summary of the results in relation to the main analysis of the cross-sectional study.  
Domain Measurement Outcome measure p<0.05 
TC NOT APPLICABLE 
LDL NOT APPLICABLE 
Cholesterol 
HDL NOT APPLICABLE 
Systolic Blood Pressure *↑ 
General Health 
Blood Pressure 
Diastolic Blood Pressure N/S 
Strength Peak Moment *↓ 
Gait velocity *↓ 
Step length *↓ Spatial-temporal 
Step time *↓ 
Distance COP N/S 
Gait 
parameters 
COP 
parameters Velocity COP *↑ 
Heel N/S 
Metatarsals *↑ Peak Pressure 
Big toe *↓ 
Heel N/S 
Metatarsals *↑ 
Kinetic data 
PTI 
Big toe N/S 
% peak activity per gait 
phase 
*↑ 
% GC muscle active  *↑ 
Time to peak (push off 
phase) 
*↑ 
Gait 
Muscular Activity 
Instant Peak Activity (Push 
off) 
N/S 
Rest N/S 
Post-
Exercise 
*↓ Muscular Blood flow 
 
Recovery *↓ 
Rest 
 
N/S 
Post-
Exercise 
*↓ 
Microcirculation Muscular 
microcirculation 
Muscular 
Oxygen 
Consumption 
Recovery *↓ 
Physical Health  *↓ Quality of Life Self-Reported Quality of life Mental Health *↓ 
* Significance value is less than 0.05 level (2-tailed); N/S no significant differences; ↑↓ reflect the DN 
group in relation to the HEALTH group. 
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6.1.7 Exploratory study   
 
This section explores the variables that may better account for the group differences 
observed in the cross-sectional study. Thus, this section explores outcome measures that 
are likely to have influenced gait characteristics, microcirculation and QOL in the 
present investigation. At the start of each section there is a brief explanation of the 
variables under investigation as well as the theoretical reasons behind that choice.  
 
Bivariate correlations (two tailed) were used to relate those parameters. Thus, Pearson’s 
correlation coefficient was used when data sets were normally distributed whereas 
Kendall’s correlation coefficient was used when variables were not normally 
distributed. Note that significance was set at an alpha level of 0.05 and no Bonferroni 
corrections, to reduce the chances of type I error, were applied. Correlations were 
carried out separately for the DN and HEALTH groups. 
 
6.1.7.1 Gait Biomechanics 
 
Gait parameters (spatial-temporal and COP parameters) and peak pressure parameters 
(PP and PTI) were used to explore gait characteristics. In relation to gait parameters, 
sensory neuropathy and muscular weakness, especially of the distal leg muscles, are 
believed to influence spatial temporal characteristics (Yavuzer, et al., 2006) and COP 
parameters (Uccioli et al., 2001). For this reason, the bivariate relationships between 
both VTP and muscular strength (at the dorsi-flexor and plantar-flexor muscles) and 
gait parameters were investigated. In relation to peak pressures, the literature has 
identified structural changes (i.e. arch index) (Giacomozzi et al., 2005), sensory 
neuropathy (Frykberg et al., 1998) and muscle weakness, especially of the distal leg 
muscles (Akashi et al., 2008), as contributing factors for the changes in foot pressures 
between healthy and DN subjects. For this reason the bivariate relationships between 
VPT, arch index and muscular strength at the dorsi-flexor and plantar-flexor muscles 
and both PP and PTI were investigated. Results on the exploratory analysis for gait 
parameters and foot pressures are presented. 
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Gait parameters 
Table 6-24 investigates the relationships between gait parameters (spatial-temporal and 
COP parameters) and sensory (measured by vibration perception threshold) and strength 
levels. Sensory neuropathy was positively correlated to step time (p=0.029) whist 
sensory neuropathy was not related to step length or gait velocity. VPT also showed a 
weak positive correlation with the total distance travelled by the centre of pressure 
(τ=0.270; p=0.005).  
 
When assessing the relationships between strength levels and spatial-temporal 
characteristics, plantar-flexor muscle strength appeared to be correlated to gait velocity, 
step time and step length. Therefore, individuals who reported higher PF moment 
seemed to walk quicker, with longer and quicker steps. Interesting, these associations 
were only present in the HEALTH group (p<0.05), whereas no correlation was found 
between the PF moment and any of the spatial-temporal parameters in the DN group. 
 
The strongest correlation between lower limb muscle strength and COP variables was 
found between the DF moment and the distance travelled by the COP. Thus, longer 
distance travelled by the COP was observed in participants who reported higher DF 
moment values. This significant correlation was observed both in the HEALTH 
(r=0.545; p=0.008) and in the DN group (r=0.533; p<0.001). The only other significant 
correlation was found between DF strength levels and the velocity of the COP at the 
heel. However, this negative correlation was only observed in the DN group (p=0.038) 
and not in the HEALH group (p=0.910).  
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Table 6-24. Gait parameters: Exploratory data (Bivariate correlation)  
* Significance value is less than 0.05 level (2-tailed); ** Significance value is less than 0.01 level (2-
tailed); NPT. Non parametric test. 
 
 
 
Foot pressures  
Table 6-25 explores the relationships between plantar pressure outcome measures at the 
heel and metatarsal regions and sensory neuropathy (measured by vibration perception 
threshold), strength levels (dorsi-flexors and plantar-flexors) and foot arch 
characteristics.  
 
Sensory neuropathy (VPT) did not appear to be correlated to peak pressures or pressure 
time integral variables both at the heel and at the metatarsals areas (p>0.05). Similar 
results were obtained when relating arch index with kinetic variables. Therefore, arch 
index did not show significant correlations with peak pressure or pressure time integral 
variables both at the heel and at the metatarsal areas (p>0.05). Strength levels seemed to 
be related to some foot pressure outcome measures. DF moment was correlated to foot 
pressures at the metatarsal region. Hence, people who reported higher strength levels at 
 Gait velocity Step Time Step Length 
COP (total 
distance) 
COP velocity 
(Heel) 
V
PT
 N=53 
(DN  group) 
r=-0.081 
p=0.398 
NPT 
τ=0.212* 
p=0.029 
NPT 
r=0.040 
p=0.676 
NPT 
τ=0.270* 
p=0.005 
NPT 
r=-0.24 
p=0.807 
NPT 
N=53 
(DN group) 
r=0.179 
p=0.203 
r=-0.086 
p=0.542 
r=0.156 
p=0.268 
r=0.140 
p=0.308 
N/A 
PF
 
 
M
o
m
en
t 
N=24 
(HEALTH group) 
r=0.575** 
p=0.005 
r=-0.479* 
p=0.024 
r=0.467* 
p=0.028 
r=0.409 
p=0.059 
N/A 
N=53 
(DN group) N/A N/A N/A 
r=0.533** 
p<0.001 
r=-0.288* 
p=0.038 
D
F 
 
M
o
m
en
t 
N=24 
(HEALTH group) N/A N/A N/A 
r=0.545** 
p=0.008 
r=-0.017 
p=0.910 
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the dorsi-flexor muscles also reported lower PTI values at the metatarsal region. 
Although there was a tendency in both groups (p<0.089), this negative correlation only 
reached significant levels in the DN group (p<0.047). In addition to that, the HEALTH 
group also reported a strong negative correlation (r=0.0492; p<0.05) between DF 
moment and peak pressure at the metatarsal region.  
 
 
 
Table 6-25. Foot pressures: Exploratory data (Bivariate correlation)  
 
Peak Pressure 
Heel 
Peak Pressure 
Metatarsals 
PTI 
Heel 
PTI 
Metatarsals 
V
PT
 N=53 
(DN group) 
τ=0.054 
p=0.701 
NPT 
τ=-0.01 
p=0.994 
NPT 
τ=0.134 
p=0.160 
NPT 
τ=0.127 
p=0.364 
NPT 
N=53 
(DN group) 
r=-0.206 
p=0.139 
r=-0.151 
p=0.280 
r=-0.166 
p=0.233 
r=-0.233 
p=0.102 
A
rc
h 
In
de
x
 
N=24 
(HEALTH group) 
r=0.372 
p=0.067 
r=0.030 
p=0.885 
r=-0.080 
p=0.704 
r=-0.069 
p=0.741 
N=53 
(DN group) 
N/A 
r=-0.004 
p=0.977 
N/A 
r=-0.291 
p=0.632 
PF
 
 
M
o
m
en
t 
N=24 
(HEALTH group) 
N/A 
r=-0.160 
p=0.297 
N/A 
r=-0.291 
p=0.189 
N=53 
(DN group) 
r=0.041 
p=0.773 
r=0.171 
p=0.221 
r=-0.103 
p=0.461 
r=-0.274* 
p=0.047 
D
F 
 
M
o
m
en
t 
N=24 
(HEALTH group) 
r=-0.164 
p=0.467 
r=-0.492* 
p=0.020 
r=-0.372 
p=0.088 
r=-0.371 
p=0.089 
* Significance value is less than 0.05 level (2-tailed); NPT. Non parametric test. 
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6.1.7.2 Microcirculation  
 
Muscular blood flow and muscular oxygen consumption during different conditions 
were used to explore microcirculation. Previous investigations have linked impairments 
in blood flow and oxygen consumption to sensory neuropathy (Dinh & Veve, 2004) and 
hyperglycaemia (Tooke et al., 2000) in patients with diabetes. For this reason, the 
bivariate relationships between VPT and HbA1c and both blood flow and mVO2 were 
explored.  
 
Table 6-26 explores the relationships between microcirculation and sensory neuropathy 
(measured by vibration perception threshold), glycaemic control and systolic blood 
pressure. Blood sugar level appeared the only variable that correlated significantly with 
microcirculation variables. Thus, higher HbA1c related to diminished blood flow and 
muscular oxygen consumption recovery from exercise (p<0.05). On the other hand, 
VPT and BP did not seem to correlate with any of the microcirculatory variables 
(p>0.05).   
 
6.1.7.3 Quality of Life  
 
Some investigations have suggested an association between QOL and physiological 
markers in diabetic patients (Wikblad et al., 1996). For this reason one of the objectives 
of this exploratory study was to investigate whether outcome measures linked to DN 
such as sensory neuropathy, glycaemic control and obesity, were associated with any of 
the dimensions of the 36-SF questionnaire.  
 
Table 6-27 shows the relationships between quality of life dimensions assessed by the 
36-SF questionnaire and glycaemic control, sensory neuropathy and obesity (referred to 
as body mass index). VPT and HbA1c correlations were only carried out on the DN 
group while correlations involving BMI were done in both groups. Sensory neuropathy 
(measured by vibration perception threshold) was not found to be correlated to any of 
the QOL dimensions as well as to the overall mental and physical health scores 
(p<0.05). In contrast, HbA1c was found to be negatively correlated to physical function 
(p=0.025) and mental health (p=0.047) dimensions as well as to the overall mental 
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health score (p<0.032). In addition to that, a tendency toward lower scores in the role 
emotional were shown in DN patients with higher HbA1c (p<0.052). In addition to that, 
both groups reported that people with higher BMI scored lower in the general health 
dimension (p<0.041).  
 
 
Table 6-26. Microcirculation: Exploratory data (Bivariate correlation) 
 
Blood flow 
at rest 
mVO2 
at rest 
Blood flow 
After 
exercise 
mVO2  
After 
exercise 
Blood flow 
recovery 
mVO2 
recovery 
V
PT
 N=53 
(DN group) 
τ=-0.091 
p=0.357 
(NPT) 
τ=-0.011 
p=0.943 
(NPT) 
τ=0.121 
p=0.240 
(NPT) 
τ=0.113 
p=0.283 
(NPT) 
τ=0.027 
p=0.859 
(NPT) 
τ=-0.202 
p=0.068 
(NPT) 
H
bA
1c
 N=53 
(DN group) 
r=0.040 
p=0.785 
τ=0.086 
p=0.409 
(NPT) 
τ=0.153 
p=0.144 
(NPT) 
τ=0.178 
p=0.097 
(NPT) 
r=-0.266* 
p=0.011 
r=-0.219* 
p=0.044 
N=53 
(DN group) 
τ=0.062 
p=0.669 
(NPT) 
τ=0.004 
p=0.971 
(NPT) 
τ=-0.003 
p=0.977 
(NPT) 
τ=-0.115 
p=0.199 
(NPT) 
τ=-0.59 
p=0.698 
(NPT) 
r=-0.170 
p=0.275 
BP
 
(sy
st
o
lic
) 
N=24 
(HEALTH 
groups) 
r=-0.184 
p=0.378 
τ=-0.187 
p=0.191 
(NPT) 
τ=0.127 
p=0.375 
(NPT) 
r=-0.248 
p=0.233 
τ=-0.055 
p=0.519 
(NPT) 
r=-0.033 
p=0.876 
* Significance value is less than 0.05 level (2-tailed); NPT. Non parametric test. 
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Table 6-27. Psychology: Exploratory data (Bivariate correlation) 
  
Physical 
Function 
Role 
Physical Body Pain 
General 
Health Vitality 
Social 
Function 
Role 
Emotional 
Mental 
Health 
Mental 
Health 
Overall 
Physical 
Health 
overall 
V
P
T
 N=53 
(DN group) 
τ=0.019 
p=0.847 
(NPT) 
τ=-0.092 
p=0.381 
(NPT) 
τ=0.052 
p=0.599 
(NPT) 
τ=0.044 
p=0.655 
(NPT) 
τ=-0.070 
p=0.473 
(NPT) 
τ=-0.097 
p=0.350 
(NPT) 
τ=0.041 
p=0.705 
(NPT) 
τ=0.089 
p=0.366 
(NPT) 
τ=-0.015 
p=0.878 
(NPT) 
τ=0.008 
p=0.933 
(NPT) 
H
b
A
1
c
 N=53 
(DN group) 
τ=-0.224* 
p=0.025 
(NPT) 
τ=0.055 
p=0.573 
(NPT) 
τ=0.066 
p=0.509 
(NPT) 
τ=-0.079 
p=0.432 
(NPT) 
τ=-0.130 
p=0.193 
(NPT) 
τ=-0.065 
p=0.538 
(NPT) 
τ=-0.207 
p=0.053 
(NPT) 
τ=-0.196* 
p=0.047 
(NPT) 
τ=-0.208* 
p=0.032 
(NPT) 
τ=-0.058 
p=0.544 
(NPT) 
N=53 
(DN group) 
τ=-0.125 
p=0.198 
(NPT) 
τ=0.055 
p=0.573 
(NPT) 
τ=-0.075 
p=0.573 
(NPT) 
τ=-0.218* 
p=0.025 
(NPT) 
τ=-0.118 
p=0.224 
(NPT) 
τ=-0.025 
p=0.811 
(NPT) 
τ=-0,018 
p=0.871 
(NPT) 
τ=-0,039 
p=0.694 
(NPT) 
τ=-0.044 
p=0.640 
(NPT) 
τ=-0.047 
p=0.623 
(NPT) 
B
M
I
 
N=24 
(HEALTH 
groups) 
τ=-0.156 
p=0.325 
(NPT) 
τ=-0.094 
p=0.579 
(NPT) 
τ=-0.131 
p=0.402 
(NPT) 
τ=-0.275* 
p=0.041 
(NPT) 
τ=-0.004 
p=0.981 
(NPT) 
τ=-0.063 
p=0.707 
(NPT) 
τ=-0.071 
p=0.677 
(NPT) 
τ=-0.135 
p=0.374 
(NPT) 
τ=-0.203 
p=0.160 
(NPT) 
τ=-0.054 
p=0.708 
(NPT) 
* Significance value is less than 0.05 level (2-tailed); NPT. Non parametric test
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6.2 INTERVENTION STUDY 
 
The aim of this study was to evaluate the effects of a 16-week strength training 
programme on identified pathologies associated with peripheral neuropathy in DN 
subjects. Adaptations to the exercise programme were calculated by comparing pre-and 
post-intervention data between groups (EX and CON) (2 way Mixed ANOVA design). 
It should be noted that the covariates used throughout this results section are carried 
over from the cross sectional results sections.  Information about the statistical approach 
used to analyse the intervention study can be found in Chapter 5 (Section 5.6.2.2.) 
Results from the intervention study are presented in different sections, namely 
demographic characteristics of the sample groups, general health, gait biomechanics, 
microcirculation and QOL. Table 6-29 shows an overview of the data presented in this 
section.  
 
6.2.1 Subjects Characteristics 
 
 
Table 6-28. Subject characteristics for the EXE and the CON group 
Group 
Inferential statistical 
results Variable 
EXE  (N=20) CON (N=21) Groups comparison  
Age (years) 60.85± 7.56a 64.95± 5.76a t(40)=-1.941, p=0.059 
Body Mass (kg) 91.78± 18.77a 95.44± 15.26a t(40)=-0.683, p=0.499 
BMI (kgּm-2) 31.52± 5.48a 33.16± 5.72a t(40)=-0.936, p=0.355 
Body fat (%) 37.81± 6.87a 38.63±6.23a t(40)=-0.399, p=0.692 
VPT (V) 17.00(40.00) b 14.00(47..50) p=0.256 (NPT) 
Height (m) 1.70± 0.97a 1.69± 0.86a t(40)=0.129, p=0.898 
Sex 
Male (n) 
Female (n) 
 
14 (66%) 
7 (34%) 
 
13 (65%) 
8 (35%) 
 
NA 
a
 Values are means ± SD; b Values are medians with range in parentheses; NPT. Non parametric test. 
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Table 6-29. Overview of the results presented in intervention study 
DOMAIN Measurement Outcome measure 
TC 
LDL Cholesterol 
HDL 
Systolic Blood Pressure 
Blood Pressure 
Diastolic Blood Pressure 
Glucose Control HbA1c 
Body mass 
Obesity 
Body fat % 
General Health 
Neuropathy VPT 
Strength Peak Moment 
Gait velocity 
Step length Spatial-temporal 
Step time 
Distance COP 
Gait 
parameters 
COP parameters 
Velocity COP 
Heel 
Metatarsals Peak Pressure 
Big toe 
Heel 
Metatarsals 
Kinetic data 
PTI 
Big toe 
% peak activity per gait phase 
% GC muscle active 
Time to peak (push off phase) 
Gait 
Muscular Activity 
Instant Peak Activity (Push off) 
Rest 
Post-Exercise 
Muscular 
Blood flow 
 
Recovery 
Rest 
 
Post-Exercise 
Microcirculation Muscular microcirculation 
Muscular 
Oxygen 
Consumption 
Recovery 
Physical Health Quality of Life Self-Reported Quality of life 
Mental Health 
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The two groups (EXE and CON groups) were matched on marginal distributions for 
age, height, mass, neuropathy and sex. Table 6-28 presents the demographic features of 
the subjects belonging to the 2 groups. No statistical differences were shown between 
the groups regarding to age, height, body mass, body fat%, VPT and gender. 
 
6.2.2 General Health 
 
Table 6-30 presents the results of the effect of the intervention programme on body 
composition, cholesterol levels, blood pressure, foot sensation and resting heart rate. 
Body composition, calculated as BMI and body fat %, was reduced in the EXE group 
when compared to the CON group over time. However, only body fat % reached 
significant levels (p=0.045) when both groups were compared over time. Although BMI 
changes over time showed a tendency toward lower values in the EXE group compared 
to the CON group, those differences did not reach significant levels (p=0.078). Table 
6-30 also shows that there were significant group*time interactions in systolic blood 
pressure (p=0.032), resting heart rate (p=0.044) and vibration sensation (p=0.027). 
Thus, the EXE group significantly lowered blood pressure, resting heart rate and 
vibration perception threshold over time when compared to the CON group. In contrast, 
no group differences were obtained over time in cholesterol levels [HDL (p=0.391), 
LDL (0.850) and TC (0.508)], diastolic blood pressure (p=0.149) and HbA1c values 
(p=0.739). 
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Table 6-30. General health: Comparison between the EXE and the CON group over timea 
Group 
Inferential 
statistics results 
Control Group 
(N=21) 
Exercise Group 
(N=20) 
Variable 
Pre-Int      Post-Int Pre-Int      Post-Int 
2 way Mixed 
ANOVA 
(Group*Time 
interaction) 
BMI (kgּm-2) 
31.31± 
5.54 
31.30± 
5.29 
33.16± 
5.72 
32.65± 
5.89 
F(1,39)=3.284, 
p=0.078 
Body fat (%) 
37.91± 
6.72 
37.92± 
5.99 
38.63± 
6.23 
37.28± 
6.53 
F(1,39)=4.288,  
p=0.045* 
Systolic blood 
pressure (mmHg) 
134.10± 
11.80 
134.35± 
17.02 
142.0± 
11.25 
135.75± 
8.90 
F(1,38)=4.974, 
p=0.032* 
Diastolic blood 
pressure (mmHg) 
78.75± 
0.12 
78.45± 
10.35 
80.90± 
7.43 
77.35± 
8.96 
F(1,39)==2.181, 
p=0.148 
Vibration Threshold 
(V) 
18.77± 
14.62 
20.20± 
15.35 
21.52± 
13.37 
18.40± 
13.14 
F(1,39)=5.267, 
p=0.027* 
Heart rate at rest 
(beatsּmin -1) 
76.15± 
3.05 
77.25± 
14.94 
77.45± 
11.45 
74.00± 
9.71 
F(1,39)=4.301, 
p=0.044* 
TC 
(mmol·L-1) 
3.74± 
0.80 
3.78± 
0.65 
3.82± 
0.94 
3.72± 
0.84 
F(1,39)=0.447, 
p=0.508 
HDL 
(mmol·L-1) 
1.20± 
0.29 
1.20± 
0.30 
1.02± 
0.29 
1.07± 
0.26 
F(1,39)=0.739, 
p=0.395 
LDL 
(mmol·L-1) 
1.95± 
0.54 
1.94 ± 
0.59 
1.67± 
0.79 
1.63± 
0.80 
F(1,39)=0.036; 
P=0.850 
HbA1c (%) 
7.63 ± 
1.76 
7.20± 
0.81 
7.61± 
1.06 
7.32± 
0.81 
F(1,39)=0.113; 
p=0.739 
a
 Values are means ± SD; *  Significance value is less than 0.05 level (2-tailed). 
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6.2.3 Gait biomechanics 
 
This section starts presenting the results of the effect of the exercise programme on 
lower limb strength levels. Thereafter three more subsections were included in which 
outcome measures related to gait characteristics, kinetic data and muscular activity data 
during gait were presented.  
 
6.2.3.1 Isometric strength  
 
Table 6-31 shows strength levels for the CON and the EXE group before and after the 
16 weeks intervention. There were no significant group*time interactions in any of the 
muscles groups under investigations. KE, KF, DF and PF reported p values of 0.115, 
0.310, 0.166 and 0.118, respectively. 
 
 
 
Table 6-31. Strength levels: Comparison between the EXE and the CON group over time a 
Group 
Inferential 
statistics 
results 
Control Group 
(N=21) 
Exercise Group 
(N=20) 
Variable 
Pre-Int      Post-Int Pre-Int      Post-Int 
2 way Mixed 
ANOVA 
(Group*Time 
interaction) 
Knee-Extension 
(Nּm-1) 
349.35± 
99.87 
382.44± 
313.13 
313.13± 
82.56 
394.14± 
104.99 
F(1,39)=2.594, 
p=0.115 
Knee-Flexion 
(Nּm-1) 
172.20± 
36.84 
170.41± 
34.37 
183.11± 
34.52 
189.09± 
36.34 
F(1,39)=1.061, 
p=0.310 
Dorsi-Flexion 
(Nּm-1) 
166.14± 
73.52 
165.54± 
68.18 
159.16± 
70.43 
182.86± 
63.37 
F(1,39)=1.989, 
p=0.166 
Plantar-Flexion 
(Nּm-1) 
96.28± 
42.06 
129.36± 
37.40 
129.56± 
78.66 
127.99± 
41.09 
F(1,39)=2.560, 
p=0.118 
a
 Values are means ± SD. 
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6.2.3.2 Gait parameters 
 
Spatial temporal parameters together with COP parameters are presented in this section. 
Based on the exploration for possible confounders carried out in the cross-sectional 
study (see Section 0), body mass was accounted for when comparing total distance 
travelled by the COP between groups over time, while gait velocity was entered as a 
covariate when comparing group differences over time in the velocity of the COP at the 
heel.   
 
Table 6-32 presents the changes in gait parameters over time when comparing the EXE 
and the CON group.  No significant changes or trends were reported in any of the 
spatial-temporal parameters under investigation when both groups were compared over 
time. Therefore, it appears that the exercise programme did not trigger noticeable 
changes in gait velocity (p=0.818), step length (p=0.404), step time (p=0.799) or 
cadence (p= 0.636).  
 
When assessing COP parameters, the only significant differences over time were 
observed in the velocity of the COP at the heel. Thus, the EXE group reported slower 
velocity of the COP at the heel (p=0.035) when compared to the CON group over time. 
All the other COP parameters did not show any significant group*time interactions.  
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Table 6-32. Gait parameters: Comparison between the EXE and the CON group over time a 
Group 
Inferential 
statistical 
results 
Control Group 
(N=21) 
Exercise Group 
(N=20) 
Variable 
Pre-Int      Post-Int Pre-Int     Post-Int 
2 way Mixed 
ANOVA 
(Group*Time 
interaction) 
Spatial-temporal data 
 
Step time (sec) 
 
 
Step length (m) 
 
 
Cadence 
(stepsּmin-1) 
 
Velocity (mּsec-1) 
 
 
0.553± 
0.047 
 
0.614± 
0.072 
 
108.71± 
9.48 
 
1.11± 
0.163 
 
 
0.557± 
0.045) 
 
0.615± 
0.061 
 
108.22± 
8.41 
 
1.11± 
0.157 
 
 
0.544± 
0.066 
 
0.624± 
0.084 
 
111.36± 
12.03 
 
1.16 ± 
0.21 
 
 
0.549± 
0.043 
 
0.637± 
0.084 
 
109.70± 
7.72 
 
1.16± 
0.19 
 
 
F(1,39)=0.066, 
p=0.799 
 
F(1,39)=0.711,  
p=0.404 
 
F(1,39)=0.228, 
p=0.636 
 
F(1,39)=0.054, 
p=0.818 
Foot floor interaction 
 
Distance travelled by 
the COP (cm) 
 
Velocity COP at the 
heel (mּsec-1) 
 
Velocity COP at the 
Forefoot (mּsec-1) 
 
Velocity COP at the 
hallux (mּsec-1) 
 
 
24.37± 
2.28 
 
0.44±  
0.12 
 
0.277± 
0.055 
 
0.812±  
0.338 
 
 
24.48± 
1.96 
 
0.45± 
0.10 
 
0.268± 
0.056 
 
0.868±  
0..346 
 
 
24.57± 
2.18 
 
0.50± 
0.10 
 
0.273± 
0.046 
 
0.874±  
0.329 
 
 
24.80± 
2.07 
 
0.46± 
0.099 
 
0.275± 
0.039 
 
0.874±  
0.350 
 
 
F(1,39)=0.270, 
p=0.606 1 
 
F(1,39)=4.729, 
p=0.035*2 
 
F(1,39)=1.067, 
p=0.308 
 
F(1,39)=0.921, 
 p=0.343 
a
 Values are means ± SD; 1 Analysis of covariance with body mass as a covariate; 2 Analysis of 
covariance with gait velocity as a covariate; *  Significance value is less than 0.05 level (2-tailed). 
 
 
6.2.3.3 Kinetic data 
 
This section presents the results of the effect of the exercise programme on the primary 
outcome measures, PP and PTI. Thereafter, results of the parameters related to PP and 
PTI are shown. 
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6.2.3.3.1 Primary outcome measures: Peak Pressure and Pressure Time 
Integral. 
 
Changes over time in PP are shown in   Table 6-33. The only foot area that showed 
significant changes over time when the EXE group was compared to the CON group 
was PP at the heel (p=0.017). Thus, the results show significantly higher PP values over 
time in the EXE compared to the CON group. No significant group differences or 
trends were observed at the metatarsals and hallux regions.  
 
Changes over time in PTI both for the CON and EXE groups are shown in Table 6-34. 
No significant changes were reported in any foot area when both groups were compared 
over time. However, there was a trend towards higher PTI values over time in the EXE 
group, both at the heel (p=0.075) and hallux (p=0.094), when compared to the CON 
group.  
 
  Table 6-33. Peak pressure values: Comparison between the EXE and the CON group over time a 
Group 
Inferential 
statistical 
results 
Control Group 
(N=21) 
Exercise Group 
(N=20) 
Variable 
Pre-Int      Post-Int Pre-Int      Post-Int 
2 way Mixed 
ANOVA 
(Group*Time 
interaction) 
PP Heel 
(kPa) 
475.05± 
196.40 
454.33±  
198.23 
431.60±  
94.76 
455.40±  
126.81 
F(1,39)=6.274, 
p=0.017*1 
PP Metatarsals 
(kPa) 
852.55±  
260.93 
826.88±  
266.31 
765.1±  
281.85 
774.35±  
282.30 
F(1,39)=1.878, 
p=0.178 
PP Hallux 
(kPa) 
523.33±  
351.79 
505.83±  
342.15 
489.89±  
290.57 
525.15±  
329.15 
F(1,39)=2.507, 
p=0.121 
a
 Values are means ± SD; 1 Analysis of covariance with gait velocity as a covariate; *  Significance   
value is less than 0.05 level (2-tailed). 
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Table 6-34. PTI values: Comparison between the EXE and the CON group over timea 
Group 
Inferential 
statistical results 
Control Group 
(N=21) 
Exercise Group 
(N=20) Variable 
Pre-Int      Post-Int Pre-Int      Post-Int 
2 way Mixed 
ANOVA 
(Group*Time 
interaction) 
PTI Heel  
(kPaּsec ) 
119.34±  
45.84 
118.28±  
58.29 
104.75±  
82.56 
112.65±  
104.99 
F(1,39)=3.348,  
p=0.075 
PTI Metatarsals 
(kPaּsec ) 
260.69±  
95.96 
259.10±  
104.27 
222.00±  
76.71 
230.82±  
79.18 
F(1,39)=1.768,  
p=0.191 
PTI Hallux  
(kPaּsec ) 
93.20±  
68.62 
89.83±  
68.18 
88.15±  
57.15 
101.03±  
76.45 
F(1,39)=2.938,  
p=0.094 
a
 Values are means ± SD. 
 
 
 
6.2.3.3.2 Secondary outcome measures: Parameters related to peak pressure 
and pressure time integral 
 
 
Since the intervention did not seem to trigger changes in plantar pressures, apart from 
PP at the heel, parameters related to PP and PTI were not expected to change either. 
However, these analyses were carried out to confirm that there were no group 
differences over time.   
 
Table 6-35 and Table 6-36 present data on the parameters related to peak pressure and 
pressure time integral for both groups over time, respectively. Table 6-35 confirmed 
that there were not significant group differences in the parameters related to peak 
pressure (Max Force, CA and arch index) over time. Similar results were found with 
regard to the parameters related to PTI (results presented in Table 6-36).  Thus, group 
differences over time did not reach significant values when comparing the amount of 
time that the heel, metatarsals and hallux remained in contact with the floor during the 
stance phase of the GC. However, there was a trend toward higher contact times at the 
heel in the EXE group over time compared to the CON group (p=0.082). 
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Table 6-35. Parameters related to Peak pressure: Comparison between the EXE and the CON 
group over timea 
a
 Values are means ± SD. 
 
 
Group 
Inferential 
statistical 
results 
Control Group 
 (N=21) 
Exercise Group 
(N=20) 
Variable 
Pre-Int        Post-Int Pre-Int      Post-Int 
2 way Mixed 
ANOVA 
(Group*Time 
interaction) 
Max Force (NּKg-1) 
 
Heel 
 
 
Metatarsals 
 
 
Hallux 
 
 
7.13± 
0.91 
 
9.27± 
0.98 
 
1.38± 
0.67 
 
 
6.97± 
0.99 
 
9.25± 
0.94 
 
1.42± 
0.60 
 
 
7.00± 
1.06 
 
9.30± 
1.16 
 
1.38± 
0.71 
 
 
7.06± 
0.98 
 
9.48± 
1.07 
 
1.49± 
0.79 
 
 
F(1,39)=0.725, 
p=0.399 
 
F(1,39)=2.791, 
p=0.103 
 
F(1,39)=0.486, 
p=0.447 
Contact Area (cm2) 
 
Heel 
 
 
Metatarsals 
 
 
Hallux 
 
 
33.41± 
4.96 
 
47.24± 
5.82 
 
8.40± 
1.76 
 
 
33.43± 
5.14 
 
47.18± 
6.26 
 
8.70± 
1.42 
 
 
34.63± 
4.24 
 
49.90± 
49.83 
 
9.15± 
1.79 
 
 
34.48± 
4.08 
 
48.83± 
6.52 
 
9.38± 
1.58 
 
 
F(1,39)=0.486, 
p=0.490 
 
F(1,39)<0.001, 
p=0.983 
 
F(1,39)=0.075, 
p=0.786 
Arch Index  
0.191± 
0.074 
0.194± 
0.080 
0.212± 
0.057 
0.202± 
0.069 
F(1,39)=2.634, 
p=0.113 
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Table 6-36. Parameters related to PTI: Comparison between the EXE and the CON group over 
time a 
Group 
Inferential 
statistical 
results 
Control Group 
(N=21) 
Exercise Group  
(N=20) 
Variable 
Pre-Int      Post-Int Pre-Int      Post-Int 
2 way Mixed 
ANOVA 
(Group*Time 
interaction) 
Contact Time (ms) 
 
Heel 
 
 
Metatarsals 
 
 
Hallux 
 
 
465.55± 
97.88 
 
611.77± 
66.54 
 
359.33± 
102.85 
 
453.57± 
103.61 
 
614.44± 
66.46 
 
376.88± 
92.69 
 
431.57± 
95.77 
 
601.47± 
81.09 
 
380.44± 
119.85 
 
447.57± 
9.75 
 
612.42± 
72.35 
 
390.88± 
123.47 
 
F(1,39)=3.200, 
p=0.082 
 
F(1,39)=0.355, 
p=0.555 
 
F(1,39)=0.147, 
p=0.704 
a
 Values are means ± SD. 
 
 
6.2.3.3.3 Kinetic parameters during the push off phase 
 
In line with the results presented in the previous sections (gait related results), the 
intervention did not trigger any changes in PP (p=0.616) or Max Force (p=0.441) 
(normalised and non-normalised to body mass) values during the push off when the DN 
and the EXE groups were compared over time. The same trend towards no group 
differences over time was observed when assessing time related parameters during the 
push off phase. Thus, the instant of the peak pressure and the instant of the Max Force 
during the push off did not show significant group differences when comparing pre- and 
post-intervention values.  These results are presented in Table 6-37. 
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Table 6-37. Pressure and Force related parameters during push off: Comparison between the EXE 
and the CON group over time a 
Group 
Inferential 
statistical 
results 
Control Group 
(N=21) 
Exercise Group  
(N=20) 
Variable 
Pre-Int      Post-Int Pre-Int      Post-Int 
2 way Mixed 
ANOVA 
(Group*Time 
interaction) 
Peak Pressure (kPa) 
901.55± 
263.66 
867.61± 
244.17 
851.36± 
268.37 
852.89± 
277.91 
F(1,39)=0.256, 
p=0.616 
Instant of Peak 
Pressure (% ROP) 
80.86± 
6.95 
79.26± 
7.47 
82.66± 
5.43 
81.59± 
6.44 
F(1,39)=0.056, 
p=0.814 
Max Force (N) 
930.46± 
161.19 
949.35± 
163.23 
1019.65 
± 156.58 
1006.01± 
170.24 
F(1,39)=0.608, 
p=0.441 
Instant of Max Force 
(% ROP) 
77.20± 
1.84 
76.57± 
2.50 
77.05 ± 
2.27 
77.37± 
1.92 
F(1,39)=2.114, 
p=0.154 
Max Force 
Normalized (NּKg-1) 
10.69± 
0.96 
10.91± 
1.25 
10.69 ± 
0.83 
10.68± 
1.19 
F(1,39)=0.324, 
p=0.572 
a
 Values are means ± SD. 
 
 
6.2.3.4 EMG  
 
This section presents pre- and post-intervention data with regard to the EMG 
measurements for the EXE and the CON group. The mean muscular activity during the 
differences phases of the GC is presented first. Thereafter, time related EMG variables 
are shown, including: 1) the percentage of time each muscle was kept activity during 
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the whole GC; 2) percentage of the GC at which TS and TA activity peaked during and 
after the push off phase, respectively; and 3) time lag from the onset to peak activity 
during and after the push off phase for the TS and TA muscles, respectively.  
 
 
Figure 6-5 shows pre-intervention (blue line) and post-intervention (red line) EMG 
activity during a GC. EMG data was presented for the TA, TS, (MGast + LGast + 
Soleus), Quadriceps (VL) and Hamstrings (BicFem) muscles. EMG data traces from the 
EXE group are displayed at the top of the figure while traces from the CON group are 
displayed below. The table at the bottom of Figure 6-5 presents the EMG differences 
between the EXE and the CON group over time throughout the phases of the GC. It 
should be pointed out that no statistical analysis has been carried out to investigate 
muscular activity during the initial swing and mid-swing phases of the GC. 
 
During the loading phase the only significant difference between the EXE and the CON 
group was observed for the HA (p<0.03). This muscle showed a decrease in muscular 
activity in the CON group when compared to the EXE group over time. In addition, 
there was a trend toward a decrease in TA activity in the CON group when compared to 
the EXE group over time (p=0.062). No significant group differences were observed 
during the loading phase when TS and QUADS were compared over time.  
 
The intervention programme did not change muscular activity patterns during the mid 
stance phase of the GC in any of the muscles under investigation (TS, TA, QUADS, 
HAMS) (p>0.05).  
 
The 2 way Mixed ANOVA analysis for the terminal stance phase revealed a trend 
towards a decrease in TS activity (p=0.058) and QUADS activity (p=0,091) over time 
in the EXE group compared to the CON group. No significant group differences were 
observed when comparing TA and HA during this phase over time. 
 
During the pre-swing phase, no statistical differences between groups were observed 
when comparing EMG data over time. However, TS and TA show a trend toward 
changes when the EXE and the CON group were compared over time. Thus, the EXE 
group showed a trend toward increased TS activity over time when compared to the 
  221 
CON group (p=0.098), whereas a trend in the opposite direction was observed when 
looking at the TA (p=0.092). 
 
No significant group differences during the terminal swing phase were observed when 
assessing EMG activity over time in any of the muscle groups under investigation 
(p>0.12).  
 
Overall, results from the present study show that 16 weeks of strengthening and 
mobility exercises did not influence muscular activity patterns substantially throughout 
the different phases of the GC in DN subject. 
 
Results from the time related EMG data for the EXE and the CON group over time is 
presented in Table 6-38.  When investigating muscular activity patterns during the 
whole GC, results from the present study show no significant group* time interaction in 
the amount of time (as percentage) each muscle was kept activity during the GC. 
Similar results were obtained when investigating time related parameters for the TA and 
TS muscles during push off phase (see Chapter 5, Section 5.4.3.4.3 for more 
information about the time windows for the TA and TS muscles). Thus, no group 
differences over time were observed both in the time lag from activation onset to peak 
activity for the TA (p=0.694) and the TS muscle (p=0.404) and in the instant that TA 
(p=0.158) and TS (p=0.136) peaked. 
 
Overall, EMG activity patterns did not seem to change secondary to a PA programme. 
This is consistent with the lack of changes in gait parameters and kinetic data presented 
above.  
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Figure 6-5. EMG patterns during the GC: Comparison between the EXE and the CON group over 
time  
 
* Significance value is less than 0.05 level (2-tailed). 
 
 
 
 
 
 
 
 
 
 
* Significance value is less than 0.05 level (2-tailed); 
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Table 6-38. Time related EMG parameters during gait:  Comparison between the EXE and the 
CON group over time a 
Group 
Inferential 
statistical 
results 
Control Group 
(N=19) 
Exercise Group 
(N=19) 
Variable 
Pre-Int      Post-Int Pre-Int      Post-Int 
2 way Mixed 
ANOVA 
(Group*Time 
interaction) 
% GC active above 
threshold 
 
TS 
 
 
TA 
 
 
QUADS 
 
 
HAMS 
 
 
 
 
67.85± 
11.24 
 
75.08± 
9.66 
 
67.51± 
12.31 
 
70.38± 
17.65 
 
 
 
67.11± 
9.96 
 
74.02± 
10.91 
 
71.49± 
12.75 
 
67.07± 
14.94 
 
 
 
69.40± 
11.58 
 
72.95± 
9.93 
 
67.79± 
9.01 
 
74.50± 
12.60 
 
 
 
66.07± 
10.15 
 
71.34± 
10.32 
 
67.1± 
11.76 
 
68.96± 
14.59 
 
 
 
F(1,36)=1.023, 
p=0.312 
 
F(1,36)=0.037, 
p=0.850 
 
F(1,36)=0.398, 
p=0.532 
 
F(1,36)=0.146, 
p=0.705 
Time From Onset To 
Peak Activity (ms) 
 
TS 
 
 
TA 
 
 
 
78.44± 
10.32) 
 
28.65± 
15.22 
 
 
77.37± 
8.28) 
 
28.82± 
13.26 
 
 
75.06± 
16.08) 
 
25.42± 
9.43 
 
 
72.78± 
18.19) 
 
23.53± 
8.36 
 
 
F(1,36)=0.157, 
p=0.694 
 
F(1,36)=0.714, 
p=0.404 
Instant of Peak Activity 
(%GC) 
 
TS 
 
 
TA 
 
 
 
47.30± 
1.18 
 
74.18± 
6.56 
 
 
 
47.11± 
2.30) 
 
71.54± 
7.40 
 
 
 
46.94± 
2.38) 
 
71.23± 
4.22 
 
 
 
47.45± 
1.34) 
 
71.37± 
5.95 
 
 
 
F(1,36)=2.082, 
p=0.158 
 
F(1,36)=2.326, 
p=0.136 
a
 Values are means ± SD. 
 
6.2.4 Microcirculation 
 
Muscular blood flow and oxygen consumption were investigated during different 
conditions: at rest, in response to an exercise bout and during recovery from an exercise 
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bout.  According to the exploration for possible confounders carried out in the cross-
sectional study (see Section 6.1.4), body mass was accounted for when comparing 
resting BF and mVO2 between the groups over time whilst EMG was entered as a 
covariate when comparing group differences over time for  BF and mVO2 responses to 
the exercise bout. It should be noted that the sample size for the statistical analysis of 
the microcirculatory related outcome measures was 17 subjects in the CON group and 
17 subjects in the EXE group whereas all other analysess were carried out with 21 in 
the CON group and 20 in the EXE group. Some individuals suffered from cramps 
during the exercise protocol and the exercise had to be stopped. This explains the 
reduction in the numbers compared to the other analyses.   
Table 6-39 presents pre- and post-intervention blood flow and oxygen consumption 
data obtained on the MGast for the EXE and CON groups during different protocols. 
When investigating group differences over time in resting microcirculation, the 2 way 
Mixed ANOVA analysis revealed no group difference over time in blood flow 
(p=0.193) or  muscular oxygen consumption (p=0.222).  
Table 6-39 also shows that there were no significant group differences over time with 
regard to the BF or mVO2 responses to the exercise protocol (p>0.05). However, there 
was a trend toward higher vasodilatory (BF) responses over time in the EXE group 
compared to the CON group (p=0.092). The only significant group difference over 
time, when assessing microcirculation, was observed during the recovery condition. BF 
and mVO2 were assessed 70 seconds after the exercise protocol finished and the % of 
recovery was calculated in relation to resting values. Even though BF recovery over 
time did not vary significantly between groups (p=0.244), significant group differences 
(p=0.040) were observed when comparing the % of mVO2 recovery over time. 
Furthermore, the EXE group reported a significant faster mVO2 recovery over time 
compared to the CON group.  
 
In summary results from the present study show that the exercise programme did trigger 
some changes in the microcirculation of subjects with DN. Thus, 1) there is a trend 
toward higher vasodilatation in response to the exercise bout over time in the EXE 
group compared to the CON group and 2) mVO2 recovery after 70 seconds was 
significantly quicker over time in the EXE compared to the CON group.  
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Table 6-39. Microcirculation parameters: Comparison between the EXE and the CON group over 
timea 
Group 
Inferential 
statistical 
results 
Control Group 
(N=17) 
Exercise Group 
(N=17) 
Condition Variable 
Pre-Int    Post-Int Pre-Int     Post-Int 
2 way Mixed 
ANOVA 
(Group*Time 
interaction) 
 
Rest 
BF 
(mlּmin -
1
ּ100g-1) 
 
mVO2 
(mlO2ּmin -
1
ּ100g-1) 
0.563± 
0.20 
 
 
0.0284± 
0.016 
0.565± 
0.227 
 
 
0.0286± 
0.033 
0.571± 
0.153 
 
 
0.0225± 
0.011 
0.513± 
0.172 
 
 
0.0266± 
0.012 
F(1,32)=1.771, 
p=0.1931 
 
 
F(1,32)=1.548, 
p=0.2221 
 
Responses 
to Exercise 
Protocol 
 
BF 
(% of 
Change) 
 
mVO2 
(% of 
Change) 
 
119.18± 
88.15 
 
 
307.26± 
246.98 
 
119.73± 
82.87 
 
 
263.42± 
173.99 
 
105.04± 
55.61 
 
 
276. 78± 
176.35 
 
136.05± 
67.37 
 
 
237.46± 
127.85 
 
F(1,32)=3.023, 
p=0.0922 
 
 
F(1,32)=0.055, 
p=0.8162 
 
Recovery 
from 
Exercise 
Protocol 
 
BF 
(% of 
Recovery) 
 
mVO2 
(% of  
Recovery) 
75.29± 
26.99 
 
 
82.26± 
23.08 
72.91± 
21.87 
 
 
80.06± 
12.63 
61.94± 
23.07 
 
 
75.38± 
23.12 
75.26± 
34.79 
 
 
94.51± 
18.08 
 
F(1,32)=1.410, 
p=0.244 
 
 
F(1,32)=4.604; 
p=0.040* 
 
a
 Values are means with SD in parentheses; 1Analysis of covariance with body mass as a covariate; 
2Analysis of covariance with muscular activity (EMG) as a covariate; *  Significance value is less than 
0.05 level (2-tailed). 
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6.2.5  Quality of life 
 
The effect of the intervention on self reported quality of life is presented in Table 6-40 
The 2 way Mixed ANOVA analysis revealed significant group differences in two of the 
dimensions under investigation, Vitality (p<0.001) and Mental health (p=0.027), as well 
as in the overall Mental Health Score (p=0.013). All the three variables reported higher 
values in the EXE group over time compared to the CON group. Although all the other 
dimensions, except from body pain, obtained higher scores over time in the EXE group 
compared to the CON group, none of these scores reached significant values (p>0.05).  
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Table 6-40. Quality of life: Comparison between the EXE and the CON group over timea 
Group 
Inferential 
statistical 
results 
Control Group 
 (N=18) 
Exercise Group 
(N=21) 
Variable 
Pre-Int      Post-Int 
    Pre-Int        Post-Int 
2 way Mixed 
ANOVA 
(Group*Time 
interaction) 
 
 
Physical Function 
 
 
Role Physical 
 
 
Body Pain 
 
 
General Health 
 
 
Vitality 
 
 
Social Function 
 
 
Role Emotional 
 
 
Mental Health 
 
 
Physical Health 
Overall 
 
 
Mental Health 
Overall 
69.44± 
24.00 
 
61.11± 
44.73 
 
69.02± 
21.66 
 
60.83± 
19.72 
 
59.72± 
21.17 
 
82.08± 
20.93 
 
77.77± 
34.29 
 
81.77± 
11.74 
 
64.82± 
22.17 
 
73.95± 
17.19 
71.11± 
24.04 
 
66.66± 
46.17 
 
64.02± 
31.49 
 
59.72± 
15.57 
 
52.77± 
24.20 
 
77.77± 
30.67 
 
74.07± 
37.14 
 
77.77± 
15.29 
 
65.38± 
26.47 
 
70.60± 
22.54 
63.33± 
22.49 
 
68.02± 
30.84 
 
75.47± 
20.64 
 
52.61± 
18.61 
 
49.28± 
18.72 
 
87.38± 
93.57 
 
85.71± 
29.00 
 
78.19± 
15.36 
 
62.76± 
14.82 
 
73.59± 
15.17 
72.49± 
22.61 
 
85.71± 
30.17 
 
74.64± 
20.75 
 
56.90± 
16.54 
 
66.90± 
17.78 
 
93.57± 
10.20 
 
93.65± 
22.65 
 
83.42± 
12.41 
 
70.08± 
17.69 
 
82.93± 
11.51 
 
 
F(1,37)=1.029, 
p=0.317 
 
F(1,37)=0.858, 
p=0.360 
 
F(1,37)=0.344, 
p=0.561 
 
F(1,37)=1.367, 
p=0.250 
 
F(1,37)=21.994, 
p<0.001** 
 
F(1,37)=2.675, 
p=0.110 
 
F(1,37)=2.233, 
p=0.144 
 
F(1,37)=5.325, 
p=0.027* 
 
F(1,37)=1.452, 
p=0.236 
 
F(1,37)=6.823, 
p=0.013*  
a
 Values are means ± SD; *  Significance value is less than 0.05 level (2-tailed); ** Significance value is 
less than 0.01 level (2-tailed).  
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6.2.6 Summary of the main results for the intervention study. 
 
Table 6-41 provides a summary of the results in relation to the null hypotheses for part 
2 of the main study. 
 
The null hypothesis 1 relating to the effect of 16 weeks of strengthening and mobility 
exercises on general health when comparing the EXE and CON groups was rejected for 
the systolic blood pressure, body composition and sensory neuropathy but was accepted 
for the diastolic blood pressure and cholesterol levels. The EXE group showed a 
reduction in systolic blood pressure, body fat percentage and VPT values over time 
compared to the CON group.  
 
The null hypothesis 2 relating to the effect of the PA programme on gait characteristics 
was rejected for the velocity of the COP at the heel and for the peak pressure at the heel 
but was accepted for all the other gait parameters and for the plantar pressures at the 
metatarsals and hallux. Compared to the CON group the EXE group increased foot 
pressures at the heel (p values for PTI at the heel only reached tendency levels) and 
reduced the velocity of the COP at the heel over time. Furthermore the null hypothesis 2 
relating the effect of the PA programme on strength levels was accepted for all the 
muscle groups.  
 
The null hypothesis 3 relating to the effect of 16 weeks of strengthening and mobility 
exercises on microcirculation was rejected for mVO2 recovery from the exercise 
protocol and accepted for all the other variables. Compared to the CON group, the EXE 
group recovered mVO2 values after the exercise protocol quicker over time. Although 
no statistically significant group*time interactions were revealed for the other 
dependent variables, changes in blood flow from baseline to post-exercise levels 
(vasodilatation) showed a tendency toward higher values over time in the EXE group 
compared to the CON group (p=0.092). 
 
The null hypothesis 4 relating to the effect of the PA programme on QOL was rejected 
for mental health and accepted for physical health. Compared to the CON group the 
EXE group showed higher overall mental health scores over time.  
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Table 6-41. Summary of the results in relation to the main analysis of the intervention study  
AIM Measurement Outcome measure p<0.05 
TC N/S 
LDL N/S Cholesterol 
HDL N/S  
Systolic Blood Pressure *↓ 
Blood Pressure 
Diastolic Blood Pressure N/S 
Glucose Control HbA1c N/S 
Body mass N/S 
Obesity 
Body fat % *↓ 
General Health 
Neuropathy VPT *↓ 
Strength Peak Moment N/S 
Gait velocity N/S 
Step length N/S Spatial-temporal 
Step time N/S 
Distance COP N/S 
Gait 
parameters 
COP 
parameters Velocity COP *↓ 
Heel *↑ 
Metatarsals N/S Peak Pressure 
Big toe N/S 
Heel *↑ (trend) 
Metatarsals N/S 
Kinetic data 
PTI 
Big toe N/S 
% peak activity per gait 
phase 
N/S 
% GC muscle active  N/S 
Time to peak (push off 
phase) 
N/S 
Gait 
Muscular Activity 
Instant Peak Activity (Push 
off) 
N/S 
Rest N/S 
Post-
Exercise 
*↑ (trend) Muscular Blood flow 
 
Recovery N/S 
Rest N/S 
Post-
Exercise 
N/S 
Microcirculation Muscular 
microcirculation 
Muscular 
Oxygen 
Consumption 
Recovery *↑ 
Physical Health  N/S Quality of Life Self-Reported Quality 
of life Mental Health *↑ 
* Significance value is less than 0.05 level (2-tailed); N/S no significant differences; ↑↓ reflect changes 
over time in relation to the exercise programme. 
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CHAPTER 7  
 
7 Discussion  
 
Diabetic neuropathy is a very complex condition that carries multiple complications, 
including cardiovascular diseases, foot ulceration secondary to gait and 
microcirculatory changes, and poor QOL. The aim of the study was twofold. In part 1 
the aim was to investigate the differences between DN and healthy individuals in the 
primary pathologies associated with DN. This aimed to broaden the understanding of 
the health problems linked to this condition and to compare the findings in this study to 
previously published data. In part 2 the aim was to investigate the effect of a 16 week 
PA programme, which included strengthening and joint mobility exercises, on 
identified pathologies related to DN. This aimed to explore for the first time whether 
these health problems can be influenced by 16 weeks of resistance training in DN 
subjects. This study also includes 3 preliminary investigations which explored the 
reliability of some of the methods used in the main part of the study. The results of the 
Preliminary studies have been discussed in Chapter 4. This chapter discusses the results 
of Part 1 of the main study, followed by the discussion of the results obtained in Part 2. 
 
7.1 Part 1 – Cross-Sectional study 
 
Part 1 was a cross-sectional study that investigated differences between DN and healthy 
individuals in the primary pathologies associated to DN, including general health, gait, 
microcirculation and QOL. Therefore, part 1 of the main study found significant 
differences in general health, gait characteristics, microcirculation and QOL when the 
DN group was compared to the HEALTH group. The discussion of the results from the 
cross-sectional study is presented in the same order as in the literature review and 
results chapter. Then, general health outcome measures are discussed first, followed by 
gait, microcirculation and QOL parameters.  
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7.1.1 General Health 
 
It is well established that type 2 diabetes increases the risk of cardiovascular diseases 
secondary to alterations in traditional cardiovascular risk factors such as blood pressure 
and cholesterol levels. The present study found that the DN group had significantly 
higher systolic blood pressure compared to the HEALTH group. Interestingly, the 
differences in systolic blood pressure were seen even though most of the DN patients 
were taking antihypertensive agents (see Table 6-3 for more information about the 
medications taken by the DN group) and subjects with uncontrolled blood pressure 
were not invited to participate in the study. Hypotensive medications may also explain 
why diastolic blood pressure was within normal range in the DN group (79.77± 9.06 
mmHg). This also explains why no group differences in diastolic blood pressure were 
observed. Cholesterol levels were not measured in the HEALTH group, so no group 
comparison was carried out on these parameters. However, DN subjects in the present 
study did not show abnormal cholesterol levels when compared to current 
recommendations (Expert Panel on Detection, Evaluation, and Treatment of High 
Blood Cholesterol in Adults, 1993). Thus the DN group reported cholesterol values of 
3.81± 0.94 mmolּL-1, 1.83± 0.73 mmolּL-1 and 1.11±  0.31 mmolּL-1 for TC, LDL and 
HDL, respectively whilst current guidelines recommend values of <5.2 for TC, <3.4 for 
LDL and >0.9 for HDL (Expert Panel on Detection, Evaluation, and Treatment of High 
Blood Cholesterol in Adults, 1993). The fact that the majority of the DN subjects were 
taking anti-cholesterol medications can explain these results (see Table 6-3 for more 
information about the medications taken by the DN group).  
 
In addition to the risk of cardiovascular diseases, another major problem linked to DN 
is foot ulceration. It seems clear that a combination of gait biomechanics and 
microcirculatory changes are responsible for the increased risk of foot ulcerations 
observed in this population. Results from the group differences in gait characteristics 
and microcirculation obtained in the present study are discussed next.   
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7.1.2 Gait biomechanics 
 
In the present study gait was investigated from different perspectives to develop a 
comprehensive understanding of the walking characteristics in patients with DN. Most 
of the investigations analyzing gait characteristics in neuropathic patients have been 
interested in kinetic data, which is believed to predict the risk of foot ulceration in this 
population (Boulton et al., 1983; Guldemond et al., 2006) and gait parameters 
(Giacomozzi, 2005), which provide descriptive information about the overall gait 
characteristics (i.e. gait velocity).  However, EMG activity, which provides insight into 
how muscles are activated to generate movement, has not been widely investigated in 
this population during gait tasks. The assessment of muscle activities in the lower limb 
may be useful for interpreting and clarifying changes in kinetic and gait parameters. 
Thus, the present study investigated differences in all three aspects of gait in DN 
patients compared to healthy individuals.  
 
The present study found a number of alterations in gait parameters, kinetic data and 
EMG activity patterns in the DN group compared to the healthy control group. Overall, 
DN gait was characterized by shorter and slower steps, higher foot pressures under the 
metatarsal heads and higher muscular activity compared to the healthy group. To follow 
the same order as the literature review, hypothesis and results section, gait parameters 
are discussed first, followed by kinetic data and EMG data.  
 
7.1.2.1 Gait parameters 
 
The results from the present study show significant differences in all the spatial-
temporal, and in some of the COP outcome measures under investigation between the 
DN and HEALTH groups. Thus, DN subjects walked with smaller step length, lower 
cadence and velocity and longer step times compared to the healthy individuals. In 
addition to that, the DN group showed a trend toward smaller distance travelled by the 
COP during the stance phase and a significantly quicker foot drop following the heel 
strike as demonstrated by the faster velocity of the COP at the heel. The possible 
underlying factors explaining the changes in 1) spatial-temporal characteristics and 2) 
COP parameters in the diabetic group are discussed.  
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Finding from the present study are in agreement with previous investigations that have 
compared spatial-temporal characteristics between healthy and DN subjects 
(Courtemanche et al., 1996; Yavuzer et al., 2006). It has been proposed in the literature 
that both sensory neuropathy (van Deursen & Simoneau, 1999; Yavuzer et al., 2006) 
and motor neuropathy (Mueller et al., 1994) may be responsible for the changes in 
spatial-temporal characteristics observed in DN subjects. Next a discussion of the 
possible effect sensory neuropathy and motor neuropathy may have had on the changes 
in spatial-temporal characteristics observed in the present investigation.  
 
It has been hypothesized that sensory feedback plays a role in adjusting step-to-step 
limb trajectories to maintain balance during locomotion (Gandevia & Burke, 1992). 
Then the loss of this feedback information that results from DN may lead to loss of 
stability in these patients during gait. Consequently, this may increase the need for 
producing a more cautious gait in this population. This idea is supported by previous 
investigations that have assessed stability in DN subjects by measuring the distance 
travelled by the COP during different conditions (Simmons et al., 1997b; Simoneau et 
al., 1994).  It is assumed that stability is negatively related to the distance travelled by 
the COP during a fixed period of time. Therefore, subjects with poorer stability are 
expected to show higher distances and vice versa. Numerous studies have reported a 
high correlation between the severity of DN and COP distance in this population 
(Simmons et al., 1997b; Simoneau et al., 1994), which demonstrates that DN may 
produce instability in this population. Furthermore, the level of neuropathy has also 
been associated with step times (negative correlation), gait velocity (negative 
correlation) and step length (negative correlation) during gait (Yavuzer, et al., 2006). 
Results from the present investigation show that the degree of neuropathy (quantified 
by VPT measurements) was positively correlated with step times in the DN group, 
which is in line with the results presented above. It is therefore possible that the changes 
in spatial temporal characteristics observed in the DN group in the present investigation 
are secondary to lack of stability in this population.  
 
However, in the present study other spatial-temporal characteristics such as gait 
velocity or step length did not show any relationship with sensory neuropathy. It is 
likely that instability, which is believed to produce changes towards a more cautious 
gait, is not only dependent on plantar cutaneous sensation (van Deursen et al., 1998b). 
This may explain why gait velocity or step length were not correlated to sensory 
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neuropathy in the present study.  The somatosensory system appears to be the biggest 
contributor of feedback for postural control (van Deursen & Simoneau, 1999). This 
sensory system is composed of several different muscle, joint, and cutaneous 
mechanoreceptors. The information from these receptors is integrated in the central 
nervous system to produce a sensation of joint position and movement (Gandevia & 
Burke, 1992). It has therefore been hypothesized that instability in DN subjects may be 
the result of a loss of peripheral sensory receptor function in the lower legs  and cannot 
be attributed exclusively to loss of plantar cutaneous sensation (van Deursen et al., 
1999). Van Deursen et al. (1998b) carried out a study on 10 young healthy, 15 DN 
subjects and 15 age-matched controls to investigate muscle spindles function in ankle 
movement perception in DN subjects compared to young healthy and age-matched 
healthy controls. Muscle spindles are a type of proprioceptors which are sensitive to 
changes in muscle length (since they are located in parallel with the contractile fibres) 
(Tortora & Derrickson, 2006). In this study, muscle spindle function was assessed by 
measuring the movement perception threshold during muscle vibration (which is known 
to particularly stimulate the muscle spindle primary endings and therefore introduces a 
bias into the muscle spindle output). They found that neuropathic subjects had the 
highest movement amplitude of all the groups, and more interestingly, muscle vibration 
had much less of an effect on their performance. These findings led the authors to 
conclude that muscle spindle function is impaired in DN subjects (van Deursen et al., 
1998b). In line with these results, other studies have reported an impairment of the 
sensory function of the foot to perceive movement (van den Bosch et al., 1995; Son et 
al., 2009). Therefore, it appears that reduced postural stability in persons with diabetic 
neuropathy cannot be attributed exclusively to loss of plantar cutaneous sensation. This 
may explain why plantar cutaneous sensation in the present investigation was not 
significantly correlated to all the spatial-temporal changes in the DN group. 
 
Beside sensory neuropathy, an efferent/motor deficit, which is identified by muscle 
weakness, may further explain the difference in walking characteristics between the DN 
and healthy groups. The results in the present study confirmed that neuropathic patients 
suffered from muscular weakness secondary to neuropathy. All the muscle groups 
under investigation (plantar-flexors, dorsi-flexors, knee-extensors and knee-flexors) 
showed significantly lower strength levels in the DN compared to the healthy group.  It 
has been hypothesized that if patients with DN are unable to generate sufficient 
moments about the ankle during walking, they will take shorter steps and walk more 
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slowly than individuals without peripheral neuropathy (Mueller et al., 1994). The 
present study supports this idea when investigating healthy individuals without 
neurological complications. Gait velocity, step time and step length were significantly 
correlated with plantar-flexion strength in the healthy group. Increased plantar-flexor 
strength appeared to enhance the ability of the plantar-flexor muscles to push off and 
resulted in larger steps, shorter step times and quicker walking velocity. On the other 
hand, ankle strength levels did not correlate to any of the spatial-temporal parameters in 
the DN group. This suggests that ankle weakness is not likely to be the main factor for 
more cautious walking strategy observed in our DN subjects.  
 
Overall, results from the present study seem to suggest that in DN subjects, the loss of 
peripheral sensory receptor function may be the main responsible factor for the more 
cautious   walking strategy observed in this population. Numerous studies have reported 
that patients with diabetes and peripheral neuropathy have a high incidence of falls 
during walking (Dingwell & Cavanagh, 2001; Macqilchrist et al., 2010; Richardson & 
Hurvitz, 1995) and a low level of perceived safety (Cavanagh et al., 1992; Simoneau et 
al., 1994). Therefore, it is likely that risk avoidance, fear of falling, and lack of 
confidence are the main factors that influence postural control and gait behaviours in 
this population. On the other hand, spatial-temporal characteristics in healthy subjects 
seem to be dependent on the plantar-flexion strength level.  
 
Beside alterations in the spatial-temporal outcome measures, the present study showed 
changes in some COP parameters (i.e. COP distance and velocity of the COP at the 
heel) in the DN group compared to the HEALTH group. Results from the present study 
show that weakness of the DF muscles may partly explain the alterations in the COP 
parameters observed in the DN group compared to the HEALTH group. On the one 
hand, weakness of the dorsi-flexor muscles may result in a reduced dorsi-flexion angle 
during heel strike, which provokes the foot to contact the floor with the most anterior 
part of the heel (Giacomozzi et al., 2002). This interpretation is supported by the 
present study that shows a significant correlation between strength levels at the dorsi-
flexor muscles and COP distances both in the DN and HEALTH groups. Therefore, it 
appears that strength of the dorsi-flexor muscles is related with the articular mobility of 
the tibiotalar joint during heel strike. Therefore stronger individuals may approach the 
floor with the posterior part of the heel (more dorsi-flexion) resulting in a larger 
distance travelled by the COP.  This may explain why distance travelled by the COP 
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tended to be shorter in the DN patients. On the other hand, weakness of the dorsi-flexor 
muscles may also contribute to the quicker drop of the forefoot after the heel strike. 
This hypotheses is well supported by the comprehensive analysis presented Perry & 
Burnfield, (2010) that explains the role that specific muscles of the leg have during the 
stance phase of walking.  They state that between heel contact and 10% stance, dorsal 
flexors act eccentrically. Because DN subjects show muscle weakness of these muscle 
group, especially TA (Schoenhaus et al., 1991), there is a general lack of foot control in 
the heel strike phase, which results in a flat-footed approach. This interpretation is 
supported by the results from the present study that show a correlation between DF 
strength levels and velocity of the COP at the heel. Interestingly this correlation was 
only significant in the DN group, which suggests that only severe (clinical) weakness 
compromise the normal drop of the foot after heel strike.  
 
Another possible explanation for the reduced displacement of the COP along the foot 
surface is a feeling of instability secondary to neuropathy (Cavanagh et al., 1992; 
Simoneau et al., 1994). This may lead to a change in walking behaviour so that the 
body mass centre is positioned in a neutral position, directly above the foot during the 
whole GC (Katoulis, et al., 1997). This mechanism observed in DN subjects to improve 
stability may explain the reduced displacement of the COP along the foot during the 
stance phase of gait (Giacomozzi et al., 2002).  Contrary to this, in the present 
investigation DN subjects with more severe neuropathy tended to show larger COP 
distances. This association does not rule out the theory that instability secondary to 
neuropathy may result in a more secure gait characterized by reduced displacement of 
the COP. Instead, it suggests that other confounding variables (i.e. age, body mass, gait 
velocity, etc.) may have influenced this correlation. Moreover, correlations in the 
present study should be interpreted with caution as the result may be due to insufficient 
sample size.  
 
Overall, results from the present investigation show some alterations in spatial-temporal 
and COP parameters in patients with DN compared to healthy controls. It is likely that 
the feeling of instability secondary to DN is partly responsible for some of the changes 
in walking characteristics observed in this population. Furthermore, results from the 
current investigation also show that muscular weakness, especially of the DF, should be 
included among causes that lead to changes in floor foot interaction parameters in DN 
subjects. This finding suggests that interventions to improve strength levels in the lower 
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limb, especially of the DF muscles, could possible influence gait characteristics in DN 
subjects. Nevertheless, changes in walking characteristics cannot explain the high rate 
of ulcers observed in diabetic neuropathic patients. Group differences in PP and PTI, 
which are considered a substitute measure to determine risk of foot ulceration (Frykberg 
et al., 1998; Veves et al., 1992) are discussed next.  
 
7.1.2.2 Kinetics data  
 
Results from the current study show significant differences in foot loading patterns 
between the DN and HEALTH groups. Thus, the most noticeable differences were 
observed under the metatarsal heads, where the DN group showed significantly higher 
PP and PTI values compared to the HEALTH groups. Group differences were also 
observed at the hallux, where the HEALTH group showed significantly higher PP 
compared to the DN group. On the other hand, no group differences in PP and PTI at 
the heel region as well as in the PTI at the hallux were observed. Furthermore results 
from the present investigation demonstrated the importance of the hallux to reduce foot 
pressures at the metatarsal region during the push off phase. This section starts 
discussing foot pressures (PP and PTI) at the metatarsal heads, which is the foot region 
more likely to develop foot complications (Boulton, 1994), followed by the foot 
pressures at heel and foot pressures at the hallux. In addition to this, the last part of this 
section discusses kinetic data on the forefoot during the push off phase, which is the 
phase of the GC where highest plantar stress occurs and is therefore more likely to 
damage the DN foot.  
 
Results from the present study, in accordance with the vast majority of previous 
investigations (Boulton et al., 1987; Caselli et al., 2002; Pitei et al., 1999), found higher 
PP on the metatarsal region in the DN group compared to the healthy group. Thus, 
different factors have been proposed in the literature to explain the higher pressures at 
the metatarsal region observed in subjects with DN compared to healthy individuals. 
These include body mass, sensory neuropathy, structural changes and foot ROM. The 
possible effect of each of these factors in the present investigation is discussed.  
 
Increased body mass, which is common in subjects with type 2 diabetes, increases the 
magnitude of the GRFs during gait and standing, but it also increases the areas of 
contact between foot and ground (van Deursen, 2004). In support of this the present 
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results show a strong correlation between contact area and body mass in both groups, 
especially in the DN group. This may explain why body mass in the present study was 
not correlated to peak pressures in any foot region. Although some investigations have 
reported a weak relationship between the two variables (Cavanagh et al., 1991), it 
appears that weight cannot explain the differences in forefoot foot pressures found in 
the current study between the HEALTH and the DN group.  
 
Sensory neuropathy has also been proposed to increase forefoot PP in DN subjects. For 
instance, Caselli et al. (2002) demonstrated an association between the level of 
neuropathy and forefoot peak plantar pressures. They investigated regional plantar foot 
pressures in 248 subjects, who were divided into 4 different groups in relation to their 
level of neuropathy (no neuropathy: mild neuropathy; moderate neuropathy; and severe 
neuropathy). They found a progression in the magnitude of the peak pressures along 
with the severity of the neuropathy. Similar results were found by Boulton et al. (1987) 
who reported higher peak pressures in the group of diabetic subjects with neuropathic 
complications (N=16) compared to the diabetic group without neuropathy (N=28) and 
the control group (N=41). In this context other studies did not find significant 
correlations between sensory neuropathy and peak pressures (Sacco et al., 2000; Mason 
et al., 1989). Sacco et al. (2000) assessed neuropathy levels through the determination 
of sensitive chronaxie (electrodiagnostic evaluation) on 2 forefoot areas (medial 
forefoot and lateral forefoot). Sensitive chronaxie is defined as the minimum time of an 
electrical pulse required to excite a sensitive nerve. They looked for relationships 
between the sensitive chronaxie and peak plantar pressure in corresponding selected 
areas and they did not find any correlations between the two.  In line with these results, 
in the current study sensory neuropathy was not correlated to PP at the metatarsal 
heads. These findings suggest that loss of sensation may not have influenced forefoot 
peak pressures in the current study. However, it cannot be ruled out that the assessment 
of neuropathy in the present study via VPT, which limits the assessment of nerve 
function to the A beta-fibre function, (van Schie et al., 2004), may not be ideal for the 
overall quantification of neuropathy. For instance, Payne et al. (2002) and Caselli et al. 
(2002), who found a correlation between neuropathy and high forefoot pressures, 
quantified neuropathy based on a variety of tests including, VPT, the presence or 
absence of ankle reflex and temperature perception, which may provide with a better 
overall quantification of the sensory nerves function (A fibres, C fibres, mechano 
receptors, etc). 
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Structural changes secondary to hyperglycaemia, such as Charcot foot, claw toes and 
hammer toes, have been proposed to increase foot pressures in diabetic patients 
(Mueller et al., 2005; Rahman et al., 2006; Robertson et al., 2002). In the present study 
in order to reduce to effect of these structural changes in foot pressures, all participants 
were inspected for foot deformities and only subjects with no severe structural changes 
were included in the study. However, results from the current study show that the arch 
index was significantly higher in the DN group compared to HEALTH group, which 
agrees with previous investigations (D’Ambrogi et al., 2002; Duffin et al., 2002; 
Giacomozzi et al., 2005). It is believed that the thickening of the plantar fascia 
secondary to non-enzymatic glycosylation of the collagenous may cause the 
development of a foot fixed in a cavus configuration, with a high longitudinal arch for 
the entire stance period (D´Ambrogi et al., 2003; D´Ambrogi et al., 2005; Giacomozzi 
et al., 2005). Plantar fascia, despite being a passive structure, actively contributes to 
counteract the GRFs acting on the metatarsal heads by absorbing forces at the midtarsal 
joints during the heel strike and the load transfer from rearfoot to forefoot (Hicks, 
1954). In support of this idea, D’Ambrogi et al. (2003) found an inverse correlation (r=-
0.52) between the thickness of plantar fascia and vertical forces under the metatarsal 
heads in a group of 61 diabetic patients with different degrees of neuropathic 
complications. Moreover, other authors have demonstrated using a regression analysis 
that arch index is an important predictor for forefoot plantar pressures during barefoot 
gait in healthy individuals (Cavanagh et al., 1997; Morag & Cavanagh, 1999). Results 
from the current study showed that there was not a direct correlation between arch 
index and peak pressures at the metatarsals region. However, lack of correlation 
between these two does not necessary mean that the high foot arch did not influence 
forefoot pressures in the present study since there are a number of variables such as 
ROM or sensory neuropathy that could have compromised this association. Moreover, 
the lack of correlations in the present study should be interpreted with caution as the 
result may be due to insufficient sample size. Therefore, it is likely that a higher foot 
arch secondary to a thickness of the plantar fascia could partly explain the higher 
forefoot pressures observed in the DN compared to the HEALH group in the present 
investigation.  
 
Limited ROM has been also associated with increased foot pressures in patients with 
diabetes mellitus (Fernando et al., 1991; Frykberg et al., 1998). It is well established 
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that glycosylation plays an important role for the limited ROM of the foot and ankle 
joints in diabetic patients (Frykberg et al., 1998; Simmons et al., 1997a; Yavuzer et al., 
2006; Zimny et al., 2004). Abnormally high sugar levels promote glycosylation of 
proteins and the consequent accumulation of advanced glycosylation end-products in 
most human tissues (Rahman et al., 2006: Yavuzer, et al., 2006). Limited dorsi-flexion 
of the ankle has been associated with abnormal foot pressures under the metatarsal 
heads particularly when the tibia rolls over the foot during the late stance phase of gait 
(Mueller et al., 1989; Salsich et al., 2005). It is therefore possible that limited ROM of 
the foot and ankle joints in the DN group in the present study could be another factor 
responsible for the higher foot pressures observed in this population. However, an 
important limitation of the present investigations is that due to technical difficulties 
ankle ROM could not be measured, and therefore it cannot be demonstrated whether 
reduced ROM was a contributing factor the higher PP observed in the DN group.   
 
Overall, the present study showed higher peak pressures at the metatarsals region in the 
DN compared to the HEALTH group. It is likely that changes in the foot secondary to 
hyperglycaemia, in the form of high foot arch and limited ROM may be responsible for 
the high foot pressures observed in the DN group compared to the HEALTH group. On 
the other hand, other factors such as body mass or sensory neuropathy did not seem to 
explain the differences in peak pressures at the metatarsal heads found in the current 
study between the DN and HEALTH groups. PTI values at the metatarsal heads will be 
discussed next. 
 
Recent investigations have looked at PTI values since they represent both, the 
magnitude and duration of plantar loading through the stance phase and have therefore 
been postulated to be a better predictor for foot ulceration compared to peak pressures 
(Mueller & Maluf, 2002). In agreement with previous investigations, PTI values on the 
forefoot were significant higher in the DN group compared to the HEALTH group 
(D’Ambrogi et al., 2005; Sacco et al., 2009; Turner et al., 2007). Results from the 
present study demonstrated that higher PTI values at the metatarsal region in the DN 
group resulted from higher peak pressures (discussed above) as well as from longer 
duration of the plantar loading in this foot region. In agreement with the results from the 
present study, previous investigations found that DN patients spent longer period of 
time at the metatarsals heads compared to healthy individuals (Courtemanche et al., 
1996). The reasons for the higher foot pressures at the metatarsal heads region were 
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discussed above: the possible reasons for the longer duration of the plantar loading at 
this foot region are discussed next.  
 
It has been proposed that a higher foot arch, which is characteristic of the DN group in 
the current investigation, makes the foot less adaptable to the floor during the foot-floor 
interaction (Giacomozzi et al., 2005). As a result, most of the plantar surface makes 
early contact with the ground, and propulsion is poorly effective. In support of this 
interpretation, the present study, which agrees with the majority of previous studies 
(Courtemanche et al., 1996; Zimny et al., 2004) found that DN patients spent a longer 
period of time at the heel and at the metatarsal heads and less time at the toes compared 
to the HEALTH group. The loading time differences between groups in the current 
study remained statistically significant even after normalization with respect to stance 
phase duration, thus indicating that the increase of the overall foot loading time during 
stance is not homogeneously distributed among foot sub-areas. These results suggest an 
early loading of the metatarsals in the DN group, which explains the prolonged forefoot 
contact time and consequently increase in PTI at the forefoot in this group when 
compared to the HEALTH group. However, the present investigation did not find a 
correlation between foot arch and metatarsal PTI values, which suggests that other 
factors are more likely to explain the increased loading times at the metatarsals region 
in the DN group compared to the HEALTH group in the present study. Thus, results 
from the current study suggest that muscular function may play an important role in the 
higher forefoot PTI values observed in the DN group. On the one hand, results from the 
present study show an early activation of the TS muscles in the DN group compared to 
the HEALTH group, which may also explain the early contact of the forefoot with the 
ground. To the best of my knowledge, Kwon et al. (2003) has been the only 
investigation demonstrating that DN activate the TS earlier compared to healthy 
individuals (a detailed explanation about the causes that may lead DN subjects to fire 
the TS early will be presented when discussing EMG data). On the other hand, results 
from the current study show that DF strength levels were inversely correlated to 
forefoot PTI values in the DN group. It is therefore likely that the weakness of the DF 
muscles in the DN group may result in an early forefoot contact with the ground in this 
population, demonstrated by the quicker velocity of the COP at the heel discussed 
earlier. Interestingly, the correlation between peak DF moments and forefoot PTI was 
only significant for the DN group, which suggests that only severe weakness 
compromise the normal drop of the foot after the heel strike.  
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Overall, results from the present investigation suggest that while structural changes are 
the main factors responsible for the high peak pressures observed in DN subjects 
compared to healthy individuals, muscular function appears to play an important role in 
the longer duration of the plantar loading at the metatarsal heads region. It is therefore 
reasonable to think that strength gains in the DF muscles in subjects with DN could 
delay the drop of the foot after the heel strike. Consequently, this could reduce PTI at 
the metatarsal heads, which is the foot region most likely to suffer from foot ulcers 
(Caselli et al., 2002). 
 
Previous investigations have reported lower loads on the heel in DN subjects compared 
to healthy individuals (Bacarin et al., 2009; Uccioli et al., 2001). It has been proposed 
that higher foot arch, weakness of the DF muscles as well as reduced dorsi-flexion 
mobility (Giacomozzi et al., 2002; Giacomozzi et al., 2005) cause subjects with DN to 
approach the floor with the most anterior part of the heel, which results in a minimum 
heel strike. In support of this theory some studies have reported lower peak vertical 
GRFs at the heel during landing (Katoulis et al., 1997; Uccioli et al., 2001). Contrary to 
this interpretation the present study did not find any significant group differences in 
regard to the magnitude of the stress at the heel. Furthermore, results from the current 
investigation show a strong association between PP at the heel and gait velocity, which 
agrees with previous investigations (Morag & Cavanagh, 1999). In fact, absolute PP 
values at the heel were significantly higher in the HEALTH group compared to the DN 
group (data not presented in the results section), but those differences disappeared when 
velocity, which was higher in the HEALTH group, was entered in the analysis as a 
covariate. It should be noted that some of the interventions, which reported reduced 
GRF at the heel in the DN groups did not control gait velocity (which is normally 
reduced in DN subjects) (Katoulis et al., 1997; Uccioli et al., 2001). In addition, some 
of the studies that did control gait velocity did not find significant group differences in 
vertical GRFs (Sacco et al., 2009; Yavuzer et al., 2006) or PP (Bacarin et al., 2009) at 
the heel between DN and healthy individuals. These results suggest that further 
investigations are warranted to clarify group difference between health and DN subjects 
in heel PP when velocity is accounted for.  
 
Results from the present study also show that the heel region in the DN group spent 
more percentage of time in contact with the ground compared to the HEALTH group, 
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which agrees with previous investigations (D’ Ambrogi et al., 2005; Sacco et al., 2009). 
It is believed that higher foot arch and weakness of the PF muscles lead to a less 
effective propulsion, which is characterized by a higher contribution of the heel during 
the push off phase (Giacomozzi et al., 2005; Mueller et al., 1994). However, PTI at the 
heel in the DN group did not show significant changes compared to the HEALTH 
group. The few studies assessing PTI in DN subjects have investigated regional PTI in 
relation to the main phases of the GC. Thus, it appears that PTI at the heel are reduced 
during the heel strike (D’Ambrogi et al., 2005) and increased during push off 
(D’Ambrogi et al., 2005; Sacco et al., 2009). It is not surprising then that overall PTI at 
the heel during the stance phase did not show significant group differences in the 
present study. 
 
In addition to foot pressures at the metatarsals and heel regions the present study also 
investigated foot pressures at the hallux. In agreement with previous studies (Boulton et 
al., 1987; Uccioli et al., 2001; Veves et al 1991), it was found that the DN group 
developed significantly lower foot pressures under the hallux compared to the 
HEALTH group. This finding has been linked to severe deformities of the toes typical 
of the most advanced stages of diabetic motor neuropathy (Schoenhaus et al., 1991). 
However, this justification cannot fully explain the results from the previous study since 
all participants were inspected for foot deformities and only subjects with no severe 
structural changes were included in the study. It is well established that DN subjects 
have reduced ROM at the metatarso-phalangeal joint (Fernando et al., 1991; Zimny et 
al., 2004), which may compromise the distribution of the load under the toes. It is 
therefore possible that changes in the mobility at the metatarso-phalangeal joint 
together with mild foot deformities secondary to motor neuropathy may explain the 
lower PP at the hallux observed in the DN group compared to the HEALTH group in 
the present investigation. However, since ROM at the metatarso-phalangeal joint was 
not measured it is impossible to draw any final conclusion regarding the exact 
contribution of the metatarso-phalangeal joint mobility in the present study. It is also 
possible that sensory neuropathy may have contributed to this finding in the present 
study. It has been proposed earlier that loss of stability secondary to sensory neuropathy 
may result in a reduction of the COP progression along the longitudinal axis 
(Giacomozzi et al., 2002). Consistent with this idea the present study found that the 
contact area at the hallux was also significantly reduced in the DN group, which 
demonstrates the reduced contribution of more distal part of the forefoot during the 
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stance phase in DN patients. However, stability was not measured in the present study. 
Therefore it is only a speculation that a feeling of instability may have contributed to 
the reduded contact area under the hallux observed in the DN group. Overall, it is likely 
that structural changes (including reduced ROM) secondary to hyperglycaemia and 
feeling of instability secondary to sensory neuropathy may explain the lower 
contribution of the toes during the stance phase in the DN compared to the HEALTH 
group in the present investigation.  
 
The present investigation has provided insight regarding how the overall foot loading 
distribution is in DN subjects compared to healthy individuals. The metatarsal heads 
appears to be the foot region that suffers most of the stress during walking in the DN 
group. On the other hand the heel and hallux regions showed no group differences and 
higher pressures in the HEALTH group, respectively. The present study also 
investigated forefoot loading during the push off phase, which may provide insight 
regarding how foot loading is distributed during the most demanding phase of the GC. 
These results are discussed next. 
 
Results from the present study highlight the importance of the hallux to reduce foot 
pressures at the metatarsal region during the push off phase. Since pressure relates to 
the amount of vertical GRF per area unit to which the force is applied, the same force 
applied to a smaller area will result in higher pressures.  In the present investigation, 
and in agreement with the majority of the literature (D’Ambrogi et al., 2003; 
Giacomozzi et al., 2005; Uccioli et al., 2001) the peak vertical GRF under the 
metatarsal heads (normalized to body mass) was significantly higher in the DN group 
compared to the HEALTH group. Interestingly, the peak vertical GRF under the whole 
forefoot (metatarsal and toes) during the push off did not differ between groups. This 
finding suggests that although the magnitude of the vertical GRF is comparable 
between the DN and HEALTH group, the load was distributed differently in the DN 
and the HEALTH group. Thus, the DN group appears to direct most of that vertical 
GRF to the metatarsal region whilst the HEALTH group seems to distribute that load 
more homogenously throughout the whole foot (metatarsal area and toes). Furthermore, 
the peak pressure when considering the whole forefoot area (metatarsals and toes) did 
not show significant differences between the DN and HEALTH groups. These results 
demonstrate that the contribution of the toes during the push off is very important to 
reduce the magnitude of vertical GRFs under the metatarsals. In support of this idea the 
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present study found that the contact area and the peak pressures under the big toe were 
significantly reduced in the DN group compared to the HEALTH group (discussed 
above). This demonstrates the reduced contribution of this foot region during the push 
off phase in patients with DN. 
 
Overall, results from the present study demonstrate that the metatarsal heads region is 
the foot area that suffers most of the stress during walking. This explains why this is the 
foot area in which most of the ulcers develop (Boulton, 1994; Mueller et al., 2005). On 
the one hand, it is likely that structural changes such as high foot arch or reduced 
metatarso-phalangeal mobility may have contributed to the higher foot pressures at the 
metatarsal heads region observed in the DN subjects. On the other hand, muscular 
function changes, such as weakness of the DF muscles and PF activation patterns, 
seemed to have contributed to the higher amount of time the metatarsals region spend in 
contact with the ground in the DN group. Longer contact time obviously increases the 
overall stress applied over that foot region. Furthermore, the present study demonstrated 
that the contribution of the hallux during the push off is very important to reducing the 
magnitude of the loads under the metatarsal heads. Actually, the lack of contribution of 
this foot region during the push off is likely to partly explain the group differences in 
foot pressures at the metatarsal heads observed in the present study. Structural changes 
and feeling of instability are likely contributing factors for the reduced loading at the 
hallux observed in the DN subjects. Beside foot gait parameters and foot pressures the 
present study investigated muscular activity patterns during the GC. These results are 
discussed below. 
7.1.2.3 EMG data  
 
Results from the present investigation demonstrated significant differences in muscular 
activation patterns when the HEALTH group was compared to the DN group. Thus, the 
DN group showed an earlier muscular activation onset for the TA and TS muscles and a 
higher overall muscular activity for the TS, QUADS and HAMS compared to the 
HEALTH group. Furthermore, the present investigation found an association between 
EMG activity patterns and loading patterns.   
 
Most of the studies assessing gait characteristics in diabetic patients have investigated 
kinetic or kinematic data, whereas the underlying functional factors that may be driving 
these changes are not well understood. EMG provides insight how muscles are 
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activated to generate movement. However, since EMG is an expression of 
neuromuscular control depending on nerve conduction, it is potentially affected by 
neuropathy. EMG signal refers to the electrical event produced by the muscle prior to 
contraction and not to the mechanical output (force) (Winter, 2009). The time lag 
between muscle activation (EMG signal) and muscle force production is known as 
EMD (Cavanagh & Komi, 1979) and it is crucial to take it into consideration when 
attempting to estimate muscle function timing (mechanical output) from EMG data . 
The fact that the current intervention accounted for EMD values may explain why the 
activation patterns in relation to the different phases of the GC presented in this study 
are more shifted to the right (activation occurs later) compared to standard EMG 
patterns reported in the literature for healthy subjects (Perry & Burnfield, 2010). For 
example, Perry & Burnfield (2010) reported that TA stays active from heel strike to the 
end of the loading phase (10% GC) in healthy individuals, while the present study 
found TA to be active until half way throughout the mid stance phase.  
 
The preliminary studies number 2 and 3 presented in Chapter 4 demonstrated for the 
first time that EMD was longer in DN subjects compared to HEALTH individuals. 
Longer EMD is expected to bring the activation patterns forward. Since the time lag 
from activation onset to muscle production is longer, muscle activation is expected to 
occur earlier. This highlights the importance of calculating individual EMD values 
when attempting to present EMG data in relation to muscular mechanical function, 
especially when comparing populations with different EMD values such as DN. It 
seems this is the first study that has investigated EMG patterns during gait in subjects 
with DN whilst taking into account alterations in electromechanical delay when 
processing EMG data. However, it is noteworthy that although previous investigations 
did not report any action to control for EMD, they presented similar EMG patterns 
compared to the present study (Akashi et al., 2008; Mueller et al., 1994). This suggests 
that previous investigations may have used signal processing to correct for EMD 
without reporting it in the methods.  
 
Results from the present study show that the peak activity for the TS and TA (during 
the end of the stance phase and early swing phase, respectively) occurred at the same 
time in the DN and HEALTH groups. Interestingly, both muscles show an earlier 
activation in the DN compared to the HEALTH group. Similar results were found by 
Kwon et al. (2003) who found an earlier activation onset for the TS and TA in the DN 
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group compared to the HEALTH group. However, Kwon et al. (2003) only found 
significant differences for the TS. It is possible that DN subjects adopt an anticipatory 
strategy to efficiently produce force at the right moment in time. Gutierrez et al. (2001) 
demonstrated a decrease in the ability to rapidly develop torque about the ankle in a 
group of 6 DN subjects compared to 6 diabetic individuals without neuropathy. Force 
generation in this study was determined from the rate of change of the ground reaction 
force vector in the lateral direction (measured with a force platform) during 1) a rapid 
lateral loss of balance and 2) a quick voluntary inversion movement of the ankle. The 
results showed that DN subjects were able to produce about half the rate of torque 
compared to a healthy group in both conditions. Although the reasons for this slower 
force production are not fully understood, evidence from animal studies suggests that 
the fast-twitch fibres (type 2) of the muscles are highly sensitive to the loss of strength 
due to atrophy (Bishop & Milton, 1997). Therefore, a generalized DN is likely to cause 
distal loss of fast twitch muscle fibres, which may result in slower force production by 
the muscles, especially the distal ones. This limitation to generate force quickly might 
require DN subjects to activate the muscles earlier as a mechanism to overcome the 
slower rate of force production and ensure the peak force is produced at the right 
moment in time. It is therefore reasonable to think that changes in the neuromuscular 
function in DN individuals may obligate this population to develop an early muscular 
activation to ensure mechanical output is produced at the right time.  
 
Furthermore, the present investigation demonstrated an association between muscular 
activity patterns during the initial phase of the GC and foot plantar pressures under the 
metatarsal heads. Alongside the earlier activation of the TS by the DN group, which has 
been discussed above, the current investigation found an earlier cessation of the TA 
following heel strike in the DN group compared to the HEALTH group. Thus, an early 
cessation of the TA activity, together with an early activation of the TS may result in an 
early contact of the forefoot with the ground. This may also explain why contact times 
and consequently PTI values under the metatarsal heads were higher in the DN group in 
the present study compared to the HEALTH group. Results from the present study then 
suggest that changes in TA and TS activity patterns following heel strike could also 
play an important role in the pathogenesis of foot complications in DN individuals. 
Previous studies investigating TA activity during the early stance phase of the GC have 
been controversial. Some investigations have reported a delayed peak activity of the TA 
muscle during the initial phase of the GC (Abboud et al., 2000; Sacco & Amadio, 
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2003). Akashi et al. (2008) did not find any group differences in activation times for the 
TA during the initial phase of the GC. The present study found an early activation 
cessation in the DN group. It should be noted that these studies have used different 
population groups, which may partly explain the different results. Similar to the present 
study, Sacco & Amadio (2003) and Akashi et al. (2008) recruited DN subjects with no 
other previous foot complications whereas Abboud et al. (2000) included patients with 
diabetes mellitus who were not assessed for neuropathy. However, studies using similar 
populations and comparable methodological approaches have also reported conflicting 
results (Sacco & Amadio, 2003; Akashi et al., 2008). Dingwell & Cavanagh (2001) 
demonstrated an increased walking variability in DN subjects, which may make EMG 
data in this population more difficult to interpret and could explain the discrepancies 
among the results from different studies presented above. Gait dynamics evolve over 
multiple strides, where each stride depends on multiple previous strides (Hausdorff et 
al., 2001). Thus, Kang & Dingwell (2009) quantified EMG dynamics over consecutive 
strides in healthy young individuals (N=17) as well as in older adults (N=17), which are 
well known to exhibit greater step variability while walking, like DN subjects. They 
proved that older adults exhibited greater interstride variability of muscle activation 
patterns during gait.  Therefore, increased interstride variability, together with different 
gait tasks (6 meters walk, 10 meters walk or treadmill walk), may partly explain the 
discrepancies between the studies presented above. Nevertheless, results from the 
present study appear to suggest that an early TS activation onset and early cessation of 
the TA activity may partly explain why contact times and consequently PTI values 
under the metatarsal heads region were higher in the DN group compared to the 
HEALTH group.  
 
Furthermore, results from the present study, in agreement with previous investigations 
(Kwon et al. 2003; Petrofsky et al., 2005a), show that the overall EMG activity in all 
the muscles was higher in the DN group compared to the HEALTH group, and that 
those differences were significant for the TS, HAMS and QUADS muscles. Higher 
coactivation of muscles suggests higher co-contraction between agonist and antagonist 
muscles. Co-contraction has been observed as a task independent strategy that is 
believed to be used to stiffen the joint and enhance stability (Benjuya et al., 2004; 
Manchester et al., 1989). Results from the present study show higher activation of all 
the muscles during the terminal swing phase in the DN group compared to the 
HEALTH group, which demonstrate a simultaneous activation of agonist and 
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antagonist muscles (co-contraction). Furthermore, results from the present study 
suggest that the joint stiffening strategy is present not only at the ankle as previously 
thought (Kwon et al. 2003; Petrofsky et al., 2005a) but also at the knee joint. It is likely 
that the feeling of instability associated with sensory neuropathy may result in higher 
co-contraction in this population. The group differences in muscle activity observed in 
this study cannot be attributed to gait speed differences, since walking speed has been 
positively correlated with EMG activity levels (Chung & Wang, 2010) and the DN 
group in the present study walked significantly slower compared with the HEALTH 
group. This strengthens the results from the present study and demonstrates that co-
contraction was present in the DN group. It is also possible that muscle weakness may 
have contributed to the higher EMG activity observed in the DN group. Since DN are 
significantly weaker compared to the HEALTH group, higher muscular activity may 
need to be generated to make sure adequate moment is produced. However, it is 
unlikely this is the reason for the group differences in overall EMG activity in the 
present investigation since EMG data was normalized to the peak activity during gait 
and not to the peak activity during MVCs. It is also possible that the anticipatory 
strategy proposed above may have contributed to these results. Thus, an early muscular 
activation may result in longer activation times and therefore higher EMG activity 
during the GC.  
 
Overall, results from the present study show EMG pattern alterations in the DN when 
compared to the HEALTH group. Thus, it appears that DN subjects adopt an 
anticipatory gait strategy to ensure an adequate moment is generated at the right 
moment in time. Although, the exact reason/s behind this adaptation is/are unclear, it is 
possible that this is a compensatory mechanism to overcome the slower rate of force 
production observed previously in DN subjects (Gutierrez et al., 2001). Furthermore it 
seems that changes in EMG patterns at the early phases of the GC may contribute to the 
higher pressures at the metatarsal heads observed in the DN group. Thus, an early TS 
activation onset and early cessation of the TA activity may partly explain why contact 
times and consequently PTI values under the metatarsals region were higher in the DN 
group in the present study compared to the HEALTH group. In addition to that, the 
present study show higher overall EMG activity in the DN group compared to the 
HEALTH group. It is likely that co-contraction secondary to the feeling of instability 
associated with DN and the anticipatory strategy mentioned above may partly explain 
the higher overall EMG activity observed in the DN group. 
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Summary of  gait biomechanics 
Overall, the present investigation showed alterations in all the different aspects of gait 
in the DN group compared to the HEALTH group. Thus, DN gait was characterized by 
shorter and slower steps, higher foot pressures under the metatarsal heads and higher 
muscular activity compared to the healthy group. It appears that structural changes 
(including limited ROM) and loss of stability secondary to neuropathy are the main 
contributing factors responsible for the alterations in gait parameters and kinetic data 
observed in the DN group in the present study. However, the present study also 
demonstrated that muscular function in the form of muscular activity patterns and 
muscular weakness should be considered among the main causes that lead DN subjects 
to change their walking strategy. For instance, weakness of the DF muscles in the DN 
group was associated with an early forefoot contact with the ground and consequently 
with higher forefoot PTI values in this group. Interestingly, muscular weakness together 
with joint mobility are modifiable conditions. Therefore, it would be interesting to 
evaluate whether changes in these condition may result in beneficial changes in gait 
characteristics in DN subjects.  
 
7.1.3 Microcirculation 
 
In addition to changes in gait characteristics, impairments in the microcirculation are 
also known to play an important role in the pathogenesis of foot ulcers in patients with 
DN (Dinh & Veves, 2005, Tooke, 2004).  The present study investigated muscular 
microcirculation (capillary) during different condition to evaluate both blood flow and 
oxygen consumption 1) at rest; 2) in response to muscle contractions (stress condition); 
3) recovery from the stress condition in DN subjects when compared to healthy 
individuals. Furthermore, this is the first study that has investigated microcirculatory 
responses to and from an exercise bout based on plantar-flexion contractions in DN 
individuals. Results from the current study, which are in line with previous 
investigations with subjects with type 2 diabetes mellitus (Kingwell et al., 2003; 
Scheuermann-Freestone et al., 2003), show diminished functional responses in blood 
flow and oxygen consumption during conditions 2 and 3 in the DN group compared to 
the HEALTH group.  No significant group differences were found during resting 
conditions in either blood flow or oxygen consumption values. Discussion of the results 
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will be presented as follows: Microcirculation at rest, microcirculatory responses to 
muscle contraction and microcirculatory recovery from the muscle contractions 
 
7.1.3.1 Microcirculation at rest  
 
Results from the present study show that at baseline both muscular uptake and blood 
flow did not differ between the HEALTH and the CON group. Previous investigations 
assessing resting blood flow in patients with DN reported increased values in the DN 
group compared to the healthy controls (Flynn et al., 1988; Urbancic-Rovan et al., 
2004). However, those investigations assessed cutaneous blood flow contrary to the 
present investigation that investigated muscular blood flow. It is known that the skin 
microcirculation is rich in arteriovenous shunts (Fagrell et al., 1999). The arteriovenous 
shunts are innervated by sympathetic nerves; the presence of diabetic neuropathy with 
sympathetic denervation may lead to the opening of these shunts with blood flow 
bypassing the skin capillaries (Korzon-Burakowska & Edmonds, 2006; Schramm et al., 
2006). Therefore, the fact that the present investigation assessed muscular blood flow 
may explain the discrepancies in the results. Regarding the baseline muscular uptake, it 
seems this is the first investigation reporting muscular oxygen consumption values in 
patients with DN. Furthermore, it is noteworthy that the absolute values reported in the 
present investigation, both for mVO2 and blood flow, are slightly lower than previous 
values reported in the literature for healthy individuals during NIRS measurements. For 
example, van Beekvelt et al. (2001b), van Beekvelt et al. (2002) and De Blasi et al. 
(1997) published mVO2 values of 0.009± 0.003 mlO2ּmin-1ּ 100g-1, 0.14± 0.02 
ml02ּmin-1ּ 100g-1  and 0.06± 0.002 mlO2ּmin-1ּ 100g-1, respectively whereas in the 
present study the DN and HEALTH groups reported mVO2 values of 0.0246± 0.012 
ml02ּmin-1ּ 100g-1  and 0.0251± 0.012 mlO2ּmin-1ּ 100g-1, respectively.  
Similarly, van Beekvelt et al. (2001a) and van Beekvelt et al. (2001b) reported BF 
values of 1.28± 0.82 mlּmin-1ּ 100g-1 and 0.72± 0.32 mlּmin-1ּ 100g-1, respectively for 
the 0.60± 0.28 mlּmin-1ּ 100g-1  and 0.64± 0.26 mlּmin-1ּ 100g-1  found in the present 
study for the DN and HEALTH groups, respectively. Although it is not clear why the 
present study showed lower vales compared to previous investigations, it is likely that 
methodological differences may partly explain these differences. Different studies have 
used: 1) different muscles; 2) different inter-optode differences (distance between 
source and detector) and 3) different differential path-length factor [used to correct for 
scattering of photons in the tissue (van Beekvelt et al., 2001b)]. Overall the present 
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investigation showed that resting microcirculation in the form of muscular blood flow 
and oxygen consumption did not differ in the DN compared to the HEALTH group. 
However, it is well known that most critical functional changes in DN subjects occur 
during stress conditions (Tooke et al., 1995). Results on microcirculatory responses to 
an exercise bout are discussed below.  
 
7.1.3.2 Microcirculatory responses to muscle contraction  
 
The current study found impaired capillary responses in the DN group in the form of 
blood blow and oxygen consumption compared to the healthy group in response to an 
exercise bout. The exercise bout consisted of 2 sets of 7 isometric contractions of 10 
seconds of duration at 50% of the MVC. Changes in blood flow will be discussed first 
whilst changes in oxygen consumption will be discussed thereafter.  
 
Previous investigations found reduced blood flow responses to an exercise bout in 
subjects with type 2 diabetes when compared to healthy individuals, which has been 
associated with the reduced exercise capacity observed in diabetic patients (Kingwell et 
al., 2003; Mohler et al., 2006; Petrofsky et al, 2005b; Scheuermann-Freestone et al., 
2003). Although similar results were expected in different diabetic populations, this is 
the first study to demonstrate impairments in the ability to increase blood flow in the 
microcirculation during an exercise bout in DN subjects.  
 
The reduced percentage of change in blood volume observed in the current study likely 
reflects a decrease in the exercise-induced vasodilatation capacity of capillaries in the 
skeletal muscle of the lower extremity in the DN group. Patients with diabetes, and 
especially individuals with peripheral neuropathy, are known to have microvascular 
alterations, including endothelial dysfunction (Pitei et al., 1997; Schramm et al., 2006). 
Endothelial-dependent vasodilatation is thought to contribute to exercise hyperaemia 
(Higashi & Yoshizumi, 2004). Boushel et al. (2002) demonstrated that a combined 
inhibition of NO and prostaglandins, which are considered the most important 
endothelium-derived vasodilator substances, reduced muscle blood flow during exercise 
in healthy individuals (up to 50%). In line with this finding, Mekus and colleagues 
(2004) carried out a very similar study and also concluded that protanoids and NO 
appear to play important roles in elevating skeletal muscle blood flow during exercise. 
It has been proposed that an increase in vascular stress resulting from increased 
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exercise-induced blood flow may induce the endothelial cells to release substances such 
as NO and prostaglandins, which allow blood flow to locally increase (Higashi & 
Yoshizumi, 2004). Kingwell et al., 2003 was the first study providing evidence that 
impaired endothelium-dependent vasodilatory responses limits blood flow during 
exercise in patients with type 2 diabetes. Evidence presented above suggests that 
impairments in the endothelial function in the DN group may be the main factor 
responsible for the group differences in the blood volume percentage of change 
observed in the current study.  Moreover, it should be noted that in the present study 
BMI and % of body fat were significantly greater in the DN group compared to the 
HEALTH group and obesity is known to be associated with endothelial dysfunction via 
numerous complex mechanisms (Caballero, 2003). Thus, it is possible that a greater 
BMI and/or body fat percentage in the DN group may have contributed to the reduced 
exercise-induced vasodilatation observed in this population. However, this association 
between obesity (as determined by either BMI or body fat percentage) and endothelium 
function was not supported by the current study, since BMI and body fat % were not 
correlated with exercise induced changes in blood flow. 
 
Although impairments in exercise–induced vasodilatation are normally associated with 
endothelial dysfunction (Kingwell et al., 2003), it is possible that other mechanisms 
may have also contributed to the results found in the present investigation with DN 
patients. For instance, reduced cardiac output due to neuropathic related changes in the 
ANS (autonomic neuropathy) may also reduce exercise-induced blood flow in this 
population (Petrofsky et al., 2005b). Although the cardiac muscle initiates its own 
electrical impulses, which is set by the sino-atrial node at about 80 times per minute 
(Wilmore & Costill, 2004), neural influences superimpose the inherent rhythm of the 
myocardium. These influences originate in the cardiovascular centre and flow through 
the sympathetic and parasympathetic components of the ANS (Tortora & Derrickson, 
2006). Those neural influences interact together adjusting HR in response to the action 
of other mechanisms such as, ventilation, blood pressure control, thermoregulation and 
renin-angiotensin system (Winsley, 2002). The net effect of sympathetic and 
parasympathetic autonomic modulation is to increase and decrease the HR respectively 
(Tortora & Derrickson, 2006). It is well known that neuropathy may alter autonomic 
regulation in this population (Howarka, et al., 1997; Loimaala, et al., 2000; Loimaala, et 
al., 2003) due to the damage, especially, to the parasympathetic nervous system. 
Petrofsky et al. (2005b) demonstrated that heart rate responses during isometric exercise 
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were diminished in subjects with type 2 diabetes compared to healthy controls, which 
suggests changes in the autonomic function prior to clinical presentation of neuropathic 
complications. Since the increase in heart rate during isometric exercise is due to a 
reduction in vagal tone, the reduced heart rate response observed by Petrofsky et al. 
(2005b) is likely to be due to impairments in the parasympathetic function in this 
population. It is therefore possible that alterations in the ANS may have affected HR 
response during the isometric exercise in the DN group in the present study (lower 
cardiac output), which may result in reduced vasodilatory response to the exercise bout. 
In line with this idea, results from the current intervention show significantly higher 
resting heart rates in the DN group compared to the HEALTH group. Since a 
predominance of vagal autonomic modulation will lower resting heart rate, results from 
the present study match previous data on impaired parasympathetic function in people 
with type 2 diabetes. It is therefore possible that changes in the ANS may have also 
contributed to the diminished exercise-induced vasodilatory capacity observed in the 
DN group. However, further studies are required to confirm (or quantify) whether 
changes in the autonomic nervous system in diabetic subjects with undiagnosed diabetic 
autonomic neuropathy are important contributing factors to the reduced exercise-
induced vasodilatory responses observed in this population. 
 
Overall, the present investigation found impairments in the exercise-induced 
vasodilatation in DN subjects. It is believed that endothelial-dependent vasodilatation 
contributes to exercise hyperaemia, which suggests that endothelial function may have 
played an important role in the reduced blood volume percentage of change in the DN 
group in the present study.  Moreover, results from the present study also suggest that 
central alterations in the ANS are likely to have contributed to the results found in the 
present study via reductions in cardiac output during the exercise bout.  Further 
investigations are warranted to understand better the underlying mechanisms in the 
impaired exercise-induced vasodilatation in DN subjects. Whilst there is agreement in 
the literature that oxygen delivery during stress conditions is affected in subjects with 
diabetes, (which the present investigation demonstrated for the first time in DN 
subjects) there is controversy among published papers on whether muscular oxygen 
consumption (which refers to the use of the delivered oxygen), is altered in patients 
with diabetes. Next, results from the current investigation, which investigated for the 
first time muscular oxygen consumption in response to an exercise bout in DN subjects, 
will be discussed.  
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Results from the present study show that the mVO2  percentage of change (from 
baseline to post-exercise values) was significantly lower in the DN group compared to 
the HEALTH group. This finding suggests that muscular oxygen uptake was also 
impaired in the DN group. Consistent with the results found in the present study Baldi 
and colleagues (2003) demonstrated that arteriovenous oxygen differences, which 
assess the muscular oxidative capacity, was reduced in type 2 diabetic subjects 
compared to healthy controls when working at maximal and submaximal intensities 
(70% VO2max). However, there is an ongoing debate about whether the reduced 
muscular oxidative capacity observed in various studies with subjects with type 2 
diabetes (Baldi et al., 2003), is solely caused by a reduction in oxygen delivery 
(Regensteiner et al., 1998) or in combination with a reduction in the muscular oxidative 
capacity (Martin et al., 1995). The author of the current investigation believes that the 
reduced mVO2 responses to the exercise bout in the DN group in the present study are, 
at least partly, due to impairment in the muscular oxidative capacity in this group. The 
reasons that led the author to conclude this are presented below.   
 
The exercise protocol chosen for the present investigation was set up at submaximal 
intensities (see Section 5.4.3.6 in Chapter 4 for more information about the exercise 
protocol and how it was controlled). When working at submaximal intensities and if 
blood flow is restricted, an increase in the amount of oxygen uptake by the muscle may 
be expected to compensate for the impaired oxygen delivery. In line with this idea, 
Nyberg et al. (2010) demonstrated that muscle blood flow  and oxygen delivery can be 
markedly reduced without affecting muscle oxygen uptake during moderate-intensity 
exercise, suggesting that blood flow does not limit muscle oxygen uptake when 
working at low intensities in young healthy individuals (25± 4 years). This study 
measured the leg oxygen consumption during a 3.5 minute one-legged knee-extensor 
exercise under two conditions: without (control) and with arterial infusion of inhibitors 
of NO (N-monomethyl-L-arginine) and prostanoids (indomethacin). Increased activity 
of several mitochondrial enzymes has been found in muscles of patients with peripheral 
vascular diseases (Bylund et al., 1976; Janson et al., 1988). For example, Janson et al. 
(1988) investigated side-differences in muscle metabolic characteristics in patients with 
unilateral arterial disease and demonstrated increased activities of enzymes involved in 
the oxidative metabolism in the claudication leg compared to the healthy leg. These 
adaptations in limbs suffering from peripheral vascular diseases suggest compensation 
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for impaired oxygen delivery. This idea is further supported by a study carried out by 
Mohler et al. (2006). They assessed the hemodynamic response to exercise in calf 
muscles in patients with type 2 diabetes, peripheral vascular diseases, or both using 
NIRS. They found that the presence of peripheral vascular diseases was associated with 
a significant increase in percentage deoxygenation during the exercise bout, which 
suggests that impairments in circulation during submaximal exercises may result in a 
higher amount (%) of desaturation of haemoglobin in the tissue. According to this logic, 
it is likely that changes in the muscle oxidative capacity in the DN group in the present 
study may be partly responsible for the reduced oxygen uptake observed in this group 
during the moderate intensity exercise protocol. In further support of this interpretation, 
there is some evidence that metabolic abnormalities may have implications in the 
oxidative capacity in diabetic patients (Scheuermann-Freestone et al., 2003; Sivitz, 
2010). Type 2 diabetic individuals have increased type IIb-to-type I fibre ratio (Marin et 
al., 1994) and lower oxidative enzyme capacity (Simoneau & Kelley, 1997; Vondra et 
al., 1977) than nondiabetic subjects. In the present study, it is therefore reasonable to 
hypothesize that impairments in the skeletal muscle oxidative capacity in the DN group 
may have resulted in less O2 being consumed following the submaximal exercise bout 
in the DN group relative to the HEALTH group.  
 
Contrary to the results from the present study, some investigations that used NIRS did 
not find significant differences in exercise-induced muscular deoxygenation when 
comparing healthy and diabetic individuals (Bauer et al., 2007; Mohler et al., 2006).  
However, both studies reported higher deoxygenation values in the control group 
compared to the diabetic group, although those differences did not reach significant 
levels. It is likely that differences in the subjects characteristics of the diabetic groups 
could partly explain why the present study was more sensitive when identifying group 
differences (diabetes vs. healthy) compared to previous studies. Firstly, the diabetic 
group in the present study was composed of subjects with peripheral neuropathy while 
Bauer et al. (2007) and Mohler et al. (2006) recruited diabetic patients without 
neuropathic complications. Although it has been demonstrated that oxidative capacity is 
reduced in subjects with type 2 diabetes (Baldi et al., 2003), a longer duration and/or 
poorer control of diabetes (>HbA1c), which is associated with DN (Pirart, 1978), may 
be expected to have a greater negative effect on muscle function. Secondly, the diabetic 
group from the current study was more obese and older compared to the other two 
studies and it is known that age and BMI are associated with mitochondrial function 
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(Rabol et al., 2010). However, the most important reason for the conflicting results 
between the present study and the other two investigations is likely to be 
methodological. NIRS measures local muscular oxygenation. Thus, it is important to 
determine the specific amount of work that the muscle under investigation is 
contributing to the whole workout. In the present study NIRS data and EMG data were 
measured in the same muscle simultaneously. This procedure was followed in order to 
be able to relate NIRS data (blood flow and oxygen consumption in the MGast) to the 
amount of work done by the MGast during the exercise protocol (see Section 5.4.1.3 for 
more information about the instrumentation set up). Thus, the percentage of change in 
the mVO2 was correlated to the average EMG activity (normalized to MVC) in the 
MGast during the 14 isometric contractions that composed the exercise bout. As 
expected and in agreement with previous investigations (van Beekvelt et al., 2002) the 
current study found that there was a significant correlation between EMG activity and 
muscular oxygen consumption both in the DN and HEALTH groups. More 
interestingly, results from the present investigation only showed group differences 
when EMG activity was entered in the analysis as a covariate. This highlights the 
importance of assessing local muscular workout when attempting to investigate local 
oxygen consumption. This may explain why Bauer et al. (2007) and Mohler et al. 
(2006), who only assessed total workout, did not find significant differences in 
exercise-induced muscular deoxygenation when comparing healthy and diabetic 
individuals. However, further studies are warranted in this context to provide insight 
how muscular oxidative capacity is affected in DN subjects.  
 
The present investigation has demonstrated for the first time that 1) muscular oxygen 
delivery is restricted in the lower limb (calf muscle) of DN subjects in response to an 
exercise bout; and 2) the muscular oxygen uptake is also diminished in the calf muscle 
of DN subjects, likely due to impairments in the muscular oxidative capacity. 
Therefore, it seems that not only the delivery of oxygen to the muscle is restricted in 
patients with DN following an exercise stress, but also the ability of the muscle to use 
that oxygen.  Results regarding the recovery of the microcirculation following an 
exercise bout will be discussed next. 
 
 
 
  258 
7.1.3.3 Microcirculatory recovery from the muscular contractions 
 
The present study found that the DN recovered slower compared to the HEALTH 
group. Since the DN showed reduced microcirculatory responses in the form of BF and 
mVO2  to the muscular contractions, it is not surprisingly that percentage of recovery 
after 70 seconds both BF and mVO2 was also reduced in the DN group. Therefore, it 
appears that the slower BF and mVO2 recovery in the DN group in the present 
investigations is secondary to impairments in the ability of the microcirculation to 
response to the exercise bout.   
 
In summary the present study demonstrated that microcirculatory function is affected in 
DN subjects compared to health individuals, especially under stress conditions. Thus, 
BF and mVO2 absolute values at rest did not differ in the DN and the HEALTH group 
whilst BF and mVO2 percentage of change 1) in response to the exercise bout and 2) 
from the exercise bout were significantly reduced in the DN group compared to the 
exercise group. Furthermore, it appears that the most critical changes in the DN group 
occurred in response to the exercise bout as demonstrated by the fact that alterations in 
the recovery capacity of the DN group were secondary to abnormalities in vasodilatory 
and oxygen uptake responses to the muscular contractions. It is likely that changes in 
the endothelial function are the main responsible factor for the reduced vasodilatory 
capacity observed in the DN group. However, it is also possible that reduced cardiac 
output secondary to changes in the ANS have also contributed to this finding. 
Furthermore the present study found that not only oxygen delivery was reduced in the 
DN group but also the ability of the muscle to uptake oxygen, which suggests changes 
in the muscle oxidative capacity. This is an important finding since previous studies 
using the NIRS device failed to find significant differences in deoxygenation values 
between the healthy and subjects with type 2 diabetes. Moreover, the results from the 
present study highlight the importance of assessing local muscular workout when 
attempting to investigate local oxygen consumption with the NIRS device.  
 
It is commonly accepted that gait alterations and microcirculatory changes are 
responsible for the high rate of foot ulcers observed in DN subjects. Results from the 
present investigation demonstrated alterations in gait characteristics, including higher 
foot pressures under the metatarsal heads, and impairments in the microcirculation in 
response to a physical stress (exercise stress) when comparing  the DN and the 
  259 
HEALTH group. These findings confirm that the DN group in the present study was at 
considerably higher risk to develop foot problems compared to the healthy controls. 
Beside the foot complications associated with diabetes neuropathy, increasing evidence 
suggest that diabetes in general and DN in particular has an important impact on 
people’s QOL (Price, 2004). The results on the differences in QOL between the DN and 
the HEALTH group are discussed next.  
 
7.1.4 Quality of Life 
 
Results from the present study, in agreement with previous investigations (Ali et al., 
2010), show that all the dimensions of the SF-36 questionnaire were significantly lower 
in the DN compared to the HEALTH group. Furthermore, early evidence suggests that 
QOL in subjects with diabetes could be associated with physiological markers related to 
the disease. For instance, the severity of diabetic complications has been associated 
with poor health-related quality of life (Currie et al., 2006). However, results from the 
current study failed to find a relationship between the severity of sensory neuropathy 
measured with VPT and any dimension of QOL. On the other hand, HbA1c was 
correlated to two different SF-36 domains, namely physical function and mental health, 
as well as with the overall mental health score. This association between blood glucose 
and QOL has been previously found in patients with type I diabetes (Wikblad et al., 
1996) and painful neuropathy (Galer et al., 2000). In addition, BMI was negatively 
correlated with general health both in DN and HEALTH groups. Hypertension and 
cholesterol levels were not correlated to any of the SF-36 domains, a not altogether 
surprising finding since these two conditions are asymptomatic in the majority of 
patients. The majority of the DN subjects were taking medications to control both blood 
pressure and cholesterol levels, which could also have influenced their association with 
QOL. Consistent with the results from the present study some investigations have found 
no association between blood pressure and QOL (Lloyd et al., 2001; UKPDS, 1998).  
 
Overall, findings from the present study support early evidence that 1) QOL is largely 
affected in DN subjects; and 2) poorer QOL in DN subjects could be associated with 
some physiological markers, such as HbA1c or BMI. However, more studies are needed 
to understand the relationship between physiological and psychological markers and 
QOL in diabetic patients in general and DN subjects in particular.  
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7.1.5 Summary of the results for the cross-sectional study 
 
The aim of this cross-sectional study was to investigate differences in the primary 
pathologies associated to DN when comparing healthy and DN subjects.  This study 
demonstrates that DN carries a complex set of complications. Thus, the DN group in the 
present study showed alterations in general health, in the form of blood pressure, in 
different aspects of gait including spatial-temporal characteristics, foot pressures and 
muscular activity patterns, in microcirculation, especially during stress conditions, and 
in QOL when compared to healthy individuals.  
 
In the present study special attention was paid to investigate differences in gait 
characteristics and microcirculation between DN and healthy subjects, due to their 
association with foot ulceration in this population. On the one hand, changes in gait 
characteristics are considered a common mechanism by which tissue damage may occur 
in diabetic patients with peripheral neuropathy. On the other hand, microcirculatory 
impairments are thought to disable the diabetic neuropathic foot to respond to injury 
and infection in the usual manner. The main findings in relation to gait biomechanics 
and microcirculation are presented next. 
 
The present investigation, in agreement with previous studies, found group differences 
in all the aspects of gait under investigation which included gait parameters (spatial-
temporal characteristics and COP parameters), foot pressures and muscular activity 
patterns. Gait parameters in the present study were characterized by a slower gait 
velocity and a shorter distance travelled by the COP during the roll over process. 
Overall results from the present investigation suggest that these changes are related to 
lack of stability secondary to DN. Therefore it is likely that risk avoidance, fear of 
falling, and lack of confidence are the main factors that lead DN subjects to develop a 
more cautious gait strategy. Beside changes in gait parameters the present study also 
shows alterations in the loading patterns in the DN when compared to the HEALTH 
group. The most noticeable group differences were observed under the metatarsal 
heads, where the DN group showed significantly higher PP and PTI values compared to 
the HEALTH group. It is therefore not surprising that the metatarsal area is the foot 
region in which most of the ulcers occur in DN subjects. Results from the present 
investigation suggest that muscular function (including muscular weakness) appear to 
play an important role in the longer duration of the plantar loading at the metatarsals 
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region. In fact, in the present study DF strength levels were inversely correlated to 
forefoot PTI in the DN group. It is therefore likely that weakness of the DF muscles in 
the DN group may have resulted in an early forefoot contact and more prolonged 
forefoot contact with the ground in this population. Furthermore, the present study 
demonstrated that the contribution of the hallux during the push off phase is very 
important to reduce the magnitude of loads under the metatarsal heads. In fact the lack 
of contribution of this foot region during this phase of the GC is likely to partly explain 
the group differences in foot pressures at the metatarsal heads observed in the present 
study.  Structural changes and feeling of instability are likely contributing factors for 
the reduced loading at the hallux observed in the DN subjects.  
 
The vast majority of studies assessing gait characteristics in DN patients have 
investigated kinetic or kinematic data, whereas only a handful of studies have 
investigated EMG activity patterns during gait in this population. Moreover, all the 
previous studies processed EMG data without taking into account EMD. It seems that 
this is the first time that EMG patterns during gait were investigated in DN subjects 
whilst taking into account individual EMD values when processing EMG data. Data 
from the present study show different EMG patterns in the DN when compared to the 
HEALTH group. On the one hand, it appears that overall EMG activity during the 
whole GC is higher in the DN group compared to the HEALTH group. It is possible 
that co-contraction of agonist and antagonist muscle is a compensatory mechanism in 
this population to improve stability. On the other hand, it seems that EMG activity 
patterns throughout the different phase of the GC differ between DN and healthy 
individuals. For instance, the present study found an early activation of the TS and TA 
muscles in the DN group compared to the HEALTH group whilst the peak activity 
occurred at the same time in both groups. This suggests that DN subjects adopt an 
anticipatory strategy to efficiently produce force at the right moment in time. It is likely 
that a slower force production rate in DN subjects may be at least partly responsible for 
this compensatory mechanism. The present study demonstrated that an early activation 
of the TS muscle is linked to higher PTI values at the forefoot. Overall, the present 
investigation, as expected, showed alterations in different aspects of gait in the DN 
subjects compared to the healthy control. It seems that structural changes, including 
limited ROM, muscular weakness and sensory neuropathy are the main factor 
responsible for the changes in gait characteristics discussed above.  Interestingly, 
muscular weakness together with joint mobility are modifiable conditions and it would 
  262 
be interesting to evaluate whether changes in these conditions may result in beneficial 
changes in gait characteristics in DN subjects.  
 
The present study investigated for the first time microcirculatory responses to an 
exercise bout based on plantar-flexion contractions in DN individuals. Results from the 
current study, which are in line with previous investigations in subjects type 2 diabetes, 
show diminished 1) microcirculatory (blood flow and oxygen uptake) responses to the 
plantar-flexion contractions; and 2) microcirculatory (blood flow and oxygen uptake) 
recovery from the plantar-flexion contractions. It appears that impairments in the 
exercise-induced vasodilatation in DN patients are associated with changes in the 
endothelial function. Furthermore, the present study suggest that central alterations in 
the autonomic nervous system are likely to have contributed to the results found in the 
present study via reductions in cardiac output during the exercise bout. Although there 
is general consent in the literature that vasodilatation is impaired in diabetic patients, 
there is an ongoing debate whether the capacity of the muscle to uptake oxygen is also 
altered in this population. The present investigation seems to suggest that the ability of 
the muscle to uptake oxygen is also affected in the DN group. However, the exact 
reasons behind this finding are not fully understood. Furthermore, the present 
investigation demonstrated the importance of assessing local muscular workout when 
attempting to investigate mVO2 responses to an exercise bout. Since NIRS measures 
local muscular oxygenation, it is important to determine the specific amount of work 
that the muscle under investigation is contributing to the whole workout.  Thus, the 
current study demonstrated that local mVO2 responses in the MGast to an exercise bout 
were dependent on the amount of work done by the specific muscle and not necessarily 
by the amount of work carried out by the whole leg. Since in the present study the DN 
showed reduced microcirculatory responses to the exercise bout in the form of BF and 
mVO2, it is not surprising that recovery of both BF and mVO2 was also reduced in the 
DN group. Overall, the present study demonstrated that microcirculatory responses to 
an exercise bout are diminished in DN subjects compared to healthy individuals. Early 
evidence suggests that PA interventions may produce positive changes in the 
microcirculation of subjects with type 2 diabetes. However, it is still unknown whether 
PA interventions could influence microcirculation in DN subjects.   
 
In addition to foot ulcerations there are further health problems associated with diabetes 
in general and DN in particular. Thus, it is well established the association between 
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diabetes and both cardiovascular diseases and poor QOL. On the one hand, it is thought 
that alterations in traditional cardiovascular risk factors such as blood pressure or 
cholesterol levels are responsible for the increased risk of cardiovascular diseases in this 
population. Results from the present investigation show that DN had higher BP (despite 
taking hypotensive medications) compared to the HEALTH group. On the other hand, 
increasing evidence suggests that diabetes may have an impact on everyday living and 
consequently diminish health related QOL. Furthermore, some investigations have 
suggested an association between QOL and physiological markers (Wikblad et al., 
1996). Findings from the present study support early evidence that 1) QOL is severely 
affected in DN subjects; and 2) poorer QOL in DN subjects could be associated with 
physiological markers, such as HbA1c or BMI.  
 
Overall, the present investigation has demonstrated that DN is a very complex condition 
which affects different aspects of health. The question remains whether the primary 
pathologies associated with DN, namely traditional cardiovascular risk factors, 
alterations in gait, impairments in the microcirculation (in particular during stress 
conditions) and QOL can be modified by rehabilitation programmes. Part 2 of the 
discussion chapter discusses the results from the effect of a 16-week PA programme on 
the whole range of primary pathologies associated with DN.  
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7.2 Part 2 – Intervention study 
 
Part 2 was an intervention study that investigated the effects of 16 weeks of 
strengthening and mobility exercises on identified pathologies associated with DN. 
Results from this intervention study documents for the first time the beneficial effects 
of a 16-week resistance training programme on sensory neuropathy in patients with 
peripheral neuropathy. Results from the present investigation demonstrate that a well 
controlled strengthening training programme does have beneficial effects on the 
microcirculation, obesity, blood pressure as well as on QOL in patients with diabetic 
neuropathy. On the other hand, the exercise programme did not seem to have a 
substantial effect on gait characteristics including spatial-temporal, plantar pressures or 
EMG parameters, HbA1c or strength levels. Importantly, it should be noted that, no 
adverse effects related to the intervention were reported in any of the volunteers who 
participated in the physical activity programme.  
 
The discussion of the results of the intervention study is presented in the same order as 
in the previous chapters. Thus, general health outcome measures are discussed first 
followed by gait, microcirculation and QOL parameters.  
 
7.2.1  General Health related to DN 
 
This section discusses the results of the intervention programme on outcome measures 
related to general health in patients with DN. This includes the effect of the PA 
programme on parameters linked to: 1) diabetic neuropathy, such as sensory neuropathy 
and motor neuropathy; 2) diabetes control such as HbA1c; and 3) cardiovascular risk 
factors, such as cholesterol levels, blood pressure or obesity. Results from the present 
investigation show that 16 weeks of strengthening exercises produce positive changes 
in sensory neuropathy and cardiovascular risk factors (i.e. blood pressure and obesity). 
On the other hand, the intervention did not seem to trigger substantial changes in HbA1c 
and strength levels. Discussion of these results will be presented as follows: DN related 
outcome measures in the form of sensory neuropathy and motor neuropathy (strength 
levels), diabetes control (HbA1c) and cardiovascular risk factors in the form of blood 
pressure, obesity and cholesterol levels.  
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7.2.1.1 Sensory neuropathy 
 
One of the most striking findings of the present study was that 16 weeks of strength 
training improved sensory neuropathy in DN subjects. To the best of my knowledge this 
is the first investigation that has demonstrated that physical activity can reverse sensory 
neuropathy in DN subjects, which obviously may have tremendous clinical implications 
in this population. Balducci et al. (2006) is the only investigation that has previously 
assessed the effect of physical activity on neuropathy. They carried out a 4-years 
intervention study on diabetic patients with no signs of neuropathy and they found that 
low intensity long-term aerobic exercise training prevented diabetic patients from 
developing both motor and sensory neuropathy. The percentage of diabetic patients who 
developed motor and sensory neuropathy during the 4 years of the study was 
significantly higher in the control group (17% and 29.8% occurrence rate for motor and 
sensory neuropathy, respectively) than in the exercise group (0% and 6.5% occurrence 
rate for motor and sensory neuropathy, respectively). Results from the present 
investigation demonstrated that a physical activity programme can not only prevent the 
progression of diabetic neuropathy in individuals with no neuropathic complications, as 
demonstrated by (Balducci et al., 2006) but can also reduce sensory neuropathy in DN 
subjects. Currently there is no effective treatment available to prevent or treat 
neuropathy, except for tight control of blood glucose (Yagihashi et al., 2011). Thus, 
some investigations have found that intensive insulin treatments, which lower HbA1c, 
can decrease the incidence of neuropathy by 60% (Diabetes Control and Complications 
Trial Research Group, 1993) and improve nerve conduction velocity and VPT (Ohkubo 
et al., 1995) in patients with type 2 diabetes. However, the absence of statistically 
significant changes on HbA1c following both the present and Balducci’s intervention 
suggest a possible direct and local effect of exercise on peripheral nerves on diabetic 
individuals.  Next possible exercise-induced changes that could have influenced sensory 
nerves in the present investigations are discussed.   
 
Nerve function depends on adequate blood flow and blood flow is known to be 
diminished in patients with diabetes. This association has led some investigators to 
believe that vascular problems may lead to peripheral nerve damage (Cameron & 
Cotter, 1994). In addition, vasodilatory treatment has been demonstrated to restore 
endoneurial blood flow and improve nerve conduction velocities in diabetic rats 
(Maxfield et al., 1993). Physical activity programmes have been shown to improve 
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circulation in patients with diabetes via an enhancement in the endothelial function 
(endothelial dependent vasodilatation) (Higashi & Yoshizumi, 2004).  It is generally 
believed that the increase in vascular stress resulting from increased exercise-induced 
blood flow may stimulate the release of NO, which consequently improves endothelial 
function (Higashi & Yoshizumi, 2004). Thus, improvements in the circulation 
secondary to physical activity training could be a mechanism through which 
endoneurial blood flow may be restored, and in turn might lead to improved sensory 
nerves. Results from the present investigation show a trend toward greater muscular 
vasodilatory responses in the EXE compared to the CON groups following the exercise 
programmes. However, the fact that the present study only found a trend toward 
improved vasodilatory responses followed the exercise programme suggests that this 
interpretation should be taken with caution. Thus, further investigations are warranted 
to confirm whether exercise-induced improvements in the circulation (blood flow) can 
influence sensory nerves in DN subjects.  
 
Beside changes in the circulation, changes in the mitochondria is another mechanism by 
which exercise training could have influenced sensory nerves in the present study. 
There is accumulating evidence indicating that mitochondrial degeneration is involved 
in the pathogenesis of DN (Leinninger et al., 2006). In most eukaryotic cells (cells with 
a nucleus), including neurons, mitochondria are essential in managing oxidative stress 
and providing energy by generating adenoside triphosphate (ATP) through oxidative 
phosphorylation (Lehmann et al., 2011). In neurons ATP is required for axonal 
transport and maintenance of ionic gradients for generation of action potentials and 
synaptic activity (Kwong et al., 2006). Reactive oxygen species (ROS), which are 
generated at low levels during the normal mitochondrial respiratory chain, are known to 
produce mitochondrial dysfunction at higher levels, which in turn may lead to 
mitochondrial degeneration (Figueroa-Romero et al., 2008; Leinninger et al., 2006). 
Hey-Mogensen et al. (2010) demonstrated that mitochondrial ROS release was reduced 
and muscle oxidative function was improved in 13 type 2 diabetes patients in response 
to a 10-weeks aerobic training programme. This finding suggests that physical training 
could potentially improve nerves function (reverse neuropathy) via beneficial 
mitochondrial changes. Interestingly, results from the present investigation demonstrate 
that a 16-week strength training programme enhanced mVO2 recovery following an 
exercise bout in DN patients. Since the current investigation did not find changes in the 
exercise-induced muscular oxygen consumption in response to the exercise programme, 
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it appears that the intervention produced changes not in the capacity of the muscle to 
uptake oxygen (i.e. changes in the muscle fibre type), but in the efficiency of its usage. 
It is therefore possible that changes in the oxidative capacity of the mitochondria may 
be responsible for the more efficient use of oxygen following the intervention, which 
could explain the beneficial changes in the sensory nerves. However, more studies are 
needed on DN subjects to better understand 1) the effect of strength training on 
mitochondrial function; and 2) the association between improvements in mitochondrial 
function and sensory neuropathy.  
 
Overall, it appears that vascular changes secondary to the exercise programme may be 
responsible for the unexpected improvements in sensory neuropathy observed in the 
present study. It is possible that exercise-induced changes in the endothelial function 
could be a mechanism through which endoneurial blood flow may be restored, and in 
turn might lead to improved sensory nerves.  However, it should be stated that the 
present study only found a trend toward greater muscular vasodilatory responses in the 
EXE compared to the CON groups following the exercise programmes. It is therefore 
uncertain at this stage whether changes in the circulation may be partly responsible for 
the results found in the present study. On the other hand, it is also possible that changes 
in the mitochondrial function could explain the beneficial changes in the sensory nerves 
observed in the current study. In support of this interpretation, the present study found a 
more efficient use of oxygen in the EXE group following the intervention, which could 
be secondary to changes in the oxidative capacity of the mitochondria. Regardless of 
the exact mechanism behind this finding, the present study found for the first time that 
16 weeks of strengthening exercises influenced sensory neuropathy in DN subjects.  It 
is worth mentioning that sensory neuropathy in the current study was quantified by 
VPT measurements whilst conduction velocity measurements of the sensory nerves, 
which is considered the gold standard to assess nerve function, were not conducted. 
Future studies should assess sensory nerve function directly to understand better the 
effect of PA on sensory neuropathy. Nevertheless, this new finding should encourage 
researchers to investigate the therapeutic tool of PA to improve sensory neuropathy in 
DN subjects. The next section discusses the effect of the intervention on strength levels. 
Due to the close link between motor neuropathy and muscular weakness in DN patients, 
strength results are discussed under the heading motor neuropathy. 
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7.2.1.2 Motor neuropathy 
 
Results from the present study show that 16 weeks of strengthening exercises did not 
produce substantial changes in muscular strength levels in DN patients. Thus, no 
significant gains in strength levels were observed in any of the muscle groups under 
investigation, dorsi-flexors, plantar-flexors, knee flexors and knee extensors. It is most 
likely that the lack of effect of the resistance training programme on strength levels in 
the DN subjects in the present investigation could be related to motor neuropathy.   
 
Diabetes related motor neuropathy can be defined as the process in which segmental 
demyelination combined with axonal degeneration of motor nerve fibres limits the 
peripheral efferent stimulation of skeletal muscles in the lower and upper extremities 
(Greene et al., 1997).Thus, a general improvement in nerve function (sensory and 
motor), which is suggested by the improved sensation discussed above, might be 
expected to trigger similar changes in motor nerves, resulting in strength gains in 
response to the exercise programmes. Numerous studies on subjects with diabetes have 
shown the efficiency of strength training to improve strength levels in this population 
with no neuropathic problems (Cauza et al., 2005; Dunstan et al., 2006). However, the 
present study shows evidence for the first time that motor function was not improved 
with 16 weeks of resistance training in diabetic patients with moderate neuropathy. 
Some investigations have demonstrated using magnetic resonance imaging (MRI) 
techniques to quantify the muscle mass, a substantial loss in muscle tissue in DN 
subjects (Bus et al., 2002; Brash et al., 1999). Brash et al. (1999) and Suzuki et al. 
(2000) found significant correlations between motor nerve conduction velocities and 
muscle atrophy, which suggests that changes in muscle tissue are secondary to motor 
nerve dysfunction. Therefore, it is possible that muscle atrophy secondary to 
neuropathy may partly explain the lack of effect of the 16 weeks of strengthening 
exercises in the DN patients in the present investigation.  
 
To the best of my knowledge there is only one previous investigation assessing muscle 
strength changes in DN patients following a PA programme. Allet et al. (2010) carried 
out a 12-week intervention (twice weekly) based on function-orientated strengthening 
exercises. Contrary to the present investigation, they reported changes in strength 
values (measured with a hand held dynamometer) in response to the exercise 
programme. However, the percentage of improvement was moderate compared with 
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strength increases found in healthy elderly persons after comparable training program 
(Rubenstein et al., 2000), and only the hip flexors and plantar-flexors reached 
significant levels. It is most likely that differences in the severity of neuropathy may 
explain why Allet´s study using a shorter and less intense intervention was more 
efficient to modify strength levels compared to the present investigation. Notably, Allet 
et al. (2010) included subjects with significantly milder DN (VPT<4) compared to the 
present study (VPT=21.52-+13.37 in the EXE group). This early evidence suggests that 
interventions to change muscle function in diabetic patients may be more efficient in 
the early stages of the condition before substantial muscle tissue is lost. Although more 
studies are required to draw any final conclusions about the ability of DN subjects to 
improve muscular strength, this finding stresses the importance of strengthening 
exercises in early DN subjects. It is noteworthy that these two studies have used 
different methods to assess muscular strength, which may also explain the discrepancy 
of the results. Thus, Allet’ study used a hand-held dynamometer, the reliability of which 
is limited, in contrast to the present study, which assessed for the first time strength 
changes in DN subjects with an isokinetic dynamometer.  
 
However, this explanation is likely to apply more to the distal muscles (mainly foot 
muscles), and it is improbable that a substantial loss of muscle tissue occurred in the 
more proximal muscles (knee muscles) of the DN subjects from the present study (who 
did not suffer from severe neuropathy). Andersen et al. (1997) demonstrated in a well 
conducted study a distal-to-proximal gradient of muscle atrophy (measured with MRI) 
from cross sections in the proximal lower leg, mid lower leg, and distal lower leg in DN 
subjects. Furthermore, Andersen et al. (1997) found that muscle area in the proximal 
lower leg is unchanged in DN subjects with severe neuropathy. Therefore, it appears 
that there must be another explanation for the lack of exercise-induced changes in 
strength levels in the present study. Next, the neuromuscular adaptations that were 
expected from the resistance training programme used in the present investigation will 
be explained. Additionally, theoretical reasons why adaptations may have been elicited 
in the present study with DN subjects will be proposed.  
 
It is well documented that gains in muscle strength following a resistance training 
programme occur from neural and muscular adaptations. Thus, neural factors account 
for the majority of the strength gains over the first 5 weeks of workouts. Thereafter, 
muscle fibre adaptations become progressively more important to strength improvement 
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(McArdle et al., 2010). It is noteworthy that the present investigation started with very 
low workloads, which slowly and progressively increased throughout the 16 weeks of 
the programme. It is likely that the workloads targeted during the first few weeks (3-4 
weeks) might not have reached a sufficient threshold for adaptations to occur. However, 
it was considered very important to improve participant’s confidence towards the 
programme and minimize the discomfort associated with the first workouts in sedentary 
people (delayed-onset muscle soreness). Nevertheless, the exercise programme had a 
sufficient duration to produce both neural and muscular adaptations so it is unlikely that 
the lack of strength gains can be associated to the characteristics of the intervention. 
 
Changes associated with neural adaptations result in more efficient recruitment of 
motor units and increase in their firing rate (McArdle, 2010). Thus, the learned 
recruitment of additional motor units, which may respond in a synchronous (the 
coincident timing of impulses from 2 or more motor units) fashion may contribute to 
enhance the muscle’s ability to generate more force without changes in the cross-
sectional area of the muscle. Motor neuropathy is characterized by loss of motor units 
and a compensatory collateral reinnervation to preserve muscle strength (Andersen et 
al., 1998; Fleckenstein, 1993) Therefore, it is likely that a reduction in the number of 
motor units available secondary to DN may limit the ability of the muscle to recruit 
simultaneously different motor units to increase muscle force. This obviously may 
result in less strength gains via neural adaptations in this population. Increases in 
muscular strength following a resistance training programme are also associated with 
changes in the cross-sectional area of the muscle. The fact that in the present study BMI 
did not change significantly following the intervention whereas body fat percentage was 
significantly reduced suggests increases in muscle mass. However, unexpectedly, those 
changes in body composition did not relate to gains in muscular strength. A limitation 
of the study is that a muscular cross-sectional area was not determined. Studies with 
other musculo-skeletal conditions have reported impairments in neuromuscular 
transmission or abnormal contractile properties in reinnervated muscle fibres (Dengler 
et al., 1990), which leads to the assumption that similar abnormalities might occur in 
DN subjects. Thus, more studies are needed on DN subjects to better understand the 
underlying factors limiting their ability to improve muscular function after 16 weeks of 
high-intensity resistance training.  
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It should be noted that strength gains are related to the specificity of the training 
exercises (McArdle et al., 2010). Thus, an isometrically trained muscle shows greatest 
strength improvement when measured isometrically. The same principle applies to 
muscles trained during dynamic conditions, where the greatest improvements in 
strength will be observed when measured dynamically. It is worth mentioning that the 
training programme was based on dynamic exercises whereas strength measurements 
were carried out isometrically. It is possible that this limitation in the methodology of 
the present study could have affected the sensitivity of the measurements to identify 
strength changes following the exercise programme. Thus, it is important that future 
studies measure strength levels taking into account the specificity of strength-training 
responses. 
 
In summary, the present study has demonstrated for the first time that 16 weeks of 
strengthening exercises did not produce strength gains in any of the muscle groups 
under investigation in the DN group. However, it is unclear why DN subjects in the 
present study did not improve strength levels following the exercise programme. On the 
one hand, it is possible that muscular atrophy secondary to motor neuropathy may have 
resulted in reduced neural and muscular adaptations to the exercise programme. On the 
other hand, impairments in neuromuscular transmission or abnormal contractile 
properties in reinnervated muscles, as demonstrated in other neuro-skeletal conditions 
could have also contributed to the results. It is noteworthy that the sample size in the 
present investigation did not reach the numbers warranted by the power calculation. 
Consequently this may have affected the power of the study. In addition, strength levels 
were assessed isometrically whereas the exercise programme was based on dynamic 
exercises. This could also have affected the sensitivity of the measurements to identify 
strength changes following the exercise programme. Thus, further studies are required 
to draw any final conclusion about the muscular adaptability of patients with DN to 
strength training programmes.  Beside, changes in outcome measures related to DN, it 
was also very important to assess whether PA could influence glucose control in DN 
patients. Results on the effect of the intervention on HbA1c values are discussed.  
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7.2.1.3 HbA1c 
 
The current investigations did not find that 16 weeks of strengthening and mobility 
exercises carried out twice weekly changed HbA1c levels in DN subjects. It is well 
established that physical activity can improve glucose control in patients with type 2 
diabetes, which obviously is one of the main targets of any health-related intervention 
in this populations. A meta-analysis carried out by Thomas et al. (2006), which 
included 13 studies, reported a clinically significant reduction in HbA1c when the 
exercise group (N=185) was compared to the non exercise group (N=176). In addition, 
numerous investigations have demonstrated the positive effect of strength training to 
lower HbA1c in individuals with type 2 diabetes (Castaneda, et al.2002; Cohen et al., 
2008; Dunstan et al., 2002). It has been proposed that PA interventions may increase 
the availability of the protein glucose transporter type 4 (GLUT4) (insulin-responsive 
glucose transporter) and enhance the glucose transport into the muscle (Holten et al., 
2004).  
 
Contrary to these findings in subjects with type 2 diabetes, the PA programme in the 
present study did not seem to produce significant changes in HbA1c levels in DN 
patients. It should be noted that Hb HbA1c A1c levels decreased in the EXE group by -
0.3% from baseline to post-intervention values which is comparable with other 
investigations which used similar exercise programmes (Cohen et al., 2008; Dunstan et 
al., 2008). However, similar HbA1c reductions were observed in the CON group, which 
explains why group differences were not significant in the present study. In the current 
study, it was not attempted to minimize hypoglycaemic medication changes, which 
could have resulted in substantial changes in hypoglycaemic medication in the CON 
group. It is noteworthy none of the subjects from the exercise group changed 
medications during the 16 weeks that the programme lasted. However, no information 
was recalled in the present study about changes in hypoglycaemic medications in the 
CON group. It is therefore possible that medication changes could at least partly explain 
the improvement in HbA1c levels observed in the CON groups over time. It is possible 
that other factors may have also contributed to the lack of significant changes in HbA1c 
levels following the interventions in the present study. These are discussed. 
 
Some investigations have found that exercise-induced improvements in glycaemic 
control were greater among persons with higher baseline HbA1c (Dunstan et al., 2008; 
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Sigal et al., 2007). Sigal and colleagues (2007), who carried out an interventional study 
with 251 participants, found that decreases in HbA1c levels were greatest for 
participants with a baseline HbA1c higher than 7.5%. The subjects in the present study 
who participated in the intervention had a baseline HbA1c of 7.61± 1.06 %, which is 
relatively low and may explain why participants in the current study were less sensitive 
to HbA1c changes compared to other investigations with comparable exercise 
programmes and higher baseline HbA1c levels (Castaneda et al., 2002; Cauza et al., 
2005; Dunstan et al., 2002). In support of this argument, other investigations which 
reported low HbA1c baseline values failed to find exercise-induced changes in HbA1c 
(Ibañez et al., 2005; Middlebrooke, et al., 2006) 
 
Another reason for the lack of effect of the present intervention on HbA1c levels could 
be the fact that the frequency of the gym based training sessions was twice per week. 
The effect of a single bout of exercise on insulin sensitivity lasts 24-72 hours depending 
on the duration and intensity of the activity (Wallberg-Henriksoon et al., 1998). 
Because the duration of increased insulin sensitivity is generally no longer than 72 
hours, physical activity guidelines for subjects with type 2 diabetes recommend that 
there should not be more than 2 consecutive days without exercise training (at least 3 
times per week) (Sigal et al., 2006). It is therefore likely that 2 sessions per week of 
controlled exercises were not enough to reduce HbA1c in the present study in DN 
subjects with low baseline HbA1c levels. 
Overall, the present investigation found that 16 weeks of twice weekly strengthening 
and mobility exercises did not produce significant changes in HbA1c levels in DN. It is 
likely that factors such as low baseline HbA1c levels, changes in hypoglycaemic 
medications or the weekly frequency of the sessions may explain the results from the 
present investigation. However, it is noteworthy that this is the first investigation 
assessing HbA1c changes following a PA programme in DN subjects so it cannot be 
ruled out that DN subjects are less sensitive to HbA1c changes compared to individuals 
with diabetes and without neuropathy. Further studies are warranted to determine 
whether PA programmes trigger comparable effects on HbA1c levels in diabetic patients 
with and without neuropathy. Beside the effect of PA on diabetes related outcome 
measures such as sensory neuropathy, motor neuropathy and HbA1c levels, which are 
discussed above, it is also important to determine the influence of the intervention on 
risk factors associated with cardiovascular diseases.The next section discusses the 
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results on the effect of the physical activity programme on traditional cardiovascular 
risk factors.   
 
7.2.1.4 Traditional cardiovascular risk factors 
 
Results from the present investigation demonstrated that 16 weeks of strengthening and 
mobility exercises improved some of the abnormalities associated with the metabolic 
syndrome: namely body composition and hypertension in DN subjects. Thus the 
intervention triggered beneficial effects on obesity in the form of body fat percentage 
and systolic blood pressure. However, cholesterol levels in the form of TC, HDL and 
LDL did not change following the intervention. Results on body composition are 
discussed first, followed by the results on blood pressure and cholesterol levels.  
 
It is well known that obesity is a common cause of type 2 diabetes and that weight loss 
should play an important role in the management of this condition. In addition, obesity 
has been linked with other metabolic disorders associated with type 2 diabetes such as 
dyslipidemias and hypertension (Krause et al., 1998; Narkiewicz, 2006) as well as with 
microcirculatory problems (Caballero, 2003). The current intervention, in agreement 
with previous reports on subjects with type 2 diabetes (Castaneda et al., 2002; Church et 
al., 2010; Dunstan et al., 2006; Ibañez et al., 2005) showed that resistance training can 
change body composition in DN subjects by reducing body fat percentage. As to the 
reasons linked to these losses of fat mass, most investigations have demonstrated an 
increase in resting metabolic rate in older individuals in response to strength training 
(Hurley & Roth, 2000) This is mainly explained (60-70% of the inter-individual 
variability) by training-induced gains in fat-free mass (Tataranni & Ravussin, 1995). 
Unfortunately, muscle mass was not measured in the present study and it is unknown 
whether resistance exercises may produce similar adaptations in diabetic subjects with 
neuropathic complications. However, the fact that only changes in body fat percentage 
and not body mass reached significant levels suggests an increase in lean mass 
following the 16 weeks intervention. 
 
In addition to changes in body composition, the present study also demonstrated that 16 
weeks of strength training can lower systolic pressure in DN patients. Moreover, the 
magnitude of the changes (-7 mmHg) agrees with previous investigations with 
comparable resistance training programmes and population groups (age and baseline 
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blood pressure) (Castaneda et al., 2002; Cohen et al., 2008; Dunstan et al., 2002). In 
contrast, other investigations did not find changes in blood pressure in response to 
strengthening programmes (Church et al., 2010; Dunstan et al., 2006; Sigal et al., 2007).  
It is well known that changes in blood pressure due to physical activity programmes are 
dependent on baseline blood pressure levels. Thus, higher baseline blood pressure has 
been associated with larger training-induced changes (Lesniak & Dubbert, 2001). Most 
subjects with type 2 diabetes take antihypertensive medications, which explain 1) why 
most of the investigations assessing the effect of a PA programme on patients with type 
2 diabetes have reported baseline blood pressure values within normal range and 2) why 
some investigations failed to find changes in blood pressure secondary to resistance 
training interventions. Studies carried out on diabetic patients that found changes in 
systolic blood pressure following a resistance training programme also reported higher 
baseline systolic blood pressure (>142 mmHg) (Castaneda et al., 2002; Dunstan et al., 
2002). The studies that did not find changes in systolic blood pressure reported lower 
baseline blood pressure values (<137 mmHg) (Church et al., 2010; Dunstan et al., 2006; 
Sigal et al., 2007) . Baseline systolic blood pressure values in the present investigation 
were 142± 11.25 mmHg, which agree with the idea that strengthening exercise are 
efficient to reduce systolic blood pressure in diabetic subjects with high baseline blood 
pressure levels. This justification may also explain why the present intervention did not 
produce significant changes in diastolic blood pressure, which was within normal 
values in the DN individuals in the EXE group (baseline 80.90± 7.43).The possible 
mechanisms responsible for the decrease in systolic blood pressure in the present 
investigation are discussed next.  
 
Exercise-induced changes in the endothelial function, due to an increased NO release, is 
potentially an important exercise-related hypotensive mechanism (O´Sullivan & Bell, 
2000). Previous investigations have demonstrated that resistance training can improve 
endothelium function (assessed by measuring vasodilatory responses to iontophoretic 
application of acetylcholine) in individuals with type 2 diabetes (Cohen et al., 2008). 
Results from the present investigation show a tendency toward greater exercise-induced 
vasodilatation in the EXE group compared to the CON group following the 
intervention, which is likely to be due to changes in the endothelial function. However 
this did not reach significant levels, suggesting that other mechanisms in addition to 
endothelial function are likely to explain these changes in BP. 
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Obesity has been consistently associated with hypertension (Narkiewicz, 2006). Based 
on population studies, risk estimates indicate that at least two-thirds of prevalence of 
hypertension can be directly attributed to obesity (Krause et al., 1998). The precise 
mechanism linking obesity to hypertension is not fully understood. However, it is 
thought that obesity may lead to hypertension by activating the rennin-angiotensin-
aldosterone system (Engeli & Sharma, 2000), which is a hormone system that regulates 
blood pressure and water balance. It is therefore possible that the presumed changes in 
body composition in the current study following the exercise programme may have led 
to changes in systolic blood pressure. In support of this idea, several investigations have 
reported weight reduction to be an efficient therapy to reduce blood pressure in 
hypertensive subjects (Goldstein, 1992). However, it is not known for certain whether 
changes in body composition are the cause for the changes in systolic blood pressure in 
the present investigation. 
 
In addition to this, adaptations in the ANS have also been proposed as a possible 
mechanism leading to lower blood pressure values. It is believed that an attenuation of 
sympathetic drive (responsible for increasing HR) and enhancement of the vagal tone 
(responsible for lowering HR) secondary to physical training may lead to positive for 
health changes in BP (Lesniak et al., 2001). Physical activity has been shown to modify 
the sympathico-vagal regulation of the HR in various populations including, healthy 
individuals (Pichot et al., 2002), cardiac patients (Tygesen et al., 2001), type 2 diabetes 
patients (Loimaala et al., 2003) as well as diabetes patients with different degrees of 
autonomic neuropathy (Howorka et al., 1997). In the present study, resting HR was 
significantly reduced after the training programme, which might suggest adaptations in 
the ANS. However, the vast majority of studies investigating the effect of exercise 
training on the ANS have used aerobic exercises, whereas it is unknown whether 
resistance training could trigger comparable adaptations. Another explanation of the 
reduced resting HR secondary to the exercise programme could be that the intervention 
increased stroke volume (volume of blood pumped by the heart with each beat) due to 
changes in the left ventricle (Tortora & Derrickson, 2006). However, it is very unlikely 
that a strength training programme can increase stroke volume, unlike aerobic training.  
Resistance training augments the thickness of the cardiac wall, which results in a more 
forceful contraction (which does not necessarily influence the volume of blood ejected 
from the heart in each contraction). Whereas aerobic training enhances the elasticity of 
the cardiac walls leading to greater expansion and therefore increased stroke volume 
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(McArdle et al., 2010). It is therefore likely that adaptations in the ANS secondary to 
the exercise programme may have led to BP changes in the present study.  However, 
further studies are needed in DN subjects to demonstrate whether resistance training can 
alter ANS function in this population. 
 
Overall, results from the present investigation demonstrated that strength training can 
lower systolic blood pressure in DN subjects. Although, the exact mechanism/s behind 
this change in the present study is/are unknown it is possible that changes in body 
composition and in the ANS may have contributed to lower BP. The fact that diastolic 
blood pressure, which was within normal levels at baseline, did not change following 
the intervention, suggests that changes in blood pressure due to PA programmes are 
dependent on baseline blood pressure levels. 
 
Contrary to the beneficial effect of the exercise programme on body fat percentage and 
blood pressure, cholesterol levels in the form of TC levels, LDL and HDL were 
unchanged in the present study. In support of the results from the present study a meta-
analysis carried out by Thomas et al. (2006) demonstrated that PA interventions do not 
appear to produce substantial changes in cholesterol levels in individuals with type 2 
diabetes. It is noteworthy that the majority of the participants in the present study were 
taking anti-cholesterol drugs, which explains why all the variables were within normal 
range (HDL, LDL and TC). Normal baseline values may also explain that our 
participants were not sensitive to changes in the lipoprotein profiles.  
 
 
Summary of general health  
Overall, the present investigation demonstrated for the first time that 16 weeks of a PA 
programme based on strengthening and mobility exercises triggered positive effects on 
different aspects of health in DN subjects including sensory neuropathy, blood pressure 
and body composition. On the other hand, the present intervention did not appear to 
produce substantial changes in strength levels, glucose control and cholesterol levels. 
The most striking finding among all is that sensory neuropathy was improved following 
the exercise programme. Although the exact mechanism/s behind this finding is/are still 
not clear it is possible that exercise-induced improvements in endothelial and/or 
mitochondrial function could be responsible for this unexpected finding. Unfortunately, 
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changes in sensory neuropathy were not followed by changes in motor neuropathy. 
Thus, the present investigation found that 16 weeks of strengthening exercises did not 
improve strength levels in patients with DN. Although the reasons why DN subjects in 
the present investigation did not gain strength levels are unknown, it is likely that 
muscular atrophy secondary to motor neuropathy may have resulted in reduced neural 
and muscular adaptations to the exercise programme. However, further investigations 
with larger sample sizes are warranted before drawing any final conclusion about the 
muscular responses to resistance training in patients with DN.  
 
In addition to health related outcome measures associated with DN the present study 
also investigated the effect of PA on HbA1c and cardiovascular risk factors in DN 
subjects. Contrary to previous investigations with subjects with type 2 diabetes the 
present study found that twice weekly 16 weeks of strengthening and foot mobility 
exercises did not produce changes in HbA1c level in subjects with DN. It is likely that 
factors such as low baseline HbA1c levels, changes in hypoglycaemic medications or the 
frequency of the gym-based sessions may explain the results from the present 
investigation. However, it cannot be ruled out that DN subjects are less sensitive to 
HbA1c changes via a PA programme compared to individuals with type 2 diabetes. 
Further studies are required to determine whether PA programmes produce comparable 
effects on HbA1c levels in type 2 diabetic individuals with and without peripheral 
neuropathy. In addition to this, results from the present investigation demonstrated that 
strength training can reduce obesity and blood pressure in DN subjects.  
The alterations in general health discussed are associated with multiple health problems 
in subjects with DN including neuropathic complications or cardiovascular diseases. 
Another major problem linked to DN subjects is foot ulceration. It is therefore essential 
to investigate the effect of PA, not only on neuropathy, glucose levels and traditional 
cardiovascular risk factors but also on the factors associated with the increased risk of 
foot ulcers in DN subjects. It seems clear that a combination of gait biomechanics and 
microcirculatory changes are responsible for the increased risk of foot ulcerations 
observed in subjects with DN. Results from the effect of the intervention on both gait 
biomechanics and microcirculation will be discussed.  
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7.2.2 Gait biomechanics 
 
Changes in gait characteristics are considered a common mechanism by which tissue 
damage may occur in diabetes patients with peripheral neuropathy (Frykberg et al., 
1998; Guldemond et al., 2006). Moreover, it has been hypothesized that therapies 
aiming to improve joint mobility and muscle weakness in DN subjects could improve 
gait in this population and consequently reduce foot pressures during walking (Herriott 
et al., 2004; Akashi et al., 2008). In contrast to this idea, the present study demonstrated 
for the first time that 16 weeks of strengthening and foot mobility exercises did not 
produce substantial changes in the gait characteristics of DN subjects including all the 
gait parameters, except the velocity of the COP at the heel, foot pressures and muscle 
activation patterns. It should also be noted that the intervention programme did not 
adversely affect gait in the DN subject, which suggests that strengthening exercises do 
not increase the risk of foot problems in this population. However, these results should 
be interpreted with caution since the sample size in the present study was smaller than 
targeted by the power calculation. This may have affected the power of the study and 
therefore compromised the interpretation of the results. Discussion of results on the 
effect of the PA intervention on gait biomechanics is discussed as follows: 1) gait 
parameters in the form of spatial-temporal and COP parameters; 2) foot pressures and; 
3) muscular activity patterns.  
 
Studies on different clinical populations that suffer from muscular weakness including 
elderly people (Rubenstein et al., 2000), have shown that interventions that improve 
neuromuscular performance are efficient to modify spatial-temporal gait characteristics 
(i.e. walking speed or step length). In agreement with this, Brandon et al. (2003) 
reported that improvements in lower extremity strength levels following 6 months of 
training were positively associated with mobility performance in subjects with type 2 
diabetes (i.e. walking speed). Interestingly, similar results have been obtained in 
diabetic patients with neuropathic complications. For instance, Allet et al. (2010) found 
that a resistance based exercise programme improved walking speed in DN patients 
when comparing pre- and post-intervention data. Contrary to this, the present 
intervention based on strengthening and foot mobility exercises did not appear to 
modify spatial-temporal characteristics in DN subjects with moderate neuropathy. It is 
noteworthy that all the studies presented above reported significant strength gains 
following the exercise programme, unlike the current study. This suggests that changes 
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in strength levels are most likely responsible for changes in spatial-temporal 
characteristics in populations with muscular weakness. 
 
It is generally believed that sensory neuropathy is associated with instability in DN 
subjects resulting in slower and safer gait in this population (Simoneau et al., 1994; 
Simmons et al., 1997b). However, in the present study improvements in sensory 
neuropathy did not result in changes in any spatial-temporal characteristics. It has been 
hypothesized that instability in DN subjects may be the result of a loss of peripheral 
sensory receptor function in the lower legs and cannot be attributed exclusively to loss 
of plantar cutaneous sensation (van Deursen et al., 1999). It is noteworthy that in the 
cross-sectional study, plantar cutaneous sensation was only correlated to step times 
whilst it was not significantly correlated to gait velocity, cadence or step length. This 
suggests that in the present investigation cutaneous sensation was not likely to be the 
main factor responsible for the alterations in spatial-temporal characteristics observed in 
the DN group. This may partly explain why improvements in VPT did not influence 
spatial-temporal in the current investigation. In line with the results from the current 
study, Eils et al. (2004) and Hohne et al. (2008) investigated changes in gait 
characteristics following a reduction in the plantar cutaneous sensation in healthy 
individuals. They found no differences in spatial-temporal characteristics between the 
control and the reduced sensation conditions. This finding further supports the idea that 
cutaneous sensation does not appear the main factor responsible for changes in spatial-
temporal characteristics. Another reason for this lack of association between sensory 
neuropathy and spatial-temporal characteristics could be that the DN patients in this 
study had been living with significant losses of peripheral sensation for many years. 
Therefore, the gait patterns of these patients reflect not only the effects of the 
neuropathy itself, but also of any locomotor control strategies these subjects had 
developed over the years to compensate for their sensory loss. It is therefore likely that 
changes in gait characteristics in relation to this intervention (if any) may happen 
beyond the duration of this study. 
 
In line with the results discussed above in relation to spatial-temporal characteristics, 
the present intervention did not seem to bring about changes in the foot-floor interaction 
variables, except for the velocity of the COP at the heel. It was hypothesized that 
strength gains in the dorsi-flexor and plantar-flexor muscles and increase ROM of the 
ankle joints might augment the distance travelled by the COP during the stance phase, 
  281 
which has been proposed to potentially reduce stress on the foot plantar surface 
(Giacomozzi et al., 2002).  However, the fact that no significant strength gains were 
observed in the current study following the intervention may explain the lack of 
changes in the foot-floor interaction variables. An important limitation of this 
investigation is that, due to technical difficulties, ROM data could not be analyzed. 
Therefore, it is impossible to determine whether changes in ROM did not alter loading 
patterns or whether floor-foot interaction changes were not observed due to lack of 
alterations in ankle mobility as well as the lack of strength changes.  
 
Interestingly, the present study found a reduction in the velocity of the COP at the heel 
following the exercise programme.  It is generally believed that weakness of the dorsi-
flexor muscles causes the foot to reach the foot flat stage quicker and in a less 
controlled manner, which may lead to increased pressures and longer contact times of 
the metatarsal heads with the ground in this population compared to healthy individuals 
(Abboud et al., 2000; Bevans, 1992). Therefore, it is possible to speculate that if 
changes in DF strength following a resistance training programme can be elicited more 
effectively this may result in a slower and more controlled drop of the forefoot to the 
ground after the heel strike. Results from the present study did not show significant 
changes in strength levels in any muscle group following the intervention. In addition to 
this, there was a tendency toward higher pressures at the heel (PP and PTI) in the EXE 
group despite no changes in gait velocity, which can theoretically be associated to 
changes in the DF muscles. Further research into effective strengthening of DF is 
however needed before conclusions can be drawn. Furthermore, the present study failed 
to demonstrate that changes in the foot drop patterns may result in changes in the 
loading patterns of the metatarsal region. Thus pressures at the metatarsal region, both 
PP and PTI, were unchanged following the exercise programme despite a smother foot 
drop in the EXE group, as demonstrated by the reduced velocity of the COP at the heel. 
This finding suggests that interventions to improve heel strike motor control (i.e. 
strengthening dorsi-flexor muscles) in DN subjects are likely not to alter foot pressures 
on the forefoot regions in contrast to previously hypothesized (Abboud et al., 2000, 
Bevans, 1992). 
 
EMG data also suggests that the 16 weeks of strengthening exercises did not 
substantially influence muscular activity patterns in DN subjects, which agrees with the 
lack of changes in gait parameters and foot pressures presented above. However, it is 
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noteworthy that there is a trend toward higher TA activity in the EXE group over time 
during the loading phase of the GC compared to the CON group. It is therefore possible 
that the above-mentioned changes in the velocity of the COP at the heel could be due to 
a higher TA activity during the loading phase over time in the EXE group and not 
necessary due to strength gains secondary to the resistance training programme. Eils et 
al. (2004) and Nurse & Nigg (2001) investigated the effect of changes in plantar foot 
sensation via ice immersion on EMG activity patterns in healthy individuals. Both 
studies found a significant reduction in TA activity for the period immediately after the 
heel strike when the iced condition was compared to the normal condition. The central 
nervous system relies on sensory input from muscle and cutaneous receptors in the 
lower extremities to generate effective motor patterns for human posture and 
locomotion (Gandevia & Burke, 1992). Feedback originating from these receptors 
provides a constant source of information regarding loading, joint kinematics, and 
pressure distribution on the plantar surface of the foot (van Deursen, 1998a, Nurse & 
Nigg, 2001). Since, the present intervention appeared to significantly improve 
sensation, it is possible that the trend toward changes in TA activity are secondary to 
improvements in sensory neuropathy. However, the fact that changes in TA activity 
only reached tendency levels (p<0.1) suggests that this interpretation should be taken 
with caution. Since neuromuscular control strategies develop over the years, it is 
possible that changes in muscular activity patterns in relation to improvements in 
sensation (if any) may become more evident beyond duration of this study. However, 
further studies are required to draw any conclusion on the effect of improvements in 
cutaneous sensation neuropathy in EMG activation patterns in DN subjects. 
 
Overall, the present investigation found that a physical activity programme based on 
strengthening and foot mobility exercises did not lead to substantial changes in gait 
characteristics in DN subjects. Previous investigations on different clinical populations 
that suffer from muscular weakness (Rubenstein et al., 2000) demonstrated that 
increases in strength levels can modify spatial-temporal characteristics. The fact that the 
present investigation did not manage to change strength levels is likely to explain the 
lack of changes in spatial-temporal characteristics. Interestingly, improvements in 
sensory neuropathy secondary to the intervention did not appear to change gait 
characteristics substantially. It is believed that sensory neuropathy is the single most 
important factor explaining gait alterations in DN subjects (Frykberg et al., 1998; Payne 
et al., 2002). However, gait parameters, foot pressures and muscular activity patterns 
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during gait in the present investigation were mostly unchanged despite improvements in 
sensory neuropathy. The DN in the present study had been living with significant losses 
of sensation for many years. Therefore, it is likely that improvements in sensation may 
take a long time before any adaptation in gait occurs (if any). This could partly explain 
the lack of association between changes in sensory neuropathy and gait in the present 
study.  On the other hand, the present study demonstrated that a PA intervention did not 
negatively affect gait in DN subjects, which suggests that strengthening exercises do 
not increase the risk of foot problems in this population. Beside gait characteristics, 
microcirculation is also known to play an important role in the development of foot 
ulcers in DN subjects. Therefore, it is important to investigate whether PA can 
influence microcirculation in DN subjects. Results from the effect of the intervention on 
microcirculatory parameters are discussed next.  
 
7.2.3 Microcirculation  
 
This study has investigated for the first time the effect of an exercise training 
programme on: 1) resting microcirculation;  2) microcirculatory responses to an 
exercise bout in individuals with type 2 diabetic neuropathy; and 3) recovery of the 
microcirculation from an exercise bout. Thus, the present investigation found that 16 
weeks of strengthening and foot mobility exercises: 1) did not change microcirculation 
during resting conditions in the form of BF and mVO2; 2) showed a trend toward higher 
vasodilatory responses to the exercise bout following the exercise programme whilst 
did not change mVO2 responses to the exercise bout; 3) improved significantly mVO2 
recovery from the exercise bout whilst did not change BF recovery.  Results from the 
effect of intervention on the microcirculation are discussed in the following order: 1) 
during resting conditions; 2) in response to the exercise bout; and 3) recovery from the 
exercise bout.  
 
7.2.3.1 Microcirculation at rest: BF and mVO2 
 
Results from the present investigation show that 16 weeks of resistance and foot 
mobility exercises did not influence resting microcirculation in the form of capillary 
blood flow and oxygen consumption. In line with the results from the present study, 
previous investigations with type 2 diabetic patients did not find changes in baseline 
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blood flow following either an aerobic exercise programme (Colberg et al., 2005) or a 
resistance training programme (Colberg et al., 2006). Regarding changes in baseline 
mVO2 values following an exercise programme, it appears this is the first investigation 
reporting mVO2 values before and after a physical activity intervention in patients with 
type 2 diabetes. 
 
7.2.3.2 Microcirculatory responses to the exercise bout 
 
The present investigation found a trend toward greater vasodilatory responses in the 
exercise group following the intervention. Furthermore, 16 weeks of strength training 
did not seem to influence the amount of oxygen consumed by the muscle in response to 
an exercise bout.  
 
With respect to changes in blood flow responses to an exercise bout, this study showed 
that exercise-induced vasodilatation was enhanced after 16 weeks of resistance training 
in DN subjects. The beneficial effects of an exercise programme on vascular function 
probably relates to increasing flow and shear stress on the endothelium, which may 
stimulate the release of NO and, in turn, improve endothelial function (Higashi & 
Yoshizumi, 2004; Goto et al., 2003). However, in the present study changes in exercise-
induced vasodilatory capacity did not reach significance and were limited to a trend 
(p<0.1). Cohen et al. (2008) demonstrated that a 14-months strength training 
programme improved vascular responses in 16 adults with type 2 diabetes. 
Interestingly, Cohen and colleagues (2008) measured vascular function at 2 months and 
14 months (end of the exercise programme), and they found that improvements in both 
endothelial function and smooth muscle responsiveness were significant after 14 
months but not at 2 months. It should be noted that the exercise programme and the 
population age (mean age 60 years) in their study were very similar to the present 
investigation, which allows the comparison between both studies. Results from Cohen´s 
study suggest that the duration of the intervention may explain why Cohen et al. (2008) 
found significant changes in the vascular function in their study while the results in the 
present investigation only showed a trend.  
 
In agreement with this interpretation, Colberg et al. (2006), who carried out a 
interventional study for only 8 weeks, found that a resistance training programme of 
this length was not sufficient to improve the responsiveness of cutaneous perfusion to 
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local heating in healthy as well as in subjects with type 2 diabetes. The same results 
were observed by the same investigator when assessing changes in cutaneous perfusion 
to local heating following 10 weeks of aerobic training in individuals with type 2 
diabetes (Colberg et al., 2005). Overall, these results suggest that there may be a 
correlation between the duration of the exercise programme and vasodilatory changes in 
type 2 diabetic patients, and that an intervention longer than 16 weeks may be necessary 
for significant exercise-induced changes in the microcirculation. It should be noted 
there are methodological differences between the studies presented above and the 
present investigation, which should be taken into consideration. Firstly, the present 
study assessed vasodilatory responses in the skeletal muscle while Colberg’ studies 
(Colberg et al., 2005; Colberg et al., 2006) and Cohen et al. (2008) measured cutaneous 
microcirculation. Secondly, the current study investigated vasodilatory responses to an 
exercise bout while Colberg and Cohen et al. (2008) examined vasodilatory responses 
to local heating and iontophoresis of acetylcholine and sodium nitroprussie, 
respectively.  
 
Although the duration of the intervention appears to be important to find vascular 
changes, Maiorana et al. (2001) found an increased vascular response to infusion of 
acetylcholine in subjects with type 2 diabetes following an 8-week training programme. 
Moreover, the magnitude of improvements was similar to the changes reported by 
Cohen et al. (2008) after 14 months. There are a few methodological differences 
between Maiorana’s and both the present and Cohen’s study. Firstly, Maiorana and 
colleagues (2001) used a combined aerobic and resistance exercise training compared to 
the other studies in which only strengthening exercises were used. A combination of 
aerobic strengthening exercise is known to reduce HbA1c more than either aerobic or 
anaerobic training alone (Church et al. 2010; Dunstan et al., 2008; Sigal et al., 2007) 
and HbA1c has been linked to vascular function. It is believed that oxidative stress, 
which is aggravated by hyperglycaemia, diminishes NO availability affecting the 
endothelium-dependent function (Schramm et al., 2006; Taddei et al., 1998).  This 
could be a possible mechanism by which a combination of different types of exercises 
may trigger greater changes in the endothelial function than aerobic or resistance 
exercises alone.  However, more investigations are required to identify whether a 
combination of exercises may trigger further changes in the vasculature compared to 
either type of exercises alone. Secondly, Maiorana’s participants were significantly 
younger (mean 52 years of age) than in Cohen et al. (2008) or in the present study, and 
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age is known to diminish physiological adaptations (ACSM, 2000).  Thirdly, Maiorana 
et al. (2001) measured vascular responses on the macrovasculature. Hamdy et al. (2003) 
provided evidence that there may be differential effects of exercise on the macro- and 
microcirculation. Thus, they found that flow-mediated dilation of the brachial artery 
(measured after 5 minutes of arterial occlusion with a high-resolution vascular 
ultrasound) was significantly enhanced following a PA intervention while the 
microvascular reactivity after iontophoresis of acetylcholine (measured with laser 
Doppler) was unchanged. These results suggest that the microcirculation may be less 
sensitive to exercise-induced changes than the macrocirculation, which may explain the 
greater changes in vascular responses reported by Maiorana et al. (2001).  
 
Overall, evidence presented above on subjects with type 2 diabetes suggests that 
strength training is likely to influence microcirculation in DN subjects and that the 
length of the intervention in the present study may not have been sufficient for 
significant changes to be found. This could explain why in the current study 
improvements in the vasodilatory capacity in response to an exercise bout  did not reach 
significant levels and were limited to a trend (p<0.1). This could also be influenced by 
the fact sample size in the present investigation did not reach the numbers determined 
by the power calculation. Thus, further investigations with larger numbers are 
warranted to draw any final conclusions on the effect of strengthening exercises on DN 
subjects.  
 
Results from the present study also show that a 16-week resistance programme did not 
promote any changes in the amount of oxygen consumed by the muscle following an 
exercise bout. This is not a surprising finding since the physical activity programme 
was based on strengthening exercise. Thus, it is well established that aerobic exercises 
are more efficient to improve muscular oxidative capacity by increasing the number of 
mitochondria, the proportion of type II muscle fibres or oxidative enzymes (McArdle et 
al., 2010).  
 
7.2.3.3 Microcirculatory recovery from the exercise bout 
 
This study investigated for the first time whether a resistance programme may bring 
about changes not only in the post-exercise microcirculatory responses but also in the 
recovery phase in DN subjects. Results from the present investigations show that 16 
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weeks of strengthening and foot mobility exercises did not influence BF recovery whilst 
improved significantly mVO2 recovery. The fact the current intervention did not have a 
significant effect on BF recovery is consistent with the lack of substantial post-exercise 
changes in the microcirculation (BF and mVO2). On the other hand, the observation that 
mVO2 returned to baseline values significantly quicker in the EXE group compared to 
the CON after the exercise programme is quite important and was an unanticipated 
finding. Although the exact mechanism behind this finding is unknown, it appears that 
the intervention resulted in changes not in the capacity of the muscle to take up oxygen 
(i.e. changes in the muscle fibre type), but in the efficiency of its usage. It is therefore 
possible that exercise-induced mitochondrial changes may explain the results observed 
in the present study. This option is discussed next.  
 
Physical activity programmes have been proven to improve not only overall oxygen 
transport (circulation) or oxygen uptake capacity, but also the capacity of the skeletal 
muscle to produce energy (ATP) through the aerobic system (oxidative 
phosphorylation) (McArdle et al., 2010). Starritt et al. (1999) assessed the in vitro 
mitochondrial ATP production rate in 7 untrained healthy volunteers, who participated 
in a 10-day cycle exercise training programme. Resting muscle samples were obtained 
from VL before and after 5 and 10 days of training. They indicated that mitochondrial 
ATP production rate measured by a bioluminescence technique can rapidly increase in 
response to endurance training. Similarly, in vivo studies have used phosphorus 
magnetic resonance spectroscopy (P-MRS) to show higher ATP production rate in a 
variety of muscles of trained compared to untrained healthy humans (Larsen et al., 
2009) and in response to endurance training of specific muscles (Forbes et al,. 2008). 
Evidence presented above demonstrates that exercise training can influence 
mitochondrial function in healthy individuals and consequently produce energy more 
efficiently. Furthermore, early investigations have reported beneficial changes in the 
muscle mitochondria function in subjects type 2 diabetes following a physical activity 
programme (determined via skeletal muscle biopsies) (Hey-Mogensen et al., 2010; 
Toledo et al., 2007). These findings suggest that changes in the mitochondrial function 
secondary to physical activity training may lead to a more efficient use of oxygen in the 
skeletal muscle of type 2 diabetic patients (higher ATP production rate). This could 
explain the quicker mVO2 recovery observed in the EXE group after the intervention.  
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It is noteworthy that all the studies presented above used aerobic exercises for the 
training programme. Aerobic exercises are well known to trigger physiological 
adaptation in the aerobic system (McArdle et al., 2010) whereas the current intervention 
was based on strengthening exercises. It is generally believed that aerobic fitness is 
reduced considerably in diabetic patients compared to healthy individuals (Ozdirenç et 
al., 2003; Regensteiner et al., 1998). Therefore, it is possible that a physical activity 
programme that is not specifically designed to enhance the aerobic system, may reach 
the minimal threshold stimulus to improve aerobic fitness in this population. In the 
present study every training session began with a 5-10 minutes warm up period at an 
increasing intensity on an aerobic machine such as bicycle or cross-trainer. It is 
therefore possible that the duration and intensity of these exercise bouts were sufficient 
to trigger physiological adaptations in the aerobic system in the DN subjects who 
participated in the present study. Consistent with this idea, Colberg et al. (2006) 
demonstrated improvements in maximal oxygen capacity (VO2max) in a group of 
patients with type 2 diabetes after a 8-weeks resistance training programme. It is also 
possible that the intervention may have had an effect on the participant´s daily 
activities. This could result in increased daily physical activity as part of lifestyle 
changes and consequently higher fitness levels. It is noteworthy that the intervention 
resulted in significant improvements in vitality as measured with the QOL 
questionnaire. Therefore it is possible that if subjects showed an improvement in 
vitality levels this may increase their capacity to lead to a more active life style, which 
may in turn lead to changes in aerobic capacity. A limitation of the present study is that 
aerobic capacity was not determined, and therefore it is not known whether 
improvements in mVO2 recovery are secondary to alterations in the aerobic capacity or 
other mechanisms may be responsible for these changes. Nevertheless, results from the 
present study show for the first time that strength training improves exercise-induced 
reoxygenation in DN subjects, likely due to changes in the mitochondria.  
 
Overall, results from the present study demonstrated for the first time that 16 weeks of 
strength training can influence microcirculatory in DN subjects. The most striking and 
unexpected finding was that a strength training programme had a significant effect on 
the mVO2 recovery. Since the exercise programme did not promote changes in the 
amount of oxygen consumed by the muscle following the exercise bout, it appears that 
the intervention resulted in changes not in the capacity of the muscle to take up oxygen 
but in the efficiency of its usage. Changes in the mitochondrial function secondary to 
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the exercise programme are likely to explain the results in the current study. 
Furthermore, the present study showed that exercise-induced vasodilatation was 
enhanced after 16 weeks of resistance training. However, this change did not reach 
significance and was limited to a trend. It is possible that the length of the intervention 
or issues related to the power of the study may partly explain why this change did not 
reach significant levels. Although gait and microcirculation represent critical outcomes 
in DN patients due to their link to foot problems, health-related quality of life outcomes 
are also important. The effect of the PA programme on self-reported QOL will be 
discussed next. 
 
7.2.4 QOL 
 
QOL represents an important goal for health care professionals and it has been 
associated with adverse outcomes in people with type 2 diabetes, including poor 
response to therapy, disease progression and even mortality (Ali et al., 2010; Landman 
et al., 2010). In addition, QOL is known to be significantly reduced in patients with 
neuropathic complications (Price & Harding, 2000), as shown by the data presented in 
the cross-sectional part of the present study. However, the question remains whether 
QOL is a modifiable risk factor or just a marker of disease burden in this population. 
Harkness et al. (2010) carried out a meta-analysis to indentify psychosocial 
interventions that improve both physical and mental health in diabetic patients. They 
concluded that although there are efficient treatments to improve both diabetes and 
mental health, they did not identify types of interventions that consistently provide 
benefits for both simultaneously. The present investigation demonstrated for the first 
time that a physical activity programme can bring about changes in multiple health-
related aspects including QOL in DN subjects.  
 
Interestingly, 16 weeks of resistance training appeared to modify mental and not 
physical aspects of QOL. Thus, the current study found significant improvements in 
various mental related dimensions of the SF-36 QOL questionnaire, which included 
vitality, mental health and overall mental health. However, it could be explained by the 
fact that strength training and consequently gait characteristics were not changed 
through the exercise programme. In support of this idea, Ruhland & Shields (1997) 
demonstrated an inverse correlation between both walking speed and lower-extremity 
muscle function and scores on the physical function scale of the SF-36 following a 
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home exercise programme in persons with chronic peripheral neuropathies (no DN 
subjects were included in the study). Therefore, early evidence suggests that changes in 
muscle function are required for changes in physical aspects of the QOL to appear.  
 
QOL has been previously associated with blood glucose in patients with type I diabetes 
(Wikblad et al., 1996) and painful neuropathy (Galer et al., 2000). In line with this 
evidence the cross-sectional study (part 1 of the main study) showed that HbA1c was 
correlated to mental health in DN subjects. Since HbA1c was not significantly changed 
by the exercise programme, it is unlikely that improvements in blood glucose levels can 
explain changes in mental health. On the other hand, data from the present study 
suggests that changes in mental health (vitality, mental health and overall mental 
health) may be related to the exercise programme itself and not to other mediators. It 
has been proposed that self-esteem and positive feeling may mediate the effect that 
physical activity has on the mental aspect of QOL (Drewnowski et al., 2001). In 
addition to this, it is well established that group dynamics can also influence levels of 
enjoyment (Turner et al., 1997). According to Rejeski & Mihalko (2001) repeated 
enjoyment with an activity may be related to cognitive judgments about one’s overall 
QOL. Thus, it is very likely that the social aspect of sharing the exercise programme 
with a group of people may have increased the enjoyment of the session and 
consequently the mental aspect of QOL.  
 
QOL has been correlated to the severity of the diabetic complications (Price & Harding, 
2000). In line with this, Currie et al. (2006) demonstrated that the severity of diabetic 
peripheral neuropathy symptoms was predictive of decreased quality of life. Since the 
present investigation improved sensory neuropathy in our DN subjects, it is possible 
that changes in the severity of sensory loss could also have influenced QOL.  
 
The present investigation demonstrated for the first time that a PA programme can be 
an efficient tool to enhance not only physical health but also mental health in DN 
subjects. However, further investigations comparing the effect of group based versus a 
home based PA intervention are required to distinguish whether changes in the mental 
aspect of QOL are related to the exercise itself, to the social environment around the 
exercise programme or to exercise-related changes (i.e. sensory neuropathy). 
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7.2.5 Summary of the discussion for the intervention study 
 
The cross-sectional study demonstrated that the DN subjects in the present study, in 
agreement with the literature, suffered from multiple pathologies linked to DN 
including general health, gait abnormalities, microcirculation and QOL. The aim of this 
longitudinal study was to investigate the effect of 16 weeks of strengthening and foot 
mobility exercises on identified pathologies associated to diabetic peripheral 
neuropathy. Therefore, results of the present study demonstrated that 16 weeks of 
resistance and foot mobility exercises can trigger beneficial changes in some aspects of 
general health and microcirculation as well as in QOL. The most striking finding of all 
is that this intervention study documents for the first time the beneficial effects of a 16-
week resistance training programme on sensory neuropathy on patients with peripheral 
neuropathy. On the other hand, the exercise programme did not seem to have a 
substantial effect on gait characteristics. Importantly, it should be noted that, no adverse 
effects related to the intervention were reported in any of the volunteers who 
participated in the physical activity programme. 
 
Regarding to general health linked to DN, the exercise programme improved sensory 
neuropathy and cardiovascular risk factors such as blood pressure and obesity. On the 
other hand the intervention did not appear to influence HbA1c levels, strength and 
cholesterol levels. Unexpectedly, 16 weeks of resistance training seemed to improve 
sensory neuropathy in DN patients. Although the underlying mechanisms are not clear 
it appears that vascular changes secondary to the exercise programme may be 
responsible for this unexpected finding. On the one hand, it is possible that exercise-
induced changes in the endothelial function could be a mechanism through with 
endoneurial blood flow may be restored and in turn might lead to improved sensory 
nerves. However, it should be stated that the exercise programme only found a trend 
toward improved vasodilatory responses following the exercise programme. On the 
other hand, it is also possible that changes in the mitochondrial function could explain 
the beneficial changes in the sensory nerves observed in the current study. In support of 
this interpretation, the present study found a more efficient use of oxygen in the EXE 
group following the intervention, which could be due to changes in the mitochondria. 
Unfortunately, changes in the sensory neuropathy were not followed by changes in 
motor neuropathy. Thus, the present investigation found that 16 weeks of strengthening 
exercises did not improve strength levels in patients with moderate severity of DN. 
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Although the reasons why DN in the present study did not gain strength levels are 
unknown, it is likely that muscular atrophy secondary to motor neuropathy may have 
resulted in reduced neural and muscular adaptations to the exercise programme. Hence, 
the present study suggests that interventions to improve strength levels in DN subjects 
may be more efficient at an earlier stage of the disease.  
 
In addition to health related outcome measures associated with DN the present study 
also investigated the effect of PA on HbA1c levels and cardiovascular risk factors in DN 
subjects.  Contrary to previous investigations on individuals with type 2 diabetes, the 
present study found that 16 weeks of twice weekly strengthening and mobility exercise 
did not produce significant changes in HbA1c levels in DN subjects. It is likely that 
factors like low baseline HbA1c levels, changes in hypoglycaemic medications or the 
frequency of the intervention may explain the results from the present investigation. 
However, since this is the first investigation assessing HbA1c changes following a PA 
programme in DN subjects it cannot be ruled out that DN subjects are less sensitive to 
HbA1c changes compared to individuals with type 2 diabetes. In line with previous 
studies with subjects with type 2 diabetes the present investigation found that a PA 
programme lowered blood pressure and body fat percentage whilst it did not influence 
cholesterol levels.  
 
The alterations in general health in DN discussed are well known to be associated with 
multiple health problems in this population such as neuropathic complications or 
cardiovascular diseases. Furthermore, another major health problem linked to DN 
subjects is foot ulceration. Changes in gait biomechanics and microcirculation are 
responsible for the increased risk of foot problems in DN subjects. Thus, the principal 
aim of the present investigation was to determine whether a PA programme based on 
strengthening and mobility exercises can influence gait characteristics and/ or 
microcirculation in DN subjects. On the one hand, the intervention in the present study 
did not produce substantial changes in gait characteristics in DN subjects. It was 
hypothesized in the cross-sectional study that strength gains in the lower limb may 
result in some changes in gait biomechanics. The fact that the present investigation did 
not manage to change strength levels is likely to explain the lack of changes in gait 
characteristics. Interestingly, improvements in sensory neuropathy secondary to the 
intervention did not appear to change gait characteristics substantially. It is believed 
that sensory neuropathy is the single most important factor explaining gait alterations in 
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DN subjects (Frykberg et al., 1998). However, gait parameters, foot pressures and 
muscular activity patterns during gait in the present investigation were mostly 
unchanged despite improvements in sensory neuropathy. The DN in the present study 
had been living with significant losses of sensation for many years. Therefore, it is 
likely that improvements in sensation may take a long time before any adaptation in gait 
occurs (if any). This could partly explain the lack of association between changes in 
sensory neuropathy and gait in the present study. On the other hand, the exercise 
programme influenced some aspects of microcirculation. Thus, the intervention had a 
significant effect on the mVO2 recovery. Since the exercise programme did not promote 
changes in the amount of oxygen consumed by the muscle following the exercise bout, 
it appears that the intervention resulted in changes not in the capacity of the muscle to 
uptake oxygen but in the efficiency of its usage. Changes in the mitochondrial function 
secondary to the exercise programme are likely to explain the results found in the 
present study. Furthermore, the present study showed that exercise-induced 
vasodilatation was enhanced by 16 weeks of resistance training. It is believed that the 
beneficial effects of an exercise programme on vascular function probably related to 
increased flow and shear stress on the endothelium, which may stimulate the release of 
NO and, in turn, improve endothelial function. However, these changes did not reach 
significance and were limited to a trend. It is possible that the length of the intervention 
or issues related to the power of the study may partly explain why this change did not 
reach significant levels.  
 
In addition to the health problems associated with DN, QOL also represents an 
important goal for health care professionals. The present study demonstrated for the 
first time that a PA programme can be an efficient tool to enhance not only physical 
health but also mental health in DN subjects. Thus, the current study found significant 
improvements in various dimensions of the SF-36 questionnaire including vitality, 
mental health and overall mental health.  
 
Overall, the present investigation demonstrated that 16 weeks of strengthening and joint 
mobility exercises influenced some of the health problems associated with DN. It is 
therefore possible to speculate that if changes in cardiovascular risk factors, 
microcirculation and QOL were elicited this may have resulted in a better 
cardiovascular health, less risk of foot problems and better mental health in the DN 
after the exercise programme. Furthermore, the fact that sensory neuropathy was 
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improved following the exercise is a very important finding in itself, since up to date 
there is not a treatment available to reverse neuropathy. However, it is noteworthy that 
sample size in the present investigation was small so further studies are warranted 
before drawing any final conclusions about the effect of a physical activity programme 
based on  strengthening exercises and joint mobility exercises on DN patients.  
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7.3 Clinical implications of the study 
 
The present study investigated, for the first time, the effect of a PA programme on the 
primary pathologies linked to DN. Several clinical implications emerge from the results 
of this study. The vast majority of previous studies investigating the effect of a PA 
programme on subjects with diabetes have been interested in health problems related to 
type 2 diabetes such as glucose control or cardiovascular risk factors. This investigation 
demonstrated that exercise-induced changes in health related outcome measures in DN 
subjects go beyond type 2 diabetes (results from part 2 of the main study). Thus, the 
present study demonstrated for the first time that 16 weeks of strengthening exercises 
triggered positive changes in sensory neuropathy in DN subjects. Furthermore, the fact 
that a PA programme can improve sensory neuropathy may potentially suggest a 
number of clinical implications. For instance, sensory neuropathy is believed to be the 
main factor responsible for the high risk of ulcers in DN subjects (Veves et al., 1992). 
This is related, on the one hand, to the mechanism that a minor trauma in the presence 
of loss of sensation can remain unattended which can be the start of an ulcer (Dinh & 
Veves, 2005; Laing, 1998). On the other hand, neuropathy has been linked to 
microcirculatory problems secondary to changes in the nerve-axon reflex (flare 
response) (Dinh & Veve, 2004; Schramm et al., 2006). It has been suggested that the 
impaired flare response observed in patients with DN may be related to both impaired 
C-nociceptive fibre function and impaired ability of the microvasculature to response to 
vasomodulators (i.e. NO) secreted by these fibres (Vinik et al., 2001). It is therefore 
possible to speculate that if an intervention can elicit changes in sensory neuropathy, it 
may reduce the risk of foot ulceration in DN subjects. Furthermore, loss of sensation is 
associated with higher number of falls (Dingwell & Cavanagh, 2001), reduced QOL 
(Currie et al., 2006) and gait abnormalities (Courtemanche et al., 1996). It should be 
noted that in the present study changes in sensory neuropathy were not associated with 
changes in gait biomechanics. However, gait patterns in DN subjects reflect not only 
the effects of the neuropathy itself, but also of any motor control strategies these 
subjects had developed over the years to compensate for their sensory loss. It is 
therefore likely that changes in gait characteristics in relation to this intervention (if 
any) may develop slowly beyond the duration of this study. 
 
Moreover, results from the present investigation suggest, not only that exercise can 
influence outcome measures related to DN, but also that adaptations to exercise 
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programmes differ between subjects with type 2 diabetes and DN individuals. Contrary 
to numerous previous investigations on subjects with type 2 diabetes (Cauza et al., 
2005; Dunstan et al., 2006), the present investigation found that 16 weeks of resistance 
training did not elicit changes in strength levels in DN subjects with moderate 
neuropathy.  This finding demonstrates that DN subjects may be less sensitive to 
musculo-skeletal adaptations compared to diabetic subjects without neuropathy. It is 
well documented that gains in muscle strength following a resistance training 
programme occur from neural and muscular adaptations. Thus, neural factors account 
for the majority of the strength gains over the first 5 weeks of workouts. Thereafter, 
muscle fibre adaptations become progressively more important to strength improvement 
(McArdle et al., 2010). Since the exercise programme lasted 16 weeks, it seems that DN 
diminishes both neural and muscular adaptations to strengthening exercises. It is 
possible that muscular atrophy secondary to motor neuropathy (Brash et al., 1999) is 
partly responsible for these reduced neural and muscular adaptations. Allet et al. (2010), 
who undertook the only previous study to assess changes in strength levels in DN 
subjects following an exercise programme, reported only moderate strength gains in DN 
subjects with mild neuropathy (VPT<4 volts). These results suggest that the 
improvements in strength levels in DN subjects are likely to occur more readily at an 
early stage of the disease. Muscle weakness is known to be an important contributing 
factor for the changes in gait characteristics observed in DN subjects (Mueller et al., 
1994). In support of this, the cross-sectional study found that muscular strength was 
responsible (at least in part) for changes in COP parameters and loading patterns 
especially under the metatarsal region in the DN group. In addition to this, motor 
neuropathy is well known to limit physical function (Resnick et al., 2000) and has been 
associated with poor QOL (Currie et al., 2006). It therefore appears critical to 
implement strengthening exercise at an early stage of DN before muscular function is 
impaired to a level which will be more difficult to influence by strength training. 
However, more studies are needed to confirm that muscular weakness, despite possible 
improvements in nerve function, cannot be improved in DN subjects.  
 
Overall, these findings highlight the importance of: 1) evaluating PA interventions on 
the whole range of health problems associated with DN, and not only on glucose 
control and cardiovascular risk factors and 2) investigating the effect of PA on DN 
subjects to challenge the assumption that similar adaptations may occur in DN 
compared to individuals with type 2 diabetes without neuropathic complications.  
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The aim of this intervention study was to evaluate whether 16 weeks of strengthening 
and foot mobility exercises could influence health in DN. In line with previous 
investigations with  subjects with type 2 diabetes the present study found that PA can 
influence outcome measures linked with cardiovascular diseases. Subsequently, it can 
be speculated that improvements in blood pressure and obesity secondary to the 
intervention may have decreased the risk of cardiovascular events in the DN subjects 
who participated in the training programme. A novel attempt of this investigation was 
to evaluate whether the risk of foot ulcers can be altered through a resistance training 
programme. Thus, results from the present study demonstrated that although foot 
pressures were unchanged, microcirculatory responses to a stress condition were 
improved following the exercise programme. It is therefore possible to speculate that if 
an intervention can enhance the ability of the microcirculation to respond to a stress 
condition, this may improve the body’s ability to respond to trauma in the foot region 
more effectively, and therefore the risk of ulcers may be reduced.  Furthermore, the 
present study demonstrated for the first time that certain aspects of QOL can be 
reversed in DN individuals via a PA programme. Interestingly it appears that aspects of 
mental health showed greater improvement following the intervention compared to 
aspects of physical health. Overall the present investigation demonstrated that some of 
the outcome measures associated with cardiovascular diseases, foot ulcers and mental 
health in DN subjects are modifiable by PA interventions.  
 
Since DN subjects are at risk to develop foot ulcers (Boulton et al., 1994) and there is 
little evidence on the effect of PA on this population, it is important to mention that the 
present intervention did not cause any adverse events in the feet in any of the subjects 
who participated in the present study. The amount of weight bearing activities among 
individuals with diabetes is thought to influence the amount of mechanical trauma 
accumulated by plantar tissue (Cavanagh et al., 1996). This suggests that an adaptation 
of the exercises used is necessary to avoid foot complications (Kanade et al., 2006). In 
the present study, to reduce the risk of foot complications related to the exercise 
programme the amount of weight bearing exercises was reduced to a minimum and 
only non-impact exercises were chosen. In addition to this, all participants were 
encouraged to closely examine their feet after each training session to prevent sores and 
were required to use proper footwear. This study suggests that a well controlled PA 
programme based on non-impact exercises can be safe in DN subjects. In addition, no 
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hypoglycaemic episodes were reported by any subject in the study. To reduce the risk 
of hypoglycaemic episodes subjects were advised before each session to check their 
sugar levels. If glucose levels were below 100 mgּdL-1 the participants were provided 
with a carbohydrate snack (Flood & Constance, 2002). Again this suggests that physical 
exercises can be done safely when glucose levels are monitored prior the session. 
 
The present investigation has provided a substantial contribution to the knowledge of 
rehabilitative exercise in the context of DN. Thus, the present investigation 
demonstrated for the first time that PA interventions can influence a variety of health 
related outcome measures in patients with DN, including both outcome measures 
related to type 2 diabetes such as blood pressure and obesity, and outcome measures 
related to neuropathy such as sensory neuropathy and microcirculation. Although this 
early evidence highlights the therapeutic role PA interventions may have on subjects 
with DN, it should be noted that a number of limitations arose from the present study.  
 
7.4 Limitations of the study 
 
A number of limitations of this study have to be highlighted. For part 1 of the main 
study, groups were not successfully matched for body mass, which could have biased 
some of the outcome measures investigated in the present study. However, to minimize 
this source of bias the effect of body mass on the outcome measures was explored prior 
to the main analysis. Thereafter, when body mass was identified as a confounding 
variable ANCOVA was used to control for the effect of body mass in the analysis. 
 
One of the aims of the present study was to investigate gait characteristics in DN 
subjects. Thus, the cross-sectional study compared gait characteristics between healthy 
and DN subjects whilst the intervention study investigated the effect of an intervention 
on gait characteristics. Range of motion is well known to affect gait characteristics in 
DN subjects including COP parameters and foot pressures (Salsich et al., 2005; 
D’Ambrogi et al., 2003). For this reason the present investigation intended to measure 
foot and knee mobility during gait. However, due to technical difficulties this data 
could not be presented in the present study. This can be seen as a limitation of the 
present study. Furthermore, the intervention programme, which was based on 
strengthening and mobility exercises, was intended to influence foot mobility during 
dynamic conditions. However, it is unknown whether the exercise programme 
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influenced joint mobility during walking in present study. Nevertheless, it is possible to 
speculate that if gait characteristics in the form of gait parameters and foot pressures did 
not change, ROM is not likely to have undergone major changes either.  
 
Another aim of the present study was to investigate microcirculation in subjects with 
DN due to its association with foot problems. However, it should be stated that 
microcirculation measurements in the present investigation were obtained from the 
MGast muscle. Thus, evidence obtained from this muscle cannot necessary be 
generalized to the foot area, which is where the vast majority of foot ulcers occur in 
subjects with DN. Future studies should investigate the effect of a PA programme on 
the foot microcirculation, which may provide insight into how the foot responds to 
stress conditions.  
 
Another limitation of the study was the sample size. For part 2 of the main study the 
power calculation determined a minimum of 22 participants per group. However due to 
difficulties during recruitment, groups in the intervention study were composed of 21 
and 20 in the EXE and CON group respectively. These sample sizes were used for the 
analysis of the majority of outcome measures. However, some data sets were lost for 
EMG and microcirculation data, which resulted in a further reduction of the sample size 
for those measurements. Thus, analysis of EMG data was carried out with 19 sets of 
data for each group whilst analysis of microcirculation data was carried out with 17 sets 
of data per group. Therefore, the sample size in the present study is viewed as a 
limitation and future research should include larger number of participants.  
 
Randomized control trials (RCT) are considered to be the preferable study design due to 
increases in the internal validity. Also the selection and testing bias related to pre-
testing subjects with the knowledge of group allocation is minimised (Craig et al., 
2008). However, the main problem of RCTs is that they are not easy to implement, for 
instance, when a substantial proportion of patients refuse the allocation group ( Rose & 
Baker, 1978). In addition to this, a high number of drop outs can compromise the 
external validity of the study (Bratcher et al., 1970). Previous studies have reported high 
rates of drop-out in PA interventions with diabetic populations (Thomas et al., 2006). 
To reduce the number of drop outs in the present study, a study design which allowed 
participants the opportunity to choose in which group they wanted to be included was 
used. Randomisation based on patient preferences is considered an acceptable 
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randomization method when patients have strong preferences for one intervention group 
or the other (Campbell, et al., 2000; Craig, et al., 2008). Furthermore, in this study the 
investigator was not blinded with respect to the intervention. However, these are viewed 
as a limitation and future research should: 1) carry out RCTs; and 2) blind the 
investigator with respect to the intervention. 
 
Strength gains are related to the specificity of the training exercises (McArdle et al., 
2010). Thus, an isometrically trained muscle shows greatest strength improvement 
when measured isometrically. The same principle applies to muscles trained during 
dynamic conditions, where the greatest improvements in strength will be observed 
when the muscle is measured dynamically. In the present investigation the training 
programme was based on dynamic exercises whereas strength measurements were 
carried out isometrically. This is viewed as a limitation of the present investigation. It is 
possible that this limitation in the methodology of the present study could have affected 
the sensitivity of the measurements to identify strength changes following the exercise 
programme. Thus, it is important that future studies measure strength levels taking into 
account the specificity of strength-training responses.  
 
 
7.5 Future research  
 
In relation to the cross-sectional study, future research should focus on investigating 
activity patterns during walking in DN patients. The majority of studies have 
investigated kinetic or kinematic data, whereas only a handful of studies have assessed 
EMG patterns in DN subjects. Furthermore, preliminary studies number 2 and 3 have 
demonstrated that EMD values differ between DN and healthy individuals, especially in 
the plantar-flexor and dorsi-flexor muscles, which highlights the importance of 
calculating individual EMD values when processing EMG activity. Therefore, studies 
are warranted to investigate muscular activity patterns in DN subjects whilst taking into 
account individual EMD values.  
 
Results from the present investigation suggest that microcirculatory alterations in DN 
subjects are linked to: 1) vasodilatory capacity and 2) oxygen uptake capacity. Whereas 
changes in the vasodilatory capacity have been widely investigated, the exact 
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mechanism/s behind the reduced skeletal muscle oxygen uptake capacity in DN 
subjects remains unclear. Therefore, future studies should attempt to clarify this issue.  
 
The present investigation is the first study that has demonstrated that 16 weeks of 
resistance training can influence some of the pathologies linked to DN. However, future 
studies with larger populations and using different type PA interventions (i.e. type of 
exercise, intensity, duration, etc.) are needed at this stage (what Campbell et al. (2000) 
referred to as “exploratory phase”), before any final conclusions can be drawn about the 
overall effect of PA interventions on the primary health problems associated with DN 
(what Campbell et al. (2000) referred to as “definitive randomised controlled trial”). 
Furthermore, due to the exploratory nature of the study, it is impossible to know for 
certain the mechanisms and/or reasons behind some of the exercise-induced adaptations 
observed in the present investigation with DN patients. For this reason future studies are 
warranted to explore these mechanisms in more detail. A number of future studies are 
proposed below to clarify the role of PA to influence factors such as sensory 
neuropathy, motor neuropathy, HbA1c, gait, microcirculation and QOL. 
 
The most striking finding of the intervention study was that 16 weeks of strengthening 
exercise influenced sensory neuropathy in DN subjects.  Sensory neuropathy in the 
current study was quantified by VPT whilst conduction velocity measurements of the 
sensory nerves, which are considered the gold standard to assess nerve function, were 
not conducted. Future studies should assess sensory nerve function directly to 
understand better the effect of PA on sensory neuropathy. Furthermore, other forms of 
physical activity should be investigated to establish which intervention is more efficient 
to preserve sensory neuropathy in this population.  
 
Results from the present study suggest that muscular weakness is more difficult to 
preserve in patients with more severe DN. There is only one previous investigation 
assessing the effect of an exercise programme on muscular strength in DN subjects and 
they found moderate strength gain in subjects with mild neuropathy (Allet et al. 2010). 
It appears that changes in muscular function are dependent on the degree of neuropathy. 
However, more studies are needed: 1) to draw any final conclusion about the 
adaptability of the muscle to strengthening exercises; and 2) to understand the reasons 
why the muscles of DN subjects may be less sensitive to exercise-induced adaptations 
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in the form of neural and muscular adaptations. Furthermore, it would be interesting to 
assess 
 
The main target of rehabilitation programmes in patients with diabetes is to improve 
glucose control. Previous studies demonstrated that strength training can lower HbA1c 
levels in subjects with type 2 diabetes (Castaneda, et al. 2002; Cohen et al., 2008; 
Dunstan et al., 2002). This is the first study investigating the effect of an exercise 
programme on HbA1c in DN subjects and contrary to previous investigations on patients 
with type 2 diabetes the present intervention did not elicit changes in this outcome 
measure. It is likely that factors such as low baseline HbA1c levels, changes in 
hypoglycaemic medications or the frequency of the intervention may explain the results 
from the present investigation. However, it cannot be ruled out that DN subjects are less 
sensitive to HbA1c changes compared to individuals with diabetes and no neuropathic 
complications. Further studies are therefore warranted to determine whether PA 
programmes result in comparable effects on HbA1c levels in both subjects with type 2 
diabetes  and DN individuals. 
 
Muscular weakness is considered an important factor explaining changes in gait 
biomechanics in DN subjects. One of the objectives of the present investigation was to 
determine whether strength gains could influence gait characteristics in DN subjects. 
The fact that the intervention did not trigger changes in strength levels may partly 
explain why gait characteristics were not altered by the exercise programme. Future 
research should focus on investigating whether strength gains in subjects with an early 
DN (who may still be more sensitive to muscular adaptations) can modify gait in this 
population. Furthermore, the present investigation found that improvements in sensory 
neuropathy did not influence gait characteristics in DN subjects. It has been speculated 
in the present study that changes in gait biomechanics secondary to improvements in 
sensory neuropathy may occur (if any) beyond the length of this study. Therefore, if 
improvements in sensory neuropathy are confirmed by future investigations, it would be 
interesting to extend the duration of the study to allow enough time for the locomotor 
gait strategies to change.  
 
The present study found a trend toward improvements in the vasodilatory capacity in 
the EXE group following the exercise programme. A few studies investigating subjects 
with type 2 diabetes demonstrated that PA can improve the vasodilatory capacity via 
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improvements in the endothelium (Cohen et al., 2008; Maiorana et al., 2001). It has 
been hypothesized earlier in the discussion that the length of the intervention in the 
present study may have been insufficient for significant changes to be found. In 
addition, the sample size in the present investigation did not reach the numbers 
determined by the power calculation. Future studies with a larger group of participants 
are warranted to further understand the effect of PA programmes in general, and 
strength training in particular, on the vasodilatory capacity in DN subjects. 
Furthermore, the present study demonstrated for the first time that a PA programme 
based on strengthening exercise can improve the mVO2 recovery. However, future 
studies are needed to confirm this novel finding. In the present study it was speculated 
that changes in the mVO2 recovery may be related to changes in aerobic fitness 
secondary to the exercise programme. Future studies assessing aerobic fitness and 
microcirculatory function are warranted to determine whether changes in the ability of 
the muscle to recover from an exercise bout are secondary to changes in aerobic 
capacity, or whether other mechanisms may trigger this adaptation.  
 
The present investigation demonstrated for the first time that a PA programme can be 
an efficient tool to enhance not only physical health but also mental health in DN 
subjects. However, further investigations comparing the effect of group based versus a 
home based PA intervention are required to distinguish whether changes in the mental 
aspect of QOL are related to the exercise itself, to the social environment the exercise 
programme is undertaken in or to exercise-related changes (i.e. sensory neuropathy). 
 
In summary, more studies are warranted to broaden the understanding of the effect of 
PA programmes on the primary pathologies associated with DN named cardiovascular 
risk factors, glucose control, sensory neuropathy, motor neuropathy, gait alterations, 
microcirculation and QOL .  
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CHAPTER 8  
 
8 Conclusions 
 
It is well established that DN is a complex condition that affects different aspects of 
health. Pathologies associated with DN include metabolic abnormalities, alterations in 
traditional cardiovascular risk factors, gait alterations, microcirculatory impairments 
and poor QOL. The question remains whether a rehabilitative exercise programme can 
influence these primary pathologies which have been linked to DN.  Thus, this 
investigation was composed of two different studies: a cross-sectional study to 
investigate differences between DN and healthy individuals in the primary pathologies 
associated with DN; and an intervention study to investigate to the effect of a PA 
programme on identified pathologies linked to peripheral neuropathy in subjects with 
DN.   
 
The aim of the cross-sectional study was two fold. Firstly, it aimed to compare the 
findings of this study to previously published investigations. The present study 
confirmed that DN produced alterations in outcome measures related to cardiovascular 
diseases, gait characteristics, microcirculation and QOL. Secondly, the cross-sectional 
study aimed to provide some additional information on: 1) gait characteristics by 
investigation muscular activity patterns; and 2) microcirculation by assessing for the 
first time exercise-induced microcirculatory responses in the form of blood flow and 
oxygen consumption in patients with DN. This study investigated gait characteristics 
not only from a kinetic and kinematic perspective, which are the most evaluated 
outcome measures in this population but also from an EMG perspective. Only a handful 
of studies have previously investigated EMG patterns in DN subjects and none of them 
took into consideration EMD when processing EMG data. Results from the present 
study provide early evidence that foot loading patterns are associated with EMG 
activity. This suggests that muscular function should be considered as a factor partly 
responsible for high foot plantar pressures, especially under the metatarsal region, 
which are often observed in DN subjects. In addition to that, EMG data from the cross-
sectional study provided some insight about motor control in DN subjects. It appears 
that the DN subjects in this study adopted an anticipatory strategy to efficiently produce 
force at the right moment in time (demonstrated by an early muscular activation and 
same peak activity). With regard to the microcirculation, the present study investigated, 
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for the first time, exercise-induced microcirculatory responses in DN subjects. The 
present study not only  found that oxygen delivery was reduced in the DN group, in 
agreement  with previous studies on individuals with type 2 diabetes, but also the ability 
of the muscle to uptake oxygen. Overall, the cross-sectional study demonstrated that 
DN is a very complex condition affecting different aspects of health such as general 
health, gait characteristics, microcirculation and self reported QOL. It can be speculated 
that if those outcome measures can be modified, health in DN subjects can be enhanced.  
 
The aim of the intervention study was to evaluate for the first time whether 16 weeks of 
a PA programme based on strengthening and foot mobility exercises can influence 
different aspects of health that are altered in DN subjects. The most remarkable finding 
was that the exercise programme improved sensory neuropathy. This is an important 
finding since sensory neuropathy is linked to a variety of health problems associated 
with DN such as foot ulcers or poor QOL. Furthermore, it shows that PA activity can 
influence health beyond type 2 diabetes related health problems. Another interesting 
finding from this study was that high intensity resistance training did to seem not 
improve strength levels in patients with moderate DN as expected, despite 
improvements in neural health as demonstrated by the changes in sensory neuropathy. 
This finding not only suggests that exercise can influence outcome measures related to 
DN, but also that adaptations to exercise programmes may differ between type 2 and 
DN individuals. This highlights the importance of investigating the effect of PA on DN 
subjects and not to assume that similar adaptations may occur in DN subjects compared 
to individuals with type 2 diabetes.  
 
Furthermore, this study represents an accumulation of evidence that PA programmes 
can influence some of the health related outcome measures, which are altered in DN 
subjects. Thus, 16 weeks exercise training improved the cardiovascular risk profile by 
decreased blood pressure and body fat percentage in DN subjects. Furthermore, the 
intervention improved exercise-induced responses of the microcirculation. Additionally, 
the PA programme improved the exercise-induced vasodilatory capacity in the exercise 
group. However, this change did not reach significance and was limited to a trend 
(p<0.1). On the other hand, the exercise programme did significantly improve mVO2 
recovery (reoxygenation) from an exercise bout in the EXE group compared to the 
CON group over time. Although there were no changes in the capacity of the muscle to 
take up oxygen following the intervention, changes in the efficiency of its use were 
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observed. The fact that a PA programme can influence microcirculation in DN patients 
is a very important finding since impairments in the microcirculation are associated 
with major health problems such as reduced exercise capacity or foot ulceration. 
Moreover, the exercise programme influenced certain aspects of self reported QOL. 
Interestingly it appears that aspects of mental health showed greater improvement 
following the intervention compared to aspects of physical health. Overall, the 
intervention study demonstrated that some of the health related outcome measures that 
affect DN subjects are modifiable via a PA programme. This is only the first of many 
steps required to fully understand the potential of PA interventions in influencing health 
in DN subjects. Thus, more evidence needs to be conducted at this “exploratory phase” 
(Campbell et al., 2000) to evaluate different components of a PA intervention (i.e. type 
of exercise, intensity, duration, etc.). This will broaden the knowledge base around the 
effect of different types of stimuli on the different outcome measures related to DN.  
 
The present study on the primary pathologies associated with DN has provided a 
substantial contribution into the research of rehabilitative programmes based on 
physical activity in patients with DN. Results from the present investigation highlighted 
the value of PA as a therapeutic tool in subjects with DN to modify different aspects of 
health in this population including sensory neuropathy. Furthermore, the present 
investigation demonstrated the importance of investigating the effect of PA 
programmes on DN subjects and not to assume that similar adaptations may occur in 
DN subjects compared to individuals with type 2 diabetes without neuropathic 
complications. 
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APPENDICES 
Appendix 1. Literature search 
 
 
Table A1. Keywords included for literature search on identified pathologies related to DN 
 
Cardiovascular 
diseases Gait Microcirculation QOL  
 
 
Cardiovascular 
disease/s 
 
Metabolic 
syndrome 
 
Type 2 diabetes 
 
Gait/Walking 
 
EMG/ 
Electromyograp
hy 
 
Foot Pressures/ 
plantar pressures 
 
Neuropathy/ 
Neuropathic 
 
Microcirculation 
 
Blood flow 
 
Vasodilatation 
 
Endothelium/ 
endothelial 
 
Neuropathy/ 
Neuropathic 
 
Quality of 
life 
 
Neuropathic/ 
neuropathy 
 
 
Results 64 119 86 66 335 
Relevant 
after 
reviewing 
21 26 39 18 
 
104 
 
 
 
Table A2. Keywords included for the literature search on the effect of PA on identified pathologies 
related to DN 
 
Cardiovascular 
diseases Gait Microcirculation QOL  
 
 
Cardiovascular 
disease/s 
 
Metabolic 
syndrome 
 
Type 2 diabetes 
 
Physical 
Activity/ 
exercise 
training 
 
Gait/Walking 
 
EMG/ 
Electromyography 
 
Foot Pressures/ 
plantar pressures 
 
Neuropathy/ 
Neuropathic 
 
Type 2 diabetes 
 
Physical Activity/  
exercise training 
 
Microcirculation 
 
Blood flow 
 
Vasodilatation 
 
Endothelium/ 
endothelial 
 
Type  2 diabetes 
 
Neuropathy/ 
Neuropathic 
 
Physical Activity/ 
exercise training 
 
Quality of life 
 
Neuropathic/ 
Neuropathy 
 
Type 2 diabetes 
 
Physical 
Activity/ 
exercise training 
 
Results 42 61 18 10 132 
Relevant 
after 
reviewing 
23 8 10 8 49 
  335 
 
Figure A1. Example of literature search (using databases AMED, MEDILINE and EMBASE 
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Appendix 2: Home exercises 
 
 
HOME EXERCISES 
 
 
Warm up: 
 
Start each session by moving each body segment. You can do it from the top to the 
bottom so we do not miss any. 
 
Note: Please do all the exercises very slowly and trying to reach the “highest 
amplitude for each movement”. 
 
 
1. Head 
a. Standing position (remember in standing position we keep the knees a 
little bit bent so the back is in a better position):  
i. Move the head forward and backwards (5 times). 
ii. Move the head from side to side (5 times). 
2. Shoulders 
a. Standing position.  
i. Move the shoulders in circles (5 moving forward and 5 
backwards) 
3. Arms 
a. Standing position 
i. Move right arm in circles. Remember to follow the hand with 
your eyes. (5 times moving forward and 5 backwards. 
ii. Repeat the same movement with the left arm. 
4. Trunk 
a. Standing position 
i. Rotate your trunk to the right and to the left During the last part 
of the rotation we perform a reaching movement with both arms. 
(5 rotations to each side) 
5. Ankles 
a. Sitting position. 
i. Make the alphabet with your feet. Both of them together. You can 
use a chair underneath the calf muscles to help hold your legs 
while doing it.  The ankles should be kept on the air. 
 
 
 
Resistant band exercisers (it is important you find difficult to make 10 reps with that 
tension). Remember you can always make the exercise more difficult by increasing the 
tension on the band; 
 
1. Shoulders 
a. Seated position:  
i. Hold the band with your arms straight and both hands just a few 
inches from each other at the lower part of your back. From that 
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position move the hands away from each other. Keep always the 
arms straight  (10 repetitions). 
ii. Repeat the same movement with the arms higher up in your 
back. Arms still straight all the way through (10 reps). 
 
2. Chest 
a. Seated position 
 
1. Place the band around your back and hold it with your 
fists (Palm facing down) by the side of the trunk (elbows 
bent and backwards). Move your arms to and extended 
position. Do not chance the position of the fist during the 
whole movement. (10 reps). 
 
3. Back 
a. Seated position 
1. Step on the band with both feet and hold the band with 
you arms a little bit in flexion aside the body. The fist 
should face the floor. Bend your body forward. Bend 
your arms with the fist always facing the floor. 
 
4. Biceps 
a. Seated position. 
 
1. Step on the band with both feet and hold the band with 
you arms straight aside the body. Without moving the 
shoulders bend your arms simultaneously (10 reps).  
 
5. Triceps 
a. Seated position 
 
i. Pick up your band with the right arm bent aside the trunk and 
elbow pointing forward. The left arm holds the other side of the 
band by the lower back. Keeping the elbow and shoulder still 
straighten the arm. (10 reps). 
 
6. Calf Muscles 
a. Seating position 
 
1. Pass the band around the forefoot of the right foot and 
hold it with both hands. Make the band tight and move 
the forefoot down (like pressing the pedal in the car). (15 
reps) 
 
2. Repeat with the left foot 
 
 
7. Tibiales  
a. Seating position 
1. Attach the band on the leg of a table, place the band 
around your forefoot. Place yourself at a distance enough 
to make the band tight. Pull your toes up. (15 reps) 
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2. Repeat with the left foot 
 
b. Ankle muscles. 
i. Sitting position 
 
1. Place the band around the forefoot of your right foot, 
step on the band with the left foot and with the heel of 
the right foot touching the floor move the forefoot out to 
the side. (15 reps) 
 
2. Do the same with the left foot. 
 
3. Place the band around the forefoot of your right foot, tie 
the band out to the side with the leg of a table and with 
the heel of the right foot touching the floor move the 
forefoot inwards. 
 
4. Do the same with the left foot. 
 
 
5. Pass the band around the forefoot of the right foot and 
hold it with both hands. Write the alphabet on the air 
with your foot. Think of the toes as the tip of a pen. (do it 
once) 
 
6. Do the same with the left foot. 
 
 
 
Cool down 
 
b. Sitting position. 
i. Make the alphabet with your feet. Both of them together. You can 
use a chair underneath the calf muscles to help hold your legs 
while doing it.  The ankles should be kept on the air. 
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Appendix 3: Invitation letter 
 
Dear________________________, 
 
 
The Department of Physiotherapy is looking at the effects of a physical activity 
programme in people with diabetes and loss of sensation. Such a programme could 
really benefit participants, so the Podiatry Department (University Hospital of Wales) 
has agreed to collaborate and contact people with diabetes that may be suitable for this 
research study. We would like to offer you the opportunity to participate in a free 
physical activity programme carried out by the Physiotherapy Department specifically 
designed for patients with diabetes and loss of sensation.  
 
 
The study will investigate: 
• the effect of a physical activity program (over 16 weeks) in preventing the  risk 
of ulcers in people with diabetes and loss of sensation 
• the effect of this program on general health (i.e. Cholesterol levels, glucose 
levels, weight loss, etc) 
 
 
The benefits to patients could be: 
• Ulcer prevention 
• Improved glucose control 
• Improved blood flow (healthier arteries). 
• Reduce risk of cardiovascular problems by improving cholesterol levels, 
reducing body weight and improving general fitness. 
 
 
A possible side-effect could be changes in glucose levels due to physical activity. More 
details can be found in the enclosed information sheet (risk section, page 3). 
Before you decide it is important for you to understand why the research is being 
completed and what it will involve. Please take a moment to read the information sheet 
(enclosed) in which a clear explanation of the study is provided. You are under no 
obligation to take part, as participation is entirely voluntary.  
To make it easer for you to respond, the Physiotherapy department will contact you 
within the next two weeks to ask whether you are interested in participating in this 
study. In the meantime if you wish to ask any questions, please feel free to contact 
either the Podiatry Department (Dr Jane Lewis) or the researcher conducting the study 
at the Department of Physiotherapy. 
 
Yours sincerely, 
 
Dr Jane Lewis Alejandro Meana-Esteban  
Podiatrist  MSc Sport and Health Sciences  
Work: 02920536680 Work: 029207 48156 
Email address:  Mobile: 07906476784 
Jane.lewis@cardiffandvale.wales.nhs.uk  meana-estebana@cardiff.ac.uk  
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Appendix 4: Information sheet 
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DATE: 11/02/2008 
VERSION Nº 3.1 
 
 INFORMATION SHEET 
(Participants with diabetic neuropathy) 
 
 
“The effect of non-impact resistance training on patients with diabetic 
neuropathy: Acute responses and lon-term adaptation”. 
 
 
We would like to invite you to take part in a research study. Before you decide you 
need to understand why the research is being done and what it would involve for you. 
Please take time to read the following information carefully. Talk to others about the 
study if you wish.  
 
(Part 1 tells you the purpose of this study and what will happen to you if you take part. 
Part 2 gives you more detailed information about the conduct of the study). Please, ask 
us if there is anything that is not clear or if you would like more information.  
 
PART 1 
 
What is the reason for the study? 
Physical activity has been recognized to have an important role in health promotion and 
prevention of diseases. It is generally accepted that exercise reduces the risk of 
cardiovascular diseases (i.e. stroke or heart attack) and mortality in both healthy and 
clinical population. However, physical activity recommendations for people with 
peripheral neuropathy are based on evidences obtained from studies with non-
neuropathic people with diabetes whereas non attempt has been made to demonstrate 
the positive effect of an exercise  program on people with peripheral neuropathy. 
 
 
What is the purpose of the study? 
The aim of this study is to determine whether and to what extent an exercise program 
using muscle strengthening exercises have a positive effect on glycaemic control, 
cholesterol levels, circulation, daily activity levels and quality of life in people with 
diabetes and peripheral neuropathy. A more detailed explanation of the exercise 
program and the type of exercises you will be asked to do can be found in the section 
“what will happen to me if I take part (next page)”.  
 
This study will be run by Dr Robert van Deursen, Professor Patricia Price and 
Alejandro Meana-Esteban (PhD student) in collaboration with Prof Keith Harding. 
 
Why was I chosen to take part in this study? 
You have been invited to participate in the study because you have been diagnosed with 
diabetes peripheral neuropathy. 
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Do I have to take part? 
It is up to you to decide. We will describe the study and go through this information 
sheet, which we will then give to you. We will then ask you to sign a consent form to 
show you have agreed to take part. You are free to withdraw at any time, without giving 
any reason. This would not affect the standard of care you receive.  
 
 
What will happen to me if I take part? 
 
If you agree to participate in the study, you will be asked: 
 
1. To undergo an exercise program for 16 weeks. The program will aim to improve 
strength levels of your legs as well as other parts of your body (arms and trunk) 
by exercising against a fixed resistance which will be adjusted throughout the 
program.  
 
The exercise program will be split between controlled and home-based sessions. 
All the controlled sessions will take place in the outpatients physiotherapy gym 
at the University Hospital of Wales (UHW). Training sessions throughout the 
study will be conducted 4 times per week (twice in the gym and twice at home). 
The gym based sessions will last for 60 minutes whereas the home based 
exercise will last for 30 minutes.  
The exercise program has been designed and will be carried out by a qualified 
practitioner (Alejandro Meana-Esteban, MSc in Health and Sport Science). 
 
Note: Not all the participants with diabetes will be asked to undergo the exercise 
training since by chance (randomly) you will be distributed into either Exercise 
or Control groups (Non-exercisers) (Please, go to Chart 1 in the last page of this 
document for further clarification regarding the study groups).  
 
2. To visit the Research Centre of Clinical Kinesiology (RCCK), situated in Heath 
Campus, twice during the study. The first visit will take place before the 
physical activity program starts and the second will take place after the exercise 
program finishes.  
 
During each visit to the RCCK each participant will be tested: glucose levels, 
cholesterol levels, blood pressure, height, weight, fat %, strength levels, 
circulation both at rest and when exercising  and walking characteristics. 
 
During each visit, you will be asked to two main tasks: 
 
1. Walk on a 9 meters walk-way to analyze your walking 
characteristics. 
2. Produce movements with your right leg against a fixed resistance to 
determine your strength levels. When performing this task a cable 
will be secured with a plaster on the skin of your leg (calf muscle), 
which will be connected to a piece of equipment to give us 
information regarding your circulation when exercising.  
 
You will also be asked to complete two questionnaires. One questionnaire will 
contain questions regarding to your daily physical activities, whereas the second 
will contain health related questions. 
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Each visit to the Research Centre of Clinical Kinesiology will last 
approximately 120 minutes. 
 
For further information on the structure of the research can be found in Chart 1 (last 
page of this information sheet).  
 
 
How will blood samples be taken?  
A lancet will be used to analyze blood for glucose and cholesterol levels. A lancet is a 
fine, sharp pointed needle used for pricking the skin. You can choose whether to prick 
yourself on the fingertip or to be pricked by a qualified person.  
 
 
Expenses  
Travel and parking expenses will be available for all participants in the study. Heath 
campus has got car parking facilities in which you can park your car.  
 
 
What are the possible benefits of taking part? 
We cannot promise the study will help you directly but the information we gather from 
this study will help improve our understanding of the effects of diabetic neuropathy on 
the lower legs and may provide recommendations for treatment of people with diabetic 
neuropathy.  
 
 
Is there any risk associated with the study? 
 
• The most common risk associated with physical activity in people with diabetic 
neuropathy is the development of foot ulcers. However the risk of foot 
ulceration will be minimized in this study by choosing non-impact activities. 
 
• When exercising people with diabetes face some metabolic risks due to the 
exercise-induced fluctuations in their blood glucose levels. However, those risks 
will be minimized in this study by controlling the sugar levels both before and 
after exercising.      
 
• Due to the type of exercises (strength training) that will be carried out in the 
present study, you may experience post-training muscular soreness. The 
principal symptom secondary to this condition is pain when exercising the 
fatigued muscles. However, the risk associated with this condition is trivial and 
no further complications related to muscle soreness are expected.  In order to 
reduce the discomfort associated to muscle soreness, your exercise programme 
will start with low loads of training and will gradually increase both its volume 
and intensity. This will reduce the potential muscle fatigue provoked by the 
exercise intervention.  However, if you experience discomfort associated with 
muscle soreness, your following training session will be adapted to minimize the 
risk of further soreness in the muscles affected.  If the discomfort persists 
training will be stopped temporarily to allow the fatigued muscles to fully 
recover. 
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On top of that you will undergo an ECG (heart scan) to make sure that you do not suffer 
from any overt cardiac condition that may be worsened by the exercise program. For 
the ECG to be done you will be asked to lie on a therapeutic bed for 10 minutes whilst 
signals from your heart will be recorded on a computer using 12 leads secured with a 
plaster on the skin around your chest.  
 
 In case of concern please feel free to contact us at RCCK on the telephone 
number: 02920687739. 
 
 
What happens if I am excluded from the study after undergoing the ECG at rest? 
If the electrocardiogram shows clinically relevant abnormalities you will be 
immediately referred to your GP.  
 
 
What if there is a problem? 
Any complaint about the way you have been dealt with during the study or any possible 
harm you might suffer will be addressed. The detailed information on this is given in 
part 2.  
 
 
What happens when the research study stops? 
After your second visit to the Research Centre of Clinical Kinesiology your 
participation in the study will finish.  
 
 
Confidentiality- Will my taking part in this study be kept confidential? 
Yes. We will follow ethical and legal practice and all information about you will be 
handled in confidence. The details are included in Part 2.  
 
 
If the information in Part 1 has interested you and you are considering 
participation, please read the additional information in Part 2 before 
making any decision.  
 
 
 
PART 2 
 
What will happen if I don’t want to carry on with the study?  
If you withdraw from the study, we will destroy all your identifiable samples, but we 
will need to use the data collected up to your withdrawal.  
 
 
What If there is a problem? 
In the event that something goes wrong and you are harmed during the research and this 
is due to someone’s negligence then you may have grounds for a legal action for 
compensation against Cardiff University but you may have to pay your legal costs.  The 
study is indemnified by Cardiff University, there is a limit of indemnity of £5,000,000. 
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If a participant, who has given informed consent, loses capacity to consent during the 
study, the participant would be withdrawn from the study and the data already collected 
with consent would be retained and used in the study.  
 
 
Confidentiality- Will my taking part in this study be kept confidential? 
All information which is collected about you during the course of the research will be 
kept strictly confidential, and any information about you which leaves RCCK will have 
your name and address removed so that you cannot be recognised.  
 
 
GP notification 
With permission, your GP will be informed of your participation in the trial.  
 
 
What happens to the results of the research study? 
The results of this study may be presented at conferences and published in scientific 
journals. A summary of the results will be sent to you after completion of the study. 
 
 
Who is organising the study? 
The study is being organized by the Department of Physiotherapy, School of Health 
Sciences, Cardiff University. 
 
 
Who has reviewed the study? 
All research in the NHS is looked at by independent group of people, called a Research 
Ethics Committee to protect your safety, rights, wellbeing and dignity. This study has 
been reviewed and given favourable opinion by the Research and Development 
Committee and the South East Wales Research Ethics Committee (Panel D). 
 
 
Contact for further information 
In case you would like to discuss any part of the project in greater detail then 
please do not hesitate to contact Alejandro Meana-Esteban. The details are displayed 
below: 
 
Research Centre for Clinical Kinesiology 
Department of Physiotherapy 
Ty Dewi Sant 
Cardiff University  
Cardiff CF14 4XN 
 
Telf: 029206 87739 
Email: Meana-EstebanA@cardiff.ac.uk 
 
Thank you very much for your attention, 
  
Alejandro Meana-Esteban 
MSc Health and Sport Sciences  
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Chart 1. Sample size distribution. Population groups: Neuropathic group (DN) and healthy group (HEALTH ); Intervention groups: exercise 
group (EX) and control group (CON); Tests: Test 1 (pre-intervention measurements) and T2 ( Post-intervention measurements).  
 
 Visit 1 to RCCK Visit 2 to RCCK 
N=120 
HEALTH 
DN 
80 
40 
EX= 40 
CON= 40 
T1 
T2 
Pre- intervention Post- intervention INTERVENTION             
(16 weeks) 
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DATE: 11/02/2008  
VERSION Nº 3.2 
 
 
 
INFORMATION SHEET 
(Healthy group) 
 
 
“The effect of non-impact resistance training on patients with diabetic neuropathy: 
Acute responses and long-term adaptation”. 
 
 
We would like to invite you to take part in a research study. Before you decide you need 
to understand why the research is being done and what it would involve for you. Please 
take time to read the following information carefully. Talk to others about the study if 
you wish.  
 
(Part 1 tells you the purpose of this study and what will happen to you if you take part. 
Part 2 gives you more detailed information about the conduct of the study). Please, ask 
us if there is anything that is not clear or if you would like more information.  
 
 
PART 1 
 
What is the reason for the study? 
Physical activity has been recognised to have an important role in health promotion and 
prevention of diseases. It is generally accepted that exercise reduces the risk of 
cardiovascular diseases (i.e. stroke or heart attack) and mortality in both healthy and 
clinical population. However, physical activity recommendations for people with 
peripheral neuropathy are based on evidence obtained from studies with non-
neuropathic people with diabetes whereas no attempt has been made to demonstrate the 
positive effect of an exercise programme on people with peripheral neuropathy. 
  
 
What is the purpose of the study? 
The aim of this study is to determine whether and to what extent an exercise programme 
using muscle strengthening exercises have a positive effect on glycemic control, 
cholesterol levels, circulation, daily activity levels and quality of life in people with 
diabetes and peripheral neuropathy.  
 
This study will be run by Dr Robert van Deursen, Professor Patricia Price and Alejandro 
Meana-Esteban (PhD student) in collaboration with Prof Keith Harding. 
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Why was I chosen to take part in this study? 
You are a healthy subject with no symptoms of diabetes and you will be part of the 
control group. It is important to create a control group with non-diabetic subjects in 
order to quantify the effect of diabetes neuropathy in that clinical population.  
 
 
Do I have to take part? 
It is up to you to decide. We will describe the study and go through this information 
sheet, which we will then give to you. We will then ask you to sign a consent form to 
show you have agreed to take part. You are free to withdraw at any time, without giving 
any reason. This would not affect the standard of care you receive.  
 
 
What will happen to me if I take part? 
If you agree to participate in the study, you will be asked: 
 
1. To visit the Research Centre of Clinical Kinesiology (RCCK), situated in Heath 
Campus, on one occasion.  
 
During each visit to the RCCK each participant will be tested: blood pressure, 
height, weight, fat %, strength levels, circulation both at rest and when 
exercising and walking characteristics. 
 
During each visit, you will be asked to perform two main tasks: 
 
1. Walk on a 9 meters walk-way to analyze your walking 
characteristics. 
2. Produce movements with your right leg against a fixed resistance to 
determine your strength levels. When performing this task a cable 
will be secured with a plaster on the skin of your leg (calf muscle), 
which will be connected to a piece of equipment to give us 
information regarding your circulation when exercising.  
 
 
You will also be asked to complete two questionnaires. One questionnaire will 
contain questions regarding to your daily physical activities, whereas the second 
will contain health related questions. 
 
Each visit to the Research Centre of Clinical Kinesiology will last approximately 
120 minutes. 
 
 
For further information on the structure of the research can be found in Chart 1 (last 
page of this information sheet).  
 
 
Expenses  
Travel and parking expenses will be available for all participants in the study. Heath 
campus has got car parking facilities in which you can park your car.  
 
  349 
 
What are the possible benefits of taking part? 
We can not promise the study will help you directly but the information we gather from 
this study will help improve our understanding of the effects of diabetic neuropathy on 
the lower legs and may provide recommendations for treatment of people with diabetic 
neuropathy.  
 
 
Is there any risk associated with the study? 
No, there are no risks for you to participate in this study.  
 
 
What if there is a problem? 
Any complaint about the way you have been dealt with during the study or any possible 
harm you might suffer will be addressed. The detailed information on this is given in 
part 2.  
 
 
What happens when the research study stops? 
After your visit to the Research Centre of Clinical Kinesiology your participation in the 
study will finish.  
 
 
Confidentiality- Will my taking part in this study be kept confidential? 
Yes. We will follow ethical and legal practice and all information about you will be 
handled in confidence. The details are included in Part 2.  
 
If the information in Part 1 has interested you and you are considering 
participation, please read the additional information in Part 2 before 
making any decision. 
 
 
 
PART 2 
 
What will happen if I don’t want to carry on with the study?  
If you withdraw from the study, we will destroy all your identifiable samples, but we 
will need to use the data collected up to your withdrawal.  
 
 
What If there is a problem? 
In the event that something goes wrong and you are harmed during the research and this 
is due to someone’s negligence then you may have grounds for a legal action for 
compensation against Cardiff University but you may have to pay your legal costs.  The 
study is indemnified by Cardiff University, there is a limit of indemnity of £5,000,000. 
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Confidentiality- Will my taking part in this study be kept confidential? 
All information which is collected about you during the course of the research will be 
kept strictly confidential, and any information about you which leaves RCCK will have 
your name and address removed so that you cannot be recognised.  
 
 
What happens to the results of the research study? 
The results of this study may be presented at conferences and published in 
scientific journals. A summary of the results will be sent to you after completion 
of the study. 
 
 
Who is organising the study? 
The study is being organized by the Department of Physiotherapy, School of 
Health Sciences, Cardiff University. 
 
 
Who has reviewed the study? 
All research in the NHS is looked at by independent group of people, called a 
Research Ethics Committee to protect your safety, rights, wellbeing and dignity. 
This study has been reviewed and given favourable opinion by the Research and 
Development Committee and the South East Wales Research Ethics Committee 
(Panel D). 
 
 
Contact for further information 
In case you would like to discuss any part of the project in greater detail then 
please do not hesitate to contact Alejandro Meana-Esteban. The details are displayed 
below: 
 
Research Centre for Clinical Kinesiology 
Department of Physiotherapy 
Ty Dewi Sant 
Cardiff University  
Cardiff CF14 4XN 
 
Tel: 029206 87739 
Email: Meana-EstebanA@cardiff.ac.uk 
 
Thank you very much for your attention, 
  
Alejandro Meana-Esteban 
MSc Health and Sport Sciences  
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Chart 1. Sample size distribution. Population groups: Neuropathic group (DN) and healthy group (HEALTH ); Intervention groups: exercise 
group (EX) and control group (CON); Tests: Test 1 (pre-intervention measurements) and T2 ( Post-intervention measurements).  
 
 Visit 1 to RCCK Visit 2 to RCCK 
N=120 
HEALTH 
DN 
80 
40 
EX= 40 
CON= 40 
T1 
T2 
Pre- intervention Post- intervention INTERVENTION             
(16-weeks) Deleted: 16 week
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Appendix 5: Phone interview 
 
QUESTIONNAIRE 
 
NAME:  _______________________________________ 
DATE OF BIRTH: ____ /____ / ____ 
CONTACT NUMBER: _____________________________ 
 
1. Which type of diabetes do you have: 
a) Type I           
b) Type II          
 
2. Are you currently taking insulin: 
a) Yes           
b) No           
 
COMPLICATIONS SECONDARY TO DIABETES 
 
3. Do you suffer from loss of sensation in your feet – (this may be slight or 
significant) 
a) Yes            
b) No (Skip to Question 5)        
 
4. Is the loss of sensation in your feet painful? 
a) Yes           
b) No           
 
5. Do you suffer from any foot deformities: 
a) Yes (Major deformity)         
b) No (Minor deformity eg: claw toes)       
 
6. Do you have any current foot ulcers? 
a) Yes           
b) No           
 
7. Do you suffer from retinopathy (severe vision loss)? 
a) Yes           
b) No           
c) No but I suffer from other diabetes related eye problems eg. Glaucoma  
  
8. Do you suffer from any form of kidney disease or are you on dialysis? 
a) Yes           
b) No           
 
9. Do you have any history of kidney failure? 
a) Yes           
b) No           
 
10. Do you have any history of heart problems eg: heart attack or angina? 
a) Yes           
 Please specify: _______________________________________ 
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b) No           
P.T.O 
 
11. Are you aware of any abnormalities or complications with your heart? 
a) Yes           
 Please specify: _______________________________________ 
b) No           
 
12. Are you on any medication? 
a) Yes           
 Please list names:  ________________        _______________ 
 _____________       ________________  _______________ 
 _____________ ________________  _______________ 
 _____________ ________________  _______________ 
    
b) No           
 
13. Do you suffer from any severe lung disease? 
a) Yes           
b) No           
 
14. Do you have any history of poor circulation in the lower limb? 
a) Yes           
b) No           
 
15. Are you capable of walking independently to perform your daily activities without a 
walking aid? 
a) Yes           
b) No           
 
16. Do you suffer from pain in the calves after walking 100 yards? 
a) Yes           
b) No           
 
17. During the last 7 days, how many days did you do moderate physical activity, e.g. 
walking to the shops, carrying light loads, or cycling at a regular pace. 
a) Number of days         
b) Average amount of time per activity     ________ 
 
 
 
18. During the last 7 days, how many days did you do heavy physical activity, e.g. DIY, 
carrying heavy loads, or cycling. 
a) Number of days         
b) Average amount of time per activity     ________ 
 
 
THANK YOU FOR COMPLETING THE QUESTIONNAIRE 
PLEASE RETURN THE QUESTIONNAIRE IN THE ENVELOPE PROVIDED 
 
 
 
  354 
Appendix 6:  Confirmation letter 
 
 
 
Dear ______ __________ , 
 
Thank you for agreeing to participate in our research study. We look forward to meeting 
you on: 
 
Date:         Wednesday 16th December 2009 
Time:        9.30 am 
Location:  RCCK Lab, Basement floor, Ty Dewi Sant, Cardiff University 
        Heath Park, Cardiff, CF14 4XN. 
      (Please see map attached) 
 
If you are travelling by car, you may park in the University Hospital of Wales Multi-Storey 
car park (expenses will be reimbursed). Please report to the car park office on arrival and 
give them the reference number “VP765” to be able to park for £3 total. 
 
We would request for you to bring (if possible) the following items when you attend: 
1 x T-shirt 
1 x Pair of shorts 
Should this however pose a problem, please do not worry as these may be supplied on the 
day. We would kindly request that you would refrain from coffee on the day you come to 
the lab and from any unusual physical exacerbation 24 hours prior to attending the lab. 
 
I will contact you the day before your appointment to confirm there are no problems. 
Should you wish to rearrange this appointment or have any further queries, please do not 
hesitate to contact us on: 029 20 687 704/029 20 687 739. 
 
Yours Sincerely 
 
ALEJANDRO MEANA-ESTEBAN 
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* You are looking for building number 116 on map The is a reception when coming 
from Concourse. You ask for the lab on the basement. If there is any problem do not 
worry, I will go to the reception to pick you up 
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Appendix 7: Informed consent sheet 
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DATE: 11/02/2008 
VERSION Nº 3 
 
CONSENT FORM 
 
 
Title of Project: “The effect of low impact resistance exercises on patients 
with diabetes neuropathy: Acute responses and long-term adaptation”. 
 
 
Name of Researchers: Dr Robert van Deursen 
                     Alejandro Meana-Esteban       Please initial box 
 
1. I confirm that I have read and understand the information sheet 
dated 11/02/2008 (Version 3) for the above study. I have had 
the opportunity to consider the Information, ask questions and 
have had these answered satisfactorily.      
 
2. I understand that my participation is voluntary and that I am free 
to withdraw at any time, without giving any reason, without my 
medical care or legal rights being affected.    
 
3. I understand that photography and/or video-recording is used in 
this study.        
  
4. I understand that relevant sections of any of my medical notes 
and data collected during the study, may be looked at by 
responsible individuals from Cardiff University, from regulatory 
authorities, where it is relevant to my taking part in this research. 
I give permission for these individuals to have access to my 
records.        
 
5. I agree my GP being informed of my participation in the study.    
                                                                                                          
6. I agree to take part in the above study.   
 
_____ ___________  ________  
Name of Patient   Signature   Date  
 
____________________ ___________  ________  
Witness    Signature   Date  
 
____________________               ___________  ________ 
Name of person taking consent Signature Date 
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Appendix 8: ECG sheet 
 
 
 
 
 
 
ECG REPORT 
 
 
Research Project: The effect of non-impact resistance training  
on patients with diabetic neuropathy: Acute responses and long-term adaptation. 
 
Subject code (as written on the ECG sheet): 
Are there any abnormalities in this subjects’ ECG  
that would exclude him/her from the study? Yes No 
 If yes, could you briefly explain the abnormalities observed in the ECG to 
inform his/her GP? 
----------------------------------------------------------------------------------------------------------
----------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------- 
Date       Signature 
 
 
Dr. Sharmila Khot, MB BS, DA, MD, FRCA, 
FFPMRCA(Consultant in Anaesthesia and Pain 
Medicine) 
 
 
This sheet (and any attachments) is confidential and may contain personal views. If you have received 
or found it in error, do not use, copy or disclose the information in any way. Please notify Alejandro 
Meana-Esteban  (contact number: 02920687739)  immediately of this error. 
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Appendix 9:  Ethical approval 
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